0001140361-12-011924.txt : 20120229 0001140361-12-011924.hdr.sgml : 20120229 20120229171845 ACCESSION NUMBER: 0001140361-12-011924 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120229 DATE AS OF CHANGE: 20120229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 12654007 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-K 1 form10k.htm VIRNETX HOLDING CORP 10-K 12-31-2011 form10k.htm


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
(Mark One)
 
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2011
or
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________ to _______________________
Commission File Number: 001-33852
 
VirnetX Holding Corporation
(Exact name of registrant as specified in its charter)
 
Delaware
 
77-0390628
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)
     
308 Dorla Court, Suite 206
   
Zephyr Cove, Nevada
 
89448
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 775-548-1785
Former name, former address and former fiscal year, if changed since last report:
Securities registered pursuant to Section 12(b) of the Act:

Title of Class
 
Name of Exchange on Which Registered
Common Stock, par value $0.0001 per share
 
NYSE Amex Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes x   No o
 
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes o  No x
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x   No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer  x
Accelerated filer  o
Non-accelerated filer o
Smaller reporting company o
(Do not check if a smaller reporting company)
 
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o  No x
 
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2011, was $1,173,043,513 based upon the closing price of the common shares of the Registrant on June 30, 2011.  This calculation does not reflect a determination that certain persons are affiliates of the Registrant for any other purpose.
 
50,671,136 shares of Registrant’s Common Stock were outstanding as of February 22, 2012.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
Certain portions of this Annual Report on Form 10-K incorporate by reference information from the Registrant’s Proxy Statement to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2011 in connection with the solicitation of proxies for the Registrant’s 2012 Annual Meeting of Stockholders.
 


 
 

 
 
VirnetX Holding Corporation
 
 
   
Page
     
PART I
     
Item 1.
5
Item 1A.
12
Item 1B.
17
Item 2.
17
Item 3.
17
Item 4.
17
     
PART II
     
Item 5.
18
Item 6.
20
Item 7.
21
Item 7A.
27
Item 8.
28
Item 9.
45
Item 9A.
45
Item 9B.
45
     
PART III
     
Item 10.
46
Item 11.
46
Item 12.
46
Item 13.
46
Item 14.
46
     
PART IV
     
Item 15.
47

 
2

 
WARNING CONCERNING FORWARD LOOKING STATEMENTS
 
 THIS ANNUAL REPORT ON FORM 10-K CONTAINS STATEMENTS THAT CONSTITUTE FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND OTHER FEDERAL SECURITIES LAWS. ALSO, WHENEVER WE USE WORDS SUCH AS "BELIEVE", "EXPECT", "ANTICIPATE", "INTEND", "PLAN", "ESTIMATE" OR SIMILAR EXPRESSIONS, WE ARE MAKING FORWARD LOOKING STATEMENTS. THESE FORWARD LOOKING STATEMENTS ARE BASED UPON OUR PRESENT INTENT, BELIEFS OR EXPECTATIONS, BUT FORWARD LOOKING STATEMENTS ARE NOT GUARANTEED TO OCCUR AND MAY NOT OCCUR. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CONTAINED IN OR IMPLIED BY OUR FORWARD LOOKING STATEMENTS AS A RESULT OF VARIOUS FACTORS. AMONG OTHERS, THE FORWARD LOOKING STATEMENTS WHICH APPEAR IN THIS REPORT THAT MAY NOT OCCUR INCLUDE:
 
 
THE DESCIPTION OF OUR BUSINESS INCLUDES A STATEMENT THAT WE INTEND TO MARKET OUR GABRIEL CONNECTION TECHNOLOGY™. AN IMPLICATION OF THIS STATEMENT MAY BE THAT WE WILL BE ABLE TO SUCCESSFULLY MARKET THIS TECHNOLOGY AND THAT IT WILL GENERATE REVENUE IN THE FUTURE. IN FACT, THERE ARE MANY FACTORS WHICH WILL IMPACT THE SUCCESS OF THIS TECHNOLOGY FOR US, INCLUDING SEVERAL FACTORS WHICH ARE BEYOND OUR CONTROL, SUCH AS THE DEMAND FOR THIS TECHNOLOGY BY POTENTIAL CUSTOMERS AND THE LEVEL OF COMPETITION IN OUR BUSINESS.
 
 
THE DESCRIPTION OF OUR BUSINESS INCLUDES STATEMENTS RELATING TO OUR INTENT TO ESTABLISH A SECURE DOMAIN NAME REGISTRY IN THE U.S. AND OTHER PARTS OF THE WORLD AND THAT WE ARE CONSIDERING MAKING APPLICATIONS TO BECOME ACCREDITED TO DO SO UNDER AUTHORITY OF THE U.S. GOVERNMENT.  THE IMPLICATION OF THOSE STATEMENTS MAY BE THAT WE WILL BE ABLE TO ESTABLISH A REGISTRY THAT WILL HAVE MARKET ACCEPTANCE AND THAT IT WILL GENERATE REVENUE FOR US IN THE FUTURE.  THERE ARE MANY FACTORS WHICH WILL IMPACT OUR ABILITY TO SUCCESSFULLY ESTABLISH A DOMAIN NAME REGISTRY, INCLUDING SEVERAL FACTORS WHICH ARE BEYOND OUR CONTROL, SUCH AS THE ACCREDITATION APPLICATION PROCESS OR THE ACCEPTANCE OF OUR REGISTRY OVER OTHERS IN THE MARKET, PARTICULARLY IF WE DETERMINE TO ESTABLISH A REGISTRY WITHOUT ACCREDITATION.
 
 
THE STATEMENTS THAT WE HAVE SUBMITTED A LICENSING DECLARATION TO THE 3RD GENERATION PARTNERSHIP, OR 3GPP, UPDATED SUCH DECLARATIONS AT THE REQUEST OF THE EUROPEAN TELECOMMUNICATIONS STANDARDS INSTITUTE, OR ETSI,  AND THE ALLIANCE FOR TELECOMMUNICATIONS INDUSTRY SOLUTIONS, OR ATIS, AND THAT WE BELIEVE WE  ARE POSITIONED TO LICENSE OUR PATENTS TO 3GPP MEMBERS DESIRING TO IMPLEMENT THE TECHNICAL SPECIFICATIONS IDENTIFIED BY US, MAY IMPLY THAT THE PATENTS WE HAVE IDENTIFIED TO 3GPP WILL GENERATE LICENSING REVENUE FOR US IN THE FUTURE. WE CANNOT ASSURE YOU THAT WE WILL BE SUCCESSFUL IN LICENSING OUR PATENTS OR THAT THIRD PARTIES WILL BE WILLING TO ENTER INTO LICENSES WITH US ON REASONABLE TERMS OR AT ALL.
 
 
OUR STATEMENT THAT WE BELIEVE WE HAVE THE FINANCIAL AND OTHER RESOURCES TO COMPLETE OUR BUSINESS PLAN MAY IMPLY THAT OUR RESOURCES WILL BE SUFFICIENT TO COMPLETE THAT PLAN SUCCESSFULLY.  HOWEVER, WE MAY NOT BE ABLE TO SUCCESSFULLY IMPLEMENT OUR BUSINESS PLAN FOR MANY REASONS, INCLUDING MANY REASONS THAT ARE BEYOND OUR CONTROL, SUCH AS THE POSSIBILITY THAT OUR FINANCIAL RESOURCES BECOME EXHAUSTED DUE TO INCREASED COSTS ASSOCIATED WITH OUR ATTEMPTS TO COMPETE WITH OTHERS WHO MAY HAVE GREATER RESOURCES, OR DUE TO OUR OTHER ACTIVITIES, INCLUDING OUR LITIGATION ACTIVITIES.
 
 
STATEMENTS DESCRIBING OUR CONTINUED LITIGATION EFFORTS MAY IMPLY THAT WE WILL PREVAIL IN SOME OR ALL OF OUR LITIGATION. HOWEVER, WE CANNOT ASSURE YOU WE WILL PREVAIL IN OUR PENDING LITIGATION MATTERS AND ANY ADVERSE RULING MAY HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS. ALSO, THE LEGAL AND OTHER COSTS WE MAY INCUR IN CONNECTION WITH LITIGATION MATTERS WILL DEPEND, IN PART, UPON ACTIONS TAKEN BY OTHER PARTIES, WHICH ACTIONS ARE NOT WITHIN OUR CONTROL AND THESE COSTS MAY HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS.
 
 
OUR REFERENCES TO THE FACTS THAT OUR CORE DEVELOPMENT TEAM HAS SPENT OVER TEN YEARS WORKING TOGETHER, AND HAS HAD PRIOR SUCCESS AT SAIC MAY IMPLY THAT OUR TEAM WILL BE SUCCESSFUL IN THE FUTURE.  HOWEVER, THIS TEAM MAY NOT BE SUCCESSFUL FOR MANY REASONS, INCLUDING MANY REASONS THAT ARE BEYOND OUR CONTROL, SUCH AS THE POSSIBILITY THAT ONE OR MORE KEY MEMBERS OF THE TEAM BECOMES INCAPACITATED, OR THAT COMPETITORS ARE SUCCESSFUL IN DEVELOPING SUPERIOR PRODUCTS.
 
 
OUR STATEMENT WITH RESPECT TO OUR INTENT TO MARKET AND SELL LICENSE AND SERVICES TO OTHERS MAY IMPLY THAT OUR PLANS TO DO SO ARE IMMINENT OR WILL BE SUCCESSFUL. HOWEVER, MARKETING AND SELLING OUR PRODUCT AND SERVICES WHILE SIMULTANEOUSLY PURSUING OUR LITIGATION AND OUR FURTHER DEVELOPMENT ACTIVITIES CAN PRESENT SIGNIFICANT CHALLENGES. OUR MARKETING AND SALES PLANS MAY TAKE LONGER TO IMPLEMENT THAN WE NOW EXPECT, MAY NOT BE IMPLEMENTED, OR MAY FAIL.
 
THESE AND OTHER UNEXPECTED RESULTS MAY BE CAUSED BY VARIOUS FACTORS, SOME OF WHICH ARE BEYOND OUR CONTROL, INCLUDING:
 
 
THE IMPACT OF CHANGES IN THE US AND GLOBAL ECONOMIES IN GENERAL AND THE CAPITAL MARKETS ON US AND OUR INTENDED CUSTOMERS;
 
 
COMPLIANCE WITH, AND CHANGES TO, U.S. FEDERAL, STATE AND LOCAL LAWS AND REGULATIONS, FOREIGN LAWS AND REGULATIONS, ACCOUNTING RULES, TAX RATES AND SIMILAR MATTERS; AND
 
 
COMPETITION WITHIN OUR INDUSTRY.
 
 
3

 
WE HAVE GENERATED NET INCOME IN ONLY ONE ANNUAL REPORTING PERIOD SINCE WE BECAME A PUBLICLY OWNED. ALTHOUGH OUR PLANS ARE INTENDED TO GENERATE NET INCOME, THERE CAN BE NO ASSURANCE THAT THESE PLANS WILL SUCCEED.
 
RESULTS THAT DIFFER FROM THOSE STATED OR IMPLIED BY OUR FORWARD LOOKING STATEMENTS MAY ALSO BE CAUSED BY VARIOUS CHANGES IN OUR BUSINESS OR MARKET CONDITIONS AS DESCRIBED MORE FULLY UNDER "PART I. ITEM 1A. RISK FACTORS" AND ELSEWHERE IN THIS REPORT.
 
YOU SHOULD NOT PLACE UNDUE RELIANCE UPON FORWARD LOOKING STATEMENTS.

EXCEPT AS REQUIRED BY LAW, WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD LOOKING STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

 
4


PART I
 
 
The Company

VirnetX, Inc. (“we” or “VirnetX”) develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or SDNI, on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.
 
Our portfolio of intellectual property is the foundation of our business model.  We currently own 20 patents in the United States and 26 foreign patents, as well as several pending U.S. and foreign patent applications.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our patented methods also have additional applications in operating systems and network security.  On December 1, 2009, we submitted a licensing declaration to the 3rd Generation Partnership Project, or 3GPP, identifying those of our U.S. and international patents which may be relevant to Long Term Evolution, or LTE. On March 14, 2011, we supplemented our licensing declaration to include five additional specifications. On April 28, 2011, at the request of the European Telecommunications Standards Institute, or ETSI, we agreed to update our licensing declaration to ETSI under ETSI's Intellectual Property Rights or IPR policy.  We agreed with ETSI that we will make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the Technical Specifications identified by us, as set forth in the updated licensing declaration under ETSI’s IPR policy. On June 17, 2011, in response to a request from the Alliance for Telecommunications Industry Solutions, or ATIS, the North American Organizational Partner for 3GPP, we also agreed to make available a non-exclusive patent license to 3GPP members desiring to implement the technical specifications identified by us, as set forth in the updated licensing declaration under ATIS' IPR policy. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We intend to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators.  We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE wireless networks. We also believe that all 4G mobile devices will require unique secure domain names and become part of a secure domain name registry.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.
 
Microsoft Corporation is our first licensee and has been granted a worldwide, irrevocable, nonexclusive, non-sublicenseable fully paid up license of our patents for Microsoft products.  We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.
 
Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Science Application International Corporation, or SAIC.  SAIC is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at SAIC and expanded the set of patents we acquired in 2006 from SAIC into a larger portfolio with 46 issued U.S. and foreign patents and numerous pending U.S. and foreign patents applications. This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.  Please see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Operations – Research and Development Expenses for a description of our research and development expenses for the past three fiscal years.  
 
We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers and others) and build our secure domain name registry.

In 2011, we moved our corporate headquarters from California to Nevada.

Industry Overview
 
We believe that the Internet is an evolving, rich and complex medium used by individuals and businesses to conduct commerce, share information and engage in real-time communications including email, text messaging, IM, and voice and video calls. We believe that users have grown accustomed to having broadband access wherever they go, and not just at home or in the office. Users can browse the Internet or send e-mails using their mobile broadband enabled notebooks, replace their fixed DSL modems with mobile broadband modems or other devices, and send and receive video or music using 3G phones. We believe that Long Term Evolution, or LTE, will further advance a transition from the cellular 3G services to an all internet packet, or "IP", based network that can provide mobile data access speeds closer to fixed DSL speeds and allow for more bandwidth intensive applications like interactive TV, mobile video blogging, advanced games or professional services. Session initiation protocol, or SIP, was developed to enable the convergence of voice and data networks and today is the predominant industry standard for establishing multimedia communications over the Internet such as voice, video, instant messaging, presence information and file transfer. SIP, XMPP and other real-time collaboration protocols use DNS lookup as the primary means of connecting Internet devices. However, because these protocols use "open architecture", we believe that they are inherently unsecure.
 
We also believe that many enterprises have concluded that security provided to communication by way of an optional add-on solution is less secure than security that can be provided by upgrading core information technology, or "IT", infrastructure (systems, networks, and management) with integrated security. We believe that, because of the complexity of today's networks and the requirement to connect users from any location at any time on any device, enterprises are reevaluating numerous parts of their technology systems, including but not limited to software solutions for smartphones, routers and switches with integrated security, massive security appliances for data centers, cloud-based security services and security solutions for virtualized environments and public and private clouds. The portions of the IP-telephony, mobility, fixed-mobile convergence and unified communications markets that could benefit from our software and technology solutions are forecasted by Infonetics and our internal estimates to grow from approximately $128 billion of worldwide revenues in 2010 to approximately $226 billion by 2015, representing a compound annual growth rate, or CAGR, of approximately 12%. We believe that this growing trend represents a significant opportunity for us to license our technology and software, and establish our secure domain name registry.
 
 
5


We also believe that various enterprises have concluded that optional add-on solution, and enterprises everywhere are currently upgrading core IT infrastructure (systems, networks, and management) to integrate security into everything. Because of the complexity of today’s networks, and the requirement to connect users from any location at any time on any device, enterprise IT is having to reevaluate everything from software solutions for smartphones to routers and switches with integrated security, massive security appliances for data centers, cloud-based security services, and security solutions for virtualized environments and public and private clouds. The portions of the IP-telephony, mobility, fixed-mobile convergence and unified communications markets that could benefit from our software and technology solutions are forecasted by Infonetics and our internal estimates to grow from approximately $128 billion of worldwide revenues in 2010 to approximately $226 billion by 2015, representing a compound annual growth rate, or CAGR, of approximately 12%.  We believe that this growing trend represents a significant opportunity for VirnetX to license its technology and software, and establish its secure domain name registry.

IP Telephony – VoIP, Telepresence and Video Conferencing
 
IP telephony includes technologies that use Internet Protocol’s packet-switched connections to exchange voice, fax, and other forms of information traditionally carried over the dedicated circuit-switched connections of the public switched telephone network, or PSTN.  The adoption of IP telephony has helped businesses significantly lower network operating costs by using a common network for voice and data. As the workforce becomes increasingly dispersed, mobile features enabled by Internet protocol-based communications such as presence, unified messaging, peer-to-peer applications, find me/follow me, white-boarding and document sharing have become more commonplace.  However, the development of the related security infrastructure has lagged behind, leaving next-generation networks vulnerable to a multitude of threats including man-in-middle, eavesdropping, domain hijacking, distributed denial of service, or DDoS, spam over Internet telephony, or SPIT, and spam over instant messaging, or SPIM.  These threats continue to highlight the need for securing next-generation networks.  As the use of IP telephony systems extends beyond the boundaries of an organization’s private network, security is likely to become an even bigger concern.  Worldwide revenue from IP telephony products like IP-PBX including IP phones, service provider VoIP and IMS equipment, VoIP gateways, Enterprise Telepresence and Video Conferencing for businesses is forecasted by Infonetics and our internal estimates to grow from approximately $30 billion in 2010 to approximately $59 billion in 2015, representing a CAGR of approximately 15%.  We believe our unique and patented solution provides the robust security platform required for providing on-demand secure communication links between enterprises intending to communicate securely without manually configuring the connections.  We believe a standard security solution such as ours will further accelerate the adoption of IP telephony products in the market and allow enterprises to take full advantage of these rich content applications and real-time communications over the Internet, thereby significantly increasing their return on investment.

Unified Communications
 
We believe that the need to enhance productivity is rapidly increasing demand for the management of and instant access to real-time information. We believe that mobile collaboration, instant Internet access and the ability to conduct business whether inside or outside of the office, are high priorities. We also believe that the ability to establish multiple secure simultaneous network connections and provide IP sessions with security and encryption will be critical to widespread deployment of next-generation networks. However, one possible shortcoming of this new communications environment is that the various modes of communication operate independently from one another and do not integrate easily, if at all. We believe that the number of individual points of contact in these environments will grow and that as a result, communication will become more sophisticated and increasingly vulnerable.
 
An array of communication methodologies integrated into a single communications experience is often referred to as unified communications. We believe that unified communications have higher utility and can increase productivity for users. The basic components of unified communications include: a directory for storing addresses, various modes of communication with each user/contact (desk phone, mobile phone, 1M, etc.), message storage for all messages regardless of communication method and secure presence of a user's status for each mode of communication (available, away, busy, etc.). Worldwide unified communications market generated approximately $462 million in revenue in 2010 and is forecasted to grow rapidly over the next few years generating approximately $1.04billion in revenue in 2015, representing a CAGR of approximately 11%. We believe the growth in unified communication products may not reach its full potential due to the lack of transparent and seamless security as users hesitate to place their presence information online for all to see and as organizations block access due to the lack of credentials verified by a neutral third party. We believe that our solutions help address these concerns and should enable significant growth in the unified communications market.
 
IP Mobility-LTE, Fixed-Mobile Convergence
 
We believe that telecommunication markets are rapidly changing and presenting new challenges to the equipment and service providers, including but not limited to increasing user demand for mobile, always-on connections with multiple devices. We also believe that traffic growth, video acceleration, cloud services and a rapidly growing number of subscribers challenge currently available network architectures and that, because of this, service providers and carriers will eventually use a single network for fixed and mobile communications, private/premium communications and Internet access, in spite of the difficulties involved challenging their business models and forcing the consideration of new network architectures. We believe that LTE technology will deliver users the benefits of faster data speeds and new services by creating a new radio access technology that's optimized for IP-based traffic and offers operators a simple upgrade path from 3G networks. Smartphones are multi-functional devices that handle a wide variety of business-critical applications and support increasingly complex functions including enhanced data processing, Internet access, e-mail access, calendars and scheduling, contact management and the ability to view electronic documents. Users have continual access to these applications while on the move making them an increasingly essential business tool for the mobile worker. These devices enable mobile workers to have similar functionality inside or outside the office thereby increasing employee efficiency. However, it is critical that this mobile environment have the same level of security as an enterprise's internal network. Fixed-mobile convergence is an environment where wired and wireless phones work together with Internet Protocol to deliver services (voice, video, data and combinations thereof) uniformly across multiple access networks, including, among others, WiMAX, WiFi cellular and fixed. Worldwide revenue from IP mobility products like smartphones and mobile data cards, femtocell equipment, rich communication devices and services is expected to grow from approximately $98 billion in 2010 to approximately $166 billion by 2015, representing a CAGR of approximately 11%. We believe in order to realize the full functionality of IP mobility, several challenges including security must be overcome. When users are mobile, connections and data need to cross multiple network boundaries, each of which poses a security threat. Wireless networks may be threatened or compromised by rogue users who enter through (insecure wireless access points. We believe that providing authenticated access to the wireless networks and enterprise applications through the wireless domain are important requirements and represent a significant market opportunity for our patented technology and secure domain names to provide users fully authenticated secure access on a "zero-click" or "single-click" basis.

 
6


Our Solutions
 
Our software and technology solutions, including our secure domain name registry, our patents and our GABRIEL Connection Technology™ are designed to secure all types of real-time communications over the Internet.  Our technology uses industry standard encryption methods with our patented DNS lookup mechanisms to create a secure communication link between users intending to communicate in real time over the Internet.  Our technology can be built into network infrastructure, operating systems or silicon chips developed for a communication or computing device to secure real-time communications over the Internet between numerous devices.  Our technology automatically encrypts data allowing organizations and individuals to establish communities of secure, registered users and transmit information between multiple devices, networks and operating systems.  These secure network communities, which we call secure private domains, or SPDs, are designed to be fully-customizable and support rich content applications such as IM, VoIP, mobile services, streaming video, file transfer and remote desktop in a completely secure environment.  Our approach is a unique and patented solution that we believe provides the robust security platform required by these rich content applications and real-time communications over the Internet.  We believe the key benefits and features of our technology include the following:
 
 
Automatic and seamless to the user.  After a one-time registration, users connect securely on a “zero-click” or “single-click” basis.
 
 
Secure data communications.  Users create secure networks with people they trust and communicate over a secure channel.
 
 
Control of data at all times.  Users can secure and customize their unified communication and collaboration applications such as file sharing and remote desktop with policy-based access and secure presence information.
 
 
Authenticated users.  Users know they are communicating with authenticated users with secure domain names.
 
 
Application-agnostic technology.  Our solution provides security at the IP layer of the network by using patented DNS lookup mechanisms to make connections between secure domain names, thereby obviating the need to provide application specific security.

Competitive Strengths
 
We believe the following competitive strengths will enable our success in the marketplace:
 
 
Unique patented technology.  We are focused on developing innovative technology for securing real-time communications over the Internet, and establishing the exclusive secure domain name registry in the United States and other key markets around the world.  Our unique solutions combine industry standard encryption methods and communication protocols with our patented techniques for automated DNS lookup mechanisms.  Our technology and patented approach enables users to create a secure communication link by generating secure domain names.  We have a portfolio comprised of twenty (20) patents in the United States and twenty-six (26) foreign patents, as well as several pending U.S. and foreign patent applications.  Our portfolio includes patents and pending patent applications in the United States and other key markets that support our secure domain name registry service for the Internet.
 
 
 
Scalable licensing business model.  We are actively engaged in pursuing licensing agreements with OEMs, service providers and system integrators within the IP-telephony, mobility, fixed-mobile convergence and unified communications end-markets.
 
 
 
Highly experienced research and development team.  Our research and development team is comprised of nationally recognized network security and encryption technology scientists and experts that have worked together as a team for over ten years.  During their careers, this team has developed several cutting-edge technologies for U.S. national defense, intelligence and civilian agencies, many of which remain critical to our national security today.  Prior to joining VirnetX, our team worked for SAIC during which time they invented the technology that is the foundation of our technology, and software.  Based on the collective knowledge and experience of our development team, we believe that we have one of the most experienced and sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and developing solutions to mitigate these problems.
 
Our Strategy
 
Our strategy is to become the market leader in securing real-time communications over the Internet and to establish our GABRIEL Communications Technology™ as the industry standard security platform.  Key elements of our strategy are to:
 
 
Implement a technology licensing program to commercialize our intellectual property, including our GABRIEL Connection Technology™.
 
 
Establish VirnetX as the exclusive universal registry of secure domain names and to enable our customers to act as registrars for their users and broker secure communication between users on different registries.
 
 
Leverage our existing technology to develop a suite of products that can be sold directly to end-user enterprises.
 
On December 2, 2009, we submitted a licensing declaration to the 3rd Generation Partnership Project, or 3GPP,identifying those of our U.S. and international patents which may be relevant to Long Term Evolution, or LTE. On March 14, 2011, we supplemented our licensing declaration to include five additional specifications. On April 28, 2011, at the request of the European Telecommunications Standards Institute, or ETSI, we agreed to update our licensing declaration to ETSI under ETSI's Intellectual Property Rights (IPR) policy.  We agreed with ETSI that we will make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us, as set forth in the updated licensing declaration under ETSI’s IPR policy. On June 17, 2011, in response to a request from the Alliance for Telecommunications Industry Solutions, or ATIS, the North American Organizational Partner for 3GPP, we also agreed to make available a non-exclusive patent license to 3GPP members desiring to implement the Technical Specifications identified by us, as set forth in the updated licensing declaration under ATIS' IPR policy. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G. We believe that we hold the patents relevant to compliance with the 3GPP Series 33 specifications that define security requirements for LTE/4G networks.
 
 
7


License and Service Offerings
 
We plan to offer a diversified portfolio of license and service offerings focused on securing real-time communications over the Internet, including:

 
VirnetX technology licensing: Customers who want to develop their own implementation of the VirnetX code module for supporting secure domain names, or who want to use their own techniques that are covered by our patent portfolio for establishing secure communication links, will purchase a technology license.  We anticipate that these licenses would typically include an initial license fee, as well as an ongoing royalty.  We expect that these licenses will include a one-time delivery of Gabriel software development kit including object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement of the techniques we have developed.
 
 
GABRIEL Connection Technology™ Software Development Kit or SDK: OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products will purchase an SDK license.  The software development kit consists of object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology.  These tools are comprised of software for a secure domain name connection test server, a relay test server and a registration test server.  We expect that customers would pay an up-front license fee to purchase an SDK license and a royalty fee for every product shipped with the embedded VirnetX code module.
 
 
Secure domain name registrar service: Customers, including service providers, telecommunication companies, ISPs, system integrators and OEMs could purchase a license to our secure domain name registrar service.  We would provide the software suite and technology support to enable such customers to provision devices with secure domain names and facilitate secure connections between registered devices.  This suite includes the following server software modules:
 
 
Registrar server software: We anticipate that our registrar server software would enable customers to operate as a secure domain name registrar that provisions devices with secure domain names.  The registrar server software is designed to provide an interface for our customers to register new virtual private domains and sub-domain names.  This server module must be enrolled with the VirnetX secure domain name master registry to obtain its credentials before functioning as an authorized registrar.
 
 
Connection server software: We anticipate that our connection server software would allow customers to provide connection services to enrolled devices.  The connection services include registration of presence information for authenticated users and devices, presence information query request services, enforcement of policies and support for communication with peers behind firewalls.

 
Relay server software: We anticipate that our relay server software would allow customers to dynamically maintain connections and relay data to private IP addresses for network devices that reside behind firewalls.  Secure domain name registrar service customers will enter into a technology licensing and revenue sharing agreement with VirnetX whereby we will typically receive an up-front licensing fee for the secure domain name registrar technology, as well as ongoing annual royalties for each secure domain name issued by the customer.
 
 
Secure domain name master registry and connection service: As part of enabling the secure domain name registrar service, we expect that we will maintain and manage the secure domain name master registry.  This service is expected to enroll all secure domain name registrar customers and generate the credentials required to function as an authorized registrar.  It also is expected to provide connection services and universal name resolution, presence information and secure connections between authorized devices with secure domain names.

 
Technical support services: We intend to provide high-quality technical support services to licensees and customers for the rapid customization and deployment of GABRIEL Connection Technology™ in an individual customer’s products and services.
 
Our research and development team was the team responsible for inventing the claimed subject matter of the patents that form the foundation of our technology.  This team has worked together for over ten years.  We intend to leverage this experience and continue investing in research and development and, over time, expect to strengthen and expand our patent portfolio, technology, and software.  While we are currently focused on securing real-time communications over the Internet and establishing the first and only secure domain name registry, we believe our existing and future intellectual property portfolio will extend to additional areas including, among others, network security and operating systems for fixed and mobile devices.
 
Customers
 
Our primary source of income since inception has been from the Settlement and License Agreement we entered into with Microsoft Corporation, our first licensee, on May 14, 2010, or the Settlement and License Agreement.  Pursuant to the Settlement and License Agreement, Microsoft paid us $200,000,000 in June 2010, which has been classified as gain on settlement. As a consequence, we dismissed the two patent infringement lawsuits we initiated against Microsoft in February 2007 and March 2010 and granted Microsoft a worldwide, irrevocable, nonexclusive, non-sub licensable fully paid up license under our patents.  The Settlement and License Agreement with Microsoft will not impact our plans to operate a secure domain name service.
 
We are currently focused on commercializing our technology and are actively offering our GABRIEL Connection Technology™ to original equipment manufacturers, or OEMs, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets.
 
We also intend to provide technology licenses and software offerings, including our secure domain name registry service, to communication service providers as well as to system integrators.
 
 
8


Marketing and Sales
 
We plan to employ a leveraged, partner-oriented, marketing strategy for our technology licenses and software offerings.  We expect the marketing strategy will primarily be focused on OEMs.
 
We plan to directly market our domain name registry services to our service provider and system integrator customers.  We hope to leverage our relationship with SAIC to extend our offering to departments and agencies within the federal government.  SAIC is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. We intend to build a sales force that will be responsible for managing accounts and pursuing technology licensing and sales opportunities with new customers.
 
Competition
 
We believe our technology and solutions will compete primarily against various proprietary security solutions.  We group these solutions into three main categories:
 
 
Proprietary or home-grown application specific security solutions have been developed by vendors and integrated directly into their products for our target markets including IP-telephony, mobility, fixed-mobile convergence, and unified communications.  These proprietary solutions have been developed due to the lack of standardized approaches to securing real-time communications.  This approach has led to corporate networks that are isolated and, as a result, restrict enterprises to using these next-generation networks within the boundaries of their private network.  These solutions generally do not provide security for communications over the Internet or require network administrators to manually exchange keys and other security parameters with each destination network outside their corporate network boundary.  The cost-savings and other benefits of IP-based real-time communications are significantly limited by this approach to securing real-time communications.
 
 
 
A session border controller, or SBC, is a device used in networks to exert control over the signaling and media streams involved in establishing, conducting and terminating VoIP calls.  A traditional firewall or network address translation, or NAT, device typically block information like endpoint IP addresses and port numbers required by signaling protocols, such as SIP and XMPP, to reach and communicate with their intended destination.  SBCs are used in physical networks to address these limitations and enable real-time session traffic to cross the boundaries created by firewalls and other NAT devices and enable VoIP calls to be established successfully.  However, SBCs must decrypt and analyze every single data packet for the information to be transmitted successfully, thereby preventing end-to-end encryption.  This network design results in SBCs becoming a single point of congestion on the network, as well as a single point of failure.  SBCs are also limited to the physical network they secure.
 
 
 
SIP firewalls, or SIP-aware firewalls, and application layer gateways, manage and protect the traffic, flow and quality of VoIP and other SIP-related communications.  They perform real-time network address translation, dynamic firewall functions; support multiple signaling protocols, and media functionality, allowing secure interconnection and the flow of IP media streams across multiple networks.  While SIP firewalls assist in analyzing SIP traffic transmitted over the corporate network to filter out various threats, they do not necessarily encrypt the traffic.  As a result, this traffic is not entirely secure from end-to-end nor is it protected against threats like man-in-middle and eavesdropping.
 
Intellectual Property and Patent Rights
 
Our intellectual property is primarily comprised of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation.
 
We have a portfolio comprised of twenty (20) patents in the United States and twenty six (26) foreign patents, as well as several pending U.S. and foreign patent applications.  Our portfolio includes a number of patents that describe unique systems and methods for securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our software and technology solutions also have additional applications relating to operating systems and network security.
 
We have included a list of our U.S. patents below.  Each patent below is publicly accessible on the Internet website of the U.S. Patent and Trademark Office at www.uspto.gov.  The term of each of our issued U.S. and foreign patents will expire during the period from 2019 to 2024.
 
U.S. Patent Number Link to Patent
 
Title of Patent
6,502,135
 
Agile network protocol for secure communications with assured system availability
6,618,761
 
Agile network protocol for secure communications with assured system availability
6,826,616
 
Method for establishing secure communication link between computers of virtual private network
6,834,310
 
Preventing packet flooding of a computer on a computer network
6,839,759
 
Method for establishing secure communication link between computers of virtual private network without user entering any cryptographic information
6,907,473
 
Agile network protocol for secure communications with assured system availability
7,010,604
 
Agile network protocol for secure communications with assured system availability
7,133,930
 
Agile network protocol for secure communications with assured system availability
7,188,180
 
Method for establishing secure communication link between computers of virtual private network
7,209,479
 
Third party VPN certification
7,418,504
 
Agile network protocol for secure communications using secure domain names
7,490,151
 
Establishment of a secure communication link based on a domain name service (DNS) request
7,921,211
 
Agile network protocol for secure communications using secure domain names
7,933,990
 
Agile network protocol for secure communications with assured system availability
7,945,654
 
Agile network protocol for secure communications using secure domain names
7,944,915
 
Third party VPN certification
7,897,274
 
Method for establishing secure communication link between computers of virtual private network
7,986,688
 
Third party VPN certification
7,996,539
 
Agile network protocol for secure communications with assured system availability
8,051,181
 
Method for establishing secure communication link between computers of virtual private network
 
 
9

 
Notwithstanding anything to the contrary set forth in any of the Company’s filings under the Securities Act of 1933 or the Securities Exchange Act of 1934 that might incorporate future filings, the information set forth on the United States Patent and Trademark Office, or the USPTO Website, shall not be deemed to be a part of or incorporated by reference into any such filings.  The Company does not warrant the accuracy, or completeness or adequacy of the USPTO Website, and expressly disclaims liability for errors or omissions on such website.
 
Assignment of Patents
 
Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, pursuant to an Assignment Agreement dated December 21, 2006, and a Patent License and Assignment Agreement dated August 12, 2005, as amended on November 2, 2006, including documents prepared pursuant to the November amendment, and as further amended on March 12, 2008. We recorded the assignment from SAIC with the U.S. Patent Office on December 21, 2006.

Key terms of these agreements are as follows:

Patent Assignment.  SAIC unconditionally and irrevocably conveyed, transferred, assigned and quitclaimed all its right, title and interest in and to the patents and patent applications, as specifically set forth on Exhibit A to the assignment document recorded with the U.S. Patent Office, including, without limitation, the right to sue for past infringement.

License to SAIC Outside the Field of Use.  On November 2, 2006, we granted to SAIC an exclusive, royalty free, fully paid, perpetual, worldwide, irrevocable, sublicensable and transferable right and license permitting SAIC and its assignees to make, have made, import, use, offer for sale, and sell products and services covered by, and to make improvements to, the patents and patent applications we acquired from SAIC, solely outside our field of use. We have, and retain, all right, title and interest to all our patents within our field of use. On March 12, 2008, SAIC relinquished the November 2, 2006, exclusive right and license outside our field of use referred to above, as well as any right to obtain such exclusive license in the future. Effective March 12, 2008, we granted to SAIC a non-exclusive, royalty free, fully paid, perpetual, worldwide, irrevocable, sublicensable and transferable right and license permitting SAIC and its assignees to make, have made, import, use, offer for sale, and sell products and services covered by, and to make improvements to, the patents and patent applications we acquired from SAIC, solely outside our field of use.

Compensation Obligations. As consideration for the assignment of the patents and for the rights we obtained from SAIC as amended, we are required to make payments to SAIC based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX, from the settlement of certain patent infringement claims of ours. 

Government Regulation
 
The laws governing online secure communications remain largely unsettled, even in areas where there has been legislative action.  It may take years to determine whether and how existing laws governing intellectual property, privacy and libel apply to online communications and media.  Such legislation may interfere with the growth in use of online secure communications and decrease the acceptance of online secure communications as a viable solution, which could adversely affect our business.
 
Due to the Internet’s popularity and increasing use, new laws regulating secure communications may be adopted. These laws and regulations may cover, among other things, issues relating to privacy, pricing, taxation, telecommunications over the Internet, content, copyrights, distribution and quality of products and services. We intend to comply with all new laws and regulations as they are adopted.
 
The U.S. government has controlled the authoritative domain name system, or DNS, root server since the inception of the Internet.  On July 1, 1997, the President of the United States directed the U.S. Secretary of Commerce to privatize the management of the domain name system in a manner that increases competition and facilitates international participation in its management.
 
On September 29, 2006, the U.S. Department of Commerce extended its delegation of authority by entering into a new agreement with the Internet Corporation for Assigned Names and Numbers, or ICANN, a California non-profit corporation headquartered in Marina Del Rey, California.  ICANN is responsible for managing the accreditation of registry providers and registrars that manage the assignment of top level domain names associated with the authoritative DNS root directory.  Although it is possible to create and manage other DNS root directories privately without accreditation from ICANN, the possibility of conflicting name and number assignments makes it less likely that users would widely adopt a top level domain name associated with an alternative DNS root directory provided by a non-ICANN-accredited registry service.
 
We are currently evaluating whether we will apply to become an ICANN-accredited registry provider with respect to one or more customized generic top-level domain (gTLD), or create our own alternative DNS root directory to manage the assignment of non-standard secure domain names.  We have not yet begun discussions with ICANN and we cannot assure you that we will be successful in obtaining ICANN accreditation for our registry service on terms acceptable to us or at all.  Whether or not we obtain accreditation from ICANN, we will be subject to the ongoing risks arising out of the delegation of the U.S. government’s responsibilities for the domain name system to the U.S. Department of Commerce and ICANN and the evolving government regulatory environment with respect to domain name registry services.

Employees
 
As of December 31, 2011, we had 13 full-time employees.
 
 
10


Corporate Overview and History
 
VirnetX, Inc., was incorporated in the State of Delaware in August 2005.  In November 2006, VirnetX acquired certain patents from SAIC.  In July 2007, we effected a reverse merger between PASW, Inc. and VirnetX, which became our principal operating subsidiary.  As a result of this merger, the former security holders of VirnetX came to own a majority of our outstanding common stock.  On October 29, 2007, we changed our name from PASW, Inc. to VirnetX Holding Corporation.
 
Available Information
 
We file or furnish various reports, such as registration statements, periodic and current reports, proxy statements and other materials with the SEC.  Our Internet website address is www.virnetx.com.  You may obtain, free of charge on our Internet website, copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.  The information we post is intended for reference purposes only; none of the information posted on our website is part of this report or incorporated by reference herein.
 
In addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549.  You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  The SEC also maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the SEC.  The Internet address of the SEC’s Internet site is http://www.sec.gov.
You should carefully consider the following material risks in addition to the other information set forth in this Quarterly Report on Form 10-Q before making any investment in the offered securities.  The risks and uncertainties described below are not the only ones we face.  Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.  If any of these risk factors occurs, you could lose substantial value or your entire investment in our shares.

Risks Related to Financial Reporting Obligations

Our consolidated financial statements have been restated in the past year in connection with our identification of a material weakness in our internal control over financial reporting; we may identify future material weakness which  may result in late filings, increased costs or declines in our share price.

In early 2011, we restated our previously filed financial statements for the fiscal quarter ended September 30, 2010, each of the then previous five fiscal quarters and the fiscal year ended December 31, 2009, to adjust our accounting for our Series I Warrants.  In connection with these restatements, we determined that we had not maintained effective control over our accounting for these Series I Warrants and, as a result, that a material weakness existed with respect to our reporting of complex, non-routine transactions as of the end of the periods covered by the Form 10-K and Form 10-Qs that included the financial statements referenced above. Although we believe that we currently maintain effective control over our disclosure controls and procedures and internal control over financial reporting as regards this issue, we may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting.  In addition, we expect that we will continue to be required to provide a management report in our Form 10-K regarding our internal control over financial reporting and that our independent registered public accounting firm will continue to be required to attest to our internal control matters.  If we experience any material weaknesses in our internal control over financial reporting the future or are unable to provide unqualified management or attestation reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of which could cause our share price to decline.

Our litigation can be time-consuming, costly and we cannot anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation matters.  We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources.  The counterparties to our litigation are all large, well-financed companies with substantially greater resources than us.  We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us.  Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend.  Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse affect our ability to develop and commercialize products.

Risks Related to Our Business and Our Industry

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through direct sales and marketing efforts; as such our business strategy and revenues will depend on intellectual property licensing fees and royalties for the majority of our revenues.  We currently derive minimal revenue from licensing activities and we cannot assure you that we will successfully capitalize on our market opportunities or that our current business strategy will succeed.  Factors on-going that may affect our ability to execute our current business strategy including, but are not limited to:
 
 
Although we entered into a Settlement and License Agreement with Microsoft Corporation, we may not be successful in entering into further licensing relationships;
 
 
Third parties may challenge the validity of certain of our patents;
 
 
The pendency of our various litigations may cause potential licensees not to do business with us;
 
 
We expect that we will face intense competition new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and
 
 
It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.

If we are not able to adequately protect our patented rights, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable.  Notwithstanding this belief, third parties may make claims of infringement or invalidity claims with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, or otherwise materially and adversely affect our business.  Similar challenges could also prevent us from obtaining additional patents in the future.  Even if we are successful in enforcing our rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect.  These risks may be heightened in countries other than the U.S., and may be negatively affected by the fact that legal standards in the U.S. and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving.  In addition, there are a significant number of U.S. and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue, and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest.  If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (ETSI), and the Alliance for Telecommunications Industry Solutions (ATIS), we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights (IRP) policies.  This was in response to our Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3rd Generation Partnership Project (3GPP) Long Term Evolution (LTE), Systems Architecture Evolution (SAE) project.  We will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) for the patents identified by VirnetX that are or become essential, to applicants desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under the ATIS and ETSI IPR policies. While we believe that our FRAND commitment positions us to license our essential security patents for the Technical Specifications identified by VirnetX, our licensing declarations under the ATIS and ETSI IPR policies may limit our flexibility in determining royalties and license terms for certain of our patents.  Consequently, we cannot assure you that the licensing of the essential security patents will be successful or that third parties will be willing to enter into licenses with VirnetX on reasonable terms or at all, which could have an adverse effect on our business and harm our competitive position.
 
 
12


Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subjected to various developments in regulation, law and consumer preferences that we may not be able to adapt to successfully.
 
The current regulatory environment for our products and services remains unclear.  We can give no assurance that our planned product offerings will be in compliance with laws and regulations of local, state, U.S. federal or foreign authorities.  Further, we can give no assurance that we will not unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the future which would cause us to be in violation of such laws or regulations.  For example, VoIP services are not currently subject to all of the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that these could result in substantial costs and adversely affect of the marketability of our products and planned products related to VoIP.  For further example, the use of the Internet and private IP networks for communication is largely unregulated within the United States, but may become regulated in the future; also several foreign governments have enacted measures that could restrict or prohibit voice communications services over the Internet or private IP networks. 
 
Our business depends on the growth of IM, VoIP, mobile services, streaming video, file transfer and remote desktop and other next-generation Internet-based applications which are relatively new.  The Internet may ultimately prove not to be a viable commercial marketplace which could cease growth or cause material decline in the number of users in these areas due to complexity or cost of these applications relative to alternate traditional or newly developed communications channels.
 
More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically or a lack of growth in acceptance of the Internet as a long term viable marketplace for communications services may materially and adversely affect our business, financial condition, operating results and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:
 
 
·
New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. .  For instance, the U.S. Supreme Court has recently modified some tests used by the U.S. Patent and Trademark Office in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license.  In addition, the U.S. recently enacted sweeping changes to the U.S. patent system under the Leahy-Smith America Invents Act (“AIA”), including changes that would transition the U.S. from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents
 
 
·
More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.
 
 
·
Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.
 
 
·
As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We expect to retain certain confidential customer information in our secure data centers and secure domain name registry.  It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure.  Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system.  The secure domain name servers that we will operate will be critical hardware to our registry services operations.  Therefore, we expect to have to expend significant time and money to maintain or increase the security of our facilities and infrastructure.Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in the techniques for attacking security solutions could make some or all of our products obsolete or unmarketable.  Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers.  Despite our security measures, our infrastructure may be vulnerable to physical break-ins, computer viruses, attacks by hackers or similar disruptive problems.  It is possible that we may have to expend additional financial and other resources to address such problems.  Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data centers and domain name registration systems may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers.  In such an event, we could face significant liability and customers could be reluctant to use our services.  Such an occurrence could also result in adverse publicity and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

A security breach could require a substantial amount of expense to rectify and could result in a product liability claim that causes us to incur substantial liability and related legal and other costs.  A security breach may also harm our reputation and make it more difficult or impossible for us to successfully market to others.  These matters could harm our operating results and financial condition.
 
 
13

 
We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

We expect that our sales cycles will be long and unpredictable due to a number of uncertainties such as:
 
 
·
The need to educate potential customers about our patent rights and our product and service capabilities;
 
 
·
Customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;
 
 
·
Customers’ budgetary constraints;
 
 
·
The timing of customers’ budget cycles; and
 
 
·
Delays caused by customers’ internal review processes.
 
 
·
Long sales cycles may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.
 
We expect that we will be substantially dependent on a concentrated number of customers.  If we are unable to establish, maintain or replace our relationships with customers and develop a diversified customer base, our revenues may fluctuate and our growth may be limited.

We expect that in the future, a significant portion of our revenues will be generated from a limited number of customers.  Substantially all of our income during 2010 was from the payments to us resulting from the Settlement and License Agreement we entered into with Microsoft. There can be no guarantee that we will be able to obtain additional customers, or if we do so, to sustain our revenue levels from these prospective customers.  If we are not able to establish, maintain or replace the limited group of prospective customers that we anticipate may generate a substantial majority of our revenues in the future, or if they do not generate revenues at the levels or at the times that we anticipate, our ability to maintain or grow our revenues will be adversely affected.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects.  Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers.  Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results and financial condition.  In addition, we could face claims for product liability, tort or breach of warranty, including claims relating to changes to our products made by our channel partners.  The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business.  Furthermore, we expect to provide implementation, consulting and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing and communications systems.  We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld.  Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products.  In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks we cannot control.

Our business will also depend upon the capacity, reliability and security of the infrastructure owned by third parties that we will use to deploy our offerings.  We have no control over the operation, quality or maintenance of a significant portion of that infrastructure or whether or not those third parties will upgrade or improve their equipment.  We depend on these companies to maintain the operational integrity of our connections.  If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted.  Also, to the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions.  System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish.  To the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures.  Our systems and operations will also be vulnerable to damage or interruption from:
 
 
·
power loss, transmission cable cuts and other telecommunications failures;
 
 
·
damage or interruption caused by fire, earthquake, and other natural disasters;
 
 
·
computer viruses or software defects; and
 
 
·
physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.
 
System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Any significant problem with our systems or operations could result in lost revenue, customer dissatisfaction or lawsuits against us.  A failure in the operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain names for a period of time.  A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation of assigned secure domain names for a period of time.  The inability of the registrar systems we establish, including our back office billing and collections infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial degradation in our customer support service and our ability to process registration requests in a timely manner.
 
 
14


Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post-deployment issues and provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products would be adversely affected, and our reputation with potential customers could be harmed.  In addition, as we expand our operations internationally, our technical support team will face additional challenges, including those associated with delivering support, training and documentation in languages other than English.  Our failure to deliver and maintain high-quality technical support services to our customers could result in customers choosing to use our competitors’ products instead of ours in the future.

Telephone carriers have petitioned governmental agencies to enforce regulatory tariffs, which, if granted, would increase the cost of online communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in service.  As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses over their traditional telephone networks.  If the relief sought in these petitions is granted, the costs of communicating via online could increase substantially, potentially adversely affecting the growth in the use of online secure communications.  Any of these developments could have an adverse effect on our business.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and may result in additional severance costs to us.

Our success largely depends on the skills, experience and efforts of our key personnel, including Kendall Larsen, our Chief Executive Officer and President.  We have no employment agreements with any of our key executives that prevent them from leaving us at any time.  In addition, we do not maintain key person life insurance for any of our officers or key employees.  The loss of Mr. Larsen, or our failure to retain other key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend in part on our ability to attract and retain qualified operations, marketing and sales personnel as well as engineers.  Inability to attract and retain such personnel could adversely affect our business.  Competition for engineering, sales, marketing and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where our facilities are located.  We can provide no assurance that we will attract or retain such personnel.

Risks Related to Our Stock

We do not intend to pay regular future dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.

Although we paid a special cash dividend to holders of our common stock with a record date of July 1, 2010, we do not have any plans to pay regular dividends in the foreseeable future.  Instead, we generally intend to retain future earnings to fund our business plan.  Our future dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities.  Accordingly, stockholders must generally look to appreciation of our common stock to realize a gain on their investment.  This appreciation may not occur.

The exercise of our outstanding stock options would result in a dilution of our current stockholders' voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.
 
The exercise of our outstanding vested stock options would dilute the ownership interests of our existing stockholders. As of December 31, 2011, we had outstanding options to purchase an aggregate of 4,906,998 shares of common stock (representing 9.7% of our total shares outstanding as of December 31, 2011) of which 3,965,140 are vested and therefore exercisable. To the extent outstanding stock options are exercised, additional shares of common stock will be issued, and such issuance would dilute non-exercising stockholders' percentage voting interests and increase the number of shares eligible for resale in the public market.
  
The fair value of accounting for our Series I Warrants as derivative liabilities may materially impact our results of our operations in future periods.

We record the Series I Warrants as a derivative liability in accordance with ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity.”  These derivative liabilities are reported at fair value each reporting period with changes in the fair value recognized as gain or loss during each reporting period.  An increase in our share price or measure of our share price volatility, for example, will generally result in an increase in the fair value of our warrant liability and a non-cash charge during the period of such increase, which could materially and negatively impact our results of operations in future periods.

 
15


Trading in our common shares is limited and the price of our common shares may be subject to substantial volatility, particularly in light of the instability in the financial and capital markets.

Our common stock is listed on NYSE Amex, but its daily trading volume has been limited, sporadic and volatile.  Over the past years the market price of our common stock has experienced significant fluctuations.  Between January 1, 2011, and December 31, 2011, the reported last sale price for our common stock ranged between $11.53 and $39.88 per share.  The price of our common stock may continue to be volatile as a result of a number of factors, some of which are beyond our control. These factors include, but not limited to, the following:
 
 
developments in any then-outstanding litigation;
 
 
quarterly variations in our operating results;
 
 
large purchases or sales of common stock;
 
 
actual or anticipated announcements of new products or services by us or competitors;
 
 
general conditions in the markets in which we compete; and
 
 
economic and financial conditions.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors.  We had a net loss of $12.5 million for the year ended December 31, 2009, a net income of $41.4 million for the year ended December 31, 2010, and we have had a net loss of $17.3 million for the year ended December 31, 2011.  The following include some of the factors that may cause our operating results to fluctuate:

 
the outcome of enforcement actions currently in progress or that we may undertake in the future, and the timing thereof;
 
the amount and timing of receipt of license fees from potential infringers, licensees or customers;
 
the outcome of actions we have taken and may take in the future to enforce our intellectual property rights;
 
the rate of adoption of our patented technologies;
 
the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc;
 
the success of a licensee in selling products that use our patented technologies; and
 
the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of December 31, 2011, our executive officers and directors beneficially owned approximately 21% of our then outstanding common stock.  In addition, a group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 12%, of our then outstanding common stock, have entered into a voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters submitted to the stockholders for a vote.  However, we cannot be certain how many shares of our common stock this group of stockholders currently owns.  Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests.  This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

Our protective provisions could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.

We have a number of protective provisions that could delay, discourage or prevent a third party from acquiring control of us without the approval of our Board of Directors.  Our protective provisions include:
 
 
A staggered Board of Directors: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting.  This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.
 
 
Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock.  Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you.  In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors.  We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.
 
 
Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting.  This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.
 
 
16

 
 
No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders.  Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.
 
 
Super majority requirement for stockholder amendments to the By-laws: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.
 
 
No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings of the stockholders.  This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In addition, the provisions of Section 203 of the Delaware General Corporate Law govern us.  These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.
 
These and other provisions in our amended and restated certificate of incorporation, our By-laws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions.

Not applicable
 
 
Our principal executive offices are located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada 89448.  We lease this property, which comprises approximately 2,090 square feet of office space, from a third party for a term that ends in 2013.  We have no other properties and believe that our office facility is suitable and appropriately supports our current business needs. Until October 2011, our principal executive offices were located at 5615 Scotts Valley Drive, Suite 110, Scotts Valley, California 95066, which we leased for a term that was scheduled to end in 2012.  In connection with the move of our corporate offices to Nevada, we terminated the Scotts Valley lease effective October 2011.
 

On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief. On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents. We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and a ruling is awaited. A jury trial is scheduled for November 13, 2012, in that lawsuit.
 
On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe three of our patents.  We seek damages and injunctive relief. On April 12, 2011 we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant.
 
A claim construction hearing date has been scheduled for July 12, 2011, and trial dates has been set for November 13, 2011, in that lawsuit.

On November 1, 2011, we initiated a new lawsuit against Apple in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Apple products infringe one or more claims of our U.S. Patent No. 8,051,181.  We seek damages and injunctive relief.  No hearing or trial dates have been set. On December 15, 2011, the court entered a stay of this matter pending the completion of ITC investigation.
 
On November 4, 2011, we filed a complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. The accused products include the latest iPhones, iPads, iPods and Macintosh computers. We have requested that the ITC institute an investigation into Apple’s allegedly infringing imports and ultimately bar Apple from importing those Apple products or further selling the infringing Apple products that have already been imported. A 16 month target date of April 6, 2013, has been set in this Case A 5 day hearing in front of the Administrative Law Judge (AJL) is scheduled for September 5 through September 11, 2012.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims.  Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims.  In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development.

Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

 
Not applicable
 
 
17


PART II
Our common stock currently trades under the symbol “VHC” on the NYSE Amex Stock Exchange. Common stock warrants that we issued in our January 2009 public offering that remain outstanding trade under the symbols “VHCOZ” and “VHCOL” on the OTC Bulletin Board.
 
The following table shows the price range of our common stock, as reported on the NYSE Amex Stock Exchange, for each quarter ended during the last three fiscal years.
 
Quarter Ended
 
High
   
Low
 
3/31/10
 
$
7.99
   
$
3.00
 
6/30/10
 
$
7.09
   
$
4.03
 
9/30/10
 
$
14.88
   
$
5.42
 
12/31/10
 
$
20.00
   
$
11.61
 
3/31/11
 
$
21.75
   
$
11.43
 
6/30/11
 
$
30.50
   
$
19.66
 
9/30/11
 
$
41.77
   
$
14.81
 
12/31/11
 
$
29.45
   
$
11.61
 
 
The closing price of our common stock on the NYSE Amex Stock Exchange on February 22, 2012 was $23.61 per share.
 
Holders
 
As of February 22, 2012, we had 49 stockholders of record. Because many of our shares of common stock are held of record by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial stockholders represented by such record holders.
 
Dividends
 
On June 15, 2010, the Company’s Board of Directors declared a special cash dividend of $0.50 per share of the Company’s common stock to holders of record on July 1, 2010.  We currently intend to retain all available funds and any future earnings to support the operation of and to finance the growth and development of our business.  We do not anticipate paying any cash dividends in the foreseeable future.  Any future determination to declare cash dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant.
 
 
18

 
Performance Graph
 
This performance graph shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference into any filing of VirnetX under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
 
The following graph compares the cumulative 5-year total return attained by shareholders on VirnetX Holding Corp's common stock relative to the cumulative total returns of the S&P 500 index and the RDG Technology Composite index. An investment of $100 (with reinvestment of all dividends) is assumed to have been made in our common stock and in each of the indexes on 12/31/2006 and its relative performance is tracked through 12/31/2011.
 
Image
The stock price performance reflected on this graph is not necessarily indicative of future stock price performance. See the disclosure in part I, Item 1A.  “Risk Factors”
 
      12/06       12/07       12/08       12/09       12/10       12/11  
                                                 
VirnetX Holding Corp
    100.00       675.86       170.11       337.93       1850.33       3111.30  
S&P 500
    100.00       105.49       66.46       84.05       96.71       98.75  
RDG Technology Composite
    100.00       115.01       65.30       105.06       118.52       118.29  

 Recent Sales of Unregistered Securities

During the year ended December 31, 2011, the Company had no sales of unregistered securities and no repurchases of stock.
The statement of operations data for the three years ended December 31, 2011, 2010 and 2009 and the balance sheet data at December 31, 2011 and 2010, respectively, are derived from, and qualified by reference to, our audited financial statements included elsewhere in this Annual Report on Form 10-K. The statements of operations data for the for the two years ended December 31, 2008 and 2007 and the balance sheet data at December 31, 2009, 2008 and 2007, respectively, are derived from our audited financial statements not included in this Annual Report on Form 10-K.

The selected consolidated financial data below are not necessarily indicative of future performance and should be read in conjunction with Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and related notes thereto included in Item 8 of this Annual Report on Form 10-K. 
 
    For the year ended December 31,  
   
 2011
   
 2010
   
 2009
   
2008
   
 2007
 
Consolidated Statement of Operations Data:
                             
Revenue
 
$
20
   
$
68
   
$
26
   
$
134
   
$
75
 
Gain on settlement
           
(200,000)
     
     
     
 
Other operating expenses
   
17,396
     
95,383
     
13,114
     
12,355
     
8,725
 
Net operating expenses
   
(17,376
)
   
(104,617)
     
13,114
     
12,355
     
8,725
 
Income tax expense (benefit)
   
(5,480)
     
34,062
     
     
     
 
Net (loss) income
   
(17,263)
     
41,417
     
(12,524
)
   
(12,072
)
   
(8,692
)
Earnings (loss) per share
 
$
(0.35)
   
$
0.91
   
$
(0.33
)
 
$
(0.35
)
 
$
(0.36
)
Dividends declared per common share
 
$
0.00
   
$
0.50
   
$
0.00
   
$
0.00
   
$
0.00
 
Consolidated Balance Sheet Data:
                                       
Cash and cash equivalents
 
$
49,482
   
$
34,635
   
$
2,011
   
$
457
     
8,589
 
Investments available for sale
   
14,438
     
43,457
     
     
     
 
Total assets
 
$
74,633
   
$
81,694
   
$
2,242
   
$
979
     
9,279
 
Long-term obligation
   
     
     
120
     
160
     
204
 
Stockholders’ equity (deficit)
 
$
68,277
   
$
59,453
   
$
(8,708
)
 
$
(894)
   
$
8,495
 
We develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines ndustry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.
 
Our portfolio of intellectual property is the foundation of our business model.  We currently own 20 patents in the United States and 26 foreign patents, as well as several pending U.S. and foreign patent applications.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry.  Our patented methods also have additional applications in operating systems and network security.  On December 2, 2009, we submitted a licensing declaration to the 3rd Generation Partnership Project, or 3GPP,identifying those of our U.S. and international patents which may be relevant to Long Term Evolution, or LTE. On March 14, 2011, we supplemented our licensing declaration to include five additional specifications. On April 28, 2011, at the request of the European Telecommunications Standards Institute, or ETSI, we agreed to update our licensing declaration to ETSI under ETSI's Intellectual Property Rights or IPR policy.  We agreed with ETSI that we will make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us, as set forth in the updated licensing declaration under ETSI’s IPR policy. On June 17, 2011, in response to a request from the Alliance for Telecommunications Industry Solutions, or ATIS, the North American Organizational Partner for 3GPP, we also agreed to make available a non-exclusive patent license to 3GPP members desiring to implement the technical specifications identified by us, as set forth in the updated licensing declaration under ATIS' IPR policy. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We intend to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators.  We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE wireless networks. We also believe that all 4G mobile devices will require unique secure domain names and become part of a secure domain name registry.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer and remote desktop.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.
 
In connection with the settlement of our lawsuit against Microsoft Corporation in 2010, Microsoft became our first licensee.  Pursuant to the Settlement and License Agreement between us and Microsoft, Microsoft paid us $200 million, which has been recognized as gain on settlement and Microsoft was granted a worldwide, irrevocable, nonexclusive, non-sublicenseable fully paid up license for our patents for Microsoft products.  We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.
 
Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Science Application International Corporation, or SAIC.  SAIC is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at SAIC and expanded the set of patents we acquired in 2006 from SAIC into a larger portfolio with 46 issued U.S. and foreign patents and numerous pending U.S. and foreign patent applications. This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.  Please see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Operations – Research and Development Expenses for a description of our research and development expenses for the past three fiscal years.  
 
We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.

 
21

 
Developments in the Year Ended December 31, 2011
 
Litigation

On January 12, 2011, we initiated a lawsuit by filing a complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these companies infringe two of our patents.  

On February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to assert U.S. Patent No. 7,418,504 against Apple and Aastra.

On April 5, 2011, we again amended our complaint against Aastra, Apple, Cisco and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, to include Apple's iPad 2 in the list of Apple products that are accused of infringing our patents.   We also asserted our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit.

Also on April 5, 2011, we amended our original complaint, filed on January 12, 2011, against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to assert our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit.

On April 12, 2011, we again amended our complaint against Siemens and Mitel in the United States District Court for the Eastern District of Texas, Tyler Division, to add Avaya Inc. as a defendant.  On November 1, 2011, we filed a new complaint against Apple Inc. in the United States District Court for the Eastern District of Texas, Tyler Division. The complaint includes allegations of patent infringement regarding our '181 patent. In our complaint, we seek both damages and injunctive relief.

On November 4, 2011, we filed a complaint with the United States International Trade Commission (ITC) alleging that Apple Inc. has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. The accused products include the latest iPhones, iPads, iPods, and Macintosh computers. We have requested that the ITC institute an investigation into Apple's allegedly infringing imports and ultimately bar Apple from importing those Apple products or further selling the infringing Apple products that have already been imported.
 
Patents

On March 15, 2011, we updated our original patent declaration from December 2, 2009 to ETSI and ATIS, to include five additional specifications in the (3rd Generation Partnership Project) or 3GPP Long-Term Evolution or (LTE) project and we indicated that we are willing, upon request, to make available a non-exclusive license under what is commonly referred to as RAND (reasonable terms and conditions that are free of any unfair discrimination) with respect to necessary claims that may issue from our identified patents and patent applications for the specifications indicated in our Statement of Patent Holder, as updated, to the extent adopted as a final standard, and subject to the conditions set forth in the Statement of Patent Holder.

On April 5, 2011, we were granted a new patent by the USPTO: U.S. Patent # 7,921,211, Agile Network Protocol for Secure Communications Using Secure Domain Names.

On April 26, 2011, we were granted a new patent by the USPTO: U.S. Patent # 7,933,990, Agile Network Protocol for Secure Communications with Assured System Availability.

On April 28, 2011, at the request of the European Telecommunications Standards Institute (ETSI), we agreed to update our licensing declaration and make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation), to 3GPP members desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under ETSI’s IPR policy.

On May 17, 2011, we were granted two patents by the United States Patent and Trademark Office, or USPTO:  U.S. Patent No.# 7,944,915, Third Party VPN Certification and U.S. Patent # 7,945,654, Agile Network Protocol for Secure Communications Using Secure Domain Names.

On July 08, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent# 6,502,135. The USPTO accepted this request and issued an order granting the reexamination on October 03, 2011. This was followed by the first non-final office action on February 15, 2012. Our response is due on April 15, 2012.

On July 11, 2011, Apple filed with the USPTO a request for a reexamination of our US Patent# 6,502,135. The USPTO accepted this request and issued an order granting the reexamination on October 03, 2011. This was followed by the first non-final office action on February 15, 2012. Our response is due on April 15, 2012.

On July 25, 2011, Apple filed with the USPTO a request for a reexamination of our US Patent# 7,490,151. The USPTO accepted this request and issued an order granting the reexamination on October 21, 2011. The USPTO has not issued the first non-final office action for this reexamination.

On July 26, 2011, we were granted two patents by the United States Patent and Trademark Office, or USPTO: U.S. Patent # 7,987,274 Method for Establishing Secure Communication Link Between Computers of Virtual Private Network and U.S. Patent # 7,986,688, Third Party Virtual Private Network Certification.

On August 2, 9011, we were granted a new patent by the USPTO: U.S. Patent # 7,996,539, Agile Network Protocol for Secure Communications with Assured System Availability.

On August 16, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent# 7,490,151. The USPTO accepted this request and issued an order granting the reexamination on October 31, 2011. The USPTO has not issued the first non-final office action for this reexamination.

On September 07, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent# 6,839,759. The USPTO accepted this request and issued an order granting the reexamination along with the first non-final office action on October 14, 2011. We responded to the first non-final office action on January 17, 2012. Cisco submitted its comments on our response to the USPTO on February 15, 2012. We are currently awaiting a response back from the USPTO.

On October 18, 2011, Apple filed with the USPTO a request for a reexamination of our US Patent# 7,418,504. The USPTO accepted this request and issued an order granting the reexamination along with the first non-final office action on December 29, 2011. Our response is due on March 29, 2012.

On October 18, 2011, Apple filed with the USPTO a request for a reexamination of our US Patent# 7,921,211. The USPTO accepted this request and issued an order granting the reexamination along with the first non-final office action on January 18, 2012. Our response is due on April 18, 2012.

On October 25, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent# 7,188,180. The USPTO denied this request on December 17, 2011. On January 17, Cisco filled a petition seeking a review of the order denying the reexamination request. No decision has been issued by the USPTO on this petition.
 
 
22

 
On November 1, 2011, we were granted a new patent by the USPTO: U.S. Patent # 8,051,181, ("the '181 patent"), Method for Establishing Secure Communication Link Between Computers of Virtual Private Network.

On December 13, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent # 7,418,504.The USPTO has not issued its decision on the request.

On December 16, 2011, Cisco filed with the USPTO a request for a reexamination of our US Patent # 7,921,211.The USPTO has not issued its decision on the request.

Commitments

On October 30, 2011, we entered into a new lease agreement with Sierra Tahoe Professional Center, LLC., for our corporate headquarters located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada 89448. The lease commencement date was October 30, 2011 and the lease term expires in 2013.

Audit

On January 25, 2011, our audit committee determined that the previously filed financial statements for: (i) the fiscal quarter ended September 30, 2009 included in the Form 10-Q filed with the SEC on November 9, 2009, (ii) the fiscal year ended December 31, 2009 included the Form 10-K filed with the SEC on March 31, 2010, (iii) the fiscal quarter ended March 31, 2010 included in the Form 10-Q filed with the SEC on May 7, 2010, (iv) the fiscal quarter ended June 30, 2010 included in the Form 10-Q filed with the SEC on August 9, 2010 and (v) the fiscal quarter ended September 30, 2010 included in the Form 10-Q filed with the SEC on November 8, 2010 (collectively, the “Periodic Reports”) should no longer be relied upon.  We determined that the financial statements contained in the Periodic Reports needed to be restated to correct our accounting for certain derivative instruments (the Series I Warrants we issued in 2009) in such financial statements, which were previously recorded as equity instruments. On January 31, 2011, amendments to the Periodic Reports were filed with the SEC with the restated financial statements.
 
Recent Developments

On January 5, 2012, a claims construction hearing was held in our case against Aastra, Apple, Cisco and NEC in the United States Distric Court for the Eastern District of Texas, Tyler Division. As of February 22, 2012 the judge had not issued his Markman order.
 
Critical Accounting Policies
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.  The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.
 
We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. ("U.S. GAAP"). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.
 
Reclassification of Gain on Settlement

In June 2010, we received $200,000 from Microsoft Corporation related to a licensing agreement and originally classified it as revenue. Upon further analysis, we determined that we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of  U.S. GAAP Accounting Standards Codification Topic 605: Revenue Recognition, or ASC Topic 605. As a result, we reclassified this amount in our 2010 financial statements to present it as a gain on settlement. This reclassification had no impact on our net income, financial position or cash flows for any period.

Revenue Recognition
 
We defer recognition of revenue in accordance with ASC Topic 605 until such time as all of the criteria below have been met:
 
 
persuasive evidence of sales arrangements;
 
 
delivery has occurred or services have been rendered;
 
 
the buyer’s price is fixed or determinable; and
 
 
collection is reasonably assured.

We expect that some or all of our future licensing agreements will provide for payments to us over an extended period of time.  For a licensing agreement with fixed royalty payments, we expect to recognize revenue as amounts become due.  For a licensing agreement with variable royalty payments we expect to recognize royalty revenue at the time that the licensees' sales occur; however, because we expect that a licensee may report sales information to us on a delayed basis, we expect our revenue recognition criterion may also be met on a delayed basis. 
 
Complex revenue arrangements may require us to make significant judgments, assumptions and estimates about when substantial delivery of contract elements will occur, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period  in which the completion of the earning process occurs. If new information subsequently becomes known to us which causes us to make different judgments, assumptions or estimates regarding material contracts, our financial results may be materially affected.
 
 
23

 
Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2011 and 2009, the Company has incurred losses; therefore, the effect of any Common Stock equivalent would be anti-dilutive during that period.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two financial institutions in the United States.  Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits.  The balances are insured by the Federal Deposit Insurance Corporation, or FDIC.  During the year ended December 31, 2011, 2010 and 2009, we had, at times, funds that were uninsured.  The uninsured balance at December 31, 2011, was approximately $29,185 compared to $9,900 for 2010 and $1,310 for 2009.  We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

Derivative Instruments
 
Our Series I Warrants contain an anti-dilutive provision which causes it to not be considered indexed to our stock. As a result, the warrants are required to be accounted for as derivative instruments.
 
We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.

Impairment of Long-Lived Assets
 
We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Income Taxes

Because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income.  We will, however, continue to assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized.  If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

Stock-based Compensation

We account for share-based compensation in accordance with the fair value method, which requires the measurement and recognition of compensation expense in the statement of operations for all share-based payment awards made to employees and directors including employee stock options based on estimated fair values.  Using the modified retrospective transition method of adopting this standard, the financial statements presented herein reflect compensation expense for stock-based awards as if the provisions of this standard had been applied from the date of our inception.
 
In addition, we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity investments issued as they vest over the performance period.
 
Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize observable inputs in markets other than active markets.

Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use quoted valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.
 
 
24

  
New Accounting Pronouncements
 
In May 2011, the FASB issued a new accounting standard update, which amends the fair value measurement guidance and includes some enhanced disclosure requirements.  The most significant change in disclosures is an expansion of the information required for Level 3 measurements based on unobservable inputs. The standard is effective for fiscal years beginning after December 15, 2011.  The adoption will not have a material impact on our consolidated financial statements and disclosures.
 
In June 2011, the FASB issued an amendment to an existing accounting standard which requires companies to present net income and other comprehensive income in one continuous statement or in two separate, but consecutive, statements.  In addition, in December 2011, the FASB issued an amendment to an existing accounting standard which defers the requirement to present components of reclassifications of other comprehensive income on the face of the income statement.  We will adopt this standard in the first quarter of 2012.
 
In September 2011, the FASB issued an amendment to an existing accounting standard, which provides entities an option to perform a qualitative assessment to determine whether further impairment testing on goodwill is necessary.  Specifically, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step test.  If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required.  Otherwise, no further testing is required.  This standard is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.  The adoption will not have a material impact on our consolidated financial statements.
 
 
25


Operations
 
Revenue - Royalties
 
Revenue generated for the twelve months ended December 31, 2011 was approximately $20 compared to $68 for the twelve months ended December 31, 2010 and $26 for the twelve months ended December 31, 2009. Our revenue in 2011, 2010 and 2009, was solely limited to the royalties earned under our single license agreement through our Japanese subsidiary.  We expect the revenue from this license will continue to be insignificant in the future.  We do not intend to seek additional licenses or other revenue through our Japanese subsidiary.

Gain on Settlement

In June 2010, we received $200,000 from Microsoft Corporation related to a licensing agreement and originally classified it as revenue. Upon further analysis, we determined that we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of U.S. GAAP Accounting Standards Codification Topic 605: Revenue Recognition, or ASC Topic 605. As a result, we reclassified this amount in our 2010 financial statements to present it as a gain on settlement. This reclassification had no impact on our net income, financial position or cash flows for any period. We did not receive a gain on settlement for the twelve months ended December 31, 2011 or 2009, respectively.

Royalty Expense

There was no royalty expense for the year ended December 31, 2011, compared to $59,207 for the year ended December 31, 2010, and zero for the year ended December 31, 2009. Under our agreements with SAIC, we were obligated to pay SAIC 35% of the proceeds from the settlement of litigation with Microsoft after reduction for costs, including legal fees and expenses, incurred by us and SAIC in connection with the Microsoft litigation.
 
Research and Development Expenses

Research and development costs include expenses paid to outside development consultants and compensation-related expenses for our engineering staff. Research and development costs are expensed as incurred.

Our research and development expenses for the year ended December 31, 2011 was $1,464 compared to $2,412 for the year ended December 31, 2010 and $864 for the year ended December 31, 2009. The decrease in 2011 was primarily due to the decrease in bonuses paid in 2011 compared to 2010. The increase in 2010 as compared to 2009, was primarily due to the increase in wages and medical costs and bonuses paid to our research and development staff.
 
Selling, General and Administrative Expenses

Selling, general and administrative expenses include compensation expense for management and administrative personnel, as well as expenses for outside legal, accounting, and consulting services.

Our selling, general and administrative expenses for the year ended December 31, 2011 was $15,932 compared to $33,764 for the year ended December 31, 2010 and $12,250 for the year ended December 31, 2009. The decrease in 2011 and increase in 2010 was primarily due to the increase in legal fees associated with the settlement of the Microsoft litigation in 2010. Legal fees represent approximately 40% of general and administrative expenses for 2011 as compared to 75% for 2010 and 57% for 2009.

Within selling, general and administrative expenses, legal fees for the year ended December 31, 2011 was $6,342 compared to $25,353 for the year ended December 31, 2010 and $6,942 for the year ended December 31, 2009. The increase in 2010 was primarily due to the increase in legal fees associated with the settlement of the Microsoft litigation.

Other Income and Expenses

Our non-cash loss related to the periodic revaluation of our Series I Warrants liability for the year ended December 31, 2011 was $5,595 compared to $30,516 for the year ended December 31, 2010 and $559 for the year ended December 31, 2009.  Our non-cash loss related to the periodic revaluation of our Series I Warrants liability decreased by $9,665 in the year ended December 31, 2011, as compared to the comparable period in 2010 as a result of a higher common share price and warrant exercises during the year ended 2011. Our Series I Warrants liability increased by $7,495 in the year ended December 31, 2010 as compared to the comparable period in 2009 mainly as a result of a higher common share price in 2010 as compared to 2009.

Interest income for the year ended December 31, 2011 was $228 compared to $1,310 for the year ended December 31, 2010, and $5 for the year ended December 31, 2009. These changes are due to timing on the maturity of the investments as well as the amount of cash available for investments.
 
Liquidity and Capital Resources

For the year ended December 31, 2011, our cash and cash equivalents totaled $49,482 and our short-term investments totaled $14,438 compared to $34,635 and $43,457, respectively, for the year ended December 31, 2010 and $2,011 and zero, respectively, as of December 31, 2009.

We recognized an unrealized loss on our investments of $4 for the year ended December 31, 2011 compared to $984 for the year ended December 31, 2010 and no gain or loss for the twelve months ended December 31, 2009, as we did not have any investments available for sale as of December 31, 2009. We have determined that this loss in 2011 and 2010 is temporary because the fair value of our investment securities is below the carrying value due to the changes in interest rates and we anticipate that this loss will be reversed over the securities remaining lives.
 
 
26

 
Before entering into the Microsoft Settlement, we allocated a large amount of  cash  to legal fees and other expenses associated with the Microsoft litigation.  We expect that our cash and cash equivalents as of December 31, 2011, will be sufficient to fund our operations and provide working capital for general corporate purposes and legal expenses including the expenses for our ongoing complaints against Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya in the United States District Court of the Eastern District of Texas, Tyler Division, as well as the complaint with the U.S. International Trade Commission, for at least the next 36 months.  While we do not expect to generate net income in the near term similar to in the net income generated during the year ended December 31, 2010, generally attributable to the Microsoft Settlement, we do expect to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry in the United States and other markets around the world over the long term.  However, we will not receive any proceeds from these claims unless and until they may be resolved in our favor, and we expect to continue to incur substantial legal and other costs associated with pursuit of our claims.

Contractual Commitments 

The following table summarizes our contractual obligations, including interest expense, and commitments as of December 31, 2011 
 
Operating Obligations
 
Total
   
Less than 1 year
   
1 - 3 Years
   
3 - 5 Years
   
More than 5 Years
 
                               
Operating Lease Obligations
    102       56       46       ---       ---  
                                         
Total
    102       56       46       ---       ---  

Off-Balance Sheet Arrangements
 
As of December 31, 2011, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.
 

Interest Rate Risk

We invest our excess cash primarily in highly liquid debt instruments of the time deposits, money market, and corporate debt securities. By policy, we limit the amount of credit exposure to any one issuer.

Investments in fixed rate earning securities carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.
 
We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term but would have an immaterial impact in the fair value of our marketable securities as they will be maturing in six months or less.

Although we have no obligation to settle our Series I Warrant obligations in cash or an unknown number of shares, the embedded liability in the Series I Warrant obligations is recorded at estimated fair value.  That estimated fair value is determined in large part by reference to our assumptions and estimates of various factors.  Notably, our liability will increase and we may incur significant non-cash expenses, all other factors being constant, if the market price of our common shares increases.  Conversely, our liability will decrease and we may recognize significant non-cash gains, all other factors being constant, if the market price of our common shares decreases 

We considered the historical volatility of our stock prices and determined that it was reasonably possible that the fair market value of our stock price could drastically increase in the near term but would have an immaterial impact to our consolidated balance sheets and statement of operations as there are only approximately 205,000 warrants outstanding.

FINANCIAL STATEMENTS
 
Financial Statements Index
 
 
Page
Report of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm
29
Consolidated Balance Sheets of VirnetX Holding Corporation as of December 31, 2011 and December 31, 2010
30
Consolidated Statements of Operations of VirnetX Holding Corporation for the years ended December 31, 2011, December 31, 2010 and December 31, 2009
31
Consolidated Statements of Stockholders’ Equity and Comprehensive Income (Loss) of VirnetX Holding Corporation for the years ended December 31, 2011, December 31, 2010 and December 31, 2009
32
Consolidated Statements of Cash Flows of VirnetX Holding Corporation for the years ended December 31, 2011, December 31, 2010 and December 31, 2009
33
Notes to Financial Statements of VirnetX Holding Corporation
34

 
28


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
Board of Directors and Shareholders
VirnetX Holding Corporation
 
We have audited the accompanying consolidated balance sheets of VirnetX Holding Corporation (the “Company”) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2011. VirnetX Holding Corporation’s management is responsible for these consolidated financial statements.  Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of VirnetX Holding Corporation, Inc. as of December 31, 2011and 2010, and the consolidated results of their operations, and cash flows for each of the three years in the period ended December 31, 2011, in conformity with accounting principles generally accepted in the United States of America.
 
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), VirnetX Holding Corporation’s internal control over financial reporting as of December 31, 2011, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 29, 2012 expressed an unqualified opinion as to the effectiveness of the Companys control over financial reporting.
 
 
/s/ Farber Hass Hurley LLP
   
Granada Hills, California
 
February 29, 2012
 
 
 
29

 
VirnetX Holding Corporation
 
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
   
As of December 31,
2011
   
As of December 31,
2010
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
49,482
   
$
34,635
 
Investments available for sale
   
14,438
     
43,457
 
Accounts receivable, net
   
     
3
 
Prepaid taxes
   
10,459
     
 
Deferred tax benefit
   
     
1,735
 
Prepaid expenses and other current assets
   
91
     
86
 
Total current assets
   
74,470
     
79,916
 
Property and equipment, net
   
56
     
25
 
Intangible and other assets
   
60
     
108
 
Deferred tax benefit
   
47
     
1,645
 
Total assets
 
$
74,633
   
$
81,694
 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable and accrued liabilities
 
$
1,227
   
$
519
 
Income tax liability
   
430
     
7,358
 
Derivative liability
   
4,699
     
14,364
 
Total current liabilities
   
6,356
     
22,241
 
Stockholders' equity:
               
Preferred stock, par value $0.0001 per share
               
Authorized: 10,000,000 shares at December 31, 2011 and 2010, respectively
               
Issued and outstanding: 0 shares at December 31, 2011 and 2010, respectively
   
     
 
Common stock, par value $0.0001 per share
               
Authorized: 100,000,000 shares at December 31, 2011 and 2010, respectively Issued and outstanding:
 50,619,136 shares and 49,341,028 shares, at December 31, 2011 and 2010, respectively
   
5
     
5
 
Additional paid-in capital
   
104,277
     
78,187
 
Accumulated deficit
   
(36,001
)
   
(17,755
)
Accumulated other comprehensive loss
   
(4
)
   
(984
Total stockholders' equity
   
68,277
     
59,453
 
Total liabilities and stockholders' equity
 
$
74,633
   
$
81,694
 
 
The accompanying notes are an integral part of these consolidated financial statements

 
30

 
VirnetX Holding Corporation
 
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
 
   
Year Ended December 31, 2011
   
Year Ended December 31, 2010
   
Year Ended December 31, 2009
 
Revenue - Royalties
  $ 20     $ 68     $ 26  
Operating expenses:
                       
Royalty expense
          59,207        
Research and development
    1,464       2,412       864  
General, selling  and administrative
    15,932       33,764       12,250  
Gain on settlement
          (200,000 )      
Total operating expenses
    17,396       (104,617 )     13,114  
Income (loss) from operations
    (17,376 )     104,685       (13,088 )
Gain (loss) on change in value of embedded derivative and warrants
    (5,595 )     (30,516 )     559  
Interest income, net
    228       1,310       5  
Income (loss) before taxes
    (22,743 )     75,479       (12,524 )
Income tax expense (benefit)
    (5,480 )     34,062        
Net Income (loss)
  $ (17,263 )   $ 41,417     $ (12,524 )
Basic earnings (loss) per share:
  $ (0.35 )   $ 0.91     $ (0.33 )
Diluted earnings (loss) per share:
  $ (0.35 )   $ 0.84     $ (0.33 )
Weighted average shares outstanding basic
    50,028,413       45,452,550       37,911,340  
Weighted average shares outstanding dilutive
    50,028,413       49,066,704       37,911,340  
Dividends declared per common share
  $     $ 0.50     $  

The accompanying notes are an integral part of these consolidated financial statements

 
31

 
VirnetX Holding Corporation
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
AND COMPREHENSIVE INCOME (LOSS)
(in thousands, except share and per share amounts)
 
                           
Other
   
Total
 
               
Additional
   
Accumulated
   
Comprehensive
   
Stockholders'
 
   
Common Stock
   
Paid-in
   
Deficit
   
Income
   
Equity
 
   
Shares
   
Amount
   
Capital
   
 
   
(Expense)
   
(Deficit)
 
Balance at December 31, 2008
    34,899,985     $ 3.50     $ 22,150     $ (23,048 )   $ -     $ (895 )
Stock issued for cash at $1.50 per share,net
    2,470,000       .30       3,273                       3,274  
Stock issued for cash at $2.52 per share,net
    2,380,942       .20       5,400                       5,400  
Deferred offering costs
                    (125 )                     (125 )
Stock-based compensation
                    3,032                       3,032  
Derivative liability
                    (6,869 )                     (6,869 )
Net loss
                            (12,524 )             (12,524 )
Balance at December 31, 2009
    39,750,927       4.00       26,861       (35,572 )     -       (8,707 )
                                                 
Stock issued for cash exercise of warrants at $2.52 per share, net
    2,380,943       .24       5,395                       5,395  
Stock issued for cash exercise of warrants at $2.00 per share, net
    1,233,741       .12       2,354                       2,354  
Stock issued for cash exercise of warrants at $3.00 per share, net
    1,235,000       .12       3,750                       3,750  
Stock issued for cash exercise of warrants at $4.00 per share, net
    1,235,000       .12       4,945                       4,945  
Stock issued for cash exercise of warrants at $1.80 per share, net
    220,000       .02       396                       396  
Stock issued for cash exercise of warrants at $4.80 per share, net
    228,648       .02       1,098                       1,098  
Stock issued for cash exercise of warrants at $3.93-3.59 per share, net
    1,787,620       .17       6,593                       6,593  
Stock issued for cash exercise of options, net
    1,269,149       .12       1,404                       1,404  
Stock-based compensation
                    3,381                       3,381  
Deferred tax benefit related to stock based compensation
                    528                       528  
Fees and commissions
                    (980 )                     (980 )
Derivative liability
                    22,462                       22,462  
Dividend
                            (23,600 )             (23,600 )
Components of comprehensive income:                                                
Net Income
                            41,417               41,417  
Change in unrealized loss on investment
                                    (984 )     (984 )
Comprehensive income
                                            40,433  
Balance at December 31, 2010
    49,341,028       4.93       78,187       (17,755 )     (984 )     59,453  
                                                 
Stock issued for cash exercise of warrants at $3.93-3.59 per share, net
    855,536       .09       3,063                       3,063  
Stock-based compensation
                    4,368                       4,368  
Deferred tax benefit related to stock based compensation
                    2,331                       2,331  
Derivative liability
                    15,260                       15,260  
Cashless exercise of $4.80 underwriter warrants
    24,178                                       --  
Exercise of options
    398,394       .04       1,068                       1,068  
Components of comprehensive income:                                                
Reclassification adjustment for net loss included in net income
                            (983 )     983       --  
Net loss
                            (17,263 )             (17,263 )
Change in unrealized loss on investment
                                    (3 )     (3 )
Comprehensive loss
                                            (17,266 )
Balance at December 31, 2011
    50,619,136     $ 5.06     $ 104,277     $ (36,001 )   $ (4 )   $ 68,277  
 
The accompanying notes are an integral part of these consolidated financial statements

 
32


VirnetX Holding Corporation
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, except share and per share amounts)
 
   
Year Ended December 31, 2011
   
Year Ended December 31, 2010
   
Year Ended December 31, 2009
 
Cash flows from operating activities:
                 
Net income (loss)
  $ (17,263 )   $ 41,417     $ (12,524 )
Adjustments to reconcile net income (loss) to net cash used in operating activities:
                       
Depreciation and amortization
    68       59       63  
Stock-based compensation
    4,367       3,381       3,032  
Net change in deferred taxes (benefit)
    5,663       (2,851 )      
Change in value of derivative liability
    5,595       30,516       (559 )
Changes in assets and liabilities:
                       
Receivables and other current assets
    (3     (39 )     140  
Prepaid taxes
    (10,459 )           94  
Accounts payable and accrued liabilities
    708       (3,960 )     2,809  
Income tax liability
    (6,928 )     7,358          
Net cash provided by (used in) operating activities
    (18,252 )     75,881       (6,945 )
Cash flows from investing activities:
                       
Purchase of property and equipment
    (51 )     (13 )     (6 )
Purchase of investments
    (34,082 )     (44,441 )      
Proceeds from sale, maturity of investments
    63,101              
Net cash provided by (used in) investing activities
    28,968       (44,454 )     (6 )
Cash flows from financing activities:
                       
Payment of royalty obligation less imputed interest
          (160 )     (44 )
Payment of dividend
          (23,599 )      
Proceeds from exercise of options
    1,068       1,341        
Proceeds from exercise of warrants
    3,063       23,615        
Proceeds from sales of common stock
                8,549  
Net cash provided by financing activities
    4,131       1,197       8,505  
Net increase in cash and cash equivalents
    14,847       32,623       1,554  
Cash and cash equivalents, beginning of year
    34,635       2,011       457  
Cash and cash equivalents, end of year
  $ 49,482     $ 34,635     $ 2,011  
Supplemental disclosure of cash flow information:
                       
Cash paid during the year for taxes
  $ 9,600     $ 29,556     $ 2  
Cash paid during the year for interest
  $     $ 10     $ 6  

The accompanying notes are an integral part of these consolidated financial statements

 
33


VirnetX Holding Corporation
NOTES TO FINANCIAL STATEMENTS
(in thousands except share and per share amounts)
 
Note 1 - Formation and Business of the Company
 
VirnetX Holding Corporation, which we refer to as we, us, our, the Company or VirnetX, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets.   To date our revenue has been limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement.
 
Note 2 - Summary of Significant Accounting Policies
 
Basis of Presentation
 
The consolidated financial statements include the accounts of VirnetX Holding Corporation and all wholly-owned subsidiaries. All material intercompany accounts and transactions have been eliminated. Certain prior year amounts have been reclassified to conform to current year presentations.
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.
 
Revenue Recognition
 
We defer recognition of revenue in accordance with ASC Topic 605 until such time as all of the criteria below have been met:
 
 
persuasive evidence of sales arrangements;
 
 
delivery has occurred or services have been rendered;
 
 
the buyer’s price is fixed or determinable; and
 
 
collection is reasonably assured.

We expect that some or all of our future licensing agreements will provide for payments to us over an extended period of time.  For a licensing agreement with fixed royalty payments, we expect to recognize revenue as amounts become due.  For a licensing agreement with variable royalty payments we expect to recognize royalty revenue at the time that the licensees' sales occur; however, because we expect that a licensee may report sales information to us on a delayed basis, we expect our revenue recognition criterion may also be met on a delayed basis. 
 
Complex revenue arrangements may require us to make significant judgments, assumptions and estimates about when substantial delivery of contract elements will occur, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period  in which the completion of the earning process occurs. If new information subsequently becomes known to us which causes us to make different judgments, assumptions or estimates regarding material contracts, our financial results may be materially affected.
 
Cash and Cash Equivalents
 
We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents.

Investments
 
Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gain and losses are reported as other comprehensive income. Realized gains and losses are included in income in the period they are realized.  The Company's investments consist of debt securities with maturity dates primarily less than nine months.
 
Property and Equipment
 
Property and equipment are stated at historical cost, less accumulated depreciation and amortization.  Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years.  Repair and maintenance costs are charged to expense as incurred.
  
Concentration of Credit Risk and Other Risks and Uncertainties
 
Our cash and cash equivalents are primarily maintained at two financial institutions in the United States.  Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits.  The balances are insured by the Federal Deposit Insurance Corporation or (FDIC).  During the year ended December 31, 2011, we had, at times, funds that were uninsured.  The uninsured balance at December 31, 2011 was $29,185. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.
 
 
34

 
Fair Value of Financial Instruments 

The carrying amounts of our financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Intangible Assets
 
We record intangible assets at cost, less accumulated amortization.  Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.
 
Impairment of Long-Lived Assets
 
We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
 
Research and Development
 
Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff.  Research and development costs are expensed as incurred.
 
Income Taxes
 
The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. See Note 12, “Income Taxes” of this Form 10-K for additional information.
 
Derivative Instruments
 
Our Series I Warrants contain an anti-dilutive provision which causes it to not be considered indexed to our stock.  As a result, the warrants are required to be accounted for as derivative instruments.
 
We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value.  We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.
 
Stock-Based Compensation
 
Our accounting for share-based compensation is in accordance with the fair value method which requires the measurement and recognition of compensation expense in the statement of operations for all share-based payment awards made to employees and directors including employee stock-options based on estimated fair values.  Using the modified retrospective transition method of adopting this standard, the financial statements presented herein reflect compensation expense for stock-based awards as if the provisions of this standard had been applied from the date of inception.
 
In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.
 
Earnings Per Share
 
Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2011 and 2009, the Company has incurred losses; therefore the effect of any Common Stock equivalent would be anti-dilutive during that period.
 
New Accounting Pronouncements
 
In May 2011, the FASB issued a new accounting standard update, which amends the fair value measurement guidance and includes some enhanced disclosure requirements.  The most significant change in disclosures is an expansion of the information required for Level 3 measurements based on unobservable inputs. The standard is effective for fiscal years beginning after December 15, 2011. We do not expect the adoption to have a material impact on our consolidated financial statements and disclosures.
 
In June 2011, the FASB issued an amendment to an existing accounting standard which requires companies to present net income and other comprehensive income in one continuous statement or in two separate, but consecutive, statements.  In addition, in December 2011, the FASB issued an amendment to an existing accounting standard which defers the requirement to present components of reclassifications of other comprehensive income on the face of the income statement.  We will adopt this standard in the first quarter of 2012.
 
In September 2011, the FASB issued an amendment to an existing accounting standard, which provides entities an option to perform a qualitative assessment to determine whether further impairment testing on goodwill is necessary.  Specifically, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step test.  If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required.  Otherwise, no further testing is required.  This standard is effective for annual and interim goodwill impairment test performed for fiscal years beginning after December 15, 2011. We do not expect the adoption to have a material impact on our consolidated financial statements.
 
 
35

 
Note 3 - Property 
 
Our major classes of property and equipment were as follows:
 
      December 31  
   
2011
   
2010
   
2009
 
Office furniture
  $ 57     $ 22     $ 22  
Computer equipment
    91       75       62  
Total
    148       97       84  
Less accumulated depreciation
    (92 )     (72 )     (61 )
    $ 56     $ 25     $ 23  
 
Depreciation expense for the years ended December 31, 2011, 2010 and 2009 was $20, $11 and $15 respectively.
 
Note 4 - Commitments
 
We lease our offices under an operating lease with a third party that requires minimum payments monthly until it ends in June 2013.  We recognize rent expense on a straight-line basis over the term of the lease.
 
For the Year
 
Minimum Required Lease Payments in Period
 
2012
 
$
56
 
2013
   
46
 
Total
 
$
102
 

 
36

 
Note 5 - Stock Plan
 
In 2005, VirnetX, Inc. adopted the 2005 Stock Plan (the "Plan"), which was assumed by us upon the closing of the transaction between VirnetX Holding Corporation and VirnetX, Inc. on July 5, 2007.  Our Board of Directors renamed this Plan the VirnetX Holding Corporation 2007 Stock Plan and our stockholders approved the Plan at our 2008 annual stockholders' meeting.  The Plan provides for the issuance of up to 11,624,469 shares of our common stock.  To the extent that any award should expire, become unexercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan.  The Plan provides for the granting of stock options and stock purchase rights to our employees and consultants.  Stock options granted under the Plan may be incentive stock options or nonqualified stock options.  Incentive stock options ("ISO") may only be granted to our employees (including officers and directors).  Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.
 
The Plan will expire 10 years after it was approved by our Board of Directors.  Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the case of an NSO,  the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant.
 
Activity under the Plan is as follows:
 
    Options Outstanding  
   
Shares Available for Grant
   
Number of Shares
   
Weighted Average Exercise Price
 
Balance at December 31, 2008
    2,651,392       4,468,595     $ 2.98  
Restricted stock granted
                 
Options granted
    (1,317,195 )     1,317,195       1.18  
Options exercised
                 
Options cancelled
    83,031              
Balance at December 31, 2009
    1,417,228       5,785,790       2.57  
Restricted stock granted
                 
Options granted
    (345,250 )     345,250       5.53  
Options exercised
            (1,269,149     1.11  
Options cancelled
    31,500       (31,500 )     5.48  
Balance at December 31, 2010
    1,103,478       4,830,391     $ 3.14  
Restricted stock granted
                 
Options granted
    (475,000 )     475,000       23.80  
Options exercised
            (398,393 )     2.68  
Options cancelled
                 
Balance at December 31, 2011
    628,478       4,906,998     $ 5.12  
 
 
37

 
Note 6 - Stock-Based Compensation
 
We account for equity instruments issued to employees in accordance with the fair value method which requires that such issuances be recorded at their fair value on the grant date.  The recognition of the expense is subject to periodic adjustment as the underlying equity instrument vests.
 
Stock-based compensation expense is included in general and administrative expense for each period as follows:
 
Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2011
   
Year Ended
December 31, 2010
   
Year Ended
December 31, 2009
 
Employee stock options
  4,367     3,381     3,032  
Total stock-based compensation
  $ 4,367     $ 3,381     $ 3,032  

As of December 31, 2011, the unrecorded deferred stock-based compensation balance related to stock options was $9,697, which will be amortized as expense over an estimated weighted average vesting amortization period of approximately 0.7 years, as compared to $4,027 and 1.2 years for 2010 and $5,741 and 1.6 years for 2009.
 
The fair value of each option grant was estimated on the date of grant using the following weighted average assumptions:
 
   
Year Ended
December 31, 2011
 
Year Ended
December 31, 2010
 
Year Ended
December 31, 2009
Expected stock price volatility
    123
%
       110
%
      120
%
Risk-free interest rate
    3.05
%
    3.66
%
    2.93
%
Expected life term (in years)
    6.6
 years
   
7.0
 years
    6.6
 years
Expected dividends
    0
%
    0
%
    0
%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $21.13, $4.83 and $1.06 during the years ended December 31, 2011, 2010 and 2009 respectively.
 
The expected life was determined using the simplified method outlined in FASB Codification Topic 718, taking the average of the vesting term and the contractual term of the option.  Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle.  We have not provided an estimate for forfeitures because we have no history of forfeited options and believe that all outstanding options at December 31, 2011, will vest.  In the future, the Company may change this estimate based on actual and expected future forfeiture rates.
 
The following table summarizes activity under the Plan for the indicated periods:
 
   
Number of
Shares
   
Weighted Average Exercise
Price
   
Weighted Average Remaining Contractual
Life (Years)
   
Aggregate Intrinsic
Value
 
Outstanding at December 31, 2008
   
4,468,595
    $
2.98
     
     
 
Options granted
   
1,317,195
     
1.18
     
     
 
Options exercised
   
     
     
     
 
Options cancelled
   
     
     
     
 
Outstanding at December 31, 2009
   
5,785,790
     
2.57
     
     
 
Options granted
   
345,250
     
5.53
     
     
 
Options exercised
   
(1,269,149
)
   
1.11
     
     
 
Options cancelled
   
(31,500
)
   
5.48
     
     
 
Outstanding at December 31, 2010
   
4,830,391
     
3.14
                 
Options granted
   
475,000
     
23.30
     
     
 
Options exercised
   
(398,393
)
   
2.68
     
     
 
Options cancelled
   
     
     
     
 
Outstanding at December 31, 2011
   
4,906,998
   
$
5.12
     
6.43
   
$
97,385
 
 
Intrinsic value is calculated at the difference between the per share market price of our common stock on the last trading day of 2011 was $24.97 and the exercise price of the options.  For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.

 
38


The following table summarizes information about stock options outstanding at December 31, 2011:
 
     
Options Outstanding
   
Options Vested and Exercisable
 
Date of Option Issue    
Range of
Exercise Prices
   
Number
Outstanding
   
Weighted Average
Remaining
Contractual Life (Years)
   
Weighted Average
Exercise Price
   
Number Exercisable
   
Weighted Average
Remaining
Contractual Life (Years)
   
Weighted Average
Exercise Price
 
2006     $ 0.24      
690,612
     
4.22
   
$
0.24
     
690,612
     
4.22
   
$
0.24
 
2007       4.20      
1,312,899
     
5.56
     
4.20
     
1,312,899
     
5.56
     
4.20
 
2007       5.88-6.47      
697,026
     
6.00
     
6.06
     
697,026
     
6.00
     
6.06
 
2008       1.74-6.20      
250,016
     
6.46
     
4.39
     
221,294
     
6.45
     
4.52
 
2009       1.15- 1.58      
1,167,695
     
7.26
     
1.16
     
799,297
     
7.27
     
1.17
 
2010       5.48-6.03      
313,750
     
8.18
     
5.47
     
160,055
     
8.21
     
5.41
 
2011       19.85-23.62      
475,000
     
9.42
     
23.30
     
83,957
     
9.38
     
23.58
 
               
4,906,998
     
6.43
   
$
5.12
     
3,965,140
     
5.99
   
$
3.70
 
 
Note 7 - Earnings Per Share
 
Basic earnings per share are based on the weighted average number of shares outstanding for a period.  Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding.  Potential common shares outstanding principally include stock options, warrants, under our stock plan.  During 2011 and 2009, the Company has incurred losses; therefore the effect of any common stock equivalent would be anti-dilutive during that period.
 
The table below sets forth the basic loss per share calculations:
 
 
Period Ended December 31,
 
 
2011
   
2010
   
2009
 
Net income (loss)
$ (17,263 )   $ 41,417     $ (12,524 )
Weighted average number of shares outstanding
  50,547       45,453       37,911  
Diluted weighted average number of shares outstanding
  50,547       49,067       37,911  
Basic earnings (loss) per share
$ (0.35 )   $ 0.91     $ (0.33 )
Diluted earnings (loss) per share
$ (0.35 )   $ 0.84     $ (0.33 )
 
For the years ended December 31, 2011, 2010 and 2009, there were the following stock equivalents:
 
   
2011
   
2010
   
2009
 
Options
    4,906,998       4,830,391       5,785,790  
Warrants
    204,908       1,090,444       12,271,946  
 
Note 8 - Preferred Stock
 
Our Amended and Restated Certificate of Incorporation, as amended in October 2007, authorizes us to issue 10,000,000 shares of $0.0001 par value per share preferred stock having rights, preferences and privileges to be designated by our Board of Directors.  There were no shares of preferred stock outstanding at December 31, 2011.
 
Note 9 - Common Stock
 
Each share of common stock has the right to one vote.  The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends.  On June 15, 2010, the Company's Board of Directors declared a special cash dividend of $0.50 per share of the Company's common stock to holders of record on July 1, 2010.  Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.
 
 
39


Note 10 - Warrants
 
Information about warrants outstanding during the twelve months ended December 31, 2011 follows:

Original Number of
Warrants Issued
   
Exercise
Price per Common Share
   
Exercisable
at
December 31, 2010
   
Became Exercisable
   
Exercised
   
Terminated /
Cancelled /
Expired
   
Exercisable
at December 31, 2011
 
Expiration
Date
                                         
  300,000     $ 4.80       30,000             (30,000 )            
December 2012
  2,619,036 (1)   $ 3.59       1,060,444             (855,536 )           204,908  
March 2015
Total
              1,090,444               (885,536 )           204,908    
 
 
(1)
Referred to as our Series I Warrants.

Note 11 - Employee Benefit Plan
 
We sponsor a defined contribution, 401k plan, covering substantially all our employees.  The Company's matching contribution to the plan was approximately, $36 in 2011, $36 in 2010 and $36 in 2009 respectively.
 
Note 12 - Income Taxes
 
The components of the income tax expense for the years ended December 31, 2011, 2010 and 2009 are as follows:

   
Year Ended
December 31, 2011
   
Year Ended
December 31, 2010
   
Year Ended
 December 31, 2009
 
Current:
                 
Federal
  $ (8,036 )   $ 27,822       -  
State
    (767 )     9,609       -  
Foreign
    (9 )     11       -  
      (8,812 )     37,442       -  
Deferred:
                       
Federal
    3,331       (3,380 )     -  
State
    1       -       -  
Foreign
    -       -       -  
      3,332       (3,380 )     -  
Total provision for income taxes
  $ (5,480 )   $ 34,062       -  

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

   
Year Ended
December 31, 2011
   
Year Ended
December 31, 2010
   
Year Ended
December 31, 2009
 
United States federal statutory rate
    35.00 %     35.00 %     35.00 %
State taxes, net of federal benefit
    2.19 %     8.28 %     0.00 %
Valuation allowance
    (4.39 %)     (9.69 %)     (33.96 %)
Stock options
    (1.92 %)     0.00 %     0.00 %
Warrants
    (8.60 %)     14.15 %     (2.07 %)
Other
    1.79 %     (3.64 %)     1.03 %
Balance at the end of the year
    24.07 %     44.10 %     0.00 %

As allowed by ASC 740, Income Taxes, we used the actual effective tax rate for the year ended December 31, 2011 because our 2011 annual profit before tax is not estimable at this time.  To the extent our expected profitability changes during the year, the effective tax rate would be revised to reflect the change.

 
40


Deferred tax assets (liabilities) consist of the following:

   
Year Ended
 December 31, 2011
   
Year Ended
 December 31, 2010
   
Year Ended
December 31, 2009
 
Deferred tax assets:
                 
Reserves and accruals
  $ 46     $ 53     $ -  
State tax
    1       3,326       -  
Research and development credits and other credits
    -       225       500  
Net operating loss carry forward
    2,822       372       10,500  
Stock based compensation
    3,155       3,109       -  
Other
    211       -       -  
Total deferred tax assets
    6,235       7,085       11,000  
                         
Valuation allowance
    (6,168 )     (3,687 )     (11,000 )
Deferred tax assets after valuation allowance
    67       3,398       -  
                         
Deferred tax liability
                       
Depreciation and amortization
    (20 )     (18 )     -  
              -       -  
Total deferred tax liability
    (20 )     (18 )     -  
                         
Net deferred tax assets
  $ 47     $ 3,380     $ -  
 
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized.  The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.

Based on the available objective evidence, we believe it is more likely than not that the net deferred tax assets as of December 31, 2011 will not be fully realizable. Accordingly, management has maintained partial valuation allowance against its net deferred tax assets at December 31, 2011. The net change in the total valuation allowance for the year ended December 31, 2011 was an increase of $1,000 and $2,488 for state and federal deferred tax assets, respectively. At December 31, 2011, the Company has federal and state net operating loss carryforwards of approximately $913 and $43,565, respectively expiring in 2027 and 2012, respectively. At December 31, 2011, the Company has federal research and development credits carryforwards of approximately zero expiring beginning in 2031.
 
 
Internal Revenue Code Section 382 places a limitation (the "Section 382 Limitation") on the amount of taxable income can be offset by net operating carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carryforward in excess of the Section 382 Limitation. Management has analyzed analysis on the utilization of its net operating loss carryforward against taxable income in future periods and determined on a more likely than not basis it will be able to use all its recognized net operating losses before they expire.
 
We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have reduced our gross deferred tax assets by zero and $128 at December 31, 2011 and December 31, 2010, respectively, for certain tax benefits which may not be sustained upon examination, and we have provided an offset through equal reductions in our deferred tax asset, which offsets by an equal reduction in the valuation allowance. Our tax returns are subject to review by various tax authorities. The returns are subject to review those from 2008 forward.
 
Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We did not have associated accrued interest or penalties nor was any interest expense or penalties recognized during the year ended December 31, 2011.
 
A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:

   
Year Ended
December 31, 2011
   
Year Ended
December 31, 2010
   
Year Ended
December 31, 2009
 
Balance at the beginning of the year
  $ 128     $ -     $ -  
Additions based on tax positions related to the current year
    -       -       -  
Additions for tax positions of prior years
    -       128       -  
Settlements
    -       -       -  
Lapse of applicable statute of limitations
    -       -       -  
Balance at the end of the year
  $ 128     $ 128     $ -  

 
41


Note 13 - Fair Value Measurement
 
Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize observable inputs in markets other than active markets.
 
Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.
 
Certificate of deposits: Fair value measured at face value plus accrued interest.
 
Corporate bonds:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.
 
Series I Warrants: Fair value measured by using a Binomial valuation model.  As of December 31, 2011, the assumptions used to measure fair value of the liability embedded in our outstanding Series I Warrants included a warrant exercise price of $3.59 per share, a common share price of $24.97, a discount rate of 0.83%, and a volatility of 123%.
 
The following table sets forth by level, within the fair value hierarchy, our financial instrument assets as of December 31, 2011:
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Certificates of deposit
 
$
2,584
     
     
   
$
2,584
 
                                 
Corporate Bonds:
                               
AA
   
2,011
     
     
     
2,011
 
A
   
9,843
     
     
     
9,843
 
Total Corporate Bonds
   
11,854
     
     
     
11,854
 
                                 
Total Investments at Fair Value
 
$
14,438
     
     
   
$
14,438
 
 
The following table sets forth, by level within the fair value hierarchy, our financial instrument liabilities as of December 31, 2011 (in thousands):
 
   
Quoted
Prices in
Active
Markets for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
       
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
 
$
   
$
   
$
4,699
   
$
4,699
 
Total
 
$
   
$
   
$
4,699
   
$
4,699
 
 
The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2011 (in thousands):
 
   
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2010
 
$
14,364
 
Net loss included in earnings
   
5,595
 
Settlements
   
(15,260
)
Balance December 31, 2011
 
$
4,699
 

 
42


Note 14 - Patent Portfolio
 
As of September 30, 2011, we own 20 issued U.S. and 26 issued foreign patents, in addition to several pending U.S. and foreign patent applications.  Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours.
 
As of December 31, 2011, the expected future amortization of the intangible assets is as follows:
 
2012
 
 $
48
 
2013
   
12
 
Total
 
$
60
 

Note 15 - Litigation
 
We have three intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181.
 
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra Technologies, Inc., Apple, Inc., Cisco Systems, Inc., and NEC Corporation.
 
On January 12, 2011, we initiated a new lawsuit by filing a complaint against Siemens Enterprise Communications and Mitel Networks Corp. On April 12, 2011, we amended this complaint to add Avaya, Inc., as a defendant.
 
We believe that Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya infringe on certain of our patents, but obtaining and collecting a judgment against these parties may be difficult or impossible.  Patent litigation is inherently risky and the outcome is uncertain.  Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya are all large, well-financed companies with substantially greater resources than us.  We believe that these parties will devote a substantial amount of resources in an attempt to prove that either their products do not infringe our patents or that our patents are invalid and unenforceable.  At this time, we cannot predict the final outcome of these litigation matters.

On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes an additional patent of ours.  We seek damages and injunctive relief.  No hearing or trial dates have been set.

On November 4, 2011, We filed a complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. The accused products include the latest iPhones, iPads, iPods and Macintosh computers. We have requested that the ITC institute an investigation into Apple’s allegedly infringing imports and ultimately bar Apple from importing those Apple products or further selling the infringing Apple products that have already been imported

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims.  Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims.  In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development.
 
Note 16 - Quarterly Financial Information (unaudited)
 
   
First
   
Second
   
Third
   
Fourth
 
   
(in thousands except per share)
 
2011
                       
Revenue
 
$
16
   
$
1
   
$
3
   
$
-
 
Income (loss) from operations
   
(2,752
)
   
(3,754)
     
(4,180
)
   
(6,690
)
Net (loss) income
   
(7,122
)
   
(9,805)
     
 5,879
     
(6,215
)
Basic earnings (loss) per common share
 
$
(0.14
)
 
$
(0.20)
   
$
0.12
   
$
(0.12
)
Diluted earnings (loss) per common share
 
$
(0.14
)
 
$
(0.20)
   
$
0.11
   
$
(0.12
)
 
   
First
   
Second
   
Third
   
Fourth
 
 
(in thousands except per share)
2010
                               
Revenue
 
$
21
   
$
23
   
$
16
   
$
8
 
Income (loss) from operations
   
(4,457
)
   
115,101
     
(2,434
)
   
(3,525
)
Net (loss) income
   
(8,900
)
   
78,576
     
(25,420
)
   
(2,839
)
Basic earnings (loss) per common share
 
$
(0.23
)
 
$
1.77
   
$
(0.54
)
 
$
(0.06
)
Diluted earnings (loss) per common share
 
$
(0.23
)
 
$
1.67
   
$
(0.54
)
 
$
(0.06
)
 
   
First
   
Second
   
Third
   
Fourth
 
   
(in thousands except per share)
 
2009
                       
Revenue
 
$
3
   
$
7
   
$
3
   
$
13
 
Income (loss) from operations
   
(3,405
)
   
(3,928)
     
(2,624
)
   
(3,131
)
Net (loss) income
   
(3,403
)
   
(3,927)
     
(2,623
   
(2,571
)
Basic earnings (loss) per common share
 
$
(0.09
)
 
$
(0.11)
   
$
(0.07
 
$
(0.07
)
Diluted earnings (loss) per common share   $
(0.09
  $
(0.11)
    $
(0.07
  $
(0.07

 
43


Report of Independent Registered Public Accounting Firm
 
To the Board of Directors and
Stockholders of VirnetX Holding Corporation
 
We have audited the internal control over financial reporting of VirnetX Holding Corporation (the “Company” as of December 31, 2011, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting.  Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.
 
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audit also included performing such other procedures as we considered necessary in the circumstances.  We believe that our audit provides a reasonable basis for our opinion.
 
A company’s internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
 
Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2011, based on the criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.
 
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements as of and for the year ended December 31, 2011, of the Company and our report dated February 29, 2012, expressed an unqualified opinion on those financial statements.
 
/s/ Farber Hass Hurley LLP
 
Granada Hills, California
February 29, 2012

 
44

 
 
None.
 
 
Evaluation of Disclosure Controls and Procedures
 
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, December 31, 2011.
 
The purpose of this evaluation was to determine whether as of December 31, 2011 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
 
Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2011, our disclosure controls and procedures were effective.
 
Management's Report on Internal Control Over Financial Reporting
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.
 
Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2011. There were no changes in our internal control over financial reporting during the quarter ended December 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Farber Hass Hurley LLP has audited our internal control over financial reporting as of December 31, 2011; their report is included elsewhere herein.
 
 
As previously reported on the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 29, 2011 by the Company, the Compensation Committee of the Board of Directors (the "Compensation Committee") exercised its discretion in determining to pay Messrs. Larsen and Sliney 100% of their  2011 target bonuses in light of the Company's overall strong performance for the year and their  contributions in achieving this performance (collectively, the "2011 Annual Incentive Bonuses").  As a result, the Compensation Committee determined to award Mr. Larsen a cash bonus for 2011 equal to $210,000 and Mr. Sliney a cash bonus for 2011 equal to $30,000.
 
On February 27, 2012, the Compensation Committee confirmed that the cash bonus amounts awarded to Mr. Larsen and Mr. Sliney, include, in addition to the foregoing amounts, an additional payment  equal to the estimated amount of payroll withholding taxes (as calculated by the Company's payroll processing agent) to be incurred by Mr. Larsen and Mr. Sliney (but that the executives would be responsible for any incremental taxes associated with such additional payment). The resulting aggregate 2011 Annual Incentive Bonus payments, including these additional amounts, paid to Mr. Larsen and Mr. Sliney were $287,671 and $43,717, respectively.
 
 
45

 
PART III
 
Certain information required by Part III is omitted from this report and is incorporated by reference to our definitive proxy statement pursuant to Regulation 14A for our 2012 annual meeting of stockholders (the “Definitive Proxy Statement”) which will be filed within 120 days of our fiscal year end.
 
 
The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Board of Directors,” “Nominee and Continuing Directors,” “Executive Officers,” “Composition of the Board of Directors,” “Board Meetings and Committees and Annual Meeting Attendance,” “Audit Committee Matters” and “Section 16(a) Beneficial Ownership Reporting Compliance.” Information regarding delinquent filers pursuant to Item 405 of Regulation S-K is included under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in our Proxy Statement for the 2012 Annual Meeting of Stockholders and is incorporated herein by reference.

Code of Ethics

We have adopted a Code of Ethics for all employees and directors to prohibit conflicts of interest between them and the Company.  A copy of our Code of Ethics is available on our website at http://www.virnetx.com in the “Highlights” link in the “Corporate Governance” subcategory under the “Investors” tab, or by writing to us at VirnetX Holding Corporation, PO Box 439, Zephyr Cove, NV 89448, Attention: Investor Relations.

We intend to post on our website any amendment to, or waiver from, a provision of our Code of Ethics within four business days following the date of such amendment or waiver.  We do not anticipate any such amendments or waivers. 

 
The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Compensation Committee Matters,” “Director Compensation,” “Executive Compensation,” “Compensation Committee Report,” “Summary Compensation Table,” “Outstanding Equity Awards at 2011 Fiscal Year-End,” and “Option Exercises in Fiscal Year 2011.”

 
The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the section “Voting Securities and Principal Holders.”

Securities Authorized for Issuance Under Equity Compensation Plans

We have a stock incentive plan for employees and others called the “VirnetX Holding Corporation 2007 Stock Plan”, or the Plan, which has been approved by our stockholders.  The Plan provides for the granting of up to 11,624,469 shares of our common stock, including stock options and stock purchase rights, and will expire in 2018.  As of December 31, 2011, there were 628,478 shares available to be granted under the Plan. We had 4,906,998 and 4,830,391 options outstanding at December 31, 2011, and December 31, 2010, respectively, with an average exercise price of $5.12 and $3.14, respectively.
 
Plan Category
 
Number of Securities to be Issued
Upon Exercise of Outstanding
Options, Warrants and Rights 
(a)
   
Weighted-Average Exercise Price of
Outstanding Options, Warrants and
Rights 
(b)
   
 
Number of Securities Remaining
Available for Future Issuance Under
Equity Compensation Plans Excluding
Securities Reflected in Column (a) 
(c)
 
Equity compensation plans approved by security holders
   
5,111,906
     
5.07
     
628,478
 
Equity compensation plans not approved by security holders
   
             
 
Total
   
5,111,906
     
5.07
     
628,478
 
 
On May 13, 2011 the Compensation Committee granted an additional 435,000 options to the employees of VirnetX Inc. Then on November 22, 2011 the Compensation Committee granted an additional 40,000 options to the employees of VirnetX, Inc.   
 
The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Transactions with Related Persons” and “Composition of Board of Directors.”
 
 
The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement for the 2012 Annual Meeting of Stockholders under “Principal Accountant Fees & Services.”
 
 
46

 
PART IV
 
 
 
(a)
The following documents are filed as part of this Annual Report on Form
 
(1)
Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.
 
(2)
Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto.
 
(3)
Exhibits: See Exhibit Index immediately following the signature page of this Form 10-K.
 
 
47

 
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
VirnetX Holding Corporation
   
 
By:  
/s/ Kendall Larsen
   
Name: Kendall Larsen
   
Title: Chief Executive Officer and President
 
Dated: February 29, 2012
 
POWER OF ATTORNEY
 
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kendall Larsen his or her attorney-in-fact, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his or her substitute or substitutes may do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities indicated.
 
Name
 
Capacity
 
Date
         
/s/ Kendall Larsen
 
Director, Chief Executive Officer and President
 
February 29, 2012
Kendall Larsen
 
(Principal Executive Officer)
   
         
/s/ William E. Sliney
 
Chief Financial Officer
 
February 29, 2012
William E. Sliney
 
(Principal Financial Officer and Principal Accounting Officer)
   
         
/s/ Robert D. Short III
 
Director
 
February 29, 2012
Robert D. Short III
       
         
/s/ Scott C. Taylor
 
Director
 
February 29, 2012
Scott C. Taylor
       
         
/s/ Michael F. Angelo
 
Director
 
February 29, 2012
Michael F. Angelo
       
         
/s/ Thomas M. O'Brien
 
Director
 
February 29, 2012
Thomas M. O'Brien
       
 
EXHIBIT INDEX
 
Exhibit Number
 
Description
3.1
 
Certificate of Incorporation of the Company. (1)
3.2
 
By-Laws of the Company. (1)
4.1
 
Form of Warrant Issued to Gilford Securities Incorporated. (2)
4.2
 
Form of Warrant Agency Agreement by and between the Company and Corporate Stock Transfer, Inc. as Warrant Agent. (2)
4.3
 
Form of Underwriter's Warrant. (2)
4.4
 
Form of Series I Warrant. (3)
4.5
 
Amended Form of Stock Option Agreement - 2007 Stock Plan. (12)
10.1
 
Form of Indemnification Agreement by and between the Company and each of Kendall Larsen, Robert D. Short III, Scott C. Taylor, Michael F. Angelo, Thomas M. O'Brien and William E. Sliney. (1)
10.2
 
Voting Agreement among the Company and certain of its stockholders, dated as of December 12, 2007. (5)
10.3
 
2007 Stock Plan. (4)
10.4
 
Securities Purchase Agreement, dated as of September 2, 2009, by and between the Company and the Purchasers. (3)
10.5
 
Form of Registration Rights Agreement by and between the Company and the Purchasers. (3)
10.6
 
Form of Underwriting Agreement between VirnetX Holding Corporation and Gilford Securities Incorporated. (2)
10.7
 
Patent License and Assignment Agreement by and between the Company and Science Applications International Corporation, dated as of August 12, 2005. (6)
10.8
 
Security Agreement by and between the Company and Science Applications International Corporation, dated as of August 12, 2005. (6)
10.9
 
Amendment No. 1 to Patent License and Assignment Agreement by and between the Company and Science Applications International Corporation, dated as of November 2, 2006. (6)
10.10
 
Assignment Agreement between the Company and Science Applications International Corporation, dated as of December 21, 2006. (6)
10.11
 
Professional Services Agreement by and between the Company and Science Applications International Corporation, dated as of August 12, 2005. (6)
 
 
48

 
10.12
 
Amendment No. 2 to Patent License and Assignment Agreement by and between VirnetX, Inc. and Science Applications International Corporation, dated as of March 12, 2008. (7)
10.13
 
IP Brokerage Agreement by and between ipCapital Group, Inc. and VirnetX, Inc., effective as of March 13, 2008. (7)
10.14
 
Engagement Letter by and between VirnetX Holding Corporation and ipCapital Group, Inc. dated March 12, 2008. (7)
10.15
 
Lease Agreement by and between the Company and Granite Creek Business Center, dated as of March 15, 2006, as amended in April 2007 and April 2008. (8)
10.16*
 
Engagement Letter dated June 9, 2009, by and between McKool Smith, a professional corporation, and the Company. (9)
10.17
 
Engagement Letter dated April 15, 2010, by and between McKool Smith, a professional corporation, and the Company. (10)
10.18*
 
Settlement and License Agreement, by and between Microsoft Corporation, a Washington corporation, and VirnetX, Inc., a Delaware corporation. (11)
10.19   Fiscal Year 2011 Director Compensation (13)
 
Subsidiaries of VirnetX Holding Corporation.
 
Consent of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm.
 
Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
 
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
32.1
 
Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
 
Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document 
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document
 
(1)
Incorporated herein by reference to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 1, 2007.
(2)
Incorporated herein by reference to the Company's Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on January 16, 2009.
(3)
Incorporated herein by reference to the Company's Form 8-K filed with the Securities and Exchange Commission on September 3, 2009.
(4)
Incorporated herein by reference to the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on March 25, 2008.
(5)
Incorporated herein by reference to the Company's Form 10-K filed with the Securities and Exchange Commission on March 31, 2008.
(6)
Incorporated by reference to the Company's Form 8-K (Commission File No. 001-33852) filed with the Securities and Exchange Commission on July 12, 2007.
(7)
Incorporated by reference to the Company's Form 8-K (Commission File No. 001-33852) filed with the Securities and Exchange Commission on March 18, 2008.
(8)
Incorporated by reference to the Company's Form 10-K (Commission File No. 001-33852) filed with the Securities and Exchange Commission on March 31, 2009.
(9)
Incorporated by reference to the Company's Form 10-Q (Commission File No. 001-33852) filed with the Securities and Exchange Commission on August 10, 2009.  
(10)
Incorporated by reference to the Company's Form 10-Q (Commission File No. 001-33852) filed with the Securities and Exchange Commission on May 7, 2010.
(11)
Incorporated by reference to the Company's Form 10-Q/A (Commission File No. 001-33852) for the period ended June 30, 2010, filed with the Securities and Exchange Commission on January 31, 2011.  
(12)
Incorporated by reference to the Company's Form 10-Q (Commission File No. 001-33852) filed with the Securities and Exchange Commission on May 10, 2011.
(13) Incorporated by reference to the Company's Form 10-Q (Commission File No. 001-33852) filed witth the Securities and Exhange Commission on August 9, 2011.
 
 *Confidential treatment has been granted by the U.S. Securities and Exchange Commission as to certain portions of this Exhibit.
             The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act of 1933, as amended, or the Securities Act of 1934, as amended, whether before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.
 
           XBRL (eXtensible Business Reporting Language) information is furnished and not filed herewith, is not a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
 
 
49

EX-21.1 2 ex21_1.htm EXHIBIT 21.1 ex21_1.htm

EXHIBIT 21.1
 
Subsidiaries of Registrant
 
Name of Entity
Jurisdiction of Incorporation or Organization
   
Network Research Corporation Japan Ltd. (known as Network Research Corporation Japan Kabushiki Kaisha in Japan)
Japan
   
VirnetX Inc.
Delaware
 
 

EX-23.1 3 ex23_1.htm EXHIBIT 23.1 ex23_1.htm

EXHIBIT 23.1
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-149884, 333-153645 and 333-162145) and Form S-8 (No. 333-149883) of our reports dated February 29, 2012, relating to the consolidated financial statements of VirnetX Holding Corporation (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2011.
 
/s/ Farber Hass Hurley LLP
 
Granada Hills, CA
 
February 29, 2012 
 
 

EX-31.1 4 ex31_1.htm EXHIBIT 31.1 ex31_1.htm

EXHIBIT 31.1
 
CERTIFICATIONS
 
I, Kendall Larsen, certify that:
 
1.
I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2011;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
 
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
 
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)
 
Date: February 29, 2012
 
 

EX-31.2 5 ex31_2.htm EXHIBIT 31.2 ex31_2.htm

EXHIBIT 31.2
 
CERTIFICATIONS
 
I, William E. Sliney, certify that:
 
1.
I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2011;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
 
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
 
(a) 
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 
 
(b) 
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
/s/ William E. Sliney
 
William E. Sliney
 
Chief Financial Officer
 
(Principal Accounting and Financial Officer)
 
Date: February 29, 2012
 
 

EX-32.1 6 ex32_1.htm EXHIBIT 32.1 ex32_1.htm

EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of VirnetX Holding Corporation (the "Company") on Form 10-K for the fiscal year ended December 31, 2011 as filed with the Securities and Exchange Commission on February 29, 2012 (the "Report"), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)
 
Date: February 29, 2012
 
 

EX-32.2 7 ex32_2.htm EXHIBIT 32.2 ex32_2.htm

EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of VirnetX Holding Corporation (the "Company") on Form 10-K for the fiscal year ended December 31, 2011 as filed with the Securities and Exchange Commission on February 29, 2012 (the "Report"), I, William E. Sliney, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
/s/ William E. Sliney
 
William E. Sliney
 
Chief Financial Officer
 
(Principal Accounting and Financial Officer)
 
Date: February 29, 2012
 
 

EX-101.INS 8 vhc-20111231.xml INSTANCE DOCUMENT 0001082324 2011-12-31 0001082324 2010-12-31 0001082324 2011-01-01 2011-12-31 0001082324 2010-01-01 2010-12-31 0001082324 2009-01-01 2009-12-31 0001082324 us-gaap:CommonStockMember 2008-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0001082324 us-gaap:RetainedEarningsMember 2008-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-12-31 0001082324 2008-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt150PerShareMember 2009-01-01 2009-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt150PerShareMember 2009-01-01 2009-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt252PerShareMember 2009-01-01 2009-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt252PerShareMember 2009-01-01 2009-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0001082324 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0001082324 us-gaap:CommonStockMember 2009-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001082324 us-gaap:RetainedEarningsMember 2009-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-12-31 0001082324 2009-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt252PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt252PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt200PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt200PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt300PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt300PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt400PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt400PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt180PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt180PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt480PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt480PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt393359PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt393359PerShareMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember 2010-01-01 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-01-01 2010-12-31 0001082324 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0001082324 us-gaap:CommonStockMember 2010-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001082324 us-gaap:RetainedEarningsMember 2010-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0001082324 us-gaap:CommonStockMember vhc:IssuedAt393359PerShareMember 2011-01-01 2011-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember vhc:IssuedAt393359PerShareMember 2011-01-01 2011-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001082324 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0001082324 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001082324 us-gaap:CommonStockMember 2011-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001082324 us-gaap:RetainedEarningsMember 2011-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0001082324 vhc:IssuedAt150PerShareMember 2009-12-31 0001082324 vhc:IssuedAt252PerShareMember 2009-12-31 0001082324 vhc:IssuedAt252PerShareMember 2010-12-31 0001082324 vhc:IssuedAt200PerShareMember 2010-12-31 0001082324 vhc:IssuedAt300PerShareMember 2010-12-31 0001082324 vhc:IssuedAt400PerShareMember 2010-12-31 0001082324 vhc:IssuedAt180PerShareMember 2010-12-31 0001082324 vhc:IssuedAt480PerShareMember 2010-12-31 0001082324 vhc:IssuedAt393359PerShareMember 2010-12-31 0001082324 vhc:IssuedAt393359PerShareMember 2011-12-31 0001082324 vhc:IssuedAt480PerShareMember 2011-12-31 0001082324 2011-06-30 0001082324 2012-02-22 iso4217:USD iso4217:USD xbrli:shares xbrli:shares 0 3000 -4000 -984000 104277000 78187000 -5595000 -30516000 559000 -0.35 0.91 -0.33 49482000 34635000 2011000 457000 0 -10000 -6000 708000 -3960000 2809000 -6928000 7358000 100000000 100000000 50619136 49341028 50619136 49341028 5000 5000 6356000 22241000 5663000 -2851000 0 0 1735000 -0.35 0.84 -0.33 0 23599000 0 4367000 3381000 3032000 0 200000000 0 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 12 - Income Taxes</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The components of the income tax expense for the&#160;years ended December 31, 2011, 2010 and 2009 are as follows:</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="80%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="44%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2011</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;December 31, 2009</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Current:</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Federal</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8,036</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">27,822</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">State</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(767</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9,609</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Foreign</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(9</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">11</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8,812</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">37,442</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Deferred:</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Federal</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,331</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,380</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">State</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Foreign</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="44%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,332</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,380</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total provision for income taxes</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(5,480</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">34,062</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="90%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="54%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2011</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2009</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">United States federal statutory rate</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">35.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">35.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">35.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">State taxes, net of federal benefit</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.19</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8.28</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Valuation allowance</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(4.39</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(9.69</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(33.96</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock options</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1.92</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8.60</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">14.15</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2.07</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Other</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.79</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3.64</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%)</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.03</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Balance at the end of the year</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">24.07</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">44.10</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td><td valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.00</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">As allowed by ASC 740, Income Taxes, we used the actual effective tax rate for the year ended December 31, 2011 because our 2011 annual profit before tax is not estimable at this time.&#160;&#160;To the extent our expected profitability changes during the year, the effective tax rate would be revised to reflect the change.</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Deferred tax assets (liabilities) consist of the following:</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="80%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="44%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;December 31, 2011</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;December 31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2009</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Deferred tax assets:</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Reserves&#160;and accruals</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">46</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">53</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">State tax</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,326</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Research&#160;and development credits&#160;and other credits </font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">225</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">500</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net operating loss carry forward</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,822</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">372</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10,500</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock based compensation</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,155</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,109</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Other</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">211</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 27pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total deferred tax assets</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6,235</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7,085</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">11,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Valuation allowance</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(6,168</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,687</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(11,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 27pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Deferred tax assets after valuation allowance</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">67</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,398</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="44%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Deferred tax liability</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Depreciation&#160;and amortization</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(20</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(18</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 27pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total deferred tax liability</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(20</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(18</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net deferred tax assets</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">47</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,380</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div style="text-indent: 0pt; display: block;">&#160;</div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized.&#160;&#160;The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Based on the available objective evidence, we believe it is more likely than not that the net deferred tax assets as of December 31, 2011 will not be fully realizable. Accordingly, management has maintained partial valuation allowance against its net deferred tax assets at December 31, 2011. The net change in the total valuation allowance for the year ended December 31, 2011 was an increase of $1,000 and $2,488 for state and federal&#160;deferred tax assets, respectively. <font style="display: inline; font-family: Times New Roman; font-size: 10pt;">At December 31, 2011, the Company has federal and state net operating loss carryforwards of approximately $913 and $43,565, respectively expiring in 2027 and 2012, respectively. At December 31, 2011, the Company has federal research and development credits carryforwards of approximately zero expiring beginning in 2031.</font></font><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Internal Revenue Code Section 382 places a limitation (the "Section 382 Limitation") on the amount of taxable income can be offset by net operating carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carryforward in excess of the Section 382 Limitation. Management has analyzed analysis on the utilization of its net operating loss carryforward against taxable income in future periods and determined on a more likely than not basis it will be able to use all its recognized net operating losses before they expire.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have reduced our gross deferred tax assets by zero and $128 at December 31, 2011 and December 31, 2010, respectively, for certain tax benefits which may not be sustained upon examination, and we have provided an offset through equal reductions in our deferred tax asset, which offsets by an equal reduction in the valuation allowance. Our tax returns are subject to review by various tax authorities. The returns are subject to review those from 2008 forward.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We did not have associated accrued interest or penalties nor was any interest expense or penalties recognized during the year ended December 31, 2011.</font></div></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="90%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="54%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2011</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Year&#160;Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31, 2009</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Balance at the beginning of the year</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">128</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Additions based on tax positions related to the current year</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Additions&#160;for tax positions of prior years</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">128</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Settlements</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Lapse of applicable statute of limitations</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Balance at the end of the year</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">128</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">128</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> 14438000 43457000 74633000 81694000 4131000 1197000 8505000 28968000 -44454000 -6000 -18252000 75881000 -6945000 -17263000 41417000 -12524000 -12524000 41417000 -17263000 14847000 32623000 1554000 228000 1310000 5000 -17376000 104685000 -13088000 -984000 -984000 -3000 -3000 0 -160000 -44000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 11 - Employee Benefit Plan</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We sponsor a defined contribution, 401k plan, covering substantially all our employees.&#160;&#160;The Company's matching contribution to the plan was approximately, </font></font><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">$36 in 2011, $36 in 2010 and $36 in 2009 respectively.</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div></div> 10000000 10000000 0 0 0 0 0.0001 0.0001 10459000 0 63101000 0 0 0 0 8549000 3063000 23615000 0 1068000 1341000 0 56000 25000 34082000 44441000 0 51000 13000 6000 -36001000 -17755000 20000 68000 26000 0 59207000 0 15932000 33764000 12250000 2.52 2.00 3.00 4.00 1.80 4.80 -9600000 -29556000 -2000 74470000 79916000 50028413 49066704 37911340 50028413 45452550 37911340 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;3 - Property&#160;</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Our major classes of property and equipment were as follows:</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="left" style="text-align: left;"><table cellpadding="0" cellspacing="0" width="90%" style="text-align: left; font-family: times new roman; font-size: 10pt;"><tr style="text-align: left;"><td valign="bottom" width="54%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="10" valign="bottom" width="10%" style="border-bottom: black 2px solid; text-align: center;">&#160; <font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">December 31</font></font></font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr><td valign="bottom" width="54%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2010</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2009</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Office furniture</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;">57</td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">22</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">22</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">91</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">75</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">62</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="54%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">148</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">97</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="54%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Less accumulated depreciation</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(92</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(72</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;">(61</td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="54%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">56</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">25</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div>&#160;</div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Depreciation expense for the years ended December 31, 2011, 2010 and 2009 was $20,&#160;$11 and $15 respectively.</font></font></div><div style="text-indent: 0pt; display: block;">&#160;</div></div></div> 1464000 2412000 864000 74633000 81694000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline; font-weight: bold;">Note&#160;14 - Patent Portfolio</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">As of September 30, 2011, we own&#160;20 issued U.S. and 26 issued foreign patents, in addition to several pending U.S. and foreign patent applications.&#160;&#160;Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.&#160;&#160;Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents.&#160;&#160;The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">As of December 31, 2011, the expected future amortization of the intangible assets is as follows:</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="80%" style="font-family: times new roman; font-size: 10pt;"><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="68%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">48</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="68%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="68%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">60</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> 0 0.50 0 47000 1645000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;6 - Stock-Based Compensation</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We account for equity instruments issued to employees in accordance with the fair value method which requires that such issuances be recorded at their fair value on the grant date.&#160;&#160;The recognition of the expense is subject to periodic adjustment as the underlying equity instrument vests.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Stock-based compensation expense is included in general and administrative expense for each period as follows:</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td align="left" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation by Type of Award</font></div></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2011</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2010</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2009</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Employee stock options</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,367</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,381 </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,032</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total stock-based compensation</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,367</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,381</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;">3,032</td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">As of December 31, 2011, the unrecorded deferred stock-based compensation balance related to stock options was $9,697, which will be amortized as expense over an estimated weighted average vesting amortization period of approximately 0.7 years, as compared to $4,027 and 1.2 years for 2010 and $5,741 and 1.6 years for 2009.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The fair value of each option grant was estimated on the date of grant using the following weighted average assumptions:</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block;"><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="40%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="3" valign="bottom" width="19%" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2011</font></div></td><td valign="bottom" width="1%" style="text-align: center; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="3" valign="bottom" width="19%" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2010</font></div></td><td valign="bottom" width="1%" style="text-align: center; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="3" valign="bottom" width="19%" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Year Ended </font></div><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December&#160;31, 2009</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="40%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected stock price volatility</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">123</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;110</font></td><td valign="bottom" width="9%"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">120</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="40%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.05</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.66</font></td><td valign="bottom" width="9%"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.93</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="40%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life term (in years)</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.6 </font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;years</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><div><font style="display: inline; font-family: times new roman; font-size: 10pt;">7.</font>0</div></td><td valign="bottom" width="9%"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;years</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;">6.6</td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;years</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="40%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected dividends</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0</font></td><td valign="bottom" width="9%"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0</font></td><td align="left" valign="bottom" width="9%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div></td></tr></table></div></div><div style="text-indent: 0pt; display: block;"><br /><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $21.13, $4.83 and $1.06 during the years ended December 31, 2011, 2010 and 2009 respectively.</font></font></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The expected life was determined using the simplified method outlined in FASB Codification Topic 718, taking the average of the vesting term and the contractual term of the option.&#160;&#160;Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle.&#160;&#160;We have not provided an estimate for forfeitures because we have no history of forfeited options and believe that all outstanding options at December 31, 2011, will vest.&#160;&#160;In the future, the Company may change this estimate based on actual and expected future forfeiture rates.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The following table summarizes activity under the Plan for the indicated periods:</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Number of </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average Exercise </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Price</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average Remaining Contractual </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Life (Years)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Aggregate Intrinsic</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Value</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at December 31, 2008</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,468,595</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.98</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,317,195</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.18</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="top" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="top" width="1%">&#160;</td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="top" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="top" width="1%" style="padding-bottom: 2px;">&#160;</td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at December 31, 2009</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,785,790</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.57</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">345,250</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.53</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1,269,149</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.11</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(31,500</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.48</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at December 31, 2010</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="padding-bottom: 2px;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,830,391</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="padding-bottom: 2px;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.14</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">475,000</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23.30</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(398,393</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.68</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="top" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="top" width="1%" style="padding-bottom: 2px;">&#160;</td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at December 31, 2011</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,906,998</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.12</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.43</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">97,385</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Intrinsic value is calculated at the difference between the per share market price of&#160;our common stock&#160;on the last trading day of&#160;2011 was $24.97 and the exercise price of the options.&#160;&#160;For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.</font></font></div><div style="text-indent: 0pt; display: block;"><br /></div><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The following table summarizes information about stock options outstanding at December 31, 2011:</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="15%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="14" valign="bottom" width="46%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Options Outstanding</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="10" valign="bottom" width="34%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Options Vested and Exercisable</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td nowrap="nowrap" valign="bottom" width="15%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Date of Option Issue</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Range of</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Prices</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Number</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Outstanding</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Remaining</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Contractual </font><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Life (Years)</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Number Exercisable</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Remaining</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Contractual Life (Years)</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2006</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.24</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">690,612</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.22</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.24</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">690,612</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.22</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.24</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.20</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,312,899</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.56</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.20</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,312,899</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.56</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.20</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.88-6.47</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">697,026</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.00</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.06</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">697,026</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.00</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.06</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2008</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.74-6.20</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">250,016</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.46</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.39</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">221,294</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.45</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.52</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2009</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.15- 1.58</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,167,695</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7.26</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.16</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">799,297</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7.27</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.17</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2010</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.48-6.03</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">313,750</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8.18</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.47</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">160,055</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8.21</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.41</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="15%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></td><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">19.85-23.62</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">475,000</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9.42</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23.30</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83,957</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9.38</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23.58</font></div></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="15%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,906,998</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.43</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.12</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,965,140</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.99</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.70</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div></div> <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 13&#160;-&#160;Fair Value Measurement</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.&#160;&#160;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).&#160;&#160;Level 2 measurements utilize observable inputs in markets other than active markets.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value.&#160;&#160;When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.&#160;&#160;We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; font-style: italic; display: inline;">Certificate of deposits</font><font style="background-color: #ffffff; display: inline;">: Fair value measured at face value plus accrued interest.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; font-style: italic; display: inline;">Corporate bonds</font><font style="background-color: #ffffff; display: inline;">:&#160;&#160;Fair value measured at the closing price reported on the active market on which the individual securities are traded.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; font-style: italic; display: inline;">Series I Warrants</font><font style="background-color: #ffffff; display: inline;">: Fair value measured by using a Binomial valuation model.&#160;&#160;As of December 31, 2011, the assumptions used to measure fair value of the liability embedded in our outstanding Series I Warrants included a warrant exercise price of $3.59 per share, a common share price of $24.97, a discount rate of 0.83%, and a volatility of 123%.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The following table sets forth by level, within the fair value hierarchy, our financial instrument assets as of December 31, 2011:</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Level 1</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Level 2</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Level 3</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Certificates of deposit</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,584</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,584</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Corporate Bonds:</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">AA</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,011</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,011</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="52%" style="text-align: left; padding-bottom: 2px; text-indent: 0pt; padding-left: 0pt; margin-left: 9pt; margin-right: 0pt;"><div style="text-align: left; text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9,843</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9,843</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total Corporate Bonds</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">11,854</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">11,854</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="52%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total Investments at Fair Value</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">14,438</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">14,438</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The following table sets forth, by level within the fair value hierarchy, our financial instrument liabilities as of December 31, 2011 (in thousands):</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Quoted</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Prices in</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Active</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Markets for</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Identical</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Assets</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Significant</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Other</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Observable</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Inputs</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Significant</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Unobservable</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Inputs</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom" style="border-bottom: black 2px solid; border-top: #000000 1.5pt solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(Level 1)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(Level 2)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(Level 3)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series l Warrants</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,699</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,699</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,699</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,699</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2011 (in thousands):</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="80%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" width="68%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fair Value</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Measurements</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Using</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Significant</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Unobservable</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">Inputs (Level</font><font style="display: inline; font-weight: bold;">3)</font></font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="68%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Balance December 31, 2010</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">14,364</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="68%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss included in earnings</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,595</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="68%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Settlements</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(15,260</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="68%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Balance December 31, 2011</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,699</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> <div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-weight: bold;">Note 16 - Quarterly Financial Information (unaudited)</font><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">First</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Second</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Third</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fourth</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="14" valign="bottom"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(in thousands except per share)</font></div></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td align="left" valign="bottom"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></div></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Income (loss) from operations</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,752</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,754)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(4,180</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(6,690</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net (loss) income</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(7,122</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(9,805)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;5,879</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(6,215</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings (loss) per common share</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.14</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.20)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.12</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.12</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Diluted earnings (loss) per common share</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.14</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.20)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.11</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.12</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">First</font></div></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Second</font></div></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Third</font></div></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fourth</font></div></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="16" valign="bottom"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(in thousands except per share)</font></div></td></tr><tr><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2010</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">21</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Income (loss) from operations</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(4,457</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">115,101</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,434</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,525</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net (loss) income</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8,900</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">78,576</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(25,420</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,839</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings (loss) per common share</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.23</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.77</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.54</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.06</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Diluted earnings (loss) per common share</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.23</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.67</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.54</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.06</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">First</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Second</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Third</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fourth</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="14" valign="bottom"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">(in thousands except per share)</font></div></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr><td align="left" valign="bottom"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2009</font></div></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">7</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">13</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Income (loss) from operations</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,405</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,928)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,624</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,131</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net (loss) income</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,403</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,927)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,623</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,571</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="52%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings (loss) per common share</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.09</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.11)</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.07</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160; </font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.07</font></div></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Diluted&#160;earnings (loss) per common share</font></font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.09</font></font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.11)</font></font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.07</font></font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></font></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.07</font></font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></td></tr></table></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> -6869000 -6869000 22462000 22462000 15260000 15260000 17396000 -104617000 13114000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline; font-weight: bold;">Note&#160;4 - Commitments</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We lease our offices under an operating lease with a third party that requires minimum payments monthly until it ends in June 2013.&#160;&#160;We recognize rent expense on a straight-line basis over the term of the lease. </font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="90%" style="font-family: times new roman; font-size: 10pt;"><tr><td align="left" valign="bottom" width="78%" style="border-bottom: black 2px solid;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">For the Year</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Minimum Required Lease Payments in Period</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="78%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">56</font></div></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="78%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 2px solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">46</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="78%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div></td><td align="right" valign="bottom" width="9%" style="border-bottom: black 4px double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">102</font></div></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;">&#160;</div></div></div> -22743000 75479000 -12524000 0.0001 0.0001 1.50 2.52 -983000 983000 0 68277000 59453000 3500 22150000 -23048000 0 -895000 4000 26861000 -35572000 0 -8707000 493000 78187000 -17755000 -984000 5060 104277000 -36001000 -4000 -5480000 34062000 0 0 0 300 3273000 3274000 200 5400000 120 1404000 1404000 2470000 2380942 1269149 -125000 -125000 528000 528000 2331000 2331000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;7 - Earnings Per Share</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Basic earnings per share are based on the weighted average number of shares outstanding for a period.&#160;&#160;Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding.&#160;&#160;Potential common shares outstanding principally include stock options, warrants, under our stock plan.&#160;&#160;During 2011 and 2009, the Company has incurred losses; therefore the effect of any common stock equivalent would be anti-dilutive during that period.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The table below sets forth the basic loss per share calculations:</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Period Ended December&#160;31,</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="left" colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2010</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2009</font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net income (loss)</font></div></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(17,263</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">41,417</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(12,524</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of shares outstanding</font></div></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">50,547</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">45,453</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">37,911</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Diluted weighted average number of shares outstanding</font></div></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">50,547</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">49,067</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">37,911</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings (loss) per share</font></div></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.35</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.91</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.33</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="44%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Diluted earnings (loss) per share</font></div></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.35</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.84</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.33</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">For the years ended December 31, 2011, 2010 and 2009, there were the following stock equivalents:</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="left"><table cellpadding="0" cellspacing="0" width="70%" style="font-family: times new roman; font-size: 10pt;"><tr><td align="left" valign="bottom" width="34%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2010</font></font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2009</font></font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="34%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,906,998</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,830,391</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,785,790</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="34%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">204,908</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,090,444</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12,271,946</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div></div> 430000 7358000 68000 59000 63000 -23600000 -23600000 91000 86000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 1 - Formation and Business of the Company</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">VirnetX Holding Corporation, which we refer to as we, us, our, the Company or VirnetX, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology&#8482;, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets.&#160;&#160;&#160;To date our revenue has been limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement.</font></font></div></div></div> 1227000 519000 3032000 3032000 3381000 3381000 4368000 4368000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 2 - Summary of Significant Accounting Policies</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Basis of Presentation</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and all wholly-owned subsidiaries. All material intercompany accounts and transactions have been eliminated. Certain&#160;prior year amounts have been reclassified to conform to current year presentations.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Use of Estimates</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Revenue Recognition</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">We defer recognition of revenue in accordance with ASC Topic 605 until such time as all of the criteria below have been met:</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr valign="top"><td style="width: 27pt;"><div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div></td><td style="width: 18pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman;">&#9679;</font></font></div></td><td><div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">persuasive evidence of sales arrangements;</font></div></td></tr></table></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr valign="top"><td style="width: 27pt;"><div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div></td><td style="width: 18pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman;">&#9679;</font></font></font></div></div></td><td><div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">delivery has occurred or services have been rendered;</font></div></td></tr></table></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr valign="top"><td style="width: 27pt;"><div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div></td><td style="width: 18pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman;">&#9679;</font></font></font></div></div></td><td><div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">the buyer's price is fixed or determinable; and</font></div></td></tr></table></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 437pt; margin-right: 0pt;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr valign="top"><td style="width: 27pt;"><div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div></td><td style="width: 18pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman;">&#9679;</font></font></font></div></div></td><td><div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">collection is reasonably assured.</font></div></td></tr></table></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">We expect that some or all of our future licensing agreements will provide for payments to us over an extended period of time.&#160;&#160;For a licensing agreement with fixed royalty payments, we expect to recognize revenue as amounts become due.&#160;&#160;For a licensing agreement with variable royalty payments we expect to recognize royalty revenue at the time that the licensees' sales occur; however, because we expect that a licensee may report sales information to us on a delayed basis, we expect our revenue recognition criterion may also be met on a delayed basis.&#160;</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Complex revenue arrangements may require us to make significant judgments, assumptions and estimates about when substantial delivery of contract elements will occur, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period&#160;&#160;in which the completion of the earning process occurs. If new information subsequently becomes known to us which causes us to make different judgments, assumptions or estimates regarding material contracts, our financial results may be materially affected.</font></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Cash and Cash Equivalents</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Investments</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gain and losses are reported as other comprehensive income. Realized gains and losses are included in income in the period they are realized.&#160;&#160;The Company's investments consist of debt securities with maturity dates primarily less than nine months.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Property and Equipment</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Property and equipment are stated at historical cost, less accumulated depreciation and amortization.&#160;&#160;Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years.&#160;&#160;Repair and maintenance costs are charged to expense as incurred.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">&#160;</font><font style="background-color: #ffffff; display: inline; font-size: 10pt;">&#160;</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Concentration of Credit Risk and Other Risks and Uncertainties</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Our cash and cash equivalents are primarily maintained at two financial institutions in the United States.&#160;&#160;Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits.&#160;&#160;The balances are insured by the Federal Deposit Insurance Corporation or (FDIC).&#160;&#160;During the&#160;year ended December 31, 2011, we had, at times, funds that were uninsured.&#160;&#160;The uninsured balance at December 31, 2011 was $29,185.&#160;We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.</font></font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Fair Value of Financial Instruments&#160;</font></font></div><div style="text-indent: 0pt; display: block;"><br /><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The carrying amounts of our financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.</font></font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Intangible Assets</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We record intangible assets at cost, less accumulated amortization.&#160;&#160;Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Impairment of Long-Lived Assets</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually.&#160;&#160;Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets' carrying value.&#160;&#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Research and Development</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff.&#160;&#160;Research and development costs are expensed as incurred.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Income Taxes</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. See Note 12, &#8220;Income Taxes&#8221; of this Form 10-K for additional information.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; font-weight: bold;">Derivative Instruments</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Our Series I Warrants contain an anti-dilutive provision which causes it to not be considered indexed to our stock.&#160;&#160;As a result, the warrants are required to be accounted for as derivative instruments.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value.&#160;&#160;We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.</font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;">&#160;</div><div style="text-indent: 0pt; display: block;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Stock-Based Compensation</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Our accounting for share-based compensation is in accordance with the fair value method which requires the measurement and recognition of compensation expense in the statement of operations for all share-based payment awards made to employees and directors including employee stock-options based on estimated fair values.&#160;&#160;Using the modified retrospective transition method of adopting this standard, the financial statements presented herein reflect compensation expense for stock-based awards as if the provisions of this standard had been applied from the date of inception.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div style="text-indent: 0pt; display: block;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Earnings Per Share</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.&#160;&#160;Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2011 and 2009, the Company has incurred losses; therefore the effect of any Common Stock equivalent would be anti-dilutive during that period.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">New Accounting Pronouncements</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">In May 2011, the FASB issued a new accounting standard update, which amends the fair value measurement guidance and includes some enhanced disclosure requirements.&#160;&#160;The most significant change in disclosures is an expansion of the information required for Level 3 measurements based on unobservable inputs. The standard is effective for fiscal years beginning after December&#160;15,&#160;2011.&#160;The adoption will not have a material impact on our consolidated financial statements and disclosures.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">In June 2011, the FASB issued an amendment to an existing accounting standard which requires companies to present net income and other comprehensive income in one continuous statement or in two separate, but consecutive, statements.&#160;&#160;In addition, in December 2011, the FASB issued an amendment to an existing accounting standard which defers the requirement to present components of reclassifications of other comprehensive income on the face of the income statement.&#160;&#160;We will adopt this standard in the first quarter of 2012.</font></font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">In September 2011, the FASB issued an amendment to an existing accounting standard, which provides entities an option to perform a qualitative assessment to determine whether further impairment testing on goodwill is necessary.&#160;&#160;Specifically, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step test.&#160;&#160;If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required.&#160;&#160;Otherwise, no further testing is required.&#160;&#160;This standard is effective for annual and interim goodwill impairment test performed for fiscal years beginning after December&#160;15,&#160;2011.&#160;The adoption will not have a material impact on our consolidated financial statements and disclosures.</font></font></div></div></div> <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;8 - Preferred Stock</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Our Amended and Restated Certificate of Incorporation, as amended in October 2007, authorizes us to issue 10,000,000 shares of $0.0001 par value per share preferred stock having rights, preferences and privileges to be designated by our Board of Directors.&#160;&#160;There were no shares of preferred stock outstanding at December&#160;31,&#160;2011.</font></font></div></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div></div> 34899985 39750927 49341028 50619136 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note 15 - Litigation</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We have three intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in&#160;all the&#160;complaints. We have one</font> complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra Technologies, Inc., Apple, Inc., Cisco Systems, Inc., and NEC Corporation.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">On January 12, 2011, we initiated a new lawsuit by filing a complaint against Siemens Enterprise Communications and Mitel Networks Corp. On April&#160;12,&#160;2011, we amended this complaint to add Avaya, Inc., as a defendant.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">We believe that Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya infringe on certain of our patents, but obtaining and collecting a judgment against these parties may be difficult or impossible.&#160;&#160;Patent litigation is inherently risky and the outcome is uncertain.&#160;&#160;Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya are all large, well-financed companies with substantially greater resources than us.&#160;&#160;We believe that these parties will devote a substantial amount of resources in an attempt to prove that either their products do not infringe our patents or that our patents are invalid and unenforceable.&#160;&#160;At this time, we cannot predict the final outcome of these litigation matters.</font></font></div></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes an additional patent of ours.&#160;&#160;We seek damages and injunctive relief.&#160;&#160;No hearing or trial dates have been set.</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On November 4, 2011, We filed a complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. The accused products include the latest iPhones, iPads, iPods and Macintosh computers. We have requested that the ITC institute an investigation into Apple's allegedly infringing imports and ultimately bar Apple from importing those Apple products or further selling the infringing Apple products that have already been imported</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims.&#160;&#160;Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims.&#160;&#160;In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div> 40 1068000 1068000 398394 10459000 0 -94000 4699000 14364000 false --12-31 2011-12-31 Yes No Yes Large Accelerated Filer 1173043513 VirnetX Holding Corp 0001082324 50671136 2011 FY 10-K 60000 108000 3000 39000 -140000 <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;5 - Stock Plan</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">In 2005, VirnetX, Inc. adopted the 2005 Stock Plan (the "Plan"), which was assumed by us upon the closing of the transaction between VirnetX Holding Corporation and VirnetX, Inc. on July 5, 2007.&#160;&#160;Our Board of Directors renamed this Plan the VirnetX Holding Corporation 2007 Stock Plan and our stockholders approved the Plan at our 2008 annual stockholders' meeting.&#160;&#160;The Plan provides for the issuance of up to 11,624,469 shares of our common stock.&#160;&#160;To the extent that any award should expire, become unexercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan.&#160;&#160;The Plan provides for the granting of stock options and stock purchase rights to our employees and consultants.&#160;&#160;Stock options granted under the Plan may be incentive stock options or nonqualified stock options.&#160;&#160;Incentive stock options ("ISO") may only be granted to our employees (including officers and directors).&#160;&#160;Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">The Plan will expire 10 years after it was approved by our Board of Directors.&#160;&#160;Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the case of an NSO,&#160;&#160;the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant.</font></font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Activity under the Plan is as follows:</font></font></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="left"><table cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="10" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Options Outstanding</font></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr><td valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td><td align="right" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline;">Shares Available for Grant</font></font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="text-align: center; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline;">Number of Shares</font></font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: center; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" style="text-align: center; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" style="border-bottom: black 2px solid; text-align: center;"><div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline;">Weighted Average Exercise Price</font></font></div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Balance at December 31, 2008</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,651,392</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;">&#160;</td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,468,595</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.98</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Restricted stock granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;">&#160;</td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1,317,195</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,317,195</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.18</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;">&#160;</td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83,031</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;">&#160;</td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Balance at December 31, 2009</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,417,228</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;">&#160;</td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,785,790</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.57</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Restricted stock granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(345,250 </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">345,250</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.53</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1,269,149 </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.11</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">31,500</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(31,500 </font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.48</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Balance at December 31, 2010</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,103,478</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,830,391</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.14</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Restricted stock granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options granted</font></div></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(475,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">475,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23.80</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options exercised</font></div></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(398,393</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.68</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" valign="bottom" width="64%" style="padding-bottom: 2px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Options cancelled</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" valign="bottom" width="64%" style="padding-bottom: 4px;"><div align="left" style="text-indent: -9pt; display: block; margin-left: 9pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Balance at December 31, 2011</font></div></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">628,478</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,906,998</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.12</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td></tr></table></div></div><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div></div> <div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;9 - Common Stock</font></font></div></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="background-color: #ffffff; display: inline;">Each share of common stock has the right to one vote.&#160;&#160;The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends.&#160;&#160;On June&#160;15,&#160;2010, the Company's Board of Directors declared a special cash dividend of $0.50 per share of the Company's common stock to holders of record on July&#160;1,&#160;2010.&#160;&#160;Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> <div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="background-color: #ffffff; display: inline;">Note&#160;10 - Warrants</font></font></div></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Information about warrants outstanding during the twelve months ended December 31, 2011 follows:</font></div><div style="text-indent: 0pt; display: block;"><br /></div><div align="left"><table cellpadding="0" cellspacing="0" width="90%" style="font-family: times new roman; font-size: 10pt;"><tr><td colspan="2" nowrap="nowrap" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Original Number of </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Warrants Issued</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Price per Common Share</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercisable </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">at </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">December 31, 2010</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Became Exercisable</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercised</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Terminated /</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cancelled /</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expired</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td colspan="2" valign="bottom" width="10%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercisable </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">at December 31, 2011</font></div></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td><td valign="bottom" width="7%" style="border-bottom: black 2px solid;"><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expiration </font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Date</font></div></div></td></tr><tr><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td colspan="2" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="7%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">300,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.80</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">30,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(30,000</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="7%"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.2pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 2012</font></div></td></tr><tr bgcolor="white"><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,619,036</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1)</font></td><td align="left" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.59</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,060,444</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(855,536</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 2px solid;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 2px solid; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 2px solid; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">204,908</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 2px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="7%" style="padding-bottom: 2px;"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.2pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 2015</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" colspan="2" valign="bottom" width="10%" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.2pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="text-align: right; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,090,444</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="right" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(885,536</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" width="1%" style="border-bottom: black 4px double;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="1%" style="border-bottom: black 4px double; text-align: left;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="9%" style="border-bottom: black 4px double; text-align: right;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">204,908</font></td><td nowrap="nowrap" valign="bottom" width="1%" style="text-align: left; padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td><td valign="bottom" width="7%" style="padding-bottom: 4px;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td></tr></table></div><div style="text-indent: 0pt; display: block;">&#160;</div><div><table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"><tr valign="top"><td style="width: 18pt;"><div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div></td><td style="width: 18pt;"><div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">(1)</font></div></td><td><div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Referred to as our Series I Warrants.</font></div></td></tr></table></div><div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><div style="text-indent: 0pt; display: block;"><br /></div></div></div> 240 5395000 5395000 120 2354000 120 3750000 120 4945000 20 396000 20 1098000 170 6593000 90 3063000 3063000 2380943 1233741 1235000 1235000 220000 228648 1787620 855536 -980000 -980000 0 24178 3.93 3.93 3.59 3.59 4.80 EX-101.SCH 9 vhc-20111231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 003000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 003010 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 006010 - Disclosure - Formation and Business of the Company link:presentationLink link:calculationLink link:definitionLink 006020 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 006030 - Disclosure - Property link:presentationLink link:calculationLink link:definitionLink 006040 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 006050 - Disclosure - Stock Plan link:presentationLink link:calculationLink link:definitionLink 006060 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 006070 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 006080 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 006090 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 006100 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 006110 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 006120 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 006130 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 006140 - Disclosure - Patent Portfolio link:presentationLink link:calculationLink link:definitionLink 006150 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 006160 - Disclosure - Quarterly Financial Information (unaudited) link:presentationLink link:calculationLink link:definitionLink 000990 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 vhc-20111231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 vhc-20111231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 vhc-20111231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounts receivable, net Accumulated other comprehensive loss Additional paid-in capital Gain (loss) on change in value of embedded derivative and warrants Change in value of derivative liability Unrealized Gain (Loss) on Derivatives CONSOLIDATED BALANCE SHEETS [Abstract] Basic earnings (loss) per share: (in dollars per share) Cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash paid during the year for interest Interest Paid Accounts payable and accrued liabilities Income tax liability Increase (Decrease) in Income Taxes Payable Changes in assets and liabilities: Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Common stock, shares outstanding (in shares) Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2011 and 2010, respectively Issued and outstanding: 50,619,136 shares and 49,341,028 shares, at December 31, 2011 and 2010, respectively Total current liabilities Liabilities, Current Current liabilities: Stockholders' equity (deficit): Net change in deferred taxes (benefit) Deferred tax benefit Deferred Tax Assets, Net, Current Diluted earnings (loss) per share: (in dollars per share) Payment of dividend Payments of Ordinary Dividends Stock-based compensation Share-based Compensation Gain on settlement Gain (Loss) Related to Litigation Settlement CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Taxes Income Tax Disclosure [Text Block] Investments available for sale Total liabilities and stockholders' equity Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Cash flows from financing activities: Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from investing activities: Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net Income (loss) Net Income (loss) Net income (loss) Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Interest income, net Income (loss) from operations Operating Income (Loss) Unrealized loss on available for sale investments, net Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Payment of royalty obligation less imputed interest Employee Benefit Plan Pension and Other Postretirement Benefits Disclosure [Text Block] Preferred stock, shares authorized (in shares) Preferred stock, shares issued (in shares) Preferred stock, shares outstanding (in shares) Preferred stock, par value (in dollars per share) Prepaid taxes Proceeds from sale, maturity of investments Proceeds from sales of common stock Proceeds from exercise of warrants Proceeds from exercise of options Property and equipment, net Property [Abstract] Purchase of investments Payments to Acquire Investments Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Accumulated deficit Revenue - Royalties Royalty expense General, selling and administrative CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) [Abstract] CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) [Abstract] Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Stock issued for cash exercise of warrants at per share, net (in dollars per share) Supplemental disclosure of cash flow information: Cash paid during the year for taxes Income Taxes Paid Total current assets Assets, Current Current assets: Weighted average shares outstanding dilutive (in shares) Weighted average shares outstanding basic (in shares) Common Stock [Member] Property Property, Plant and Equipment Disclosure [Text Block] Research and development Total assets Assets Patent Portfolio Intangible Assets Disclosure [Text Block] Dividends declared per common share (in dollars per share) Deferred tax benefit Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement [Table] ASSETS Statement [Line Items] Preferred Stock [Abstract] Fair Value Measurement Fair Value Disclosures [Text Block] Quarterly Financial Information (unaudited) Quarterly Financial Information [Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Derivative liability Adjustments to Additional Paid in Capital, Warrant Issued Operating expenses: Total operating expenses Operating Expenses Earnings Per Share [Abstract] Commitments Commitments Disclosure [Text Block] Income (loss) before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Common stock, par value (in dollars per share) Stock issued for cash, net (in dollars per share) Reclassification adjustment for net loss included in net income Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax Total stockholders' equity Balance Balance Stockholders' Equity Attributable to Parent Income tax expense (benefit) Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2011 and 2010, respectively Issued and outstanding: 0 shares at December 31, 2011 and 2010, respectively Statement, Equity Components [Axis] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Accumulated Other Comprehensive Income (Loss) [Member] Other Comprehensive Income (Expense) [Member] Equity Component [Domain] Stock issued for cash, net Stock Issued During Period, Value, New Issues Stock issued for cash exercise of options, net Stock Issued During Period, Value, Stock Options Exercised Stock issued for cash, net (in shares) Stock Issued During Period, Shares, New Issues Stock issued for cash exercise of options, net (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Deferred offering costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Deferred tax benefit related to stock based compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Earnings Per Share Earnings Per Share [Text Block] Income tax liability Depreciation and amortization Dividend Dividends, Common Stock, Cash Prepaid expenses and other current assets Adjustments to reconcile net income (loss) to net cash used in operating activities: Formation and Business of the Company Nature of Operations [Text Block] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Formation and Business of the Company [Abstract] Preferred Stock Preferred Stock [Text Block] Balance (in shares) Balance (in shares) Shares, Outstanding Commitments [Abstract] Litigation Legal Matters and Contingencies [Text Block] Exercise of options Stock Issued During Period, Value, Other Exercise of options (in shares) Stock Issued During Period, Shares, Other Income Taxes [Abstract] Patent Portfolio [Abstract] Fair Value Measurement [Abstract] Employee Benefit Plan [Abstract] Quarterly Financial Information (unaudited) [Abstract] Stock-Based Compensation [Abstract] Prepaid taxes Increase (Decrease) in Prepaid Taxes Summary of Significant Accounting Policies [Abstract] Derivative liability Derivative Liability, Notional Amount Amendment Flag Current Fiscal Year End Date Document Period End Date Entity [Text Block] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Intangible And Other Assets Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. And, aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Intangible and other assets Receivables And Other Current Assets The net change during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities. And, the net change during the reporting period in other operating current assets not otherwise defined in the taxonomy. Receivables and other current assets Stock Plan [Text Block] The entire disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used. Stock Plan Stock Plan [Abstract] Common Stock Disclosure [Abstract] Common Stock [Abstract] Common Stock Disclosure [Text Block] The entire disclosure for common stock. Common Stock Warrants [Text Block] The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants Warrants [Abstract] Litigation [Abstract] Stock Issued During Period, Value, Warrants Exercised Value stock issued during the period as a result of the exercise of warrants. Stock issued for cash exercise of warrants, net Stock Issued During Period, Shares, Warrants Exercised Number of shares of stock issued during the period as a result of warrant exercises. Stock issued for cash exercise of warrants, net (in shares) Adjustments to Additional Paid In Capital Fees and Commissions Fees and commissions associated with stock equity transactions that is deducted from additional paid in capital. Fees and commissions Cashless exercise underwriter warrants value Value of common stock underwriter warrants exercised. Cashless exercise underwriter warrants Cashless exercise underwriter warrants Shares Number of common stock underwriter warrants exercised. Cashless exercise underwriter warrants (in shares) Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Maximum The maximum exercise price of each class of warrants or rights outstanding. Stock issued for cash exercise of warrants at per share, net - maximum (in dollars per share) Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Minimum The minimum exercise price of each class of warrants or rights outstanding. Stock issued for cash exercise of warrants at per share, net - minimum (in dollars per share) Cashless exercise of underwriter warrants The exercise price of each class of underwriter warrants or rights outstanding. Cashless exercise of underwriter warrants (in dollars per share) Issued at $1.50 per share [Member] Stock issued during the period at $1.50 per share. Issued at $2.52 per share [Member] Stock issued during the period at $2.52 per share. Issued at $1.80 per share [Member] Stock issued during the period at $1.80 per share. Issued at $2.00 per share [Member] Stock issued during the period at $2.00 per share. Issued at $3.00 per share [Member] Stock issued during the period at $3.00 per share. Issued at $3.93-3.59 per share [Member] Stock issued during the period at $3.93-3.59 per share. Issued at $4.00 per share [Member] Stock issued during the period at $4.00 per share. Issued at $4.80 per share [Member] Stock issued during the period at $4.80 per share. Stock Issuance [Axis] Information pertaining to issuance of stock. Stock Issuance Price [Domain] Information pertaining to the per share price of stock issued. EX-101.PRE 13 vhc-20111231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 image1.jpg begin 644 image1.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`A0" M8P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/W\HHHH`****`"BBB@`HHHH`****`/F;XX?\%E/^"7W[-OQ^A_9 M@^./[:/@[PYXVDF:*YTJ]GE,6G2"-9=E[=)&UO8DHRD"XDC+9`&3Q7HW[5G[ M;G[*'[#_`,+T^,O[5GQTT/P9XZC*TCWT@C,GEVT,*O+&6./:4*%2H7CU?\`:"\?_!W]FK_@LK\#/VB? MVE?$&@>"?@--^S%J/AWX4:GXMM5TW3O#GBMM4L[B2.26X1$L)9=*2*.-9'4X MMI5"KM8D`^T_V3?VU/V5OVZ/AI_PM[]DOXWZ+XWT!9EAN;K2I'66SF*!Q%<0 M2JDUM)M96\N5$;!Z5E?L8?\`!07]C_\`X*$_"S5?C7^R%\9(?%GAC0]:ETG5 MM3?1[W3OLUW'!%.Z-'?00R;1%/&WF!=AR0&)5@/EG]C[X@^!/VC_`/@NG\6/ MVC/V-O'?A[Q)\'[?]GC1?#WQ`\2>$I8KC3=9\:KK-S<6QCNX5:*ZE@TUW60I M)E1<1!@DVUPR M>'?%%MXYU*REU5VB("-_8FKSS;LQMC0D&_:-T(!^PW_#^K_@D]_PRQ_PVM_P MU9_Q;+_A8'_"$_\`"3?\(+KO_(=^P_;_`+)]G^P_:/\`CV_>>;Y?E?P[]WRU MZ9^Q1_P4K_8;_P""BFC:KKG[&G[0VE>-4T)XUUFTAL[JRO+(.6$;R6MY%%.J M,4<*Y3:VTX)Q7X@^)/!_C/X>_L]7_@']E[3O#EGXAT/_`(+ERZ?\.[3Q0LPT MB&]AM#'8)=BV_>BU$BQ"3ROG\L-LYQ7Z)V/PO_;`_8KO?CE_P6M_X*2^.?A7 M>?$/P_\`L_S>'-'\)_!:RU*WT5;2SN)[^(RR:E)YES=37#01*SH/+4E%)5J` M/K;]F;_@H7^QW^V+\4OB-\%OV;_C)%XE\3?";6!I?C_34T6^M?[,NO/N(-BR M7,$<=R/,M)UWP-(GR`[L.A;RC]J/_@O5_P`$GOV+OCMKO[-'[2_[5G_"->-O M#7V7^V]$_P"$%UV\^S?:+6*ZA_?6MC+"^Z&>)_E7GQFT_Q$/'7B&ZGN?$=IJ%U: M02M);7#7*:D%:0R,%OO*\P*@4]RNK?\`!5S0?^"V_P"WSK/_``2]\,?`[6KF MUM_AE)XNTGXPR:HEQ=L/"[&RBTTV4L408_Z4)#<2(O\`J<,/G-`'Z.>)_P#@ MI/\`L.>$OV-KK_@H+J'[0^DW7P=LA#]J\;Z+:W.HPQF6]CL43R;2*2Y"3N"@$C+_:__P""KG_!/#]@GQGHWPY_:U_:F\/^#]?U[RFT_19XKF[N MA%*SHEQ-':Q2M;0%D<>?,$BRC?/P:_*7]I?3O`$7_!K#^T]XIT+XC#6_&?BK MXS?V_P#&'2/[(;3/^$6\777C'2&O]%%BT\_V-;;;$@02,KC]\I(E!/T=_P`% M"_&'@S]FS_@H-\1?C=^R7_P4[^$/PE^,6L>`=&7XF_"']HW31:^&O&MG#'.F MF36U_<-`RLL?VF)ULWF!8@2"(@[P#]'_`/AH?X$?\*-'[31^+_AP?#PZ$-:' MC5M7B&F?V>4WBY^T%MGE[>=V?;K7E/[(O_!67_@G3^WAXWU7X:?LG_M6>'?% MWB'1FF^V:)%'<6EU(D142301W44374`++^^A#Q_,,-7P[^U!\3;7]HK_`((B M?LN_M/>$/V9+#X5?"*R^,W@CQ;\9?A?IF@Q"PL_!=MJTK7K16UO#L-BTWV:_ M#!8\V_[Q]OSJ>X_;H_:9_9E_;2_:H_8X\&_\$[?C[\/_`!W\1O#7[0&F^(=7 MOO`6KVNJ/HG@B#3[U-:2YDM?-^QQ312PP!)-FZ22-05;!`!]R?L]?ME_LT?M M5^)OB#X,^`7Q2M_$&J_"SQC<^%O'VGK87-M+I.JP.\'?&/[-'Q/_`&K?^"IWPBTF_P!2F\!? MMV?$;P]\9/#&GQL[:]X'FNM-EFN51`6DNM+E:6^A4`EHWO8@,S@CZZ_X-$?$6L-#]DT2 M6*YN[J..4L(YIX[6*5K:$E&_?3!(Q@Y85V/QB_;F_9.^`W[*5Q^W%\2/C5ID M?PGMK*RO&\:Z-#/JMK);W=S#;6\L0L8YI)E>:>)UTI];\$3Z?8IHJ6TM MUY0NXH8HI8"D>_;)'(I+-DGY,_:4TCQ'#_P:_?M>^,[2W%M\./&/[1NH>(?@ M;8K8FV2W\&W7C?27LO+B**5BDE%U/']X&.=&#;2``#]1OV*?^"S/_!-C_@HE M\4]0^"G['7[2'_"8>)]+\/RZW?:9_P`(?K&G^581SP0/-YE]9PQMB6Y@7:&+ M'?D`@,1O?MS?\%3/V#O^";$OAB#]M3X[KX,?QDMXWAM!X:U/4C=BT\CSR186 MT_EA?M,/^LV[MQV[MK8=^PQ^SQ^W9\!/^$I_X;6_X**_\+^_M;[#_P`(S_Q: M+2_"O]A>5]H^T?\`'A(_VKS_`#(/OX\O[/\`+GS&KY._X*^^%_V9-;_X*%?" MF^_:/_X*0_$#]FJ6W^#GB5_"WBOPOJEAH=K>3QZEI6\,<9R%`H`^IOVI?^"P7_``3P_8H\!_#WXE?M2?'B M\\'Z1\5-+FU'P-)J'@76Y)[^WBCMI)#);PV3S6C*MY;DQW"1/F3&W*L%V?V& M/^"H_P"PG_P4H_X2G_ABGXY_\)I_PA?V'_A)O^*9U33OL?VS[1]G_P"/^V@\ MS?\`99_N;MNSYL;ES\/?\'`.I>(-!_X*2?L*:AX/_;3\/?LZWT(^)PMOC#XH MTG3KVP\/`Z-IRGS(-2DBM7\]2;5?,<8:Y4KEPH/J'[/W[6WC']FG]D+]HC]I MWXJ_\%IOA]^V-'\/_!4>L:=;^!O"WAS2_P#A&IXX+YHX9CH]S,)#?2K$B>?M MVFU;9G<^`#ZH_9F_X*%_L=_MB_%+XC?!;]F_XR1>)?$WPFU@:7X_TU-%OK7^ MS+KS[B#8LES!''%/VQ?^"?W[:/[-\O[4W[!&K_``DT;Q]X%U+X7>)_'EY\9M/\1#QUXANI M[GQ'::A=6D$K26UPURFI!6D,C!;[RO,"H%/+M)^,,FJ)<7;#PNQLHM--E+%$&/^E"0W$B+_`*G##YS0 M!^K?P#_:$^"7[4OPKTSXW?L\?$W2?%_A36`_]G:YHMT)892CE'3U5U=65D8! ME(((!K@/VT?^"E'[#7_!/'1M/UK]L?\`:+T;P4-6#-I5C<07%W>WB*Z([Q6E MI'+/(BLZAF5"JYR2`#7B'_!`C3O`$7['/BOQ3H7Q&&M^,_%7QF\3Z_\`&'2/ M[(;3/^$6\775TK7^BBQ:>?[&MMMB0()&5Q^^4D2@GAM!^-GP:_9!_P""X/[1 MWQ`_;[^,?@WP3I_COX:^"1\"?$?CK4;?3;5M&LX+V/6-/M[RY$<9E&H2+-)` M'9RL\3=,*H!]7ZE_P46_8GT_X:?#CXR6_P"T+HNI^%?BWX^L?!7P\U_P_'/J M=MJ^O7CS1P60>TCD$+%[>9&>78D;1E9&0\5U7Q$_:C^!/PH^.WPZ_9H\?^.? ML'C;XL_VO_PK_1/[,NI?[5_LNU6ZOOWT<30P>5"ZO^^>/?G";FR*_,C]OGXC M?L4^-OV*?V;?VM/V)_#VEZ#\$_!/_!0;PQXK\=>)K32#IVG000:I?6FH:S\X M7S;=KN:-?.3<"&```0A?2/CG^T-^S]^VK_P7+_8@U+]D+X[^"OB=;?#?0OB? MK'CNY\">*[/5(]#LKS1;2QMI;AK>1PGF7+K&$SOR,!;0F\#W4,D>^V$R#;O+!"&/Y.?"_X^^//^"=7Q#_`&EO^"CGPX\&ZIXA M^T?MK_&?X9ZYX?TFUFE>]O=0MM/O_#TKB(-\J:I8?9`2AV_VN^T@G9+Q/QL_ M9"\;_!C]EO\`X*D?LL^'Q/XDU_P;\._@!<>)-04@2:A<66GV^H:OJ+EW))8Q M7ET^69CEN78Y(!^_?Q]_:C^!/[+_`/PA7_"]/'/]A_\`"Q/B!IO@GP=_Q++J MY_M#7;_S/LEI_H\4GE>9Y4G[V79$NWYG7(R?`+]J/X$_M0?\)K_PHOQS_;G_ M``KOX@:EX)\8_P#$LNK;^S]=L/+^UVG^D11^;Y?FQ_O8M\3;OE=L''Y]?\%1 M/VP?V3OV[/'_`.Q;\*?V-OVF?`/Q,\3Q?MG>#/%=UX?\&>+K.^O;31M.M]0N M+V\GACD+P)%$=S"0*W8`L,55_P"".O[;O[%_[-?BK]LSP+^T9^UW\+_`&MW? M[=_Q$O[71O&OC_3M*NIK5GLHUN$BNID=HB\4J!P-I:-QG*G`!]U_ML?\%`?V M1/\`@G5\-],^+?[9'Q>3P=X?UG6TTC3;XZ)?:@T]XT,LPC$5C!-(!Y<,A+E0 M@P`6!90>@_:9_:N^`'['G[/^L?M2_M%_$!?#_@/0([1]5U]--NKT0K=7,-M` M1%:12S.&FGB7Y$.-^3A02/S=_P""REO\??VN/^"B6A_LX_`K]@JZ_:(T'X4? M!?6)O&OA6/XLV/A6WL-0\60W&F6UT\ETV)IH;&TO?+`0M&;W>K1L`3];?\$2 M/C7XT^,G_!-KX?:5\6(+R#QU\.H+CP!X_M=1OTNKB'6=#F;3I_-F1W$KOY"2 M%]S;O,SELY(!0_9<_P""]7_!)[]M'X[:%^S1^S1^U9_PDOC;Q+]J_L31/^$% MUVS^T_9[66ZF_?75C%"FV&"5_F<9VX&6(!]-_9L_X*2_L6_M=W'@ZV_9Z^,C M:^WC_P`*ZKXC\'L_AK4K)=2TW3=1&FWLJM=6T05HKLB,Q.5E((D5#&=]?.7_ M``0+_P";U/\`L_\`^(__`+CJ^&/V'_&UK^R)_P`$*?V'/^"HSV1:Q^!_Q.\1 M67CZ6&:196\):]XBU?2K\*L:-]H,=Q+I]PL+`!FME(96"F@#]E=8_;/_`&:] M!L/B]JNJ?$9H[7X#VC7/Q6N5T6]>/1(UTQ=4;#+"1=,MFZ2LEMYK+N"$!SLK MYQ^$_P#P<>?\$8_CC\4_#7P4^%O[9/\`:GB?QAX@LM$\.:9_PKSQ%!]KO[N= M(+>'S)M/2./?+(B[G957.6(`)KR'X1>&O%=]_P`&XW[1'[3GQ*TZ.W\6_M`_ M"CXC_%+Q!''?/=>6FL:9>S:?!YKJI80Z8MA``%54$(51M45X]_P2=\??&C_A M5G[-.B?\10'P?_LC_A'_``;!_P`,Y_\`"O\`P;_:OV;R+-?^$4^T_;?MWVG9 M_H/F^7]HW_-L\SY:`/U>_:C_`&H_@3^Q=\"==_:7_:7\<_\`"->"?#7V7^V] M;_LRZO/LWVBZBM8?W-K%+,^Z:>)/E0XW9.%!(\`_9<_X+U?\$GOVT?CMH7[- M'[-'[5G_``DOC;Q+]J_L31/^$%UVS^T_9[66ZF_?75C%"FV&"5_F<9VX&6(! M^OZ^`/\`@@7_`,WJ?]G_`/Q'_P#<=0!['\>/^"S/_!+S]F/X\P_LS?';]M#P MCX>\:R3&&YTFYDGDCTZ38LFR]N8HV@L2592!<21YR,9K7_;8_P""JW[`O_!. MRQ\(:I^V%^T!#X4MO'L-W+X1N+?P[J6J1ZC':BW,SJVGVTX55%W;D%]H82?+ MNPV/B;_@E;^U_P#L)_LB_P#!.CQ9^S=_P4I^/7PV\/?%[1/&'C$?'OPOXOU" MTL]3\1W\^LW\_P!I6SG\N6_2XM);=HFCC(9&3:`,5TO[/G@+XZ_#'_@TVU_P M1^T?%*K+]D[QF9+2]@:*:TT^33M3DTZVD1D1D>*P>UB967*M&02Q!8@'U MK^Q)_P`%4_V"?^"C%GXNU#]CCX]IXO@\"1VFK8)="X,#$W]M!Y M@86MP?DW;?+^;&5ST/[$_P#P4`_9&_X**_#;4_B[^QO\75\8^'M'UQ]'U*_& MAW^GF&]6&*9HS%?00R$>7/$V\*4.X@$E6`^-_B?\8_&_PA_X-BOA?I_PDM[J MX\<^/_V=?`G@+P%::?J"6MS-K&N:78:9;^3,[H(I$^TM*'W+M\K.1C(\_P#^ M".`^/7[(/_!175?V;?CS^P7>?L\:'\7/@SI#^"O"K_%BQ\56VH:EX3MX-.N; MM)+5L0336%U9^8"H:0V>]FD8DJ`?I7\`OVH_@3^U!_PFO_"B_'/]N?\`"N_B M!J7@GQC_`,2RZMO[/UVP\O[7:?Z1%'YOE^;'^]BWQ-N^5VP<=!\6?BEX$^!W MPL\3?&OXI:[_`&7X8\'^'[W6_$>I_999_LEA:0//<3>7"KR2;(HW;:BLS8PH M)(%?FA_P1U_;=_8O_9K\5?MF>!?VC/VN_A?X`UN[_;O^(E_:Z-XU\?Z=I5U- M:L]E&MPD5U,CM$7BE0.!M+1N,Y4X^T/^"L7_`"BR_:6_[-_\9?\`ICO*`/+? M@9_P<.?\$;/VCOB=I?P<^%'[;NDW'B'6[F.VTFSUGPSK&DQW4[NL<<*SW]G# M"9'=U54W[F)X!KLOVUO^"S/_``38_P""=OQ3T_X*?MB_M(?\(?XGU3P_%K=C MIG_"'ZQJ'FV$D\\"3>98V&/AY%J'Q0^'NE:O<^(O#FF0C3;C2EU.2YO(4L)+@PV M]O+?6T4L<$DQ/RH#_VL[M/&%PD M?Q&\%>']&TVUTZ,6MH1I3Q:1/-`TL9+3EV82%;Q`0%5"?B;_`()*^!?%OQ1_ MX-%;GX9^`=$EU/7?$7P6^*&F:+IL#*'N[NXU#7XH8E+$`%G=5&2!D\F@#]"/ MB7^WK^R=\'_V-K;_`(*!?$7XK?V=\(KOP_I.MV_BW^PK^;?8:F]NEC-]EB@: MZ'F-=VXVF+-O#7V7 M^V]$_P"$%UV\^S?:+6*ZA_?6MC+"^Z&>)_ED?#+2?%UG)KDVLP7^AQS69LO,\V- MD:"4,SJJC9G=@@GN%U;_`(*N:#_P6W_;YUG_`()>^&/@=K5S:V_PRD\7:3\8 M9-42XNV'A=C91::;*6*(,?\`2A(;B1%_U.&'SF@#]'/$_P#P4G_8<\)?L;77 M_!074/VA])NO@[9"'[5XWT6UN=1AC,M['8HGDVD4DY?[3*D3((]R$G<%`)'1 M_%7]LO\`9H^"OAGX<^,_B-\4K>TTKXM^,=(\+?#O4+2PN;R+6=5U1'DL($:V MBD\M9DC9A-)LB4`;G7(S^-W[2^G>`(O^#6']I[Q3H7Q&&M^,_%7QF_M_XPZ1 M_9#:9_PBWBZZ\8Z0U_HHL6GG^QK;;8D""1EH^''8#;&-.NKNV^S`D%K2 M]BC`_P!&8D`_8CX;?M!?!;XPZ[K?AKX9?$;3M9O/#]\+34HK.0D;_LUKXWLPN+DN[>?.`VP3/F01JD081QHB]Q0`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`45\(?\%&?VPOBWX*_:5T3P[\`&^*&I M6GPJT^TUOQCH_P`-OAGK?B*/7M3GU;29GT(RZ397-O'??\(W'KJ_8]4DM8%D M\1Z)>*0R1WM@>)OV\/VT/BS^TW'\-?V6O'/P/LOA[J_QPM/`_A3QQJ?AS4?$ MTFJ6MQ\-(_&@OA'::I8P&)2C11S1SR+'/VS?C[^T M]X5_9ZL_V'PVE);VMYICS2N_B M&)A=F955;%U^SL;@-!Y?K?\`P4W_`&I_&/PLUC]J[X6Z3\/]!\$^"OV0/"/Q MT\1^!-?\.WVJ:KK/]JP>(+RXT>VU:&_M8;';#HJ0I=/87.'N&E:%E00D`^R? M%7[-7[.?COXF:5\:O&_P!\$ZSXRT(,-#\6ZKX5L[C4].#+M;R+J2,RPY7Y3L M89'%;?Q$^&GPX^+_`(0O/A[\6?A_HGBC0-1B,>H:'XBTJ&]L[I",%9(9E9'! M!(P01S7R7^T3_P`%`OC[\,_C+JUIX.G^%]GX4T+]H_P'\'9M"\6-=1ZSJ]UK M@\/7]UJ>GSI.L=Q+'8ZU+$NF&`,HLYM0:[=(38/Z_P#M=^+/%7P)\5>!/VK; M?Q-J"^#?"NH3Z)\4M&-ZXL8=`U5[:-M=>(%(EETV\M[&XEO+AUBM-)DUR3#N MT>`#U7X=_#3X:M'!X6CTE/"<6@Z+/I7VJ..VE%BT$FH0L))(M2GU/[)<0P MW,JR]A\>_P!L3]OKX):Q\5->UG4_@_%I_P`#?V?].^*?C7PK:^#]5O9M<^TW MGBB231;'56U.W6U\JTT&&V&H2V$OFS2R71LX4*V2`'T__P`,G?LL?]&T_#__ M`)*!_P`)W_R)MC_R-7_0>_U7_(2_Z??]?_MUO_%/X2?"GXY^!;WX7_&WX9>' MO&/AG4C$=1\.^*M%@U"QNC'(LL?F6]PCQOMD1'7%-&^"WA_PW\.?$'Q`\:^`?!7BSQ'9:68;/5=#;6+>/4`Z^)DO]=\R MXT29WTJ+2M/>.&>9Q>M'8M<77A^F?M0_M/?V M4'O_`(EZU<)++'X6\.VUGIMR_P`1Y+?49[M-2OM"34T6ZL(=ESKTFIB0@)90 MP6X!^E?C_P"#GPB^*\6B0?%+X5^&_$J>&=._$?Q2\)_#3P_I?B?QA]C_X2WQ'IVC0 M07^M_9(C#:_;+A$$ESY,3&./S&;RU)5<`XKQ#_@H-J'Q"^!?[&>@6/[/FJZ@ M=;TKXH?#+1]"&M>-;^*348Y/&>A6;6E]JC"ZNVBN89'@N9Y%N))(YI3(DY9E M?R^Y_:Z_:G^!'Q3_`&JOC3^TO\,?#]M_PJC]F#PSXRT3X>>#OBE?:QI5UY$_ MC:>:1;FZTJR^QW-S]@B@D9;63Y+6W8O)M$<8!]1^*?V6?V8_'.A^*_#'C;]G M+P'K&F^/+ZWO?'.G:KX0LKB#Q%^'_`(3\2ZMIMUI4=RGANXTRUU6&VO%GDEMA]K@@URVG MLY+AIK\06^GM;EY@#]2FL+%K$Z8UE$;8Q>4;\UN7PGX7M-.;4+ACEIIS;QH9I"0,L^2?6OG/ MQE^V)^U/X2^.WQ'\0_VG\/[CX9?#_P#:`\%?#+_A$?\`A#[Y-=O_`/A(+7PJ MO]H?VO\`VF;>+[/<^)O-\C^SW\V*R\KS(VF\^+/\+?\`!0+X^ZY^U!\+/!]Y M/\+X?!OQ8^.'C[P/I_AF1KJ/Q1IMKX3A\16]Q?1DSF+4HKF\TBUF>98;9=/2 MZAM62]>Z6[@`/JOP9\&_A#\.+37[#X>?"KPWH,'BS7+K6O%,.BZ';VJ:SJ5T M%%S>W0B11<7$H51)+)N=]HW$X%2?"WX3_"SX'>!+'X6_!3X:>'_!_AC2_-_L MSPYX6T:#3["T\R5YI/*MX$2./?+))(VU1N9V8Y))KQ#XLZ!/^T5^VAJ/[,?Q M7\;^,/#W@W1?A?I7BCPA9>"O'.J>%KKQ+J?_`!]_;@^,OPM\*^,?$OP`^)G@_P`9^%/@=^SAH_Q6 M\2^)?$FE#4[KXGZ==)K;QQ65YI=Q96>E2RQ>'II/MR6MY;NVIQO':(EMYM:'Q*^#WPD^,WP\N_A'\8/A;X<\5^$[](4OO#'B71+>^TZY6&1)8A);3 MHT3A)(XW4%3M:-6&"H-?(?[2_P#P4+_:G^"/_"_OB+I^F?!^R\$_![XP>"?! M.D7'C+5;[3_MW]M?\(=+>7.I7P+0Z7;6D.N7Q^U+%<[O.A=H(UT]UU'W_P#9 M)^,7Q3^(EU\2OAA\:[KP_J'B?X5_$"/PQJ?B+PMH\^F6&M>=H>DZU'<16,]S M=R6>R+5X[9D:YGWM:M,&03"&(`]@KFOBA\&/@]\;]%M_#GQH^$_AKQ?IUI?1 M7MI8>*-"M]0AAN8V#1S(DZ,JR*P!5P,@@$$5\2_MT?$?]J?P3X[_`&Y-0T;X M^_8?#'A;]B"PUWP5I&BV=]9W^@ZK)%XP$=_!>+?F..Y$NGS-)-%;QO(O]G(& MC-@SW6A\>OV__P!O/X*_$Q?V4[/X0^#_`!5\4O%&H>&[GPT_@K2S=6NBVNK6 M7BZ]DL'MM4U?3$UF6T3P?=1F^:^TI;A=029;.%K7[+=@'W;!!#;0I;6T*QQQ MJ%CC10%50,``#H*P?$7PG^%GB_QWX<^*7BSX:>']4\3^#_MG_")>(]1T:">_ MT3[7$(;K['<.ADMO.B41R>6R^8H"MD#%>0?#OXT_%WXR?\$^_$'Q-^)WCCP_ M\%?&T'A_Q/IVK>,7N])U*P\(W^G7%]8'6+B..^NK&+R7M?MW"VK+):3 M7,K0R2MY?\"_''@O]B?Q5XI?]IQ?BA\.;O1OA?K?B[7;37?C?K/Q+\+Z[HVD MO9R7NJ:9=ZHTVJ02Z='>6T4L)M=--P^I2*D.I+:PW$`!]'_'3]D[]EC]J#^R M_P#AI?\`9I^'_P`1/[#\_P#L3_A.O!MCJ_\`9_G>7YWD?:HI/*\SRHMVW&[R MDSG:,<]X?_X)Y_L!^$O`OB'X7^%?V'/@]IGAGQ<;0^+/#NG_``STJ&QUHVDC M2VOVNW2W$=SY,C,\?F*WELQ9<$YKXA_X6Q^U/\%/V0/VO/AA\'+J;3VN M+:8W3?6'[!_@'XR^#O%7C74=<\`_%#P5\/;W3](C\+^"_C-\2QXLU^'68WOS MJFH"]_M75BEC/;R:1%%;F]PDMC=N+:'S3+<@'M?C_P"#GPB^*\6B0?%+X5^& M_$J>&=._$?Q2\)_#3P_I?B?QA]C_X2WQ'IVC007^M_9(C#:_;+A$$ESY,3&./S&;R MU)5<`XKY`_X*7-\2;+XIZM\9_$6M?VM\(O@Q\'Y_$_C?PAX!_:4\1^"/%5M# M+/=3WFI26.C0A=6_T31S%IL=Q>6,)G&J)([;TEM<_P"#?C/XA/\`&7X5_':Y M^*GC"YUOXC_M7_$WX>>+;&]\7W\^C3^'=''C@:=:P:1),=/L98AX=TC-U;6\ M5S(;>4R2N;JZ,P!]I^%_AC\-O`^OZ[XK\%?#W0]'U3Q1?)>^)M2TO28;>XU> MY2-8DFNI(U#7$BQJJ!Y"Q"J%!P`*SOC'\`?@1^T3X97P5^T#\%/"7CK1DE$J M:3XQ\-VNIVRN""'$5S&Z!@0#G&>!7Q[_`,$X_&?Q"G\5?LU>,=;^*GC#6KOX M_?LH:E\0_B?#XD\7W^IVMYXBA?P>\=U96MW-)!H\0.NZF/LNG);6Q6>-3$5M M[<1:'B#]H7]J?1/VE/'?P=^"GQ(\/VFH>+_VO[;P;IFH_$+0;[7[#P_I4?P@ ML/$4D=K90:C8LF^[LI#M6=4#7L\A1G$K/28[F3`7?(MK$@=L*HR%]`T>?X7^' M=;L=/^)^J^._%'C5KJUT"\M?`GB6V\/WJ(RS[]#BU![D7@O97U!=,BB='@U$ M_O1X?\.O^"C_`.W9X+_98^#%E\'?A'_PL#_A$OV0/`7Q*^*WBOQ9J>EM_:W] MI6-Z'2\U75_$.E_V/G^Q;N274S#J_P#Q\M+);)]F"7@!^A%K^S/^SA8Z1JN@ M67[/W@B&PU[QA_PEFN647A2S6'4=?\Z*?^UYT$>V:^\V&&3[2X,N^)&W94$: MNA?"'X3^%_&WB7XE^&OAAX=T[Q'XS6T7QAX@L=$@AOM=%K$8;87DZ()+H0Q, MTH:M\/S_`,(E]IUO5]7L9YVN=5TJ M=%-GI5O9F3_1M2LOM=C+J,K2S)';W.CS+`G]OHFF=?\`MD_&OQ5^S]^SQK'Q M&\!:?I]WXB?4-*T;PU9ZG$\L=QJ>IZE:Z;9Q")'B$TK7%W$L<,D]I!+(4CFO M;"%I+R``T/A=^R=^RS\#O%^K_$'X*_LT_#_P?KVORM)KVM^%O!MCI]YJ3EF< MM<301*\Q+.[$N2VD%^]S-J-M8+<6[Q_;Y`# M]'?#GP@^$W@[Q]XB^*OA'X7^'=*\4>+_`++_`,)9XDTW1((+_6_LT9BMOM=P MB"2Y\J,E(_,9MBDA<#BCX>_"#X3?"0ZVWPI^%_AWPP?$NO7&M^(SX>T2"R_M M74Y]OGWUSY*+Y]Q)M7?,^7;:,DX%>)?MO:W\?=)_:1_93T[X1?%C3_#VB:U\ M<+ZP\9Z7=Z-=7+:U:KX0\07GV=GAOK=!$$LY\)+',HNFLKG!%FT%S\WVO_!0 MO]J?]C_X$^)_V@_BEIGA_P`<>"?^%P?&W1_#F@3:K??V[+_8-UXVUVWN)M3F M+PVULL/A]](BTY+67RHOL]TMWM4Z>@!]_P#@#X3_``L^%']M_P#"K?AIX?\` M#7_"2^(+G7?$?]@:-!9_VKJMQM^T7]SY*+Y]S+L3?,^7?:NYC@5CZ;^S)^S; MHWP2;]F?1_V>_`]I\-WMY8'^']MX3LX]$:*69IY8S8K&("KRN\C+LPSLS')) M->4?L'_'_P#;"^)GBKQK\+OVROA-I_AK6_#FGZ1JNE7$<&D:9=7=K?/?P[)- M)T_Q'KSP1(^GN4O9;J-;EI9HD@4V4DDOR?\`L_-^T[JO[3OASQ'JNM>(-'LO M''[3_P`1=)\/_%"^_:4\5:Q#+#HGBK6IG\-OX+GA.D0?:M%TO4K*"82&&UAL MVNP\=ZMG;3@'Z3ZM\//`&O>`+GX4:YX&T>]\+7NCOI-YX:N],BDT^?3WB,+V MCV[*8V@:(F,Q%2A0E2,<5Y/X3_X)D_\`!-OP%XJTSQUX%_X)\_`_1=;T74(; M_1M9TGX3Z/;75A=0N)(KB&6.V#Q2HZJZNI#*R@@@BOG#XS7WC'PEJG[8_P"U MUX6^+OQ`_P"%@?"3X@6ME\(O#7_"Q=8DT*_O/^$&\+W5CX>_X1_[5_9]Y_:6 MI:A+:>6EO]LEEU/_`$66*[^SS1>P?M"PZQ\9_P!J?Q)\!/B!=_$!/#'A;X/V M'C#P-X5^&GCV\\)ZKXVU=[[5+;4HH]0MKZQDN?L44&CQB#[5#:1/X@CDO=YD ML)+<`^GZY_P!\)_A9\*/[;_X5;\-/#_AK_A)?$%SKOB/^P-&@L_[5U6XV_:+ M^Y\E%\^YEV)OF?+OM7ZC^UC^Q+H_B;Q_J7C"2+Q3I^JZ?_:^I MK;Z'K-]IRW=U:6]^+G0;V6W\V>U2*XCU+3)TM[D2I>6BVT4T4,7SA\&?B!XQ M_8Y_X)__`!#_`&@/AI)\0/B-XVU/]H#7/`?A_3_'7Q.UCQ)L_P"+F7_A71Q! M#K6J+"OV>&XMRT2W-E]L^S(L]W$Q^U1`'V3XT_9I_9R^)'Q#TCXN_$3X`>"= M?\6>']W]@^)]:\*6=UJ.F[AAOL]S+&TL.0,'8PR*Z;Q9X3\*^/?"NI^!?'7A MG3]:T36M/FL-9T;5K)+FUO[69#'+;S12`I+$Z,R,C`JRL000:^0/`W[:/[;7 MB/P/X;^$GCKP%X/\%?%CQ+\<)_A]'K.N:=:7UKITFVE M>WMFLTLVUCS"LL&H%ECE2S/G_P`1/VP_VT/A9\6_CE\8]'\>?"_Q+HGP9_9P MT?Q3X[L-+U34;[3-6NM(UOQW!>V6E6JS*FCWU^FEB.YN)9;QM,GL([1X=5$? MVB,`^W=7_9T_9\U_PIX3\":]\"?!M[H?@&^L;WP+HUWX8M)+3PY$*BM#Q+\(/A-XS\>>'?BGXP^%_AW5O$_@_[5_P`(EXCU M+1()[_1/M,8BN?LEPZ&2V\V,!)/+9=Z@!L@8KYB\9?MB?M3^$OCM\1_$/]I_ M#^X^&7P__:`\%?#+_A$?^$/ODUV__P"$@M?"J_VA_:_]IFWB^SW/B;S?(_L] M_-BLO*\R-IO/B\?_`&Z_V^?VI](_9`^*7Q6T;Q!X?T?PQXL_X6_\/O!5AX*RM7MSJ$.+F0V;&Y`/J_Q9_P3 M)_X)M^/?%6I^.O'7_!/GX'ZUK>M:A-?ZSK.K?"?1[FZO[J9S)+<32R6Q>65W M9G9V)9F8DDDU[!XL\)^%?'OA74_`OCKPSI^M:)K6GS6&LZ-JUDES:W]K,ACE MMYHI`4EB=&9&1@596(((-?,'Q+_;-^/OAGXR^,=<\/0^#U^'OPY^.'@SX7Z[ MX7O="NI=9UNZ\0#PYMU6#5%O$@L8K<^*+QN6F&FRC[1%]K4VOG_C#_@H M%^VAKGQ,\(^#_@O/\#X9?BQ\4/B7X'^'WAGQBVHQZGIMUX3LO$MNE]<&"<_V ME8W.IZ1937$T,-LVGP726H2]ENDNX`#[*N_@S\']0^$P^`E_\*?#4_@5=$31 ME\%S:%;MI(TU(Q$EE]C*>3]G6-501;=@4!0,#%<;\5_V#OV'/CQJ^G^(/CC^ MQG\*/&=_I&D1:5I5[XK^'>F:C-96$3.T5I$]Q`[1P(TDA6)2$4NQ`&XUC?L> M_M4^*OVO-1\2?$C1?AUJ'AOX>V6GZ-8:):^*M(>SUW^WS;O=:U;W"K+)!Y5F M;FQTUT4B6#4]-UJVE'^CH3P'P;L].^,'B#7_`-ICX\_M$^,/!GC+PE\<-4\( MVNAV7Q!N-*T;2K*#Q`UAHVESZ++(;&YEU?3Y=/N1->P37LQ\012V4T"'3!:@ M'O\`\%/V>O@%^S7X5N/`O[.?P.\'^`-$N]0>_NM&\%>&;72K6:Z9(XVN'BM8 MT1I2D42%R-Q6-!G"C&A\+?A/\+/@=X$L?A;\%/AIX?\`!_AC2_-_LSPYX6T: M#3["T\R5YI/*MX$2./?+))(VU1N9V8Y))KYP^&G[9OQ]\3?&7P=KGB&'P>WP M]^(WQP\9_"_0O"]EH5U%K.B77A\>(]VJSZHUX\%]%<'PO<$6B6-LT(U*(?:) M?LC&Z\/_`&;_`/@IO^WUXVM?`WQ8^->D_!^#PQX@^'_P9\0ZGX/\+>'=5-^_ M_">ZY=:#&T6JSW_EP_9I;>/46A:QERL[6`F8Q#4I0#[=T/\`9)_94\,?%Z[_ M`&@O#7[,OP]T[Q[?J5OO&]CX+L8=8N00@(DO$B$SC$:#ESPB^@KHO#OPG^%G MA#QWXC^*7A/X:>']+\3^,/L?_"6^(].T:""_UO[)$8;7[9<(@DN?)B8QQ^8S M>6I*K@'%?*'BG_@H%\?=#_:@^*?@^SG^%\W@WX3_`!P\`^!]0\,QM=2>*-2M M?%D/AVWM[Z0B<1:;%;7FKW4R3-#&+?Q-(VL:IXA:>X@-C.?"MPTD::9 M$UK'J2MYMQ]B878!])^*?V6?V8_'.A^*_#'C;]G+P'K&F^/+ZWO?'.G:KX0L MKB#Q%&)O$&AV]Z^D:E"^%]1T>ZT);CP5XOOK2:_T6Q\17MIJUB9M*@D MBN8M6N;6Y9KRV\JRO]),\?C_`,%/^"BW_!17P#^R/\'-.\'?#S3_`(GW?A/] ME#P;\3?BCXRUK^S[:/5+75(M1,%O?:EK7BBQ.D2I;Z/+]IU@QZJLLDTMRUE; M+"MO<`'ZGT5X?_P4&\6>*O!?P&T#6/!WB;4-)NYOCA\,K":ZTR]>"1[6Z\=: M%:W5N60@F*:WFEAD0_*\/OAEX<\/:!X/OM/U70O[!G\4-;ZA#?VV?VL M?#'[+'BSXS_M"?"GP_IWB?X6_$"/2_%?A"!K!-5\56$UC93P6=A8Z;K>K1Z7 MK'OB#XQ\3>#] M7N_$&GC58;_P!>O=Z,]K\,Z?87>OZ M@M_KMU96212:C=+;PVJW$[*`9I1;VUO"'?+"."),[44#G_"?[/7P"\!0:9:^ M!?@=X/T6+1=0AO\`1H])\,VMLMA=0Z6-(BN(1'&/*E33%6P5UPRVJB`$1#97 M844`>?\`C_\`9._98^*_PLT3X%_%+]FGX?\`B7P3X:^S?\(YX.U_P;8WFE:5 M]G@:WM_LUI-$T,'E0N\2;%&Q&95PI(KH/$?PG^%GC'^W_P#A+OAIX?U7_A*_ M#Z:%XI_M+1H)_P"V=*3[3LL+K>A^T6R_;+S$,FY!]JGPO[U\]!10!X!\2_\` M@GC\-OC!^U/;?M2?$7XD^(-1GM/[)6W\+?\`"/>'(;9(=,OK?4[&V_M*+25U MLVT>JVEOJ7V8ZCY+W$>'1H6:`^W^+/"?A7Q[X5U/P+XZ\,Z?K6B:UI\UAK.C M:M9):*0%)8G1F1D8%65B""#6A10!S_C7X3_"SXE>=_P`+%^&G MA_7_`+3X?U#0KC^V]&@NO-TJ^\G[=8-YJ-NMKC[/;^="?DE\B/>K;%P>(_A/ M\+/&/]O_`/"7?#3P_JO_``E?A]-"\4_VEHT$_P#;.E)]IV6%UO0_:+9?MEYB M&3<@^U3X7]Z^>@HH`X_1OV>O@%X<^,NK?M&>'O@=X/L/B%K^GK8:[X[LO#-K M%K.HVJB%5MY[U8Q/-$!;6X".Y4""(8^1<'PD_9Z^`7P!TY='^!/P.\'^"K1- M/BL%M?"7AFUTV,6L=Q=74=N%MXT'E+<7U[,J?=$EY<.`&E?_#K]D[]ECX/^!'^%OPD_9I^'_A;PQ+X@M]= MD\.>'/!MC8V#ZK;RV\T%^;>&)8SC6T+*P,:$%K^R=^RQ9?\)# M]B_9I^'\/_"6_P!L_P#"5^5X-L5_MK^U_L_]J_:\1?Z3]M^R6OVGS-WVC[-# MYF_RTQZ!10!S][\)_A9J/]I?VA\-/#\_]L^(++7=7\[1H&^W:K9_9?L=_-E/ MWMS!]AL?*F;+Q_8[?:P\I-OD'A'_`()X_#;P_P#M8ZC^U_XD^)/B#Q'X@O/$ M#:W:V%]X>\.6$-I?K87FF6DSW6EZ3::AJ'V33=0OK&!=0N[I4ANF)#2K',GO M]%`''_&O]GKX!?M*>%;?P+^T9\#O!_C_`$2TU!+^UT;QKX9M=5M8;I4DC6X2 M*ZC=%E"2RH'`W!9'&<,O@%\8_%7ACQU\7?@=X/\`%6M^"=0-_P"# M-9\2>&;6^NM`NM\4GVBREFC9[67?!`^^(JVZ&,YRBX["B@#S_P"*_P"S1\+/ MBWXYU/5=$U'3+ZSDN7,;>=G^R+&V= MF!#?#GC#0_$FC:#X#TNUT MRUM;K2]>M==B1((X?*2*6\M5,P5`SK+*0RNV\>H44`)=/L;#Q':^)/#-K?1ZK:V5Q+=6=O!?`OAG3]%T31=/AL-&T;2 M;)+:UL+6%!'%;PQ1@)%$B*J*B@*JJ```*X_X%_LG?LL?LO\`]J?\,T?LT_#_ M`.'?]N>1_;?_``@O@VQTC^T/)\SR?/\`LL4?F^7YLNW=G;YKXQN.?0**`/+_ M``3^Q%^Q?\-/"M]X%^'/[(GPO\/Z)J>GZE8:EHVB>`-.M+6[M=12VCU"WEBB MA5)(KI+*S2=&!69;2`.&$2;?4***`./^(_[/7P"^,?BKPQXZ^+OP.\'^*M;\ M$Z@;_P`&:SXD\,VM]=:!=;XI/M%E+-&SVLN^"!]\15MT,9SE%P:-^SU\`O#G MQEU;]HSP]\#O!]A\0M?T];#7?'=EX9M8M9U&U40JMO/>K&)YH@+:W`1W*@01 M#'R+CL**`./^''[/7P"^#GBKQ/XZ^$7P.\'^%=;\;:@+_P`9ZSX;\,VMC=:_ M=;Y9/M%[+#&KW4N^>=]\I9MTTASEVSH?\*G^%G_"1_\`"8?\*T\/_P!K_P#" M0?V[_:G]C0?:?[5_L[^S/M_F[-WVG^S_`/0_.SO^S_N=WE_+7044`+-"M;WPS:RQZ=K[7$UTVKP*T9$-\;BYN)C1Y7]F;HC]@V?9K;;Y&S;]GBQCRUQZ!10!S]G\)_A9IW]F_V?\-/#\']C>(+ MW7=(\G1H%^PZK>?:OME_#A/W5S/]NOO-F7#R?;+C@44`O@%X"@TRU\"_`[P?HL6BZA#?Z-'I/AFUMEL+J'2QI M$5Q"(XQY4J:8JV"NN&6U40`B(;*S_%/[)W[+'CC['_PFO[-/P_UC^S_[=^P? MVIX-L;C[-_;?F_VSY?F1'9]O\Z;[7C'VGS7\W?N.?0**`.?\?_"?X6?%?^Q/ M^%I?#3P_XE_X1KQ!;:[X<_M_1H+S^RM5M]WV>_MO.1O(N8M[[)DPZ;FVL,FB MS^$_PLT[^S?[/^&GA^#^QO$%[KND>3HT"_8=5O/M7VR_APG[JYG^W7WFS+AY M/MEQN8^:^[H**`./^"G[/7P"_9K\*W'@7]G/X'>#_`&B7>H/?W6C>"O#-KI5 MK-=,D<;7#Q6L:(TI2*)"Y&XK&@SA1C0_X5/\+/\`A'/^$/\`^%:>'_[(_P"$ M@_MW^R_[&@^S?VK_`&C_`&G]O\K9M^T_VA_IGG8W_:/WV[S/FKH**`//_P#A MD[]EC_A>W_#4?_#-/P__`.%F_P#11?\`A#;'^W?^/7[)_P`?_E?:/^/;]Q]_ M_5?)]WBM#XU_L]?`+]I3PK;^!?VC/@=X/\?Z)::@E_:Z-XU\,VNJVL-TJ21K M<)%=1NBRA)94#@;@LCC.&.>PHH`*Y^?X3_"RY\":O\+;GX:>'Y/#'B#^T?[> M\./HT!L-2_M"6::_^T6Y3RYOM,MQ/)-O4^:T\C/N+L3T%%`'G_\`PR=^RQ_P MHG_AES_AFGX?_P#"LO\`HG7_``AMC_87_'U]K_X\/*^S_P#'S^_^Y_K?G^]S M6A;?L]?`*S\*WO@6S^!W@^+1-1\'VWA/4-&C\,VJVMUH%LD\=OI$D0CV/8Q) M=72);,#$BW,P50)&SV%%`'/WOPG^%FH_VE_:'PT\/S_VSX@LM=U?SM&@;[=J MMG]E^QW\V4_>W,'V&Q\J9LO']CM]K#RDV\_J?[)W[+&M^._%/Q2UG]FGX?W? MB?QSX?DT+QKXCNO!MC)?^(-*DBBADL+ZX:(R7=LT4$,9AE9D*PQJ5PB@>@44 M`M& M9X8B+FX!1'"D3RC'SMGS#PC_`,$\?AMX?_:QU']K_P`2?$GQ!XC\07GB!M;M M;"^\/>'+"&TOUL+S3+29[K2])M-0U#[)INH7UC`NH7=TJ0W3$AI5CF3W^B@# MC_@1\%/"O[/GPSM?AEX2U#4+Z)-0U#4]2U75I4>ZU34]0O9]0U"_F\I(XDEN M+RZN;AHX8XH$:8I#%%$J1J:S^SU\`O$?QETG]HSQ#\#O!]_\0M`T]K#0O'=[ MX9M9=9TZU83*UO!>M&9X8B+FX!1'"D3RC'SMGL**`./T;]GKX!>'/C+JW[1G MA[X'>#[#XA:_IZV&N^.[+PS:Q:SJ-JHA5;>>]6,3S1`6UN`CN5`@B&/D7!I_ M[/7P"TG3K31]+^!W@^VM+#3]$L+&UM_#-JD=O:Z-<-=:1;QJ(\)%8W#--:H, M+;R,7B",2:["B@#R_P`+?L>?`+PU\;_$'[1EYX#T_6O&6M>,)?$FGZ]KNEVM MS=>';J;0=+T*X33)S");2*>STFU$H5RTC-(&8H51.@T;]GKX!>'/C+JW[1GA M[X'>#[#XA:_IZV&N^.[+PS:Q:SJ-JHA5;>>]6,3S1`6UN`CN5`@B&/D7'844 M`>?_``M_9._98^!VCV/AWX*?LT_#_P`'Z?I?B"77=,L?"W@VQT^&TU62S>QD MOXD@B18[E[222V:90':%VC+%"5K/M?V(OV+['3O!6CV/[(GPOAM/AKJ$M_\` M#FUB\`:'8S2(KDE@#7J%%`&?XF\)^%?&FG M1Z/XQ\,Z?JUI#J%I?PVNIV23QI=6MQ'=6MP%<$"6&XABFC3HT"_8=5O/M7VR_APG[JYG^W7WFS+AY/ MMEQN8^:^[H**`//[7]D[]EBR_P"$A^Q?LT_#^'_A+?[9_P"$K\KP;8K_`&U_ M:_V?^U?M>(O])^V_9+7[3YF[[1]FA\S?Y:8T/`W[/7P"^&'A7PWX%^&OP.\' M^'M$\&:A/?\`@_1M#\,VMI:Z%=3)P MHH`S_#/A/PKX+TZ31_!WAG3])M)M0N[^:UTRR2"-[JZN)+JZN"J``RS7$TLT MCGYGDE=V)9B3H444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!117G_`.U'\=/^&;/@3KOQG_X1;^U_[(^RIY,]]]DL[7[1=16WVV_N MMDGV'3;;SOM5[>>7+]EL[>XG\N7RO+8`]`HKX@^`?_!47X[?%#_@G'\.OVU_ M$7PC^#^E?V]X?MK_`,8>-/%?QTM?#_@2QWQV<9$>HK;W]W!W9LOL-Q:K] MGNK#4()+EO*LYM0]0_:C_P""@T_P!_9'\#?M$^&OV=_&&J^*_B9J&A6'@[X4 MZSH.J0:R+J_B^V7-O?0:78:EZW;_9=*CNM#@GO MM7B'A[5$N=/U"+23:W21VKREO.>#T#P#^WAXJ\8_&70-#U'X*Z?9?#WQK\4/ M$WP[\%^*(?%SS:S-K^A#6?MIO=+-DD%I8L?#VK"&>*^N)7'V(O;Q>?*+8`^C MZ*X_XC_M"_`+X.>*O#'@7XN_''P?X5UOQMJ!L/!FC>)/$UK8W6OW6^*/[/91 M32*]U+OG@39$&;=-&,9=<]A0`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!7/\`Q2\`?\+/\"7W@J/QKX@\-SW7 ME266O^%M2^RW^G7,4J30SQ,5>.39+&C-!/'+;SJ&AN(9H9)(GZ"B@#Y0_9J_ MX)80?LO_`+-7A#X+_##]L;XH>'_%>A:?9P>)/B+X8.EQR>(V@TG3=)59=+U" MSO=-CBCL]'TN"%A;M=0QV>/M3O=7\MWV%O\`L>^.]$^S_!OX5?''Q!\-?A7X M*^'_`(4TCX0VW@74XGU7P_?Z?_:]K?F<:E:W4&H6TVG3Z5;K'?"\4/:O.L<- MS'%'[K1/C#;V-WIC?\++L M+O4=3U*\AU-IK&1K/S[O7-3VR M'4I?+AC$5J+?W"B@#P#_`(*Q?\HLOVEO^S?_`!E_Z8[RO?Z\`_X*Q?\`*++] MI;_LW_QE_P"F.\KW^@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBN?\`BE\4O`GP7\"7WQ)^).N_V?I&G^4L MDB6LMQ-/-+*D,%M;P0J\UU*+%3:VMU)]KT?2K:ZNX8 MHX;_`$]VNMAM634;"2.:2*^M))O3_'_[4?P)^'/PLT3XSZGXY_M?P_XH^S?\ M(C-X-TRZ\07/B/[1`US%_9MKI<5Q<:CNMDENO]&CEQ;PS3G$44DB@'H%%>'Z MS_P4;_8]T+3M)UB\^)NH2VFI:>U_?W5AX,U>ZC\,6J7$UK+<:^T-HP\-Q17% MK>PROJOV189-.OTD*-970BZ#PS^V3^SQXO\`C+)\"=!\8ZA)K8U"[TZTOIO" MVI0Z-J6HV@D-WIUEJ\ENNGW]]`(+KSK.VN)+B(V-Z'C4VEP(@#D/^"L7_*++ M]I;_`+-_\9?^F.\KW^O`/^"L7_*++]I;_LW_`,9?^F.\KW^@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`**^'O^"CW_``6:\,?LM_%^R_8- M_9)^%M_\8?VF_%U@$\)^`M&5'T_1[J4(T$NLS^;&;>,0-+>&-2&\BWWS26D, MT=S7T/\`L,?"3]H;X'_LL^%OAY^UC\<_^%D?$B+[=?\`C+Q>D3)#=7UY?7%Z M\,"L%VVUO]H%M"`D2^3;Q[88%Q"GJXC)\5@\NIXNO:'M&N2+^*4;.\TND$TD MF[?_M1_"W6/C-\"==^'OAW0 MO#^IZA=?9;BQL?$UU>6MM+-;745R@2\L66ZTRY#0@V^I6X>:PN!#=QQ3/;K" M_H%%`'P!^Q]^QK_P42^"W_!,KX??LT^,K?P_K-[%X?TVSUGX>:C\;?$'AN_\ M*PP:?IBI#9^+M%BN;ML7ME?W$EHD)A1=8%C;W8LM,B6]]`U?X+?M':7=?"+X M%_#CP/X?UO5_V8?#_A3Q)HWB;5[1O"GAOQW?W6A^*/"]_IT*Z?8W,.B_987B MU`16T-RJBYMK;RH(W2X'U_10!\`:G_P3(_:GL/AU\5?`'AS5OA_>?\-(_#_6 MO#'Q,N[[Q%?6_P#P@7]J>(?%NLRW&F*MA)_PD/D?\)C(!XCW: M5/I;6:06,5N?%%P!=I?7+3#38C]GB^UL+7ZOHH`^0/\`@M!^S3\.OB5^P+\> M_C%XB\1_$"VU?0/V?_%/V&ST#XL>(=)TJ7R-*OIT^TZ98WT5C>9=B'^T02>: M@6.3?&JH/K^O`/\`@K%_RBR_:6_[-_\`&7_ICO*]_H`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHKDOCO\=_A!^S'\(-?^/?Q[\?6'ACPAX7L#>:WK>I M.1'!'D*JA5!>61W9(XXHU:261TC16=U4W3IU*U14Z:;DW9):MM[)+JV#:2NS MK:_,3X[_`/!3_P"+_P#P53^+^O\`_!-S_@C'XAO]/CT^_-G\8OVHO(#:/X5T M<@*[:))'*'N[V=Q<002@Q$FWDDMF,9_M"TP?%7C7]N7_`(.#_$^I>&_V8?B+ M?_!O]B'[?-X=\4>-'LC;>)OBQ:JY^VOI:S0,]K9;X!9@NT2E+FX\];IA-IUO M^EGP(^!'P@_9C^$&@?`3X">`;#PQX0\+V`L]$T334(C@CR69BS$O+([L\DDL MC-)+([R.S.[,?K%A\'PNN?%157%]*>\:+[U5:TI]J6T?^7EW[AA>5;X=(]^_ MIY>?W'DO_!.'_@G#\(/^"(Q$W*%?'OA73/'7@7Q-I^ MM:)K6GPW^C:SI-ZES:W]K,@DBN(98R4EB=&5U=2596!!(-:%`!1110!X!_P5 MB_Y19?M+?]F_^,O_`$QWE>_UX!_P5B_Y19?M+?\`9O\`XR_],=Y7O]`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`445\6_\%%O^"P?@C]F'QP/V+/V3O"__``MS M]J;Q)]FM/!OPGTN&5X;&:ZBDE2]U6Y79%;6T,,9N9(C*DQA:*1C!;R&[B[LN MRW&YKB50PT.:6[[12WE)[1BNLFTEU9,YQ@KL]+_X*/?\%/\`]E+_`();?""R M^+7[3?B&_>36+\6?AOPGX=@BN-8UJ12GG-;P2RQ)Y<*.KRRR.D:!D3<9)88Y M/DOX$?L&?MR_\%5?B_H'[7W_``66AL-"^$>EWX\2_";]DNW4M'IMTX,4$GB/ M=!&;J2.!$E\B8R,TE[/')'91?:-/E]:_X)P_\$AO$_[.OQ?O?VX/V]/VC;_X M\_M#:M8&WM/%NLQO_9_@NUG#RW6GZ-#(Q$49GN+M1,D<"B"3RHK>U62X2;[A MKWZF98#(:;H96U.LU:5>STOO&BFDX*VCJ/WY:\O*M\E"55WGHNW^?^10\*^% M?#'@7PQIO@GP3X_!/Q5XM\'VL M^++_PS;178M)8K@7-I%LCADU>[^V7]K+96FO7UY#]/_MH>"O@U\>/ MV1_`G[%.M_&?XX:MX:\)Z?X'\1?%*2'X3'Q1XNU?PZ8M1.C7&KV.IZ;/--+< M:SHMO)>1QZ==7.^VDCN[2"UGN)X?N^L^V\)^%;/Q5>^.K/PSI\6MZCI]M8:A MK,=DBW5U:VSSR6]O)*!O>*)[JZ=$8E4:YF*@&1L@'Y0>)?V;?%5K\$/%'A3Q M!^QEJ":W>_`^[T3]C2?P]\%'B;PUXH77O%S6>NA-.LEM_`VKWMK=>$-0N[R= M-)1;K+$6YTZ6&S]P^!_P@UC2_P!LGPGJL'P&\0:?\7=/_:`\?:O\8?B3-X#O M+;^V?A]=)XH_L"RF\2/`MKK%LBW?A,1:7%=SR6WV.W#6\7]F2"V^_P"B@#Y` M_P""T'AS]J?4?V!?CWJ_PM^,GP_T;P3!^S_XI_X2/P]K_P`-+[4M5OMNE7S7 M'V;4(=9M8;7?"41-]G/Y;JTC>:K")?K^O`/^"L7_`"BR_:6_[-_\9?\`ICO* M]_H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`**Y+X[_'?X0?LQ_"#7_CW\>_'UAX8\(> M%[`WFMZWJ3D1P1Y"JH507ED=V2..*-6DED=(T5G=5/YI^*O&O[&/!\,,\J165O) M-:S1WUS=R0,J2QPW$+0DO`)1YMQ9?2W_``3I_P""6_[//_!._P`$&X\.6O\` MPF/Q1US[3<_$/XT^)K19O$/BB^NY8Y[QY;F0O+%;/-%&ZVHD908U=VFF,D\G MK7[./[+_`.SS^R'\,;7X-_LR_!W0?!7ANTV-_9NA6"Q?:9EAB@^TW$G,EU!RV#IX?K>WM*C[U)+=+7E@O=CVK_!>@4445\Z:A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`> M`?\`!6+_`)19?M+?]F_^,O\`TQWE>_UX!_P5B_Y19?M+?]F_^,O_`$QWE>_T M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`5Y+^VW^VW^SS_P`$^/V>=8_:6_:6\8?V7H.EXAL[ M.V59+[6;YU8PV%E"67S[F38V%RJJJ/)(T<4&;M9O$/BB^NY9(+-(K:,/+%;/-%(C71C908V M1%FF,<$G@_[$G_!,G]KWXT_M#:/_`,%#?^"UGQ#T'QG\0O#&9_@[\*/#R(?# MWPX^T,MU)*8U01W.HPR%8$E+7'EBSBE-U=R);26OT679/1CAEC\RER4/LQVG M5:Z4]-ME*;]V-].:2Y3*=1WY8;_@O7_(Y+X$?LS_`+5O_!:[XOZ!^UY_P55^ M`U_\+_@IX$OQ/\+?V6=;>5Y-8UB(&.76_$"S0PO/&K^:D%M+#&'C)!C6!YFU M+]+/"OA7PQX%\,:;X)\$^'+#1M%T:PAL=(TC2K-+>UL;6)!'%!#%&`D4:(JJ MJ*`JJH```J_17'FN;ULSG&*BJ=*&D*<;\L%\VVY/>4FW*3W>R50IJ'F^X444 M5Y)84444`%%%%`!1110`4444`%%%%`!1110`5X_^WKJ>L:+^R=XKU;1OBE_P MAOV;[#)J&O/<7EK"E@+^W-Y;W%_91R7&C6T]MYUO-K,2EM*AGDU`%?LFX>P4 M4`?CC^QG^U)^S!X,_P""1'P(TC]H7]IOQAX>EET^RT#X=^%KK]I";PIH?B'4 MUT#29YKJ'Q-;&TU"/2-.,MTEY%)/-!I]_-J.EPV]_+9Z);#Z_P#VD_C5X5TO MX&?`'P7\5/VY-/U?PI>:AHDWQ[^+7ACQBGA:.^T"Y\,:[)I^ORW^EW43:'8Z MEKVG6(AF@N(HIY&^QI)*DKPR?7_A/PGX5\!>%=,\"^!?#.GZ+HFBZ?#8:-HV MDV26UK86L*".*WABC`2*)$545%`554```5GZ;\+?`FD?%/6?C7I^A>7XG\0> M'],T35]3^U2G[18:?/?SV?ABP1`H!^6'BS]HOXA)\* M?'^J>.?VG_&&EZWH/POUR]_8D4_$B_L)/'VLQ>*O&EOHZV<<=RG_``G4LNF6 M/@DI#>#4A,;37_`('^,[?5==\-WNC16OAN M/^QYE^TWJZAJ%M/)%B1WQ:17,FV"3Y-QC63ZOKP#_@K%_P`HLOVEO^S?_&7_ M`*8[RO?Z`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`KXM_X*+?\%@_!'[,/C@?L6?LG>%_^%N?M3>)/ MLUIX-^$^EPRO#8S744DJ7NJW*[(K:VAAC-S)$94F,+12,8+>0W<6#^WW_P`% M2/&^M_$ZV_X)P_\`!)RZT'X@_M%^)OM4&L:Y!=Q7>A_"JQ@G-M>:IK$J"2-+ MF"0,B6;JS++L\V)V>WM+SUK_`()T_P#!+?\`9Y_X)W^"#<>'+7_A,?BCKGVF MY^(?QI\36BS>(?%%]=RQSWCRW,A>6*V>:*-UM1(R@QJ[M-,9)Y/J,+E^"RG# MQQN:P)/M-WXR^+&J32O#8S744<3V6E6S;(K:VAAC% MM'*(DF,+2QJ(+>06D7VE117BYCF6-S7$NOB9\TMEVBEM&*VC%=(I)+HC2$(P M5HA1117"4%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`'@'_!6+_E%E^TM_P!F_P#C+_TQWE>_UX!_P5B_Y19?M+?]F_\`C+_TQWE> M_P!`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!7YX_MM_MM_M#?MN_M#:Q_P2@_X)0>,/[+U[2\0_M!?M!6RM M)8_#2Q=F22PLI$9?/UJ39)&%C=6A9'16CECN+C3C]MO]MO\`:&_;=_:&UC_@ ME!_P2@\8?V7KVEXA_:"_:"ME:2Q^&EB[,DEA92(R^?K4FR2,+&ZM"R.BM'+' M<7&G?6G[$G[$G[//_!/C]GG1_P!FG]FGP?\`V7H.EYFO+RY99+[6;YU437][ M,%7S[F38N6PJJJ)'&L<4<<:?58?#T.'Z$<7BXJ5>23ITVKJ*>U2HOQA!_%\4 MON((1$D]U._P#VT<0Q+';QO/,T44?FN#[Q117SN+Q>*QV(E7Q$ MW.>\_L^W9;B]^R_98&66>-AZ!7/_%+X6^!/C1X$OOAM\2= M"_M#2-0\II(TNI;>:":*5)H+FWGA9)K6Y@FCBGAN872:":*.6)TDC1P`?"'P M4_X*8?M<7?\`P0UN/VX+71/!_P`3?B?X:^%[ZQK-^XET.ULI(/#,>M2W>MZ= M(D<]M*`VR."R$D>HK<:?>0/8V6H^98?3_P"WW\:/VG_@U\&M+/[&_P`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` M\@_X+4_''P7\*_\`@FW\;_!WB?1?&%U=^+O@?XSLM*F\-_#W6=9M8)/['F3= M>W6GVDT&FQ9F0^==O#'M$C;ML4A3ZOKP#_@K%_RBR_:6_P"S?_&7_ICO*]_H M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`KX>_X*/?\%'OB_I/Q?LO^"97_!,K1;#Q9^TKXLL!/J6I78$FC_"[1W"; M];U9]KHL@26-X;9EW_^"P?_``46\;_LP^"-+_9._8L7_A)/ MVIOBYLL?A/X-T_3(K^:QA:4K.2WM[LQ=Y_ MP2W_`."=/@C_`()W_L\Q>'+AO[<^*/C'RM:^-/Q#OM3EU"^\4>(9%,ES*]Y/ M&DLMLDTLX@5U4A7:1P9IIY)/I\!@\-E>!CF>.@IN3?LJ3VFU_P`O)K?V47HD MOCDG&Z2D8RE*OY%__@G#_P`$X?A!_P`$Y/A!>^$?".M7_BSQQXLO MSJ_Q2^*7B(F36/&.L.7>2ZN)'9W6,/+*8H"[B,2.S-+-+//+]#T45X.,QF)S M#%3Q&(FY3D[MO^M$MDEHEHM#6,8PC9;!1117,,****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\`_P""L7_*++]I;_LW M_P`9?^F.\KW^O`/^"L7_`"BR_:6_[-_\9?\`ICO*]_H`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OEK_@K7_P4>T__`()S M?LTGQ1X)T6P\5?%SQE?Q:'\&_AM(+B:Z\3:Q--%%B.WM5::>.`3+*ZKL$C>5 M;B6.6YA)[S_@H+^W'\(/^"=O[*7BK]J'XP:Q8)'HUA*GAS1+S4#;R>(M8:*1 MK32X&6.5_,F=,%UC<11K),X$<4C+\T_\$E/V'/B_XW\3C_@KA_P4QT>_OOVC M_'UA*F@^'-FVADD-K))`YDE>0BY1;F2&0+,]])=?1Y1 ME^&HX?\`M3,%>A"5HPV=6:UY%V@E9U)=$TE[TE;&I-M\D=_R_KH=Y_P2@_X) MPZA^ROX8U#]JW]J76K_QE^TW\7;"#4/B[XY\1&WDNM/DD2-_[!L_L[/#;V5J M4CBVP-Y75M;K)-)%`C3!YI8HE>1>PKC_C]\,=1^,_P:\0_"S2_$&GZ=+KF MGFV:36O#=OK&G7,9(,EI?6-QA+RQN$#6]S`'BDDMYI5BGMY2D\8!X!X3_P"" MM_P:M_\`@FWIG_!1CX[?"_QAX'M+SP?#K3^!'TPW^IW\DFCC6!#I31!8]5B: MQ+70N8RL<,$-P]Y]B:ROH[7V_P#:$_:$T?\`9_T?06;P'X@\6^(/%OB#^Q/! MW@[PL+-;_6[\6=U?R0Q27]Q;6D/EV5C>W+-<7$*E;9D0O*\44GSA^RM_P2M\ M5?!S_@D1XB_X)Q>.OC#I\>M^./A?=^&]9U/PYI+MH?AZZN]`ATF5]-LY)$=H MB\37TY9XVO;^[O[LK;&[\F+U#]H/X.?M'?''X[6-SX1U7P_X3T_X7_V+XL^% M'C#6-#;5[:[\27-KXFT?6K/4+&*_M9I[:+2[ZS>'RY+4K<7(G^'+[Q9IGPD^(&J:?X1\/W6M_&&XL;33%_X5I86FHZGIMY-J:S7T M;7GD7>AZY$RZ0-19_P"RI6B$B36C7/7^#?V[_A[XT^,ME\,+;X:>,+/1-<\8 M:QX1\)?$:]AL/[&U_P`1:4+\ZCI<$4=V^H0RP'2=7!FN;."V0:K_P`$G/%1\%^,?`OAG]I/3[6T^,_@_4O#?QZDO_`CW$FIVNHZSX@U>\?0 M"FH1C1)?M'BK6DB-V-56.,6`996MYGN_0/`/[!_BKP=\9=`US4?C5I][\/?! M7Q0\3?$3P7X7A\(O#K,.OZZ-9^VB]U0WKP7=BI\0ZL88(K&WE0?8@]Q+Y$IN M0#0_X*Q?\HLOVEO^S?\`QE_Z8[RO?Z^0/^"T'[)W[+'Q7_8%^/?QT^*7[-/P M_P#$OC;PU^S_`.*?^$<\8Z_X-L;S5=*^SZ5?7%O]FNYHFF@\J9WE38PV.S,N M&)-?7]`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M7!_M0?M'?#']D/\`9Y\8_M-?&75?LGAOP5H,^J:ELG@CFN?+7]W:P>?)'&]S M/(4@AC9U\R:6-`_CWX^L/#'A#PO8&\UO6]2 M]*RM?.3NVQTX*$; M=>OF%%%%>66%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110!X!_P`%8O\`E%E^TM_V;_XR_P#3'>5[_7@' M_!6+_E%E^TM_V;_XR_\`3'>5[_0`4444`%%%%`!1110`4444`%%%<'\;?VI_ MV8OV:/[,_P"&COVC?`?P_P#[;\[^QO\`A-O%]EI7V_R?+\[R?M4J>;L\V+=M MSM\Q,XW#.E*C5KU%"G%RD^B5W]R$VDKL[RBOA[Q5_P`'(G_!%3P=XGU+PCJ_ M[<%A-=Z5?S6=U+I7@S7;ZU>2)RC-#(H1WDC]:** M_*;PK_P>&?\`!+7Q#XGTW0-7^&GQIT*TOK^&WNM;U7PIIKVNGQNX5KB9;;4I M9FCC!+L(HI)"JG8CMA3]+?!K_@O[_P`$=/CMXGG\(^"?V\?"5C=VU@UY)+XR MM;WPY:F-71"JW.K06T+R9D4B)7,A4.P4JCE8Q?!_%6!CS5L%42WNH-I>K2:7 MS".(H2VDC[#HJAX5\5>&/'7AC3?&W@GQ'8:SHNLV$-]I&KZ5>)<6M]:RH)(I MX98R4EC=&5E=2596!!(-7Z^<:<79[FP4444@"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*H>*O%7ACP+X8U+QMXV\1V&C: M+HUA-?:OJ^JWB6]K8VL2&26>:60A(HT169G8A55220!1XJ\5>&/`OAC4O&WC M;Q'8:-HNC6$U]J^KZK>);VMC:Q(9)9YI9"$BC1%9F=B%55))`%?F)_Q<[_@X MX^)W_,>\'?L(>#M>_P"F^GZI\O+V="G;GG:]K[1BM.:['U;:BFUG.?+HM6P_P"+G?\`!QQ\3O\`F/># MOV$/!VO?]-]/U3XY:I:3_P#`);;189H_]EV=.UT/^)5^G?A7PKX8\"^&--\$ M^"?#EAHVBZ-80V.D:1I5FEO:V-K$@CB@ABC`2*-$555%`554```4>%?"OACP M+X8TWP3X)\.6&C:+HUA#8Z1I&E6:6]K8VL2".*"&*,!(HT15544!550``!5^ MC-^62'RF)"SI./A!K'@G3 M_$MIXK\'ZGH]UXTBE#F-IXHWDC5BZ(S*%/Y MH?LT?L6?M,>/OV?_`!#J'[3'[,GQ@UW1K']H#4O$*>&QXTT7P;\1?$/D>)O% MM[`TMWHTUE9WFFV]]JFEZO;0M?V6W4/[5O+6:2S33+:[`/T/M?VW?V+[[3O! M6L6/[7?POFM/B5J$MA\.;J+Q_IS1^*KJ*X2UEM]-838OI4N)$A9(=[+(ZH0& M(%=!HW[0OP"\1_&75OV<_#WQQ\'W_P`0M`T];_7?`EEXFM9=9TZU80LMQ/9+ M(9X8B+FW(=T"D3Q'/SKGX0\8?LG_`+=FH?"+XN^`/$/PB\0>*M0_:$_9_F^& MGAW4KCQ=I=Q-\/[9-6\8-I0\2W-W?+-=_9M+\2:3!/>H?"C]G7]H?2?C+\/?AAKWP9U"QT3X9?M'_`!`^*%W\1IM8TU]&UK3M?'BX MVEA911W3:A]NC/BBU$PN;.WMP;&]V3R@6YN0#U#_`(*Q?\HLOVEO^S?_`!E_ MZ8[RO?Z^0/\`@M!\&_B+XQ_8%^/?Q"\._M8_$#PII&E?L_\`BG[=X%T#3?#T MFE:SY6E7TK_:9+[2KB^7S480O]GNH<(BF/RY-TA^OZ`"BBB@`HHHH`**^>/V M\_\`@JE^PU_P3=\,/J_[4?QNL-/UJ6P-UI'@?2B+S7=54I<-%Y-G&=Z1RO:R MPK5;"4!'F0FOA[_AZ?_P5[_X*V?\`$E_X(V_LG_\`"IOAO<_\W!_&VWB3 MSMOS?Z%;;+BW;%S9WMC+Y$>IX\Z)G^Q-\P^AR[AC-LPP_P!9<52H=:M1\E/Y M-ZR?E!2D^B,IUH0=MWV6Y^EG[1W[4'[//[(?PQNOC)^TU\8M!\%>&[3>O]I: M[?K%]IF6&6?[-;Q\R75RT<,K);PJ\TGED(C'BOSQ^)O_``-IR@6%/B=:_M%_MT_&7QY^TO\`$CY)-6U;XCZF_P#9=]<0 M3Q&TG>T+RW$_E6T$-L8;J[N;>1/,#1;2B1_H=\,OA9\,?@IX(L?AE\&OAQH/ MA+PWIGF_V;X>\,Z/!86-IYDKRR>5!`JQQ[I)'=MJC+.S'))-=_M.#\H^",L9 M4[RO2I?^`I^TE;I=P3OJNA-J\]_=7WO_`"_,_+7_`(8>_P"#D_\`X*%_\3[] MKK_@H-H/[+_AN[_T^Q\#_!N!Y=4TN^@_T5(99K*XCD>VGC,UTP.K72AY(@85 M(5;?O/@E_P`&G7_!(3X4_P!I_P#"=^#?'GQ+^W^3]E_X3;QQ+;_V;L\S=Y/] MCI8[O,WKN\[S,>4FS9E]_P"EE%9U>-<_]FZ6$FL-3_EHQ5-?^!1]]^LI-[ZZ MNXL/2O>6K\]3YX\*_P#!(_\`X):^#O#&F^$=(_X)V_!::TTJPAL[675?AKIM M]=/'$@16FN;F&2:XD(4%I97>1VRSLS$D_0]%%?.8G&XS&-/$5)3:O\3;WWW? M7J;*,8[(H>*O"OACQUX8U+P3XV\.6&LZ+K-A-8ZOI&JV:7%K?6LJ&.6":*0% M)8W1F5D8%65B""#7S3\9?^")'_!)7X[>&(/"/C;_`()_?#2QM+:_6\CE\&^' MU\.71D5'0*USI)MIGCQ(Q,3.8RP1BI9$*_4M%7A,QS#`2YL+6E3>_NR<=?DT M*4(R^)7/RF\5?\&J_P`(/AAXGU+XE?\`!.+]OSXT_`#Q3JU_,EU=Z5K1O;6# M1Y7,K:7"+:2RO#&LJ6Q5Y[N<[;<;Q(Y$JT/^&LO^#D__`()G_NOVNOV3-!_; M!\-ZMS8^(O@V'MM4TR^E^Y:RQ66FK(;:..UF=G.F[=][$#>9"P5^M%%?1KC+ M,,4N3-:<,5#_`*>1]]>E2/+473[3VV,OJ\(_`^7T_P`MCXM_8D_X.`_^"7G[ M=FKZ/X&^'GQZ_P"$4\9ZWE;/P/\`$2R.E7SS&[6UAMHYBSV5S&X>24P3Z4C?88@(I M@4MU?]G<,9OK@<0\/4?V*[O!OM&M%))=%[2,>EY:BYZU/XE==U_E_D?K117Y MX_LB_P#!QY^R%\6O'$WP`_;:\%Z]^R]\5[';_:7A#XNJ]G8IOBFN8]NH3Q0+ M#FU2"4_;8K3>UW%'#Y^0Q_0ZO!S/)\SR:LJ6-I.#>JOM)=XR5XR7G%M>9K"I M"HKQ84445YI84444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7)?'? MX[_"#]F/X0:_\>_CWX^L/#'A#PO8&\UO6]2(?% M%]=RR06:16T8>6*V>:*1&NC&R@QLB+-,8X)/EKX$?\$X?VK?^"I/Q?T#]O?_ M`(+#:U?Z/X'2_&K_``\_8VS*VCZ+'$"--NM;5V5+J]V3W3SP20"1S+'',T4( MDTR/Z++LCA+#+'9C/V6'Z/[=1K[-./6_\[]R+W=]'E.IKRPU?Y>O]7,'PKX* M_;E_X.#_`!/IOB3]I[X=7_P;_8A^WP^(O"_@M+TVWB;XL6JN/L2:HT,[/:V6 M^`WA"+$I2YM_(:Z80ZC;_J5X5\*^&/`OAC3?!/@GPY8:-HNC6$-CI&D:59I; MVMC:Q((XH(8HP$BC1%5510%55```%7Z*Y9LI MNRYIO5V2T223A34-6[M]0HHHKQS0****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/`/^"L7 M_*++]I;_`+-_\9?^F.\KW^O`/^"L7_*++]I;_LW_`,9?^F.\KW^@`HKY+_X* M#_\`!;;_`()Y_P#!-C[1X>^.WQ?_`+7\9P;/^+<>"8X]1UQ=WV9OWT7F)%8_ MN;J.=?M)YL_N[J/3H[BVM[A+PRQ=;EH4' M_P`O*CY4U_=7Q3_[39QG>D_X:H_ MX+D_\%FO^);^Q+\)_P#AE'X!ZO\`+_PMWQW&6\3Z[I0M%:R?;(&N8[AO-O8VGD4W<@-?<-=G]H\/9)IE]+ZQ57_+V MJO<3[PI:KT=1R_PHGDJU/C=EV7^?^1\/?L&?\$!OV&OV+O$Z?''QMI-_\9/C M%0M%:R?;(&N8[AO-O8VGD4W<@-?<-%%?/ M9CFF8YMB/;8RJYR[M[+LELEY))&T(0IJT58****X"@HHHH`****`"BBB@`HH MHH`****`/)?VNOV$OV0OV\?!$/P^_:X^`6@^-;"TW?V;<:A"\5]IVZ6&63[) M>P,ES:>8UO")/)D3S5C"/N3*G\\?^'6'_!7O_@DG_P`3K_@C;^UA_P`+9^&] MM_S;Y\;;B)_)W?+_`*%<[[>W7-S>7M]+Y$FF9\F)7^VM\I_6BBO>RSB3,\LH MO#IJI0>]*HN>F_/E?PO^]!QEYF4Z,)N^S[K<_,3X-?\`!R;\-_A%XGG_`&?/ M^"Q7[.WBW]FWXFZ18-)=75SH%YJ>A:ZL3I;-=6+6T M!FCDVR1NC;6.&1E.""*H?&7X!?`G]HOPQ!X)_:#^"OA+QWHMK?K?6ND>,O#E MKJEK#=*CQK.L5S&Z+($ED4.!N"R.,X8Y_.+XF_\`!MWJ_P`!O'%]\9?^"-G[ M=OCS]G759O*O[KP(^JW>I>'M9OK*)#IT,Y:;S?LWG?:&F%XNHJ1>2!(1&##) MZ7+PEG.SE@ZK[WJ47Y*W[R'S]HNFBU(_?T_[R^Y_Y/\``_4JBOR7_P"&X?\` M@Y/_`.">G_$A_:Z_X)\Z#^U!X;M/]`L?''P;G>+5-4OI_P#2DFEALK>21+:" M,36K$Z3:J7CB)F8E6N.\^"7_``=B_P#!(3XK?VG_`,)WXR\>?#3[!Y/V7_A- MO`\MQ_:6_P`S=Y/]CO?;?+V+N\[R\^:FS?A]F=7@K/\`V;JX2"Q-/^:C)5%_ MX#'WUZ2BGOIH[-8BE>TM'YZ'Z645\\>%?^"N'_!+7QCX8TWQ=I'_``42^"T- MIJMA#>6L6J_$K3;&Z2.5`ZK-;7,T;%NVYV^8F<;AG2E1JU MZBA3BY2?1*[^Y";25V=Y17YI_&W_`(.Q?^"0GPI_LS_A!/&7CSXE_;_.^U?\ M(3X'EM_[-V>7M\[^V'L=WF;VV^3YF/*??LRF_@_^&X?^#D__`(*%_P#$A_9% M_P""?.@_LO\`AN[_`-`OO''QEG>75-+OH/\`2GFBAO;>.1[:>,PVJD:3=*'D ME(F4AFM_J*7!6?\`LU5Q<%AJ?\U:2IK_`,!E[[](Q;VTU5\7B*5[1U?EJ?I9 M^T=^U!^SS^R'\,;KXR?M-?&+0?!7ANTWK_:6NWZQ?:9EAEG^S6\?,EU)]2^"O\`P0H_9`O]0T6*_FTO5_VC M?BA9&ST+2F#F"6>T@D^1Y(DNM/OXUF,MR8C('TMP,UUO[./_``;4_!#3_B=: M_'C_`(*3?M0>//VKO&>D;(/#TWQ'O;E=+LK2*>*X@B>UENKF6ZV3"Z)BEN&M M)$O)%>U)R[?H[X5\*^&/`OAC3?!/@GPY8:-HNC6$-CI&D:59I;VMC:Q((XH( M8HP$BC1%5510%55```%:>WX6R3^!'ZY5_FFG"BO2&DY_]O.*_NL+5JF_NK\3 MX\_X)T_\$4?@A^Q+XX/[37QE^)&O?'+]H*[^TQZE\;?'USOZ@UAH5K>WJ12:C=+;S736\"L09I1;VUQ,43+"."5\;48C0K\P/^ M"WOPWUC4?VT_V>?'&A_"'Q!X[U>Y\0/8^%_#5]X8O+JPOK^#0/%5PEKH^L:? M%=2FF>S\_49E18V@T75(Y&C\.7RKZ!_P2_\`A!K'@;XI_#&YTOX#>(/" M'B?0OV?[_2/VJ]>U+P'>:+_PEGQ!:?PZ8+VZO[B"*/Q7)O&=KX^'_P"W[0^?'=12WMQ>WEQ^_MKB2%HI#+:?)$[6LC(=WWM_ MP4D^%_[4_P"T!^RQXW_9H_9H\!_#_4?^%E?#_P`0>&-;UOQUX]OM&_L3[=8M M:PW$$-KI-]]MQYTKLC/;X\I`&;S"8S_A8W_!4W_HS?\`9_\`_$EM<_\`F,KQ M\=2XKCC(8C)LS>$<5K:AAZUWTDG7IU'%K^[;ON>QEN-RC#4I1QF"C7;>C+;:5[M4:3_A%]6UC*E7./)L[577D#]X3M&,$985P__#QK]K?_`*-2 M\7?^&.\5_P#QJO8/^%C?\%3?^C-_V?\`_P`26US_`.8RC_A8W_!4W_HS?]G_ M`/\`$EM<_P#F,KS*G`?$F)ESU^(,5S?W(T::_P#`8T[?/J85>)*5.=L'EV&C M#M.-:I*_7WO;QT[*VAX__P`/&OVM_P#HU+Q=_P"&.\5__&J/^'C7[6__`$:E MXN_\,=XK_P#C5>P?\+&_X*F_]&;_`+/_`/XDMKG_`,QE'_"QO^"IO_1F_P"S M_P#^)+:Y_P#,94?\0\SK_HH,9]]+_P"5F?\`K1B?^@#!_P#@FM_\TGE6@?M_ M_MB>)==LO#FG?LL>(H[C4+N.V@DU#X/>);2!7=@JF2>=$BA0$C=)(RHHRS,` M":]/_P"%C?\`!1G_`*('X2_\#(__`)/J;_A8W_!4W_HS?]G_`/\`$EM<_P#F M,H_X6-_P5-_Z,W_9_P#_`!);7/\`YC*VI>'N9I?O,^QK])T5^=%F]'BI13]K MEV$;\J=5?G7D0_\`"QO^"C/_`$0/PE_X&1__`"?1_P`+&_X*,_\`1`_"7_@9 M'_\`)]3?\+&_X*F_]&;_`+/_`/XDMKG_`,QE'_"QO^"IO_1F_P"S_P#^)+:Y M_P#,96G_`!#[&_\`0]QW_@RC_P#*#;_6O#?]"S#?^`5/_EIY5K_[?_[8GAK7 M;WPYJ/[+'B*2XT^[DMIY-/\`@]XENX&=&*L8YX$>*9"0=LD;,C##*Q!!JI_P M\:_:W_Z-2\7?^&.\5_\`QJO8/^%C?\%3?^C-_P!G_P#\26US_P"8RN/^.`_X M*[_%3P79>&/!WP%^!_A&[M?&'A[6)M5TS]I77S)/:Z=K-EJ%UIYV>$8SY5Y; MVTME)EBOEW3[DD7,;\S\/,ZOIQ!C/_`J7_RHXWQ1B+Z8#!_^":O_`,T''_\` M#QK]K?\`Z-2\7?\`ACO%?_QJC_AXU^UO_P!&I>+O_#'>*_\`XU7L'_"QO^"I MO_1F_P"S_P#^)+:Y_P#,91_PL;_@J;_T9O\`L_\`_B2VN?\`S&4O^(>9U_T4 M&,^^E_\`*Q?ZT8G_`*`,'_X)K?\`S2>:^!?^"@O[4^M>*K73-6_9'\6SV\N_ MS(O^%5^(],W81B/])N8&BCY`/S`[ONCE@:]$_P"&Q_CI_P!&2^+?^^[K_P"0 MJF_X6-_P5-_Z,W_9_P#_`!);7/\`YC*/^%C?\%3?^C-_V?\`_P`26US_`.8R MMZ?!?%N%CR8?B&OR[^_2P]1W_P`4J5TO+:]WU.BCQ#E=2-\;E="4^CINM25O M./M97=[ZWVLK::\O\2_^"DNN?!;0H?%/QC_9TN_">F7%VMK!J/B;76L())V5 MW6)9)[55+E4=@H.2$8XP#7):!_P6N^!&M:[9:,+3PZ_VN[CAV:?X_M;B=MS! M<1Q>6OF/S\J;AN.!D9S7JO\`PL;_`(*F_P#1F_[/_P#XDMKG_P`QE'_"QO\` M@J;_`-&;_L__`/B2VN?_`#&5$^$_$+GO3XCG;L\+AW]]HQT]+/S(J9UDDJGN M9734?^OE=OSL_:V]+Q?HR'_AY5\"_P#H5/%O_@!:_P#R11_P\J^!?_0J>+?_ M```M?_DBIO\`A8W_``5-_P"C-_V?_P#Q);7/_F,H_P"%C?\`!4W_`*,W_9__ M`/$EM<_^8RMO[`\2O^AY2_\`"-?_`#0=']J\&_\`0LG_`.%#_P#E1+H7_!1G M]G_5M5BT^_LO$.EPR;M]]?:;&T46%)&X0RR/R0`,*>2,X&2.A_X;D_9:_P"B MH?\`E$OO_C-<%XNN/^"B?Q`M[2S\>?L!?LTZW#87?VJQBU?]H35[E;>?RWB\ MV,2>"R$?RY94W#!VR.,X8@Y/_"%?ML_](SOV4_\`P^>I?_,30LO\5L+[E+'X M2LM^:IAZD)>EJ=>UNM]]7Y"6+X'KOFJ86O3\H5H237=N=*Z>ZMM9)]6>I_\` M#7YWD_:K1_*W^5%NVXW>6F<[1C(_X0K]MG_I&=^RG_X?/4O_`)B: M/^$*_;9_Z1G?LI_^'SU+_P"8FM*2\8:%13IXG!1DNJI8A/[U7&ZG`#5G2Q/_ M`(,I?_*SYQ\5?\$G_P#@VO\`&/B?4O%VK_LWV$-WJM_->746E:SXKL;5))7+ MLL-M;7$<-O&"Q"Q1(D:+A455``^>/^(;_P#X(0_]'B_'C_P,L_\`Y15]R_$O MX!_\%`_''C3X>^)_#W[#G[,>@6G@WQA/K&NZ59?'+5?+\26KZ-J>GKI\^WP: M@\I;B^M[T;UD7S+"+Y`VV2/L/^$*_;9_Z1G?LI_^'SU+_P"8FOH\-Q=](G"I MJGFN%MIO#$RV[AB?_`Z7_RL_.K_`(=#V_PJ_P"*!_8V_P"# MB;X\?#3X;V'_`"+G@G^R-;N/[-W_`+RX_>6-[8V[>9/-$+W^V( MQI?\` MS$T?ZV>,O_/K)_\`PAG_`/+0]GP!_)B__!M/_P"5GYAZA\9?^#GNSOY[2W_X M*8_"Z[CBF9([JW\'::(YE!(#J'\.JP4]1N53@\@'BHO^%A?\')/CS_BAOB;_ M`,%0?".D^&]:_P!`\0ZKX5\)Z>NJ65C-^[GFLS%I%K(+E(V=HRES;L'"[9HC MB1?T9U#]EOXXZM?SZKJO_!'#]BNYNKF9I;FYN/BIR;\C\Z_\`AW?\=_%W_%)_&W_@O+^U+XI\&:I_HGB[PS_9 M]U'_`&OIBP:=M69F%O+HYM?,>3*[DF63B$%"F'#_I M/\+?!'[;'P.^W?\`"E/^"9O[*7@_^U/*_M/_`(1;XYZEI_VOR]_E^;Y'@E/, MV>9)MW9V[VQC)KK?^%C?\%3?^C-_V?\`_P`26US_`.8RG4SCQXQ.'=*7$T*- M]_8X*G3>^Z<9I7\W%]MCHCCN$52YEE34_P"]B)SC\TJ=.37HX^I\Q_!+_@HU M_P`$Z_V:/[3_`.&;+ MMW9V^8^,;CGO/^'X/P(_YX^$?_#E6O\`\9KV#_A8W_!4W_HS?]G_`/\`$EM< M_P#F,H_X6-_P5-_Z,W_9_P#_`!);7/\`YC*^1J\+>)=>HYU.)YRD^KPN';^] MHE9SE25EEM'_`,"Q'_R\\?\`^'X/P(_YX^$?_#E6O_QFC_A^#\"/^>/A'_PY M5K_\9KV#_A8W_!4W_HS?]G__`,26US_YC*X_6A_P5WU3X^^&?B[9_`7X'VFB M:'X/US1]0\&1_M*Z_P#9=4NKZZTF:WU"3'A$)YMJFG742;HW;;J4VUXQN63/ M_5'Q&_Z*6?\`X28;_P"1'_;.5_\`0MH_^!8C_P"7GBWQ+_X+Z?#+PYKL5CH> MK>$K:)[17:/-WK&6+.,^=9A47@#]V1N&,DX85SW_`!$)^"_^AG\)?^$KK'_Q M5?77_"QO^"IO_1F_[/\`_P")+:Y_\QE'_"QO^"IO_1F_[/\`_P")+:Y_\QE< MT_#WBZM)SJ\28GF>_+"E%?**C9>B.2?$690FUA\'@E#HI4*\Y6\Y?6U=^=D? M(O\`Q$)^"_\`H9_"7_A*ZQ_\51_Q$)^"_P#H9_"7_A*ZQ_\`%5]=?\+&_P"" MIO\`T9O^S_\`^)+:Y_\`,91_PL;_`(*F_P#1F_[/_P#XDMKG_P`QE3_Q#GBC M_HH\5]U/_P"1(_UDSO\`Z!,!_P"$U?\`^;#Y%_XB$_!?_0S^$O\`PE=8_P#B MJ/\`B(3\%_\`0S^$O_"5UC_XJOKK_A8W_!4W_HS?]G__`,26US_YC*/^%C?\ M%3?^C-_V?_\`Q);7/_F,H_XASQ1_T4>*^ZG_`/(A_K)G?_0)@/\`PFK_`/S8 M>/\`_#QK]K?_`*-2\7?^&.\5_P#QJC_AXU^UO_T:EXN_\,=XK_\`C5>P?\+& M_P""IO\`T9O^S_\`^)+:Y_\`,91_PL;_`(*F_P#1F_[/_P#XDMKG_P`QE=?_ M`!#S.O\`HH,9]]+_`.5G=_K1B?\`H`P?_@FM_P#-)X__`,/&OVM_^C4O%W_A MCO%?_P`:H_X>-?M;_P#1J7B[_P`,=XK_`/C5>P?\+&_X*F_]&;_L_P#_`(DM MKG_S&4?\+&_X*F_]&;_L_P#_`(DMKG_S&4?\0\SK_HH,9]]+_P"5A_K1B?\` MH`P?_@FM_P#-)X__`,/&OVM_^C4O%W_ACO%?_P`:H_X>-?M;_P#1J7B[_P`, M=XK_`/C5>P?\+&_X*F_]&;_L_P#_`(DMKG_S&4?\+&_X*F_]&;_L_P#_`(DM MKG_S&4?\0\SK_HH,9]]+_P"5A_K1B?\`H`P?_@FM_P#-)X__`,/&OVM_^C4O M%W_ACO%?_P`:H_X>-?M;_P#1J7B[_P`,=XK_`/C5=AHH_P""N^E_'WQ-\7;S MX"_`^[T37/!^AZ/I_@R3]I77_LNEW5C=:M-<:A'GPB4\VZ34;6)]L:-MTV'< M\@VK'V'_``L;_@J;_P!&;_L__P#B2VN?_,91_P`0\SK_`**#&??2_P#E8?ZT M8G_H`P?_`()K?_-)X_\`\/&OVM_^C4O%W_ACO%?_`,:H_P"'C7[6_P#T:EXN M_P##'>*__C5>P?\`"QO^"IO_`$9O^S__`.)+:Y_\QE'_``L;_@J;_P!&;_L_ M_P#B2VN?_,91_P`0\SK_`**#&??2_P#E8?ZT8G_H`P?_`()K?_-)X_\`\/&O MVM_^C4O%W_ACO%?_`,:H_P"'C7[6_P#T:EXN_P##'>*__C5>P?\`"QO^"IO_ M`$9O^S__`.)+:Y_\QE'_``L;_@J;_P!&;_L__P#B2VN?_,91_P`0\SK_`**# M&??2_P#E8?ZT8G_H`P?_`()K?_-)X_\`\/&OVM_^C4O%W_ACO%?_`,:H_P"' MC7[6_P#T:EXN_P##'>*__C5>P?\`"QO^"IO_`$9O^S__`.)+:Y_\QE'_``L; M_@J;_P!&;_L__P#B2VN?_,91_P`0\SK_`**#&??2_P#E8?ZT8G_H`P?_`()K M?_-)X_\`\/&OVM_^C4O%W_ACO%?_`,:H_P"'C7[6_P#T:EXN_P##'>*__C5> MP?\`"QO^"IO_`$9O^S__`.)+:Y_\QE'_``L;_@J;_P!&;_L__P#B2VN?_,91 M_P`0\SK_`**#&??2_P#E8?ZT8G_H`P?_`()K?_-)X_\`\/&OVM_^C4O%W_AC MO%?_`,:H_P"'C7[6_P#T:EXN_P##'>*__C5>P?\`"QO^"IO_`$9O^S__`.)+ M:Y_\QE'_``L;_@J;_P!&;_L__P#B2VN?_,91_P`0\SK_`**#&??2_P#E8?ZT M8G_H`P?_`()K?_-)X_\`\/&OVM_^C4O%W_ACO%?_`,:KZG_9P^(WB[XM?!C1 MOB#X[\*7>AZKJ'VC[5I=_H=WILL'EW,L2[K:\`FCRB*PWCY@P8?*PKSC_A8W M_!4W_HS?]G__`,26US_YC*W_`-DGPE^U/HEU\2O&7[5C^'[34/%_Q`CU7PQX M9\+>-[[7[#P_I4>AZ38?9(KB\L;%DWW=E>W;1QVZH&O6;+.[L?>X=X5S'(\; M*O7S3$8I.+CR57!Q3;3YERPB^96MO:S>AQ8[.:V8T53GAL/32=[TJ=2,NJLW M*K47+K=JR=TM=T_8****^S/*"BBB@`HHHH`****`"BBB@`HHKY0^.GP4GTW_ M`(*%Z?\`'CQ;J'Q0UCPI?_LX?$/3-?G\/RZH\?AZ#[9X/:&PTM-'19X+Z<0Z MG*?A/^SU^R?XP^$>B? M'?QAX:\,^+?A"OP+UGP=X=\+^$5-]>:S+J#3Z?;0OJ^IZ-;ZCIEUJ.G;TAN; MC0;%)\6\.JW'F'_#-?QLN?V?_"?A_P"!O[//B#PUXVT;X/Z38?MAZGJOPDU- M8?&OB2/Q-X-GU*?4H]MJWQ"W:?9>-/--C/>F\AO+N!)BVKQ"Y`/U^HKYP_X) M?^')_"GP"U?1+/X,:?X,T2/QA<'PTFA^`=4\&:9JUJ;6T,EY9^%M4FEN/#47 MVHW5N]HQ5;F>UGU)5QJ6YOH^@`HHHH`****`"BBB@`HHHH`**^(/BI\)_#GP M>_:$_:B^+/QU^&GQ@^*_@GQ)\'_`=Y>Z-H^C:CK-SXEN8->\7.?#>GV5BD<, MMM'#+IMM-8*JV\EOW,_A_Q%^`_Q;^.?["VH_LR_L8?#+QAX3N_$ M^H>*O'4_A/2?A_K?@+P[X1U/2="MSH.@>'Y-5LM.N+&4>)+CP[JT=TJ6D&H7 M.G:_=L;97FTX`'ZGT5^>&F_`C]F#4/"OQ_\`B9\)_P#@E]I_BGX+^&_A?HVN M>`_@AXD^!,WARUU[Q[IB>)I;][+0=3TR.5+ZXL[K1+/^TH[)_.4QP(\QM7BC M^O\`]B_]E_PK^QG^R_X0_9M\)/I\L7AS3W.I7NDZ*FF6M_J=S-)=ZA>0V,3- M%813WD]S.MI"1!;K*(856*-%`!ZA1110`4444`%%%%`!1110`445^>'[5?PI M\%_!_P#:5^./Q-^.W[-OQ0^/^@>,/!_P\.B^&K[PMK/B'1M5UD:MXV1;&YL] M,L;FW32-,M;BRGEC^QW`A,=M>F"[U6:"2Z`/T/HK\P/BU^S]XQ^+?P7^%?P[ M\`^"_B!XD^&7P=^P>-?$^GZ[\+-8\.QZG_:/C**UU#2])T2[A%Z^FV'A>'QI MIW_".R"7.EZSH]O'%J32P2)S_P`0_@#:WMU<:SH'[+?]F_L^7'Q`URX^&7@_ MQS^RSKGC#PWHL,FA^$H5"_#VRCM-1TRYEU.S\430:E)';PVXDU(M%*=>MYR` M?J_17G_[)VA>._"_[+'PT\,_%+3_`!!:>)].^'^C6OB.T\6>*8M!?CW^RO\0/CC>^*_P!H#S_!GB'XD_"'Q#X_T*'S?`WA);_Q M7J6GZ99RV]QY5S;W5M:Q6T,&V5Y].LGTVR-[+::'QA^`\_Q-^*WPN^*/Q<^& M7Q0^)GP'^#&GZ!X+U>S^)7P_U36-=\4Z9>>%=0OM2U74-%%D;K7XKC59?`(D M$MK+/:ZGH%]*;:S%K<3N`?I?17Y`_M"_LL_&S5_V?Q;>`_A7X@M_&VI^'_&% MK^SO8^+OV?\`4_$D/A6&;Q-X@N?"R>'KRSNK=OAKJ46GWFB))=:G'!#;0VVC M(%B;1;N&']?J`"BBB@`HHHH`****`"BBB@`HK/\`%FC:CXC\*ZGX>T?Q9J&@ M7=_I\UO:Z[I,=N]UITCH56YA6ZBF@:6,D.HEBDC+*-Z.N5/YP:_\,OA3\'/V M,_#?P9^.'[%?C#XF:E-\F_:.*[MK>\U"^B`/TOHKY`^"/[/>L?&_QW?W6L>//C!9^$ MO`/P?\-?#KP'XS\7&\T;QAJZ745GJ_B._>XGMXK@_P!I6T?ARRGNRL-]:WNE MZHMN-/N$,\GR?^QU^SI\0O"WPD^%'AKX@_LP>,+7X\6NH?!6X^&_C'4/AO?F MZ\,>"-/T3P;'XDTO^WS;�HLV7BZ.?2)[JVFG:ZN4^SR'4HQ<@'ZWT444`% M%%%`!1110`4444`%%%<_\4O`'_"TO`E]X`D\:^(/#\&I^5'>ZEX6U+[%?FV$ MJ--!%=$KP-/`8[B)96>WF@F6.:,`Z"BORPU3X?_"FP_8O_`&6/@'\= MOV3_`(H1_$*+]G#PK9:E\3;;X%^*O$EU\)([73H(YFT46&GW0TCQ3)<%ECFC M6"2W:RANKQI?L&GV-WZA^V9^S1\4_P!IS]D#]LWXM7FD_$"QUWQ9X?\`$'AW MP#X5T.">RU?7-"\/:+J-EIVDSP01^;-;7/B&XUK5;?[._FW]IJ%C%/)):ROI MX`/O^BOG#7/@IXJTW_@J_P""OCPFH>,-8TJ_^!_C;3+N>]E=]&\/-_:?@UK2 MP@2-%@@EG,.HW)DDWW5P5E4RO!9V\-M]'T`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`5\M?\`!3[_`(*"?';]@[PQ MX1N_V?/^">/Q+_:"UKQ/?W275AX$L;HVNC6MND9:6ZN+:TNWCDD>:-88S$%D M5+AO,4Q!9/J6BNO`U\-AL7&IB*2JP6\6W%/3O%IK771]"9)N-D['Y+_\1#/_ M``4Z_P"E;/X\?^!&M?\`S.T?\1#/_!3K_I6S^/'_`($:U_\`,[7ZT45]+_;W M#/\`T*(?^#J__P`F8^RK?\_']R/R7_XB&?\`@IU_TK9_'C_P(UK_`.9VOJ?X MS?\`!3;5_@=\:_A3J'Q/\&+X/^%_Q,^`_B7QBT?C;1YK#7]%UK2K2SU-M-O" M9S#;NNGR7ADMRC2+)9R$2%485]@U\W_\%,?^"7_P(_X*G_"30_@_\=?'7C?P MU:^']>DU2QU7P!JUM97S&2RN;*:V>2XMIU-O+#=2+(@4%L*"=NY6\G-9I"$XOWI7^X^5%_X+[ZC^S=X(\,^//V[?"5VE MW)^R3H/Q=\8>#_AY\-?+F@DU7Q):Z/"L%Y?Z\"NPWL(>REM<@+),+S.+6OH; MX^?\%@/@_P#LX_%O6O@?\0/V=/BM)XB\-?`NX^+GB*TTVQT>5=.\,V^IO87, MLCG4U#31"-[EHDW$PC"%YB(#E_MM_P#!#S]DC]O'QCX@\9_%3QKX^T67Q%\% MM-^&%S9^%-4L8(+?1K'Q#;:_#)$L]G,RW/VJUCC9F9HS"641AR)!W7[0O_!+ M_P"`7[2GQ]\.O%_C"TUOQ_^SAJ?P4UFUTG4+6.UAT"^NI+J6YA62V=U MO@\K!9&=X@H`,+'D^*:'FOQ7_P"#@C_@F?\`!_X@>'_`_B/XRP36^L:!H.M: MEKL.J:;#!H=EK44;#-%,XLK>Z-M#(DUR((G60\)\/O^"R7 M[2'Q<_9Z^/O[3>E_LFP>"]$_9K^.>H>'O'>D>*]3MKVYU3PYID:?VLMO+8WC M+;ZO:J_VEE*3V;KY<$$UPSO-#[-\,_\`@D!^SY\%-7\/:K\%OBY\3_!_]G^# MO"GAKQC'X7\306#^.[/PW;I;Z0^K7$-LMP)8HD\MVLI;03QNT,HDA(B$Z_\` M!(W]G>UF\=Z'I'Q$\?6/@WXF?&&/XF>.OAY;ZM9G2M8UPN);I97>T:\^R74T M5K+-:BY$1-G&B".-YXY@#N_V`?C]\5OVK?V=+#]IKXBZ1H.F:1X\NY-9^'6E M:/#-Y]MX9F"G3VOI))&$MY+%_I#^6L21B=8=I:)I'^#/^"=W_!?;]H3]LCQW M^Q;\.O%GPO\`#^GZA\>_^%C?\+3N(/A]KVGV%K_8D5S+IO\`8=]>2FUN]RP` M77ERWGEL=C?9W(6OT8_9D_9C\%?LG^#=5^&_PS\2:]<>'+WQ-?:OH^AZQ=Q3 M0>'DNI/-DL+$K$CI9K,TLB12-(8S,R*PC6.-/!_V;_\`@BI^RQ^R_P#\,V?\ M(!X^^(%Y_P`,M_\`"8_\*_\`[8U6QD_M#_A)?-^W?VAY=G'YOE^:WD^3Y&W` MW^9SD`Z3_A[/^RE_PT+_`,*(\S7/[/\`^%H?\*R_X6/Y-I_PCW_"<_9_M/\` MPC7F?:/M/V[R^-WV?[/YG[GS_._=U\H_L\_\'!7B_P")_P#P3`TWX[^(OAKI M6J_'[5/@-X_^)=:?\(]_P`)S]G^ MS?\`"2^7]G^T_;O+YV_:/L_F?OO(\[]Y7F'@;_@WU_8T^&?P'T/X#>`/B5\2 M]*ATGX4>*?AKJ'B:VU/2SJNN>&->O;J^NK"\E;3S&RQ7=T\\#11Q,C(`Q='F M24`\ZUC_`(.!/"OP!\%^#/BC^U+H>H7-I?\`[&'A'XR^*_#7@#P`CR"ZUG6; M#22;2_N]<0>4MQ?*!926I81J9?MSL/L[>^^(O^"Q_P"R[X/UCQS\/_%_A+QG MI?CWP/\`$30/!#_#>\M=/&KZUK&NQM-HD-CB]-LXO85:6,RSQ>6B2&<0>7(% MX+XX?\&]/[%_Q^\%V7@7QC\3OBA;6EA^SAX>^"D,FF:UIR2'0-&UFRU>UN27 ML''VYKBQB220`1&-G"PHQ#KI?M9?\$=?!7Q-^(WQ-_:<^#^KW-Q\2_B+XZ\$ M^+F_X236X;.VT/5?"ME/:Z7=:1*M9L+ M7PSJ]GJ=MK\6D66I7EBFK)?K))#--(UJ&_L][*`*)23=Y3:_4?\`!+3]AGQM M^PW\+_B1:_$[QA9ZMXG^+'QI\0?$CQ##IU[)=VVF7.J-"/L45S)!`]VL:6Z9 MG>&$R.SMY<8(4;'PQ_X)S_#CX,>-=-U'X5?&[XG^'O!FD^*+[Q)9?"G1O$\5 MKH']JWEQ/<7$\IB@6^N(7EN)7^Q2W;V0+`BW!52`#(_X>S_LI?\`#0O_``HC MS-<_L_\`X6A_PK+_`(6/Y-I_PCW_``G/V?[3_P`(UYGVC[3]N\OC=]G^S^9^ MY\_SOW=<%X$_X+J_LU_$']EWX0_M=Z3\!/BS!X3^./Q;T_X=>`%N]+T@7=SJ MUW=7]JLDD2:DPCMTET^571[$?Y]G>_\.F/V4O\`AH7_`(7OY>N?V?\` M\+0_X6;_`,*X\ZT_X1[_`(3G[/\`9O\`A)?+^S_:?MWE\[?M'V?S/WWD>=^\ MKQ/XM_\`!$0^%?V.?V6?V)?V0?B;<0^&?V?_`-I?1/B%?ZQX]U@#5)]+@O=3 MO+Q();.R$3W?FZB?)5HHH]J#>X(RP!]9_LC?M>_"[]LSX?:QXY^&MEJFFW7A M?QAJ7A3QCX:UY;==0\/ZYI\OE7>GW0MIIH?-0E3F.61&5T=796!/JE>7_LF_ MLC_"S]CGP!J_@?X9S:C?7/B;Q;J/BKQCXCUMH&U#Q#KE_()+S4;HV\4,1ED8 M+Q'''&BHB(B(BJ/4*`"BBB@`HHHH`****`"BBB@#\_-?_P""QO[9UMKM[;^% MO^"+'QEO-,CNY%TZ\U"#4;:>>`,1'))"FE2K$[+@LBR2!22`[`;C4_X?)_MU M_P#2$;XM?]_M3_\`E+7Z'45X#RS.6_\`?Y?^"Z?_`,B?+O)^(&[_`-IS_P#! M5+_Y$_/'_A\G^W7_`-(1OBU_W^U/_P"4M=?\&/\`@JC^UW\3=>U;PWXK_P"" M1?Q9\-SP^%-5U#0)YEN3!?ZC:VDES!82RW=C:Q6WV@Q&%)66:PO9+:>-74J6CFB97B<`Y5T8,IP000#6E' M+LVIUHRGC922>J<*:NNUU%-7\C7#Y5GE*O&=3,)3BFFXNG22:ZJZBFK]TSY0 M_P"":'[;?QV_:HLKW4/CYXH^%=K=P^#].UK7/!&C:?JFA^*/`U]<[S+I6JZ; MJ,DQDBB",JZD'MUG>.0+:HJASR?_``2P_P""F/[1?[=/QA\>Z#\3/A[X"L/! MV@%H=%UWPMJY?S+XW=R+>T@D>XD&KV\VFPP:DFHP1P0XNC`(V:WDD/IWP[_X M)6?L_P#AKQ5XJ\=?%GQWXY^+.M^+/A8_PTN]9^)VKVUY=0>#W>21]'66VMH' MGC=Y7>2XN3/=RM@RSN0*S/V8_P#@D+^SG^RU\?\`P_\`M*>%OB%X\UWQ+X1^ M'\?@/PFWB/4;$P:5X5A`%KHZ):VX,MT=H$D\@&*]L^C/E__`()` M_P#!;;]J#]O3QA\%]%^(]K\*O%1^*7A[Q7?>.-$^%>CW5K>_"A])NC#9/K#7 M&J7F^+4E`,`:*V<%@5$J9$M9\- M7FH^.OB3\0/AEK'B/3]'N9=0L=/T:T8Z?J%C'9F[N)[E!)<2A"80`000WL_[ M!7[%/PL_X)V_LG>%/V.O@IK_`(@U3PQX/^W?V9?>*;J">_E^UW]Q?2>:\$,, M;8EN9`NV-<*%!R06.7^V)_P3]^#O["&^MK^&+4+*1'1S'=6EO()H?*G*JT+2-#++$X!\[?'?_@L_J'PA_X*:Q?L M=VW@[1YO!^C?$SP'\.O%=[/!.2-HI#*=0 MW"6'[.RR'P(_X+/ZA\7O^"FLO['=SX.T>'P?K/Q,\>?#KPI>P07(U)==\(Z; MI-_J$]Q(S&)X)UU&XCCC6*,Q'3]QEF^T*L?OWCO_`()J_LS?$/\`;!TS]M77 MK#5U\36%]I>I7>EV][&NFZGJFF6U_:Z9J5Q&8S*UQ:V^IWT4>R5(V$X,L_P!%%%`!1110`4444`%%%%`!7F/QS^// MCKX5Z[9:%X*_9_\`$/B_S[0SW-YIT4JP098JL8>.&7<_RL64A=H*'G=QZ=17 ME9S@\QQ^`E1P6*>'J-JU2,83:2>J49IQUVU3MTUU.[+L1A,+BE4Q-%5H*_NN M4HI_.+3TWT9\]?\`#8_QT_Z,E\6_]]W7_P`A4?\`#8_QT_Z,E\6_]]W7_P`A M5]"T5\;_`*J<:6E M,ZF11\H0M&WT.091G^65*CS#,I8M22LI4J5/E:W:=.,;WZWOMI;6_E9KF&58 MV$5A,'&@U>[4YROZ\[=K>5O,\1_X*"_\%-_VO/V&]0N]1UHZ?JT]K<:3!J M\5_\%4[[XM?$KP'\&/V9O%7@CP5-XL_9B_X7MKGQ!^*NF7-WI'AWPTTUK';B M:WCNK#<7\Z=I)6NHA;I;[V1PV!V?[1O_``21^"O[3O[1-S^TEX[^-_Q+L=5U MCX)2?"?QAI.BZAI<5EXE\,2W/_$/A7X@?#GQMXG^&'B_P3X4G\,>&/%_@"2Q%W9:).ULTNG^3J-K= MVDL1-I`09('>,IF-D))/TQXIU7[*WQB?X_?L_>&?BW/XO^'VO3ZM:2?;-5^% M?B[^W?#\\\4TD,HLKXQ1&=%DC=#E%*NKH>5)/R7^S#^W9^V5JO[=_P"TK\!/ MVK?C1\%;+X<_LN:5X>U/Q?XET7X7ZII=QJ]GJNA7.IM.);C7[J/3DM#""Y:. MY\V-7QY)(9?JO]D']DSX*?L,?LY^&_V5_P!G?0KK3?!WA2.Y72;2]U"2ZF4W M%U-=3,\LI+,6FGE?T&["@*`!R?A?_@G=^SWH'QW_`&@OCQJZ:MX@G_:7TG1= M+^)7AK7IX)=*:STW3)=,C@MXDA214EMYI!,)))-Q/R[!\M`'B7PO_P"#A[_@ MF=\3/A]X_P#B2WQ3DT6P^'O@^'Q9?PW][IMW<7^B37*6L%U#'I]YS$%TMO/,3;I]GNXIKBSD#;E,JG([72?^"1?[.D MW[-?B7]D'XH_$?XD>/\`XX<1(!I>/\`_@F#\+/BUX"^&/@OXL?'CXJ^*+OX7?'/3OBO MIOB37_%$%U?ZGKME)/)'#<;[8P0V!-PX^R6<5M'&JJL(B`((!P6@_P#!+O&_A-/!%CI^CB]TCQ!X5LX;O4],O))-26V6 M4I/$(I(II8'+9:5$^>GI_P`%W/V(-=^$WA7XP?#*V\8>,[+Q%\.-2^(6J:;X M;TRU-]X8\):==M9:AK6HQ7%U%M@M[F.6%HX#/<2/#((891&Q&A\*?^"*G[+' MP?\`VL='_;%\,^/OB!/XGT3XP>/?B/:6-]JMBU@^J^+K"UL=2A=$LUD-M'%: M1F!!('1F8R22@A1S'@3_`(-_/V+OAG\!O"GP$\">/?B-ID'ASP+KG@75O$MO MJNG?VMXI\):OJ<^IW^@:C*;`QM:/<7$A5[>.WN8@3YVMM<37]W<7/B&/3;6."19C%-;SQ30 M^5$L/F/-*F),,%KO[O\`X+%_LR:#X:UVV\<^#?&7AWXA^'O'NA>"KWX+ZO'I M@\3R:]K<0FT:RC6*^>R^-_ M'_@S49M'O/V>K;X-)X"M;F&'1+3P[;:G'J5K)!&L(GANX+B&'RI5FVH(DQ'N M4-7(_'#_`((\>%=6^%^LZO\`#CQ)<^,/B_K'Q*T#QSJ7Q3^(FIVEGKMYJVAP M-#H\T5[9:7):6#VB;(XS_9EQ"8FN$D@E:YDEH`['X.?\%??V>_C1XF7PWI/P ML^(FDA?VA]9^"]_J.MZ38I;6'B73K$W;>'_`U]J>F:%9ZY$EL/$-Y;ZK_9%O-"T# M3%;*XO2H29@&\H^88U%>$67_``1V_:=L?V*/B=^RM'XF\'MKOQZ^-^N?%#Q9 MX[/CO4XKKX=:S<7=A=:=-I'V?3HI-8EMY+)',LLNF[G3=M*R&-/LZ+]AK]G" M7]B6V_X)\ZSX'%[\,8?`L/A.31GNI$>6PC@6$$RHPD$IVA_-#!]_S9SS0!2\ M`>-?VK/A%8^*_B!^V]XS^$B^`M%\,OKC^*?"]GJ&D3Z*L2/+=6]Y;74]W%-# M!"A?[*_CWX[\!?$;3(/#G@70_'6D M^&KC2M._M;Q3X2U?4X-,L-?TZ(7YC:T>XN(PR7$EO*_@)X[\>_$;4X/$?@70_`ND^);C5 M=._M;PMX2TC4X-3L-`TZ46`C6T2XMXRSW$=QF,GA.WULH-)U*X>'4'6:UN/,CPM ML9KB+?F:"(*Y73\"?\%G_P!EWQM\4I_AO=>!/'6A6+M=L=/BTJ M3QE9(LB6:M'>O.4NEW_9Y#"`S1%9!"SQ+)%^TA_P14_98_:@_P"&D_\`A/\` MQ]\0+/\`X:D_X0[_`(6!_8^JV,?]G_\`"->5]A_L_P`RSD\KS/*7SO.\_=D[ M/+XQPW[('_!&)O`7Q5^('Q,_:M\:P>(+6Z_;$\3_`!L^''A+0=0$NE6]Q>K" MFF7U\D]FDPU&U7[4`D4IMP9E<^:\<31`'KO[/7_!6?\`92_:6^+WA[X5>`I- M*XDG?[,X.?M$,'FHK20^=&K./G M_P#:)_X.'_V>-!_9C^)7QO\`@?X>\;16G@:Z6VB\9W'P[M?$>G&XBUFSTVZA MN-.MMO\`@DQ^RE^S3\7O#WQ5\!1Z MY<6G@'^W?^%2^#=3FM&T?X??VU-YVK?V2D5O'.GVER<_:)I_*1FCA\F-F0^6 M?M5_\&]W['?[9MOKEK\>/C%\7-47489X=$N7\2V,EYX?BN-0M;^XC@O9K&2[ MO4>6TC54U&:]2WC+);"W&-H!;T[_`(+4>%?!W[4'[6/PQ_::^"FI?#OX=_LN MZ5H%UJ7Q`U#5K*Z^WMJ4;/;HUO!.\BO>;XC9Q1+*S*&%R;6=X[8^Q_L&?\%* MOV9O^"B>E>*9?@-KV-6\$7]M:^+/#\VLZ7J,NGFYB,MK)]JTB\O+&>.5%?:\ M%S(%:*6-]DD4B+A?%S_@DE^R1\;_`(E?&?Q]\0K/7;RQ_:"\-Z5I7Q;\)-?0 MMINMR:7&L>EZ@I>%KFTNK55'EM;3Q1EL.\T_9_\`A=\:_#/P MG_X2_P#X6-\0-(\+W-[X"\66>L^&]*2Y\36?AZXU,:Y;YM[BV6YO(VMH0J7U MR'`DM+7R+\V/?_MW_LF_\-M_LL>,/V;X/B]X@\"W/B?P_J&FVOB30)-_V?[7 M8W%E*ES:.PAO[9X;F9'MY?[RRPO;W,-O:[N"(1"OVO5(WEFB@BBB5;B2.W2W01B,`\@ M^(W_``5;_P"%-Z/K/QP^)7P%V_"*U\0>./#VAZ[H?BG[5XDO-5\*6>NW6IK/ MI,MK#:VULZ^&=86WF349GD)L?,AA\^;[+Z_^SU^T+\4_'?Q3\6_L_P#[0'PD M\/\`A/QMX3\/Z+XAFA\'>,Y]?TJXTK5)]3MK5ENKG3]/F6Y$VCWPDA-ML5#; MLLTC221P\AXG_P""7_P"\?:CK&A_$CQ?XP\0?#W5-0\2ZG:_">]U"U@T;2]3 M\06^I6^LW\%S:VT6J-+*OC1XP^(WC+Q-I^GZ9J?C#QK'I<-U_9E@]W+9V"0Z38V5HL44VH:A*)/(, M[M>.))72.%(@#D/`G_!2/]F?Q+\21\&-?\:?9/$[>(+_`$TG3O#^M7&D6GE^ M(]6\/V27FK2Z=!9V5S=7VCW5K';S2+YMVA@MGNP\$T^__P`-Z_LG-X<_X2># MXK>=`GA_^U[JUMM"OY;RS0ZC_9<5E<6B0&>VU*;45FL(-+E1+ZXO+2[MH;>2 M:TN(XN0T7_@E_P#`+0M6\3:Q9^+_`!@TOBKQAH?B34%DU"U*QW6E>/-6\<6Z M1XMAB)M3UFZA<-N8VL<**R2JT[GB[_@E9^R/XV\%_%7P)K_AS4+FQ^+6H6][ MK4=[/%=QZ?);ZS=Z_;K!!7]FL?#7@#6M3FT??>2V(_ME+6SD;0-MW;W M=L_]IBU\N:POHWVO9W*Q:Q\);VS^*'B";3_@S]LD\(:)8^#?"&BPQW-U>375Q.DVC:'9W5CYS211 MSP6$UI;WD-LL5W#/Y_BCXM\07\'CKX@:5XVM] M,U'1]!U.P\.Z[9:''H+7=G::EIES!#[;1$\*0W5]81:5X@URSTNVU>YU"S MM[BULK9UN)YK5[EX4OVLI8;>1G5RG?\`C_\`:C^!/PO^*>B?!CQQXY^Q^(-= M^S?9X4TRZFMK+[5.UM8_;KJ*)K?3?MERDEK9_:Y(?MMQ&\%MYTJ-&/,/%'_! M,OX2>(I_`VZZ:8K.* MWO#<2;-+6P5ENY(V!B2!(>O^+?[%/PL^,GQLTWXV^(]?\06D\/\`87_"1:#I MUU`MAXE_L+4Y=6T+[9YD+SQ?8-1GGNX_LDUMYS2&.Z^U0A85`-#X-_MD_L\? M'SXA:_\`"SX9^,=0GUOPYJ&J65W;:KX6U+3([Z33;]M.U)M/FO;>*+5(K2\4 M6]Q-9O/'!)+"LC*9XM_/^+OVR]1T']KA_P!E3P]^SKXPUN6+X7^(/%<6NQ?9 M[*/5KW3)=$7^Q]-6]DA2[E=-;MRUV\D-E'(5@\]Y4O%L]#X4_L4_"SX/_$G1 M_BEX9U_Q!/J&B?\`">_9(;ZZ@:%_^$N\1VOB'4MX2%6/EW=I''!AALA9ED\U MR)!T'Q'_`&>]'^('Q3TSXUV7CSQ!X>\3Z)\/_$7A/1-3T0V;?8H=8GTJ>:\6 M.ZMYHWN89='M6A\Q7A&Z0212A@%`/(+[]OGXI^`?`GQ4A^+W[/GA]/'OP]_L M.RT?0O`WQ!GU?1->UW7)?LNB^'FU:XTRS:QU*:[DL1/'-:^5:6VL:;=R2F*X M;RM#X3_MX>*O$'QE\8_"+XP_!73]&N_"O@^?Q/?Z;X"\7/XPUGP[:H+>6+3_ M`!#I^GV0.F:O=6]W'+:6-I)J*W@M-0\B:1;:-[@^"/\`P3>\/_"'PKX4\`>) M_P!J3XH?$'P[X.\86WB;2M"\;IX?\BYU&%+]O.OFT_2;634Y7OKY-6>>[>:X M;4K"TO/-$R2-+U_P=_8]T?X4_%.+XMZ_\(+'4$^('B?P\WPR_MJSEU40^'M4UA-8D^T1LUE]IM]'T'5M M3\CS_)E>T^R174CRQ2R9_P`:?^"IGQ;_`&;]1N/@W\8OV4=/E^+%SJ&A)X=\ M/>`?$^M^)=&N[75+?Q!;5$E2/PMK'F16^D72H39,9!'+:G<_N(XY(KF M&*\U"QM;F)XYH;/4[V(NYG=SGW'_``3>\/ZMJ+_$CQ9^U)\4-9^*4&H:=<:# M\8+U/#\>LZ+'96^JVUO;06EOI,>DR1+!KVNQDW%A-(1JLK%]T%HUL`;^@?MG M:=JG[!FN?ML:[X:T_05\-^#]/CY\0M?^%GPS\8ZA/K?AS4-4LKNVU7PM MJ6F1WTFFW[:=J3:?->V\46J16EXHM[B:S>>."26%9&4SQ;\^^_8I^%FH_L;> M+OV)[S7_`!`_A_QWX?\`$>G>*]?^U0#5;ZYUY[N;5=2W"'[/%-Y=L<$<2I$I\*?V*?A9\'_`(DZ/\4O#.O^()]0T3_A/?LD-]=0-"__``EW MB.U\0ZEO"0JQ\N[M(XX,,-D+,LGFN1(`#0TW]L+X(:]XJ\6^$O##>,-9E\$Z M??W6N:EH?PSUZ^TR1K)Q%=VEGJ%O9/::E?13;X'L;26:Z$\,\/E>;!*B$=;^+G@_2-:A\.:AH>I/'H1`_P#95A:2:EY$21003ZF][<6T,;)#-&+BZ\_@/AA_ MP2F^"?PR\.?#GPFGQ;^(&M:?\/?#_AK1)[?6+O3!_P`)/8>&M1EU+PQ#J#6] MC$R_V5=S-+"UF;5KC`6^-ZGRD`T-=_X*A_LP1:WX.B\)>-M/O=$\0>,+C3-? M\1ZW/-HUKH^D1^&M>UV+Q%$][`B7^D3IH-S'!J,+?89U$\D-S(+:1#Z_XF^. M_P`,_!?P:C^/7C'5-0TGP[-I]I=0C4_#][!J+M=&-+6T&G/"+PWTTLT4$=B( M?M3W$J0+$9F$9\`\4_\`!&W]D?XF?"7P_P#L^?&_4O&'CWX>^$M0B_X17P+X MJUF*33-(TFWT35-&L=(@CA@C*Q6EOJUQ)%?%CJK3P6W_$O]GO1 M_C!\";;X(_$7QYX@U&>T_LF[M_&6;.'54U?3+JWO;'5]L5NMF;F.^M+>[\HV MWV1WCV/;M"S0D`S_``Q^V3^SQXT\5>`?!/A3QCJ%_JOQ*T_6KWPO9VWA;4F9 M(](>&+5%OS]GQI$MK<3PVLT-^;>1+I_LQ43@Q#G_`(T_M[_!#]GCXRW'PB^* MU_J!NY-/T)]%TWPEX2U[Q#K-_=:D/$$JQ#3],TV<^4+?P[?2K+')*V(+CSH[ M=4@>YT/A%^Q3\+/@UXQ\'^/_``[K_B"\U?PEX?\`%FG-=ZE=0-_;%SXEUBPU MG6-2NECA11,?V*?A9XV_:QT+]L75=?\01^) M_#_]D_8K&WNH!8/_`&?8>*;&'>AA,AW1>+M2+XD&6@M2-H2190#`_:#_`."B M_P`"?@S:^!8/!FH_\)YJ'Q!\0>#[;1$\*0W5]81:5X@URSTNVU>YU"SM[BUL MK9UN)YK5[EX4OVLI8;>1G5RF_J?[>O[)VBZQXIT;5OBM]F_X0WS&U[4)M"OU ML$A@O(K*_N8+PP?9[NVTZYFCAU*YMY)(=*8D7[VNULF>'/AAX3 M\*?%OX@:+I_PV\/^!-$O+>QN],D_X2^P\':BFI:!#J;7%C(R>1=B>5FL#9-- M]KE60NBPK$>%/^"3_P"SW\.OC9\0_CA\*O%OB#PCJ'Q.^V_\),/"VCZ#8W_^ MGZG!J.I^5KD>F#75^US1S*V[46^SK=-]C^R/;V3VH![_`.`/BEX$^*/]MR>` M-=_M.#P_X@N=$U*]AM91;&_MMHN889F41W/DRLUO*T+.L5Q!<6[E9K>:./R# MQC_P4C_9G^%/Q=\1?!WXO>-/[+U#1?$%U9"72?#^M:E#8V=II.@ZA>ZAJUQ% MIPM='MK=?$%B9;J:=K..&:*22Y1S/!;=?\)OV:UTV2X?36LX["YVK/:6-F+741#9$R1HNK>5$8;:RL[:'@/B MI_P2_P#@%\7O&GQ5\=>)?%_C""[^+_@_Q1X;\2QV.H6JQVUKKVC>&](O'M@] MLQ25+?PMI[Q%S(JR37)99%>-(@#T_P#X:C^!/_"]O^&;?^$Y_P"*M_U7V;^S M+K[']L^R_;?[,^W^5]D_M+[%_IO]G>=]L^Q_Z5Y/V?\`>UP'[)W_``47^!/[ M4'P=^&GC_P#M'^P_$'Q$_L;3_P#A%?)NKG^S]=O_``A#XN_LO[3]GC27R])E M\_[1A(FV[,K*?*'7Z-^RMX5\.?M#ZM^T%X>^(OC"P77]075]=\%V6KI%HVHZ MXNFPZ4NK3JL0N9I1IUM;VPM7N#8`P17'V3[6BW(\P^"?_!*;X)_L_P#BWX8Z MY\./BW\0(-(^%_\`9UW9>$[J[TR6PUO5[+PDWA&'5[YS8_:OM/\`8WE0&*VG MM[0M;QR_9Q(9&D`#0?\`@J+\(O'GQ)\6^$_AQIWVKP_X9_X5VMEXTURVU;3K M#7W\5>([W186TXG37^W6W^BQ2VM_;&6QO6NT7[3;Q1R72]?\,?\`@HW^Q[\7 M_@UJ'QZ\$_$W4#X=T_3]-OR-8\&:OIFHWMKJ1V:7<6>G7EI%>7\5_+F"R>VA ME6]N$>"V,TR-&.0^'W_!*;X)_#VUO=&M?BW\0-1TC_BWUIX9T;4;O3/)\,Z1 MX+UR76M"TBS>*QCFEMHYI7ADEO)+F[EAP&N/,_>UG^*O^"7_`(5\'?L\3?#G M]GSQ?J#>(M'^%_P[\(^$KSQ;J">7"O@G4KC4M&NS+!;$0WQN+EV:XD@NK5)( M[>233KN&.:SN0#U_0/VR?V>/$?[,&N?MD6?C'4+;X>^&M/UR]\0ZKJWA;4K& MZTZ/1IKJ#4UFT^YMTO(Y;>6RND:%H1(6B(56R,FI?MD_L\:'XJ\)>"?$'C'4 M--U7QII]A>Z;9ZIX6U*V;3X[]S%IZZJ9;=1HDMWH:U=_$73_&2>._$6DS6ZW2R>)]0U*^O1 M#,MI#!++"=3EC6X%G;QRM$)?LENK_9DT/C[_`,$W?V>_VA?VI_!7[8OB:V^Q M^-O!7]FQP7W_``BV@ZI]MMK"^DOK2#?J^FWDVG^7-/='S]-DLKAOM&7F9H+9 MH``\"?\`!2/]F?Q+\21\&-?\:?9/$[>(+_32=.\/ZU<:1:>7XCU;P_9)>:M+ MIT%G97-U?:/=6L=O-(OFW:&"V>[#P33[_P#PWK^R'_P"U M[JUMM"OY;RS0ZC_9<5E<6B0&>VU*;45FL(-+E1+ZXO+2[MH;>2:TN(XN0T7_ M`()?_`+0M6\3:Q9^+_^*O&&A^)-0634+4K'=:5X\U;QQ;I'BV&(FU/6;J M%PVYC:QPHK)*K3N>+O\`@E9^R/XV\%_%7P)K_AS4+FQ^+6H6][K4=[/%=QZ? M);ZS=Z_;K!!7]FL?#7@#6M3FT??>2V(_ME+6SD;0-MW;W=L_P#:8M?+ MFL+Z-]KV=RL7D'@S_@M;^R).K86+_"'Q7?31Z5X M7U86-[J]PD6DB2TMEBGL99GF14M9KF2TDD,UK.J=!\//^"5?P=^'FL?"6]L_ MBAX@FT_X,_;)/"&B6/@WPAHL,=S=7DUU<3I-HVAV=U8^'/&WA/Q%\6_B!?:?XU\/_$[1&MY;O3$_L>P\=:C M::EK$-HT=BK'R[NT,MLUP9VC^U3+(9D$2Q`'?_\`#=W[,_\`PJS_`(6W_P`) M1X@^S?\`"0?V%_PC7_"`:U_PDW]J^1]J^P?\(_\`8_[6^T_8_P#3O)^R[_L7 M^F;?LW[ZBZ_;U_9.M_BGX>^$,'Q6^VZAXI\/Z/K>BZQI>A7]YH4EAJ\]Q;Z3 M-)K4$#Z;!]NGM9H;19;A&NI=D<(D>6-7Y#]HK_@EQ^S5^T]X?\9Z+\3/[0N9 M?&/Q0L_'XNKW3-)U2/2=9M_#]GX?5X++5+&ZL9XFT^T*&.\M[D+)(%^P^'_AKI$:V,&F6,/D^"-.VV@T`7_V4/VZ_AG^TY^SQXH_:5U32M0\">'?"/C#Q5H^M M77CG3;W1H[6UT74KJU;4)6U.VM3%$UO;K/+E=MK(9[:5_.M9PN!XT_X*;?!# M3=1^%_AOX=^&?&&OZS\4?BA'X*M--N_`.O:?)X>NDMQ?W9UB&33VN=*E73@; MN""Z@C:XCEAN"8;#[1J%MU_@[]BGX6>'_@3\2?V:/%VO^(/%W@GXH>(/%>HZ MYHFOW4$7V2V\175S=:EIMM-8PVTRVQFO;QT:1Y+A/M#`3E4C"9_@;]A#X>^$ MM;\-^.-?^)?C#Q/XKT+XH3^/]4\6:Y-81W7B+69/#5SX91[R*SM(+5(H]*GB MA2.T@M@6LX)'WNT[3`!^U?\`MU_#/]ESQ!X7^'T^E:AXB\5^)_&'A71UT32M M-O9H]+M=:\06NCQZAJ%W;VTT&FQ9FN7M_MC0+>R6,UO`Y=',9H'[?W[/!T37 M+_QWX]T_2[O1=0UR)+*RM=2N6U./3O$MUX>,=@LME#)J5]]NAM[:6RLX[B2. MZU"SAC-PM[8S79^T#^PA\/?V@OBWI'Q?OOB7XP\-7=KJ'A>X\2:;X;FL#:^* M8_#FMG6]&MKT7EI<2116]])%-2U M=O$%[/X1^('B#Q98O-JBK]IFU?Q1'XKGLYA'&H-M'K=IIEW%LV3#^RK>%Y9( M9;R*Z`.?\?\`_!47X1>!M+T33[+3O^$D\3ZW\8+;P3_8OA>VU:[MM+AE\?V:L>F8EANWC2Z$4-W<6%U:V=Q="/[2>_UK]O7]D[P[_PL"36OBM]G M@^&7A_5=;\5WKZ%?FV:PTK(U6:QF$'EZM]@E`M[Q;%KAK2X=+><13.D;)[7Q-X<^+?Q`T3S?B!!XL\56.G7>F20^*)K7QI?>,]/L[S[38RO# M;6FK:E?&/[&]M-)#<&.>6?9&R9]Q_P`$<_V44\5?&WQ'H$^H:-%\>O!_B70/ M&5OI/AOP[%=0+KS^=J5U#JQTHZM+*\[2S+%=WMQ:QM(%2W6*&WCA`/3_`/AN M[]F?_A5G_"V_^$H\0?9O^$@_L+_A&O\`A`-:_P"$F_M7R/M7V#_A'_L?]K?: M?L?^G>3]EW_8O],V_9OWU8'[)W_!1#X1?M3>#OAI^+=;\2>.-`^)?C#PQXKUWXH0>/]+\6:'-8277AW68_#5MX9=[.*\M)[5XI M-*@EA>.[@N0&O)Y$V.L#0X'[/7_!,OX2?LZ_$SP/\2]`^*7C#69?AQ\+],\! M>#[+5K31(&M=(LK*.TCBFOK#3;;4+Z)BLMRUG=W4UB+JX-PELDL%JUN`?1]% M9_A/1M1\.>%=,\/:QXLU#7[NPT^&WNM=U:.W2ZU&1$"M"O#4[Z?\`\(J@&D26Q.H7EU]LD=IA<3<091)U M\_\`V'O^"B'Q3^,O[:^M?LM77COX?Q:1HOQ`^(5K?>'=&DG\3:ZT=AXEUFW@ M>_FDUXWWAS*1V[JD^ES:6(OLT-O?6\FH6>FVOW_10!\0?#O_`(*EZP?V-OB+ M^TY\;O'GP_T2?0?#^D7*6VFZ+>'_`(0+Q)J[M:P^#M>%Y=P6^*-/6+Q-\+_C,-5T[P ME,(=&U*31O&_AS2=/OA!!J.H6[RBU$I62.\NXU-Y<>3.\4NYON^B@#X0\7?\ M%+?VN/#'PI^*OB<_L_Z?+J7P8T^WT?Q7=QZ/+';WFLW/BJ[TDZL$N[VVATVQ ML]&LH/$TUE=7@#Z?K^GL^I6=O'_:%UY_^UK_`,%P/&GP-_X)H^"?VFM`\2?" M_3OBEXLT_P`3:CHNBWM_HVM:-XBLM"DGMKB6"XMO%%O:12S3/IKFSL]1U:]M MS=RV\5OJ+6T\\?Z'^`/A;X$^&']MR>"M"^RS^)/$%SK>OWLUU+<7.HW\^T-- M--,SR2;(HX;>)2Q6"WMK>WB$<,$4:=!0!X_^SS\8OBG\4?V@/CWX1\677A]/ M#'PX^(&E^&/"5GIVCSQ7YW^&='UBZN+RY>Y>.??+JXCC2."'REMB6:8R?N_E M#Q%_P5Y_:'TGQ5^U;X;E^$W@_2KOX)_"_P`=>)O"NB:YKFFKJ=O)H#F*QFO- M/AUE]4O;'5(VCU!)Y-/TJ.W@>"*.74%NX+ROT/HH`_,#_@HO_P`%'/VI_A;^ MS%\<_@;XF^+WP_\``?B;P5X?\9:/=_&Z+2+[2K#6M5@\*Z#K&FZ-HUL^JB32 M];O(O$D@M7-_>.&\.W4\=K,)C'9^X>.?VGOVE8/V@_$GP/\`@/KG@_0M5U[] MJ^#P)!KOC71=6\0VMGIR?"BV\3O(EBNK6HBE:XM_)"6\L%N%D>5H7GDFEE^S MZ*`/@#QI_P`%;?BGJ-K^S]XR\,VWP_\``&G_`!=\/_"K6[3PSXY2?4+_`,8? M\);KD%AJ6E:%<)=6*_:=%M)([NXE%O>;UU"U:2"U0!I^P_X*)_$;X9^%/VT/ M@QX5^-'[4WC#X::)J'PO\>7WAX>#O&][IUUJWBBVU'PDFF1V^G6S,GB&^5+F M]^SZ5-;7R7+2/&;2X#&-OH_Q_P#LN?`GXH?%/1/C/XX\#?;/$&A?9OL\R:G= M0VU[]EG:YL?MUK%*MOJ7V.Y>2ZL_M<>V\F5VD/H%`'PAXW_X*3_MA M?!GX^_L[_L^_'#X%>#_#^M^/_!_A*;X@)J7B72-.M;W7]5NFLM5TW2+F_P!; MA=Y=)=%N3;V-OK:OX.U26]N;&34C+;V*6>N M-:75NVHE9XK>=C-"EQY4/W?10!^>%E_P5Y_:'3XY_!?X8ZM\)O!\>B>.]0AL M1XMO])]0T-=3T"75-9MY1$+.SL]=BM;*#79+FWURPM?-MQ+;W M]U](?`/XW?%/XR_LS_%+XG_%+Q;_`&/_`&?\0/B%H7AR\^&G@V>XU71]*T36 MM2T>WECMIO[0_M34O^)>]R`EL4E>6.%;-]I\WW^B@#X@_89\0ZQ\7=8^-7P] M_93_`&KOM7@F#^PX_!_C?1?B;>?%6PLGEO-26^N(-*_V?_#NNW']MZSY M^JZSLTK3?MU^WFN9KC;->6_G3'=A[J/>VZ5<^_T4`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`45X!X9^,7[4_Q7_:8\?:#\+;KX?VG@GX5?$#3?"?B/PY MK^CWS:KKGVC1=(U>XU*VU6&Y\FR\F'6D5+)["X\]]/96NK=;P26F_P#\-K?" MS_AIC_AF7^P/$'VG_A(/^$9_X2K[+!_97_"3?V+_`&__`&%_KOM7VG^QO]/\ M_P"S_8MG[K[5]I_T>@#V"BOD#X??\%J_V6/$?@[1_'_Q3\`_$#X::1KGP_7Q MM87?C'2K&YSH4VCZAK-E=LND7E\P^U:?HNOSQQ8\U/[$N$G2"2>P2\[#XL?M M_P`'@7QQ:?"BX^$/C#P_K<>G_#K5/$-[JVEZ7J%KHZ^*O%B:!;:1,MMJZ.U\ M7BO@T]N9[6W6`S;[HB*UN`#Z/HKXP_:5_P""N4'P\U9_!GP/_9X\8>(]2?QA M:Z9H&M7,&EIIGBE;/QYX?\)>(;"P$FJ07$-];W6M-;PR7T5K:O/#YHEEMP'D MS_C%_P`%>_$?@[XQ?#+PO\-?V7_$&M>'_'WA_7=/NKG5KS3K+^QO&5MXOT3P MG%I=[.E]*\-M::MJ3VM_<6MK?@_:;6>R-[%'<$`'V_17R!_P3]_X*$^._P!H M/XIZC\#?BW>>']+/V+_ M`()?M:>"H?A?'J7Q!^%_AO6H/AV^A:C>:G\0?%&I:=]N?P]I3+>0IH<02-F& MH3_VDD$$EQ=744%OIDTMP`?9]%>/_MK?%OXV?!OX6:?XC^"7AKSI[OQ!%::] MXB_X034_%?\`PC5@8)Y/MW]A:3+%?ZOON([:R\FUD1H?M_VN0F&TF5OG#X]? M\%'OVE;/X9_"SP?^S-J_POUWXE^.-0ET_5]8N?#&K7&AZ-SZ9ICZU:W%U MI\GA>*]OK>>VDAN[J?4+6_M9M*M+'6[F.:6``^[Z*^$/C3_P4[^+?B#]I6X\ M&?L+^)_!_P`3/"D'POT+Q+X7M/"7POUOQ;'XXU.\U;Q!82:6/$VD7HTOPU$9 M-&BMUO\`4(I8(9)KB63WE#Z7<%[6\2VNHE>$R0H7P/( M/CA_P51U'PI\0O'%CX!^'NH6G@3P3\#_`(I>*9OB#JN@V]]'JVL^$+_2;"Z@ MT^R35;>XFBM;JYU&"XBNUL1TU.35)HA?VT-[;20ZMH#Q6 M\%XEQ)_;5O'(+5H;YK('_!2OP=X[_98^/7[2'P\\#>(-&TCX,>'];G?7=;M] M'U+[1>:?8W%U-"VDV>L)?6MS`D<+S:9JG]E7B_:8XI!;R>;Y(!]/T5\X>*O^ M"H'P"\'Z=\2]?U?PAXP_LKX=>#_&'B2VU2+3[5H_%=KX4N!9^(TTU/M/F)+8 MWS16;"^2T6>257MFN(`\Z^G_`+/?[0FC_M`:/KS+X#\0>$O$'A+Q!_8GC'P= MXI%FU_HE^;.UOXX99+"XN;2;S+*^LKE6M[B90MRJ.4E26*,`]`HKXP^+_P#P M5R@G_9XO/B-^S!^SQXP\1^(M3U#P7'X.L]3@TM([S0_%VI-IN@>*A%)JEN); M&XN(YECL)I[._,D:1W4>FPRF\B]0_P""A/Q0_:G^"_PZ\,^/_P!FCQY\/])^ MU?$#PUX8UNT\=>`K[6O/_MSQ#I6C0W$#6NK6'D?9OMTL[(PE\_:B!H,%R`>_ MT5\P?`C]N;QW,/V3/VB?!O^DZ1\0++P=X2^(_AS1HK31->U?_A"-+\2 M75@;9]2NKZVN2DNK72%X_LB6UO#";J6YXFZ#]AC_`(*7?LL?\%$/^$I_X9M\ M6?VC_P`(K]AN+G_3[&Y\_3K[[1]@OO\`0KF?[)Y_V2Y_T*\^SZC;^3_I-I;^ M9%Y@![_17YP?%O\`X+>_%/X9?LG?M">+E^!_A^X^+OPW^('B[2/A=X6?49UL M/$^A:=?^(TM]G,UQ#;&]%U(MO0![_17@'[/?[3OQ)O_`-H[7OV3_P!I6[\/Q>-O^$?_ M`.$GT"T\+>"?$=E8)8*UJE[8Q:EJ-L+'6OL+W^FHVH6L\33M>LLFFV#6Y$O' MW7_!7GX&:3\,_P!GGXI^)?A-XPT>T_:5U#3;?P)I>K:YX8@U.WCU"]L+6RN9 MK)M9\^YBD&I6MPPT]+R2W@&HDMI#YY19;-/&'AJ>Z(8QF/5`+9[J6WNHH M-#XB_P#!33X1>%?C9\*K;P'XA_X6#\,OB/\`#_QCJ\'B?X2^$=6\;337^D:G MH%G$(?[`BN\6P_M&_2:1HRJS0PIYD;920`^GZ*^(&_X*;_%.+]G_`/99^(MS MI/A]/$_QT^'_`(.\0Z]I2>'9WL(O[3\3>!=)OVMYS?K);>5%XJG,,+Q7&]A& M[S(+9HKOT"?]M;XIM^QUJ_QMMM`\/IXGF_:`U'X9:"7M9VL+/?\`$B;P=8:A M<0"827/DQ-!=S0)-#]H:.2-)+42*\0!]/T5X_>_&+XI_LV_`G4O''[7-UX?\ M2:O8^(++2=#N?AIH\]C_`,)/)/%.E>&X-$2Z\*VO MA&]MM/\`$*7OV[5+>*:6UO+G[/BRDNEF:&1X&EBV2.`?5]%?.&L_\%(?#^E^ M'])MK']EOXH:CX[U'XH-X`O/A59/X?76=+UD>'YO$82>XEU9-+:(Z1$EV)(; MZ48N8HCB82Q1GQ<_X*C_`+-7PIT[X#^)8/[0\0Z)^T5J&D6_P\U73-3TFRDE MCU.XTV"TN3I^IWUIJ%Q$3JEM)(+.UN9+>,.\Z1`+N`/H^BOE#P!_P51^'OQI M^"&D_%;PO\/?&'@>[U?4/AM>Z?HOC70;"]NKSP[XPUZWTS2]21=/U5H(XKD_ M;8AON!STRZTZ M:2\73+^+3=2S$+SS-(BM;Z>&&2ZUE-.M3&SWDH:+\']>\9>%M$\4ZAIVI0W'V33[FZLI)9M%O[FU MN+:X6**96MKMMT,R_.CDA;^C?MW_``]U3]JK5OV6+[X:>,-.ET[Q@OA&S\;7 ML-@VC:IXB/AR'Q*=+@$5V]ZLHTJ5[@S36L5MFVEC$QE,22`'N%%>7_LO_M4^ M%?VK?"K>.O!7PZ\8:-HE[I]EJ_A76?$FD)%:^)M#O4:2QU:REAEE3RIT1G^R MSF&_MU\LW5I;B>#S/$/^"@G_``5C^%G["_QL\/\`PP\4>./A_IT%CX?@\5_$ M.+QAXN@TV_&A3:G'IZ#2[>:1)-0N1$-7U(I:I=RE?#YLOLZS:M93H`?7]%?, M'Q1_;6^*?@G_`(*3^#_V.M*T#P_)X8\0?\(W]MOKBUG-^G]H:/\`$2^FV.)A M&-LOA'30F8SA9[H'<7C:+H/B%^W-H^CZQX]\,Z'X-\0:;_PKGXP>`_`>K>)- M1T:SO;#5+_Q!>:'FWLXH]2AN!Y5MKEF)+B9(UA:X$D<=]Y$ENP![_17QAXV_ MX*Y0>(/A3J_CK]GO]GCQA?7=AJ'PNU/PU'X@@TM(_''A?QAXJ72+._TH)JBF M"6>WAO7ACU(V+PR-;FXB1?,0'Q#_`."N4'@OXM^#FL_V>/&%S\.]1^%_CG6_ M&FK^1I:W6@:YX>UO3='NM.G=]42*"*TO)KJUO+Q@]@C7-G=K>BP@O[RW`/L^ MBN/^`/Q>@^/WP:\/?&BQ\&:AH%IXET\7^G:?J>JZ7?2&UW^!/Q,_:7\2>$O$&@>"?AIX@M]"NM;UO6-!C_`+1U6>ZCM8K!H4U-IM$N M1-<6230ZXFF/9_;8S=K;+'<�^'?_!33X2?&S3OAS??L_?"WQAX^;XE>#_% MVOZ4GAB[T1H[-?#EQ;66H6LMS/J45M-*VHW<%C#+:2W%K-(_G"X%I_I5`'T? M17RA\0O^"S/[%_@;X2R?'*QUS4-6\+SZAH&F:#K4EUIVAVNLZGJ^B#Q!!81W M&NWEA#:RQZ-);7[R7KVT#+=PV\4LUYOM$/CG_P`%0/"NGZ)\.KS]EKPAJ'CB M+QUJ'PTU.]\2MIZ0:9H/A?Q;XEM=+L;^ZCN[FUNS+=P_VBMO';PW#PSVRM=Q M0Q,OF`'U?1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110!Y?XF_8V_9X\7_&6/X[:]X.U"36QJ%IJ-W8P^*=2AT; M4M1M!&+34;W2([A=/O[Z`06ODWES;R7$1L;(I(IM+);>ZU74?$ M=GI%C+;_`-F6KZC=W/\`9.FW/GW5O+IT?FV8T[5M8LHX8_[1DN%]_P#'/[+G MP)^)7C'4/'_C7P-]MU?5?^$6^WW?]IW4?F_\(YK$VLZ-\LZG\1:7XEFN)(8KPV1E75=&L)D>RL[!IU69M2.JW$SW1]/O/V"OV3M1UC M2]9U+X4_:O[*_P"$Q5-/NM=OY+"^A\57AO=?MKZS:\8^-M6\1ZK<0P M>88+9K_5KFYNOLT337#QVPD$,;W5PZ(KSRL_'Z;_`,$Z_P!E73?B9XM^*DN@ M>,-0N_'VH7][XXT/7/BMXCU'0-?DO+(6%PMYHMU?R:;A?V7H4?D?Z(O]G:G!YF_[+:^9+)NEF^R6_F._D1[? M?Z*`./\`C7\"/AG^T'X5M_"7Q-TO4'BL=02_TK4M#\07ND:GI=TJ21?:+/4- M/FAN[.5H99X'>"5&>"XGA8M%-(C>?ZS_`,$Y/V/==T[2='O/AEJ$5IINGM87 M]K8>,]7M8_$]J]Q-=2V^OK#=J/$D4MQ=7LTJ:K]K6:34;]Y`[7MT9?<**`/+ M_P!F_P#8V_9X_9+TZWTOX$^#M0TR*T\'Z7X5MFU/Q3J6JR1:-IMQJ%Q860DO M[B9Q%;OJEZ(QG*QR)$#Y4,*1]AX-\`?\(=XC\6>(O^$U\0:K_P`)7X@CU7[# MK.I>?;:-LTZSL?LE@FT?9[9OL?VEH\MFXNKF3/[W:.@HH`\?_96_81_9G_8N M^W?\,]^%_$%A]O\`#^DZ$_\`;_C_`%K7OLVE:7]J_L^PMO[4O+C[);0?;;K9 M#!Y:#SF^7IC/\1_\$Y/V/?%GBKQGXMU_X9:A/+X_\'Z_X7\2::OC/5X],.F: MX\$NLQVNGI=BTT^6]FMXI[BXM(H9YIPTSR-+([M[A10!Y?X__8O_`&8/BAJ/ MCS6/''P@T^\N_B9X/NO"_C:ZCGF@DU#3+JW2UNXPT3J8)9[>&TAFN(=D\T>G M:>DDC+86@AS]$_81_9GT?X6>.O@[>>%_$&NZ1\2_#\VA>-[SQCX_UK7=5U32 MI()X/L#:GJ-Y/?1VR)=71CACG5(7N[B2-4DGD=O8**`/']:_8*_9.\1?\+`C MUKX4_:(/B;X?U71/%=D^NWXMEL-5R=5AL81/Y>D_;Y2+B\:Q6W:[N$2XG,LR M)(OH'@WX6^!/A_XC\6>+/".A?9-0\<^((];\4W'VJ63[;?QZ=9Z:DVUV*QXM M-/LXML853Y.XC>[LW044`>/^%OV"OV3O!GAR\\)^'?A3Y.GW?B#0M76WEUV_ MF^QOHNHQ:EH]E:-).S66FV-W$);;2[UPR,RGH M**`//_\`AESX$_\`"Q?^%L?\(-_Q4'_"P/\`A-O[0_M.Z_Y#O_"/?\(W]KV> M;L_Y!/\`HWE;?*_Y:[/-_>4?`O\`9B^$7[-W]J6WP?M/$&GZ?JGD*F@WWC;5 MM0TK288?,$-MIEA>7,MKI%LBR%%MK&."%42)`@2&)4]`HH`\/\3_`/!-[]B7 MQEIVL:7XF^`>GW<6OZ?XELM7:34+L27,>O7&I7&I,9!,'$K/K.L"&8$26<>K MZA%:M!%>7"2=A_PRY\"?^%[?\-)?\(-_Q5O^M^T_VG=?8_MGV7[%_:?V#S?L MG]I?8O\`0O[1\G[9]C_T7SOL_P"ZKT"B@#S_`.!?[+GP)_9L_M3_`(4QX&_L MC^U_(BF\W4[J[^RV=OYGV73+3[3+)]ATVV\Z?[-IUOY5G:_:)O(AB\V3=P#_ M`/!+_P#8L_MCP/K-K\.O$%G_`,*[\/\`A71/#.GZ=\2=?MK#[!X:O&O="AO+ M.*^6WU+['VT'V'2_LUI)NM[3^Q=)^SQ1?V78_9_0-2^%O@35 M_BGHWQKU#0O,\3^'_#^IZ)I&I_:I1]GL-0GL)[R'RPPC?S)=,L6W,I9?(PI4 M.X;H**`/'Y/V"OV3I?#GPX\)R?"G.G_"3P_I^B?#VW_MV_\`^)586.HZ+J5K M#N\_=/LN_#VCR[IC(S?8]K%DEF63H)_V7/@3U!=1UJ^UGQ3J5_K-[J,9A-OJ,FKW-Q)J#WUN;6T^S M7AN/M%J+*T$$D0MH!'GZQ^P5^R=X@\"+\-M9^%/VC2/^%?\`B3P7/&^NW_G7 M>D>();:;6UN)Q/YUSRN]V\WF2F;S)I7?V"B@#P#]H3_`()W_"+X M]^+=!\3+KWB#PSY'Q@_X6%XQE\+>*-6TR_UV_7PE=>&8UBOK"]M[C3MML]D6 M-NX61;)HWC/VF5ZO^+_^"&OB5??#+4--N_".G^&[#0])\,>,]7 MT;1DM?#]_)J&BV\NDV%W#87,5E=2O+"DT$BH3@#:`H]PHH`\?T#]@K]D[POX M'H=S3EF^R7SW-I9Z M?J,-OI]S/YM8XIIVGNC*[_:KCS?8**`//Y_V7/@3<_LXZO^R7<^!O,\ M!>(/#^HZ-KVD/J=T9M2MM0687\EQ>&7[5-;^\KT"B@#R_P"$G[&W[/'P)U%=4^$O@[4-%E34(KB%;?Q3J3QP MV\-O=6]KI<<;W#)'I%JE[=&UTA0-/M))C+;V\4H#CH+KX`_!K5-1\:ZIXA^' MNGZQ+\1=/BT[QJNO(=0CU33HK=[>/3GCN2Z+8A);@_8T"V_F7EW+Y?FW5P\G M844`>7V?[&W[/%K\3/#/QFF\':A>^*_"&GZ59:'X@U;Q3J5[=+'IUEK5C:-- M)<7#F[E6W\0ZPK33^9)*UZ9)6=XXG30UG]ESX$^(/^$C_M?P-YW_``EOQ`T3 MQMXA_P")G=+]KUW2/[*_L^[^64>7Y7]B:9^Z3;$_V;YT?S)=_H%%`'RA^RU_ MP2A^&?P'G\62_$CQ[J'CF+7-0\)#1;&26]LK72+'POJD^JZ$D=O]LEBMI8;R MX:1X-/6PTG;%#';Z79Q"5)N_\8_\$Z_V5?&D^CWTN@>,-#N]!U#Q->Z9J/@K MXK>(_#UTDGB'5$U;6%>?2[^WDEBN+Z..1_VS;0?O/+AU#[2B_:;KY?\`29_,]@HH`\?\._L(_LS^'?`G MB/X?R>%_$&M0>*OL?]LZUXN\?ZUK>MM]CE,]AY.K:A>37]K]CN&>ZM/(GC^R M7,DES;^5-(\C=!\/_P!F+X1?#76/#'B;0[3Q!?ZOX.\/ZQHF@:WXI\;:MK=_ M%8:I>6=Y>PRW.HW,\USOFT^S*M,\C1+`L<92/*'T"B@#Q_\`X8*_9.MOA9_P MIOP[\*?^$?T:/Q!_;=C-X3UV_P!'U'3;\0?94FL]1L9XKRQ\NQQIT2V\T:Q: M#?$7C3POX@O=0\#?V+_95\?'^M1S:C_9%Y'? M:7_:SI>!M=^RW<9N8O[2-ULFFGD'SW$S2>P44`9_AGPSIWA/3I-+TNYU"6*7 M4+N]9M3U:XO9!) XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2011
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 - Summary of Significant Accounting Policies
 
Basis of Presentation
 
The consolidated financial statements include the accounts of VirnetX Holding Corporation and all wholly-owned subsidiaries. All material intercompany accounts and transactions have been eliminated. Certain prior year amounts have been reclassified to conform to current year presentations.
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.
 
Revenue Recognition
 
We defer recognition of revenue in accordance with ASC Topic 605 until such time as all of the criteria below have been met:
 
 
persuasive evidence of sales arrangements;
 
 
delivery has occurred or services have been rendered;
 
 
the buyer's price is fixed or determinable; and
 
 
collection is reasonably assured.

We expect that some or all of our future licensing agreements will provide for payments to us over an extended period of time.  For a licensing agreement with fixed royalty payments, we expect to recognize revenue as amounts become due.  For a licensing agreement with variable royalty payments we expect to recognize royalty revenue at the time that the licensees' sales occur; however, because we expect that a licensee may report sales information to us on a delayed basis, we expect our revenue recognition criterion may also be met on a delayed basis. 
 
Complex revenue arrangements may require us to make significant judgments, assumptions and estimates about when substantial delivery of contract elements will occur, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period  in which the completion of the earning process occurs. If new information subsequently becomes known to us which causes us to make different judgments, assumptions or estimates regarding material contracts, our financial results may be materially affected.
 
Cash and Cash Equivalents
 
We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents.

Investments
 
Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gain and losses are reported as other comprehensive income. Realized gains and losses are included in income in the period they are realized.  The Company's investments consist of debt securities with maturity dates primarily less than nine months.
 
Property and Equipment
 
Property and equipment are stated at historical cost, less accumulated depreciation and amortization.  Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years.  Repair and maintenance costs are charged to expense as incurred.
  
Concentration of Credit Risk and Other Risks and Uncertainties
 
Our cash and cash equivalents are primarily maintained at two financial institutions in the United States.  Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits.  The balances are insured by the Federal Deposit Insurance Corporation or (FDIC).  During the year ended December 31, 2011, we had, at times, funds that were uninsured.  The uninsured balance at December 31, 2011 was $29,185. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.
 
Fair Value of Financial Instruments 

The carrying amounts of our financial instruments, including cash equivalents, accounts receivable, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Intangible Assets
 
We record intangible assets at cost, less accumulated amortization.  Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.
 
Impairment of Long-Lived Assets
 
We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets' carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
 
Research and Development
 
Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff.  Research and development costs are expensed as incurred.
 
Income Taxes
 
The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. See Note 12, “Income Taxes” of this Form 10-K for additional information.
 
Derivative Instruments
 
Our Series I Warrants contain an anti-dilutive provision which causes it to not be considered indexed to our stock.  As a result, the warrants are required to be accounted for as derivative instruments.
 
We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value.  We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.
 
Stock-Based Compensation
 
Our accounting for share-based compensation is in accordance with the fair value method which requires the measurement and recognition of compensation expense in the statement of operations for all share-based payment awards made to employees and directors including employee stock-options based on estimated fair values.  Using the modified retrospective transition method of adopting this standard, the financial statements presented herein reflect compensation expense for stock-based awards as if the provisions of this standard had been applied from the date of inception.
 
In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.
 
Earnings Per Share
 
Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2011 and 2009, the Company has incurred losses; therefore the effect of any Common Stock equivalent would be anti-dilutive during that period.
 
New Accounting Pronouncements
 
In May 2011, the FASB issued a new accounting standard update, which amends the fair value measurement guidance and includes some enhanced disclosure requirements.  The most significant change in disclosures is an expansion of the information required for Level 3 measurements based on unobservable inputs. The standard is effective for fiscal years beginning after December 15, 2011. The adoption will not have a material impact on our consolidated financial statements and disclosures.
 
In June 2011, the FASB issued an amendment to an existing accounting standard which requires companies to present net income and other comprehensive income in one continuous statement or in two separate, but consecutive, statements.  In addition, in December 2011, the FASB issued an amendment to an existing accounting standard which defers the requirement to present components of reclassifications of other comprehensive income on the face of the income statement.  We will adopt this standard in the first quarter of 2012.
 
In September 2011, the FASB issued an amendment to an existing accounting standard, which provides entities an option to perform a qualitative assessment to determine whether further impairment testing on goodwill is necessary.  Specifically, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step test.  If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required.  Otherwise, no further testing is required.  This standard is effective for annual and interim goodwill impairment test performed for fiscal years beginning after December 15, 2011. The adoption will not have a material impact on our consolidated financial statements and disclosures.
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A960T M,39D9#!A8F(B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R M;W!E#I%>&-E;%=O M#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5M<&QO>65E7T)E;F5F:71?4&QA;CPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DEN8V]M95]487AE#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9A:7)?5F%L=65?365A M#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E%U87)T97)L>5]&:6YA;F-I86Q?26YF;W)M871I M;SPO>#I.86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X- M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V0U-F0R8C(P7V-B935?-#-E-U\Y,C`V M7V%E9#0Q-F1D,&%B8@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]D M-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A960T,39D9#!A8F(O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^3&%R9V4@06-C96QE2!0=6)L M:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,3QS<&%N/CPO'0^1ED\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA"!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XT-SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A M960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#4V M9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@8VAA2`H9&5F:6-I="DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6%L=&EE'!E;G-E2!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S&5R8VES92!O9B!O<'1I;VYS+"!N970\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!U;F1E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!O9B!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XT,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S&5R8VES92!O9B!W87)R86YT7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&5R8VES92!O9B!W87)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A M960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#4V M9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XV.#QS<&%N/CPO&5S("AB96YE9FET*3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6%B;&4@86YD M(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S2`H=7-E9"!I;BD@;W!E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,2D\2!O9B!I;G9E2`H=7-E M9"!I;BD@:6YV97-T:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@ M8VQA6UE;G0@;V8@2!O8FQI9V%T:6]N(&QE6UE;G0@;V8@9&EV M:61E;F0\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!O9B!O<'1I;VYS/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`V.#QS<&%N/CPO&5R8VES92!O9B!W87)R86YT65A65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3QB3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/&1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V)A M8VMG3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D M:7-P;&%Y.B!I;FQI;F4[)SY6:7)N9718($AO;&1I;F<@0V]R<&]R871I;VXL M('=H:6-H('=E(')E9F5R('1O(&%S('=E+"!U2!O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQD:78@3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@ M3H@ M:6YL:6YE.R<^3F]T92`R("T@4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S/"]F;VYT/CPO9F]N=#X\+V1I=CX\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^5&AE(&-O;G-O;&ED871E9"!F M:6YA;F-I86P@65A2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V M,#L\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^/&9O;G0@3H@:6YL:6YE.R<^57-E(&]F($5S=&EM871E2!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\ M9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P M;&%Y.B!I;FQI;F4[)SY4:&4@<')E<&%R871I;VX@;V8@9FEN86YC:6%L('-T M871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(&%C8V]U;G1I;F<@<')I;F-I M<&QE'!E;G-E2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^4F5V96YU M92!296-O9VYI=&EO;CPO9F]N=#X\+V9O;G0^/"]D:78^/"]D:78^/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9&EV(&%L:6=N M/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE3H@8FQO8VL[(&UA M3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SX\='(@=F%L:6=N/3-$=&]P/CQT9"!S='EL93TS1"=W:61T:#H@ M,C=P=#LG/CQD:78^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H M.B`Q.'!T.R<^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G M:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SYP M97)S=6%S:79E(&5V:61E;F-E(&]F('-A;&5S(&%R3H@ M8FQO8VL[(&UAF4Z(#$P<'0[)SX\='(@=F%L:6=N/3-$=&]P/CQT9"!S='EL93TS M1"=W:61T:#H@,C=P=#LG/CQD:78^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W=I9'1H.B`Q.'!T.R<^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@5&EM97,@3F5W(%)O;6%N.R<^)B,Y-C6QE/3-$)V1I3H@8FQO8VL[(&UAF4Z(#$P<'0[)SX\='(@=F%L:6=N/3-$=&]P/CQT9"!S='EL M93TS1"=W:61T:#H@,C=P=#LG/CQD:78^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W=I9'1H.B`Q.'!T.R<^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<^)B,Y-C6QE/3-$)V1I65R)W,@<')I8V4@:7,@9FEX960@;W(@9&5T97)M:6YA8FQE.R!A;F0\+V9O M;G0^/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS M1&IU3H@ M8FQO8VL[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W=I9'1H.B`R-W!T.R<^/&1I=CX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&UA6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!4:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SYC;VQL96-T M:6]N(&ES(')E87-O;F%B;'D@87-S=7)E9"X\+V9O;G0^/"]D:78^/"]T9#X\ M+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6UE;G1S('1O('5S(&]V97(@ M86X@97AT96YD960@<&5R:6]D(&]F('1I;64N)B,Q-C`[)B,Q-C`[1F]R(&$@ M;&EC96YS:6YG(&%G&5D(')O>6%L='D@<&%Y;65N M=',L('=E(&5X<&5C="!T;R!R96-O9VYI>F4@'!E8W0@=&AA="!A(&QI8V5N2!R97!O65D(&)A'!E M8W0@;W5R(')E=F5N=64@2!A;'-O M(&)E(&UE="!O;B!A(&1E;&%Y960@8F%S:7,N)B,Q-C`[/"]F;VYT/CPO9&EV M/CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I"!R979E;G5E(&%R M&5C M=71I;VXL('=H971H97(@86UO=6YT2!B M92!M871E6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT M2!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I M=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^5V4@8V]N2!L:7%U M:60@:6YV97-T;65N=',@<'5R8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA M3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D M:7-P;&%Y.B!I;FQI;F4[)SY);G9E2=S(&EN=F5S=&UE;G1S(&-O;G-I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^4')O<&5R='D@86YD($5Q=6EP;65N M=#PO9F]N=#X\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&IU3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D M:7-P;&%Y.B!I;FQI;F4[)SY02!A;F0@97%U:7!M96YT(&%R92!S M=&%T960@870@:&ES=&]R:6-A;"!C;W-T+"!L97-S(&%C8W5M=6QA=&5D(&1E M<')E8VEA=&EO;B!A;F0@86UOF%T:6]N+B8C,38P.R8C,38P.T1E<')E M8VEA=&EO;B!A;F0@86UOF%T:6]N(&%R92!C;VUP=71E9"!U2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY/=7(@8V%S M:"!A;F0@8V%S:"!E<75I=F%L96YT2!T:&4@1F5D97)A M;"!$97!O2!L;W-S97,@;VX@;W5R(&1E<&]S M:71S(&]F(&-A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE M.R<^1F%I3H@8FQO8VL[)SX\8G(@+SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG6EN M9R!A;6]U;G1S(&]F(&]U2!S:&]R="!M871U6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^26YT86YG:6)L92!!6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R<^5V4@F%T:6]N+B8C,38P.R8C,38P.T%M M;W)T:7IA=&EO;B!O9B!I;G1A;F=I8FQE(&%S65A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^/&9O;G0@3H@:6YL:6YE.R<^26UP86ER;65N="!O9B!,;VYG+4QI=F5D($%S M3H@8FQO8VL[(&UA M3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!D:7-P;&%Y.B!I;FQI;F4[)SY792!I9&5N=&EF>2!A;F0@2!T:&4@ M86UO=6YT(&)Y('=H:6-H('1H92!C87)R>6EN9R!A;6]U;G0@;V8@=&AE(&%S M&-E961S('1H92!P6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE M.R<^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]F;VYT/CPO9F]N=#X\+V1I M=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF M>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A M8VMG3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I&5S(&ES M(&-O;7!U=&5D('5S:6YG('1H92!A'!E8W1E9"!F=71U69O2!E;F%C=&5D('1A>"!R871E&%B;&4@:6YC;VUE(&EN(&5F9F5C="!F;W(@=&AE('EE87)S(&EN('=H M:6-H('1H;W-E('1A>"!AF5D(&]R('-E='1L960N(%1H92!#;VUP86YY(')E8V]R9',@82!V86QU871I M;VX@86QL;W=A;F-E('1O(')E9'5C92!D969E2!T:&%N M(&YO="!T;R!B92!R96%L:7IE9"X\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I"!P;W-I=&EO;B!W:6QL(&)E M('-U&%M:6YA=&EO;B!B>2!T:&4@=&%X:6YG(&%U=&AO MF5D('5P;VX@2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT M+7-T>6QE.B!I=&%L:6,[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5R:79A=&EV M92!);G-T2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\ M+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!4:6UE&5D('1O(&]U6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)V)A8VMG3H@8FQO8VL[(&UA M3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!D:7-P;&%Y.B!I;FQI;F4[)SY/=7(@86-C;W5N=&EN9R!F;W(@65E'!E;G-E(&9O3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY);B!A9&1I M=&EO;BP@87,@65E2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^0F%S:6,@96%R;FEN9W,@<&5R('-H87)E(&%R M92!C;VUP=71E9"!B>2!D:79I9&EN9R!E87)N:6YG2!T:&4@=V5I9VAT960@879E2!D:79I9&EN9R!N970@:6YC;VUE(&)Y('1H92!W M96EG:'1E9"!A=F5R86=E(&YU;6)E3H@8FQO M8VL[(&UA3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA M3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY);B!-87D@,C`Q,2P@ M=&AE($9!4T(@:7-S=65D(&$@;F5W(&%C8V]U;G1I;F<@3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY);B!*=6YE(#(P,3$L('1H92!& M05-"(&ES3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^ M26X@4V5P=&5M8F5R(#(P,3$L('1H92!&05-"(&ES2!B96QI979E3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A M960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#4V M9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@8VAA6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O M;G0@3H@:6YL:6YE.R<^3F]T928C,38P.S,@+2!028C,38P.SPO9F]N M=#X\+V9O;G0^/"]D:78^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV M(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-30E('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&-O;'-P86X],T0Q,"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,"4@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^1&5C96UB97(@,S$\ M+V9O;G0^/"]F;VYT/CPO9F]N=#X\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$ M)V1I#LG/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#LG M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI M9#LG/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`P.3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF4Z(#$P<'0[)SXD/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M-3<\+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`M.7!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXY,3PO9F]N=#X\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`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`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)A8VMG'!E;G-E(&9O65A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R M,%]C8F4U7S0S93=?.3(P-E]A960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9#4V9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V M9&0P86)B+U=O'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T928C M,38P.S0@+2!#;VUM:71M96YT2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG6UE;G1S(&UO M;G1H;'D@=6YT:6P@:70@96YD3H@8FQO8VL[(&UA6QE/3-$)V)O M"!S;VQI9#LG/CQD:78@86QI9VX],T1L M969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)V1I M#LG/CQD:78@86QI9VX],T1L M969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/"]T#LG/CQD:78@86QI9VX],T1L M969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4;W1A;#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXQ,#(\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=? M.3(P-E]A960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9#4V9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@ M8VAA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^3F]T928C,38P.S4@+2!3=&]C:R!0 M;&%N/"]F;VYT/CPO9F]N=#X\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I M=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG2`U+"`R,#`W+B8C,38P.R8C,38P M.T]U2!A=V%R9"!S:&]U;&0@97AP M:7)E+"!B96-O;64@=6YE>&5R8VES86)L92!O2!B92!G65E2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF M>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A M8VMG2!O=7(@0F]A&5R8VES92!P2!A<'!O:6YT960@8V]M;6ET=&5E('1H97)E;V8L M('!R;W9I9&5D+"!H;W=E=F5R+"!T:&%T('1H92!E>&5R8VES92!P3H@8FQO8VL[(&UA6QE M/3-$)V)A8VMG#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!C96YT97([('1E>'0M:6YD96YT.B`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP M=#L@;6%R9VEN+7)I9VAT.B`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`M.7!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`M M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SY/<'1I;VYS(&=R86YT960\+V9O;G0^/"]D:78^/"]T M9#X\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXU+C4S/"]F M;VYT/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\+W1R/CQT3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/<'1I;VYS(&5X97)C:7-E M9#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXI)B,Q-C`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`M.7!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`M.7!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE M/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@ M3H@ M:6YL:6YE.R<^3F]T928C,38P.S8@+2!3=&]C:RU"87-E9"!#;VUP96YS871I M;VX\+V9O;G0^/"]F;VYT/CPO9&EV/CPO9&EV/CQD:78@3H@8FQO8VL[(&UA M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^5V4@86-C;W5N="!F;W(@97%U M:71Y(&EN'!E;G-E(&ES('-U8FIE8W0@=&\@<&5R:6]D M:6,@861J=7-T;65N="!A6EN9R!E<75I='D@:6YS=')U M;65N="!V97-T3H@8FQO8VL[(&UA3H@ M8FQO8VL[(&UA6QE/3-$)V)A8VMG'!E;G-E(&ES(&EN8VQU9&5D(&EN(&=E;F5R86P@86YD(&%D M;6EN:7-T6QE/3-$)W!A M9&1I;F3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1O8VLM M0F%S960@0V]M<&5N6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(F(S$V,#LS,2P@,C`Q,3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB M97(F(S$V,#LS,2P@,C`Q,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^1&5C96UB97(F(S$V,#LS,2P@,C`P.3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`[ M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T M>6QE/3-$)V)O"!S;VQI9#L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT#LG M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)V)O M"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXT+#,V M-SPO9F]N=#X\+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`P<'0[(&1I3H@8FQO M8VL[)SX\8G(@+SX\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@:6YL:6YE.R<^07,@;V8@1&5C M96UB97(@,S$L(#(P,3$L('1H92!U;G)E8V]R9&5D(&1E9F5R'!E;G-E(&]V97(@86X@97-T:6UA=&5D('=E:6=H=&5D(&%V97)A9V4@ M=F5S=&EN9R!A;6]R=&EZ871I;VX@<&5R:6]D(&]F(&%P<')O>&EM871E;'D@ M,"XW('EE87)S+"!A65A2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\ M+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@:6YL:6YE.R<^5&AE(&9A:7(@=F%L=64@;V8@96%C:"!O<'1I;VX@ M9W)A;G0@=V%S(&5S=&EM871E9"!O;B!T:&4@9&%T92!O9B!G6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W!A M9&1I;FF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&-O;'-P86X],T0S('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Y)2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1&5C M96UB97(F(S$V,#LS,2P@,C`Q,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=T97AT+6%L:6=N.B!C M96YT97([('!A9&1I;F6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!C96YT97([('1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E#LG/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A'0M:6YD96YT M.B`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@2!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`\+V9O;G0^/"]T9#X\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQD:78@86QI9VX] M,T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY2:7-K+69R964@:6YT M97)E3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXS+C`U/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9&EV(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`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`P<'0[(&1I6QE/3-$)V1I65AF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I65A3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^-BXV/"]T9#X\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I65A M6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24@3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXE/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UEF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!D:7-P;&%Y.B!I;FQI;F4[)SY"87-E9"!O;B!T:&4@0FQA8VLM4V-H;VQE M2X\+V9O;G0^/"]F;VYT/CPO9&EV/CQD:78@3H@8FQO8VL[(&UA3H@ M8FQO8VL[(&UA'!E M8W1E9"!V;VQA=&EL:71Y(&]F('1H92!S=&]C:R!O<'1I;VYS('=A2!O9B!C;VUP87)A8FQE('!U M8FQI8VQY+71R861E9"!C;VUP86YI97,@870@82!S:6UI;&%R('-T86=E(&]F M(&QI9F4@8WEC;&4N)B,Q-C`[)B,Q-C`[5V4@:&%V92!N;W0@<')O=FED960@ M86X@97-T:6UA=&4@9F]R(&9O2!M87D@8VAA;F=E('1H:7,@97-T:6UA=&4@8F%S960@;VX@86-T M=6%L(&%N9"!E>'!E8W1E9"!F=71U6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO M8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y M.B!I;FQI;F4[)SY4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;FF4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R<'@@6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W!A M9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^3&EF92`H665A#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQD:78@ M86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^06=G6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@ M;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`P M<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@ M;6%R9VEN+7)I9VAT.B`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`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`P<'0[(&1I6QE/3-$)V1I#LG/B8C,38P.SPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`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`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`R<'@@3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXM/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[ M(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)W!A M9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O M"!S;VQI9#LG/CQD:78@86QI9VX],T1R M:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)V)O"!S;VQI9#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG/CQD M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S M;VQI9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`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`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$ M)W1E>'0M:6YD96YT.B`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T;W`@=VED M=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[ M/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG M/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI M9#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W!A9&1I;F6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!D;W5B;&4[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@-'!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`T<'@@9&]U8FQE.R<^/&1I=B!A;&EG;CTS1&QE9G0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)V)O"!D;W5B;&4[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I#LG M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXY-RPS.#4\+V9O;G0^/"]D:78^/"]T M9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y M.B!I;FQI;F4[)SY);G1R:6YS:6,@=F%L=64@:7,@8V%L8W5L871E9"!A="!T M:&4@9&EF9F5R96YC92!B971W965N('1H92!P97(@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$ M)V1I3H@:6YL:6YE.R<^5&AE(&9O;&QO M=VEN9R!T86)L92!S=6UM87)I>F5S(&EN9F]R;6%T:6]N(&%B;W5T('-T;V-K M(&]P=&EO;G,@;W5T6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\='(^/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R<'@@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M)B,Q-C`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`[/"]F;VYT M/CPO=&0^/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,"4@6QE/3-$)W1E M>'0M:6YD96YT.B`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`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M:6YD96YT.B`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`L-C$R/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV.3`L-C$R/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`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`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`P/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/"]T6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXT+C4R/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UEF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+#$V-RPV.34\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXW+C(V/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I M6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)W!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXY+C0R/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)W!A9&1I;F#LG/CQF;VYT('-T M>6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,RXS,#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD M96YT.B`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`P<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`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`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`T<'@@9&]U8FQE.R<^/&1I=B!A;&EG;CTS M1&QE9G0@3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W!A9&1I;F2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX\+V1I=CX\+V1I=CX\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/&1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R<^0F%S:6,@96%R;FEN9W,@<&5R('-H87)E(&%R92!B87-E9"!O M;B!T:&4@=V5I9VAT960@879E2!D:6QU=&EV M92!C;VUM;VX@2!H87,@:6YC=7)R960@;&]S2!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$ M:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4 M:6UE6QE M/3-$)V)A8VMG2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV(&%L:6=N/3-$;&5F M=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T M:#TS1#$P,"4@#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1C96YT97(@ M3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M4&5R:6]D($5N9&5D($1E8V5M8F5R)B,Q-C`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R M9VEN+7)I9VAT.B`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`M.7!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\ M9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P M;&%Y.B!I;FQI;F4[)SY&;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q M+"`R,#$Q+"`R,#$P(&%N9"`R,#`Y+"!T:&5R92!W97)E('1H92!F;VQL;W=I M;F<@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,"4@6QE/3-$)V1IF4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@#LG/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^,C`Q,#PO9F]N=#X\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`P.3PO9F]N=#X\+V9O;G0^/"]D M:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`M M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,#0L.3`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`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`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY/=7(@06UE;F1E M9"!A;F0@4F5S=&%T960@0V5R=&EF:6-A=&4@;V8@26YC;W)P;W)A=&EO;BP@ M87,@86UE;F1E9"!I;B!/8W1O8F5R(#(P,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@:6YL:6YE.R<^16%C:"!S:&%R M92!O9B!C;VUM;VX@2!O=7(@ M0F]A3H@8FQO8VL[ M(&UA7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3H@8FQO8VL[(&UA6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@8FQO8VL[)SX\8G(@+SX\+V1I=CX\9&EV(&%L:6=N/3-$ M;&5F=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W M:61T:#TS1#DP)2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\='(^/'1D(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQD:78@3H@8FQO8VL[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F M;VYT/CPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^5&5R;6EN871E9"`O/"]F;VYT/CPO9&EV M/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V%N8V5L;&5D("\\+V9O;G0^/"]D:78^ M/&1I=B!A;&EG;CTS1&-E;G1EF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)W!A9&1I;F6QE/3-$ M)V)O"!S;VQI9#LG/CQD:78@3H@8FQO8VL[(&UA&5R8VES86)L92`\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&-E M;G1E#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^17AP:7)A=&EO M;B`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`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`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`R<'@@'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH.#4U+#4S-CPO9F]N=#X\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`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`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`P<'0[(&1I3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-39D,F(R,%]C8F4U7S0S93=? M.3(P-E]A960T,39D9#!A8F(-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9#4V9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@ M8VAA65E($)E;F5F:70@4&QA;CQB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O M;G0@3H@:6YL:6YE.R<^3F]T92`Q,2`M($5M<&QO>65E($)E;F5F:70@4&QA;CPO M9F]N=#X\+V9O;G0^/"]D:78^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\ M+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY792!S<&]N2!A;&P@;W5R(&5M<&QO>65E2=S M(&UA=&-H:6YG(&-O;G1R:6)U=&EO;B!T;R!T:&4@<&QA;B!W87,@87!P2P@/"]F;VYT/CPO9F]N=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG3H@8FQO8VL[(&UA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-39D M,F(R,%]C8F4U7S0S93=?.3(P-E]A960T,39D9#!A8F(-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO9#4V9#)B,C!?8V)E-5\T,V4W7SDR,#9?865D M-#$V9&0P86)B+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@:6YL:6YE.R<^ M3F]T92`Q,B`M($EN8V]M92!487AE2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV(&%L:6=N/3-$;&5F M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@8V]L M6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$96-E;6)E#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O M"!S;VQI9#LG/CQD:78@86QI9VX],T1C M96YT97(@3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY996%R)B,Q-C`[16YD M960\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&-E;G1EF4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#EP=#L@;6%R9VEN+7)I9VAT.B`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`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`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`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`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`[16YD960@/"]F;VYT/CPO9&EV/CQD:78@ M86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$96-E M;6)E6QE/3-$)W!A9&1I M;F6QE M/3-$)V)O"!S;VQI9#LG/CQD:78@86QI M9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY996%R)B,Q M-C`[16YD960@/"]F;VYT/CPO9&EV/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$96-E;6)E#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY996%R)B,Q-C`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`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24@F4Z(#$P<'0[)SXE/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M M:6YD96YT.B`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`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH.2XV.3PO9F]N=#X\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`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`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`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`],T1N;W=R87`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`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`[16YD960\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&-E M;G1E3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@8V]L6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY$96-E;6)E#LG M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@8V]L6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@8V]L6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@8V]L M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT M3H@8FQO8VL[(&UA6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXT-CPO9F]N=#X\+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`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`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`\+V9O;G0^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`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`],T1N;W=R87`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`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`\+V9O;G0^ M/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24@6QE/3-$)V1I M6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@#LG/CQF;VYT('-T>6QE/3-$)V1I#LG M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'0M86QI9VXZ(')I9VAT.R<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@ M,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\+W1R/CQT3H@8FQO8VL[(&UA6QE/3-$)V1I3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1IF4Z(#$P<'0[)SXI/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH,3@\+V9O;G0^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)V1IF4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)V1I"!A3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE M/3-$)V)O"!D;W5B;&4[('1E>'0M86QI M9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXS+#,X,#PO9F]N=#X\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I2!T:&%N(&YO="!T:&%T('-O;64@<&]R=&EO;B!OF5D+B8C M,38P.R8C,38P.U1H92!U;'1I;6%T92!R96%L:7IA=&EO;B!O9B!T:&4@9&5F M97)R960@=&%X(&%S2!D:69F97)E;F-E3L@=&5X="UI;F1E;G0Z M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY"87-E9"!O;B!T:&4@879A:6QA8FQE(&]B:F5C=&EV92!E=FED96YC M92P@=V4@8F5L:65V92!I="!I2!T:&%N(&YO="!T:&%T M('1H92!N970@9&5F97)R960@=&%X(&%S"!A M65A2!H87,@9F5D97)A;"!A;F0@2`D.3$S(&%N M9"`D-#,L-38U+"!R97-P96-T:79E;'D@97AP:7)I;F<@:6X@,C`R-R!A;F0@ M,C`Q,BP@2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@8V]L6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;FF4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@8V]L6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`M.7!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT M.B`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`M.7!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXQ,C@\+V9O;G0^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM M/"]F;VYT/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\+W1R/CQT6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT M/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M+W1R/CQT6QE/3-$)V1IF4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24@6QE/3-$ M)V1I#LG/CQF;VYT M('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24@6QE/3-$)V1I M6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY"86QA;F-E(&%T('1H92!E;F0@;V8@=&AE('EE87(\+V9O M;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T M>6QE/3-$)V)O"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXQ,C@\+V9O;G0^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG M/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)V1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO M8VL[(&UA7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3H@8FQO8VL[(&UA6QE/3-$ M)V1I3H@8FQO8VL[ M(&UA3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY&86ER('9A;'5E(&ES('1H92!P2!G:79E2!T;R!U;F%D:G5S=&5D('%U;W1E9"!PF4@;V)S97)V86)L M92!I;G!U=',@:6X@;6%R:V5T3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D M:7-P;&%Y.B!I;FQI;F4[)SY/=7(@9FEN86YC:6%L(&EN2!T:&4@:6YC;VUE(&%N9"!M87)K970@87!P6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA6QE/3-$)V1I3H@:6YL:6YE.R<^.B8C,38P.R8C,38P.T9A:7(@=F%L=64@;65A M2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$ M)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG3H@ M:6YL:6YE.R<^4V5R:65S($D@5V%R3H@:6YL:6YE M.R<^.B!&86ER('9A;'5E(&UE87-U2!E;6)E9&1E9"!I;B!O=7(@;W5T3H@8FQO8VL[(&UA3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY4 M:&4@9F]L;&]W:6YG('1A8FQE('-E=',@9F]R=&@@8GD@;&5V96PL('=I=&AI M;B!T:&4@9F%I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`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`R<'@@6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@#L@8F]R M9&5R+71O<#H@(S`P,#`P,"`Q+C5P="!S;VQI9#LG/CQF;VYT('-T>6QE/3-$ M)V1I#L@8F]R9&5R+71O<#H@(S`P M,#`P,"`Q+C5P="!S;VQI9#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#L@8F]R9&5R+71O<#H@(S`P,#`P M,"`Q+C5P="!S;VQI9#LG/CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3&5V96P@,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT M.B`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`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`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`Q M,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXY+#@T,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$ M)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`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`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`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`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`T<'@@9&]U8FQE M.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^/"]T3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG2P@;W5R M(&9I;F%N8VEA;"!I;G-T2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA#LG/CQF;VYT('-T>6QE/3-$)V1I#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A M9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)V)O"!S;VQI M9#L@8F]R9&5R+71O<#H@(S`P,#`P,"`Q+C5P="!S;VQI9#LG/CQD:78@86QI M9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^4VEG;FEF:6-A;G0\+V9O;G0^/"]D:78^/&1I=B!A;&EG M;CTS1&-E;G1E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R!B;W)D97(M=&]P.B`C,#`P,#`P(#$N-7!T('-O;&ED.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^56YO8G-E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26YP=71S/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@#L@8F]R9&5R+71O<#H@ M(S`P,#`P,"`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`R<'@@F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$#LG/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N M/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE M/3-$)V)O"!S;VQI9#LG/CQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V)O"!S M;VQI9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UEF4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F#LG/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\ M9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X M.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$#LG/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV M(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXT+#8Y M.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!D;W5B M;&4[)SX\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W!A9&1I;F2!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY4:&4@ M9F]L;&]W:6YG('1A8FQE('-E=',@9F]R=&@@82!S=6UM87)Y(&]F(&-H86YG M97,@:6X@=&AE(&9A:7(@=F%L=64@;V8@;W5R($QE=F5L(#,@9FEN86YC:6%L M(&EN65A3H@8FQO8VL[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-"PS-C0\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA6QE/3-$)V1I6QE M/3-$)W!A9&1I;F6QE/3-$)V)O M"!S;VQI9#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE M/3-$)V)O"!S;VQI9#LG/CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W!A9&1I;F#LG/CQD:78@86QI9VX],T1L M969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]D-39D,F(R,%]C8F4U7S0S93=?.3(P-E]A960T,39D9#!A8F(-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#4V9#)B,C!?8V)E-5\T,V4W7SDR M,#9?865D-#$V9&0P86)B+U=O'0O:'1M;#L@8VAA6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^3F]T928C,38P.S$T("T@4&%T96YT(%!O2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\ M+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG6UE;G1S(&1E<&5N9',@=7!O;B!T:&4@='EP92!O9B!V86QU92!G M96YE&EM=6T@2!P87EM96YT M(')E<75I3H@8FQO8VL[(&UA6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,#$R/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I#LG/CQD:78@ M86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S M;VQI9#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/"]T#LG/CQD:78@ M86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4;W1A M;#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)SX\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV,#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@8FQO8VL[)SX\8G(@+SX\+V1I=CX\+V1I=CX\+V1I=CX\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/&1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@ M8FQO8VL[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!4:6UE2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V M,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!D:7-P;&%Y.B!I;FQI;F4[)SY/;B!!=6=U2!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A8VMG2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF M>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)A M8VMG6$@:6YF2!R:7-K>2!A;F0@=&AE(&]U=&-O;64@:7,@=6YC97)T M86EN+B8C,38P.R8C,38P.T%A3H@8FQO8VL[)SX\8G(@+SX\ M+V1I=CX\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY/;B!.;W9E;6)E6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY/;F4@;W(@;6]R92!P;W1E;G1I86P@:6YT96QL96-T=6%L('!R M;W!EF4@;W5R(&EN:71I86P@<')O9'5C M=',L('=H:6-H(&%R92!C=7)R96YT;'D@:6X@9&5V96QO<&UE;G0N/"]F;VYT M/CPO9&EV/CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!&:6YA;F-I86P@26YF;W)M M871I;VX@*'5N875D:71E9"D@6T%B'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)W1E>'0M:6YD96YT.B`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`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`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`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[ M(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E M>'0M:6YD96YT.B`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`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXI/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)V1I M3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`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`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`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`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,34L,3`Q/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY.970@*&QO3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH."PY,#`\+V9O;G0^/"]D:78^/"]T M9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH,"XR,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&1I=B!A;&EG;CTS1&QE9G0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`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`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#LG/CQD:78@ M86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^4V5C;VYD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$ M)V)O"!S;VQI9#LG/CQD:78@86QI9VX] M,T1C96YT97(@3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^5&AI3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@#LG/CQF;VYT('-T>6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`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`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`P M<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXQ,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M/"]T6QE/3-$)W1E>'0M:6YD96YT.B`M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#EP=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH,RPQ,S$\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`M M.7!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#EP=#L@;6%R9VEN M+7)I9VAT.B`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`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`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY"87-I8R!E M87)N:6YG3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY$:6QU=&5D)B,Q-C`[96%R;FEN9W,@*&QO3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`[/"]F;VYT/CPO=&0^/"]T3H@8FQO8VL[(&UA7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C M:&5M87,M;6EC'1087)T7V0U-F0R8C(P7V-B935? :-#-E-U\Y,C`V7V%E9#0Q-F1D,&%B8BTM#0H` ` end XML 18 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Formation and Business of the Company
12 Months Ended
Dec. 31, 2011
Formation and Business of the Company [Abstract]  
Formation and Business of the Company
Note 1 - Formation and Business of the Company
 
VirnetX Holding Corporation, which we refer to as we, us, our, the Company or VirnetX, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets.   To date our revenue has been limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement.
XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Current assets:    
Cash and cash equivalents $ 49,482 $ 34,635
Investments available for sale 14,438 43,457
Accounts receivable, net 0 3
Prepaid taxes 10,459 0
Deferred tax benefit 0 1,735
Prepaid expenses and other current assets 91 86
Total current assets 74,470 79,916
Property and equipment, net 56 25
Intangible and other assets 60 108
Deferred tax benefit 47 1,645
Total assets 74,633 81,694
Current liabilities:    
Accounts payable and accrued liabilities 1,227 519
Income tax liability 430 7,358
Derivative liability 4,699 14,364
Total current liabilities 6,356 22,241
Stockholders' equity:    
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2011 and 2010, respectively Issued and outstanding: 0 shares at December 31, 2011 and 2010, respectively 0 0
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2011 and 2010, respectively Issued and outstanding: 50,619,136 shares and 49,341,028 shares, at December 31, 2011 and 2010, respectively 5 5
Additional paid-in capital 104,277 78,187
Accumulated deficit (36,001) (17,755)
Accumulated other comprehensive loss (4) (984)
Total stockholders' equity 68,277 59,453
Total liabilities and stockholders' equity $ 74,633 $ 81,694
XML 20 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) (USD $)
Dec. 31, 2009
Issued at $1.50 per share [Member]
Dec. 31, 2010
Issued at $2.52 per share [Member]
Dec. 31, 2009
Issued at $2.52 per share [Member]
Dec. 31, 2011
Issued at $3.93-3.59 per share [Member]
Dec. 31, 2010
Issued at $3.93-3.59 per share [Member]
Dec. 31, 2010
Issued at $2.00 per share [Member]
Dec. 31, 2010
Issued at $3.00 per share [Member]
Dec. 31, 2010
Issued at $4.00 per share [Member]
Dec. 31, 2010
Issued at $1.80 per share [Member]
Dec. 31, 2011
Issued at $4.80 per share [Member]
Dec. 31, 2010
Issued at $4.80 per share [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock issued for cash, net (in dollars per share) $ 1.50   $ 2.52                
Stock issued for cash exercise of warrants at per share, net (in dollars per share)   $ 2.52       $ 2.00 $ 3.00 $ 4.00 $ 1.80   $ 4.80
Stock issued for cash exercise of warrants at per share, net - maximum (in dollars per share)       $ 3.93 $ 3.93            
Stock issued for cash exercise of warrants at per share, net - minimum (in dollars per share)       $ 3.59 $ 3.59            
Cashless exercise of underwriter warrants (in dollars per share)                   $ 4.80  
XML 21 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Litigation
12 Months Ended
Dec. 31, 2011
Litigation [Abstract]  
Litigation
Note 15 - Litigation
 
We have three intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints. We have one complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181.
 
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra Technologies, Inc., Apple, Inc., Cisco Systems, Inc., and NEC Corporation.
 
On January 12, 2011, we initiated a new lawsuit by filing a complaint against Siemens Enterprise Communications and Mitel Networks Corp. On April 12, 2011, we amended this complaint to add Avaya, Inc., as a defendant.
 
We believe that Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya infringe on certain of our patents, but obtaining and collecting a judgment against these parties may be difficult or impossible.  Patent litigation is inherently risky and the outcome is uncertain.  Aastra, Apple, Cisco, NEC, Siemens, Mitel and Avaya are all large, well-financed companies with substantially greater resources than us.  We believe that these parties will devote a substantial amount of resources in an attempt to prove that either their products do not infringe our patents or that our patents are invalid and unenforceable.  At this time, we cannot predict the final outcome of these litigation matters.

On November 1, 2011, we initiated a lawsuit against Apple in the United States District Court, Tyler Division, pursuant to which we allege that Apple infringes an additional patent of ours.  We seek damages and injunctive relief.  No hearing or trial dates have been set.

On November 4, 2011, We filed a complaint with the United States International Trade Commission (ITC) alleging that Apple Inc has engaged in unfair trade practices by the importation, sale for importation, and sale after importation of certain devices with secure communication capabilities that infringe one or more claims of our U.S. Patent No. 8,051,181. The accused products include the latest iPhones, iPads, iPods and Macintosh computers. We have requested that the ITC institute an investigation into Apple's allegedly infringing imports and ultimately bar Apple from importing those Apple products or further selling the infringing Apple products that have already been imported

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims.  Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims.  In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development.
 
XML 22 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:      
Net income (loss) $ (17,263) $ 41,417 $ (12,524)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 68 59 63
Stock-based compensation 4,367 3,381 3,032
Net change in deferred taxes (benefit) 5,663 (2,851) 0
Change in value of derivative liability 5,595 30,516 (559)
Changes in assets and liabilities:      
Receivables and other current assets (3) (39) 140
Prepaid taxes (10,459) 0 94
Accounts payable and accrued liabilities 708 (3,960) 2,809
Income tax liability (6,928) 7,358  
Net cash provided by (used in) operating activities (18,252) 75,881 (6,945)
Cash flows from investing activities:      
Purchase of property and equipment (51) (13) (6)
Purchase of investments (34,082) (44,441) 0
Proceeds from sale, maturity of investments 63,101 0 0
Net cash provided by (used in) investing activities 28,968 (44,454) (6)
Cash flows from financing activities:      
Payment of royalty obligation less imputed interest 0 (160) (44)
Payment of dividend 0 (23,599) 0
Proceeds from exercise of options 1,068 1,341 0
Proceeds from exercise of warrants 3,063 23,615 0
Proceeds from sales of common stock 0 0 8,549
Net cash provided by financing activities 4,131 1,197 8,505
Net increase in cash and cash equivalents 14,847 32,623 1,554
Cash and cash equivalents, beginning of year 34,635 2,011 457
Cash and cash equivalents, end of year 49,482 34,635 2,011
Supplemental disclosure of cash flow information:      
Cash paid during the year for taxes 9,600 29,556 2
Cash paid during the year for interest $ 0 $ 10 $ 6
XML 24 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Dec. 31, 2011
Dec. 31, 2010
Stockholders' equity (deficit):    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 50,619,136 49,341,028
Common stock, shares outstanding (in shares) 50,619,136 49,341,028
XML 25 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Warrants
12 Months Ended
Dec. 31, 2011
Warrants [Abstract]  
Warrants
Note 10 - Warrants
 
Information about warrants outstanding during the twelve months ended December 31, 2011 follows:

Original Number of
Warrants Issued
  
Exercise
Price per Common Share
  
Exercisable
at
December 31, 2010
  
Became Exercisable
  
Exercised
  
Terminated /
Cancelled /
Expired
  
Exercisable
at December 31, 2011
 
Expiration
Date
                     
 300,000  $4.80   30,000   -   (30,000)  -   - 
December 2012
 2,619,036(1) $3.59   1,060,444   -   (855,536)  -   204,908 
March 2015
Total
       1,090,444       (885,536)  -   204,908  
 
 
(1)
Referred to as our Series I Warrants.

XML 26 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information (USD $)
12 Months Ended
Dec. 31, 2011
Feb. 22, 2012
Jun. 30, 2011
Entity Registrant Name VirnetX Holding Corp    
Entity Central Index Key 0001082324    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Large Accelerated Filer    
Entity Public Float     $ 1,173,043,513
Entity Common Stock, Shares Outstanding   50,671,136  
Document Fiscal Year Focus 2011    
Document Fiscal Period Focus FY    
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2011    
XML 27 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Employee Benefit Plan
12 Months Ended
Dec. 31, 2011
Employee Benefit Plan [Abstract]  
Employee Benefit Plan
Note 11 - Employee Benefit Plan
 
We sponsor a defined contribution, 401k plan, covering substantially all our employees.  The Company's matching contribution to the plan was approximately, $36 in 2011, $36 in 2010 and $36 in 2009 respectively.
 
XML 28 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Revenue - Royalties $ 20 $ 68 $ 26
Operating expenses:      
Royalty expense 0 59,207 0
Research and development 1,464 2,412 864
General, selling and administrative 15,932 33,764 12,250
Gain on settlement 0 (200,000) 0
Total operating expenses 17,396 (104,617) 13,114
Income (loss) from operations (17,376) 104,685 (13,088)
Gain (loss) on change in value of embedded derivative and warrants (5,595) (30,516) 559
Interest income, net 228 1,310 5
Income (loss) before taxes (22,743) 75,479 (12,524)
Income tax expense (benefit) (5,480) 34,062 0
Net Income (loss) $ (17,263) $ 41,417 $ (12,524)
Basic earnings (loss) per share: (in dollars per share) $ (0.35) $ 0.91 $ (0.33)
Diluted earnings (loss) per share: (in dollars per share) $ (0.35) $ 0.84 $ (0.33)
Weighted average shares outstanding basic (in shares) 50,028,413 45,452,550 37,911,340
Weighted average shares outstanding dilutive (in shares) 50,028,413 49,066,704 37,911,340
Dividends declared per common share (in dollars per share) $ 0 $ 0.50 $ 0
XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Plan
12 Months Ended
Dec. 31, 2011
Stock Plan [Abstract]  
Stock Plan
Note 5 - Stock Plan
 
In 2005, VirnetX, Inc. adopted the 2005 Stock Plan (the "Plan"), which was assumed by us upon the closing of the transaction between VirnetX Holding Corporation and VirnetX, Inc. on July 5, 2007.  Our Board of Directors renamed this Plan the VirnetX Holding Corporation 2007 Stock Plan and our stockholders approved the Plan at our 2008 annual stockholders' meeting.  The Plan provides for the issuance of up to 11,624,469 shares of our common stock.  To the extent that any award should expire, become unexercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the Plan.  The Plan provides for the granting of stock options and stock purchase rights to our employees and consultants.  Stock options granted under the Plan may be incentive stock options or nonqualified stock options.  Incentive stock options ("ISO") may only be granted to our employees (including officers and directors).  Nonqualified stock options ("NSO") and stock purchase rights may be granted to our employees and consultants.
 
The Plan will expire 10 years after it was approved by our Board of Directors.  Options may be granted under the Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the case of an NSO,  the exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant.
 
Activity under the Plan is as follows:
 
  Options Outstanding 
   
Shares Available for Grant
  
Number of Shares
  
Weighted Average Exercise Price
 
Balance at December 31, 2008
  2,651,392   4,468,595  $2.98 
Restricted stock granted
  -   -   - 
Options granted
  (1,317,195)  1,317,195   1.18 
Options exercised
  -   -   - 
Options cancelled
  83,031   -   - 
Balance at December 31, 2009
  1,417,228   5,785,790   2.57 
Restricted stock granted
  -   -   - 
Options granted
  (345,250 )  345,250   5.53 
Options exercised
      (1,269,149   1.11 
Options cancelled
  31,500   (31,500 )  5.48 
Balance at December 31, 2010
  1,103,478   4,830,391  $3.14 
Restricted stock granted
  -   -   - 
Options granted
  (475,000)  475,000   23.80 
Options exercised
      (398,393)  2.68 
Options cancelled
  -   -   - 
Balance at December 31, 2011
  628,478   4,906,998  $5.12 
 
XML 30 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments
12 Months Ended
Dec. 31, 2011
Commitments [Abstract]  
Commitments
Note 4 - Commitments
 
We lease our offices under an operating lease with a third party that requires minimum payments monthly until it ends in June 2013.  We recognize rent expense on a straight-line basis over the term of the lease.
 
For the Year
 
Minimum Required Lease Payments in Period
 
2012
 
$
56
 
2013
   
46
 
Total
 
$
102
 
 
XML 31 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Information (unaudited)
12 Months Ended
Dec. 31, 2011
Quarterly Financial Information (unaudited) [Abstract]  
Quarterly Financial Information (unaudited)
Note 16 - Quarterly Financial Information (unaudited)
 
   
First
   
Second
   
Third
   
Fourth
 
   
(in thousands except per share)
 
2011
                   
Revenue
 
$
16
   
$
1
   
$
3
   
$
-
 
Income (loss) from operations
   
(2,752
)
   
(3,754)
     
(4,180
)
   
(6,690
)
Net (loss) income
   
(7,122
)
   
(9,805)
     
 5,879
     
(6,215
)
Basic earnings (loss) per common share
 
$
(0.14
)
 
$
(0.20)
   
$
0.12
   
$
(0.12
)
Diluted earnings (loss) per common share
 
$
(0.14
)
 
$
(0.20)
   
$
0.11
   
$
(0.12
)
 
   
First
   
Second
   
Third
   
Fourth
 
 
(in thousands except per share)
2010
                               
Revenue
 
$
21
   
$
23
   
$
16
   
$
8
 
Income (loss) from operations
   
(4,457
)
   
115,101
     
(2,434
)
   
(3,525
)
Net (loss) income
   
(8,900
)
   
78,576
     
(25,420
)
   
(2,839
)
Basic earnings (loss) per common share
 
$
(0.23
)
 
$
1.77
   
$
(0.54
)
 
$
(0.06
)
Diluted earnings (loss) per common share
 
$
(0.23
)
 
$
1.67
   
$
(0.54
)
 
$
(0.06
)
 
   
First
   
Second
   
Third
   
Fourth
 
   
(in thousands except per share)
 
2009
                   
Revenue
 
$
3
   
$
7
   
$
3
   
$
13
 
Income (loss) from operations
   
(3,405
)
   
(3,928)
     
(2,624
)
   
(3,131
)
Net (loss) income
   
(3,403
)
   
(3,927)
     
(2,623
   
(2,571
)
Basic earnings (loss) per common share
 
$
(0.09
)
 
$
(0.11)
   
$
(0.07
 
$
(0.07
)
Diluted earnings (loss) per common share $
(0.09
 $
(0.11)
  $
(0.07
 $
(0.07

XML 32 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
12 Months Ended
Dec. 31, 2011
Income Taxes [Abstract]  
Income Taxes
Note 12 - Income Taxes
 
The components of the income tax expense for the years ended December 31, 2011, 2010 and 2009 are as follows:

   
Year Ended
December 31, 2011
  
Year Ended
December 31, 2010
  
Year Ended
 December 31, 2009
 
Current:
         
Federal
 $(8,036) $27,822   - 
State
  (767)  9,609   - 
Foreign
  (9)  11   - 
    (8,812)  37,442   - 
Deferred:
            
Federal
  3,331   (3,380)  - 
State
  1   -   - 
Foreign
  -   -   - 
    3,332   (3,380)  - 
Total provision for income taxes
 $(5,480) $34,062   - 

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

   
Year Ended
December 31, 2011
  
Year Ended
December 31, 2010
  
Year Ended
December 31, 2009
 
United States federal statutory rate
  35.00%  35.00%  35.00%
State taxes, net of federal benefit
  2.19%  8.28%  0.00%
Valuation allowance
  (4.39%)  (9.69%)  (33.96%)
Stock options
  (1.92%)  0.00%  0.00%
Warrants
  (8.60%)  14.15%  (2.07%)
Other
  1.79%  (3.64%)  1.03%
Balance at the end of the year
  24.07%  44.10%  0.00%

As allowed by ASC 740, Income Taxes, we used the actual effective tax rate for the year ended December 31, 2011 because our 2011 annual profit before tax is not estimable at this time.  To the extent our expected profitability changes during the year, the effective tax rate would be revised to reflect the change.

Deferred tax assets (liabilities) consist of the following:

   
Year Ended
 December 31, 2011
  
Year Ended
 December 31, 2010
  
Year Ended
December 31, 2009
 
Deferred tax assets:
         
Reserves and accruals
 $46  $53  $- 
State tax
  1   3,326   - 
Research and development credits and other credits
  -   225   500 
Net operating loss carry forward
  2,822   372   10,500 
Stock based compensation
  3,155   3,109   - 
Other
  211   -   - 
Total deferred tax assets
  6,235   7,085   11,000 
              
Valuation allowance
  (6,168)  (3,687)  (11,000)
Deferred tax assets after valuation allowance
  67   3,398   - 
              
Deferred tax liability
            
Depreciation and amortization
  (20)  (18)  - 
        -   - 
Total deferred tax liability
  (20)  (18)  - 
              
Net deferred tax assets
 $47  $3,380  $- 
 
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized.  The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.

Based on the available objective evidence, we believe it is more likely than not that the net deferred tax assets as of December 31, 2011 will not be fully realizable. Accordingly, management has maintained partial valuation allowance against its net deferred tax assets at December 31, 2011. The net change in the total valuation allowance for the year ended December 31, 2011 was an increase of $1,000 and $2,488 for state and federal deferred tax assets, respectively. At December 31, 2011, the Company has federal and state net operating loss carryforwards of approximately $913 and $43,565, respectively expiring in 2027 and 2012, respectively. At December 31, 2011, the Company has federal research and development credits carryforwards of approximately zero expiring beginning in 2031.
 
 
Internal Revenue Code Section 382 places a limitation (the "Section 382 Limitation") on the amount of taxable income can be offset by net operating carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carryforward in excess of the Section 382 Limitation. Management has analyzed analysis on the utilization of its net operating loss carryforward against taxable income in future periods and determined on a more likely than not basis it will be able to use all its recognized net operating losses before they expire.
 
We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have reduced our gross deferred tax assets by zero and $128 at December 31, 2011 and December 31, 2010, respectively, for certain tax benefits which may not be sustained upon examination, and we have provided an offset through equal reductions in our deferred tax asset, which offsets by an equal reduction in the valuation allowance. Our tax returns are subject to review by various tax authorities. The returns are subject to review those from 2008 forward.
 
Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We did not have associated accrued interest or penalties nor was any interest expense or penalties recognized during the year ended December 31, 2011.
 
A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:

   
Year Ended
December 31, 2011
  
Year Ended
December 31, 2010
  
Year Ended
December 31, 2009
 
Balance at the beginning of the year
 $128  $-  $- 
Additions based on tax positions related to the current year
  -   -   - 
Additions for tax positions of prior years
  -   128   - 
Settlements
  -   -   - 
Lapse of applicable statute of limitations
  -   -   - 
Balance at the end of the year
 $128  $128  $- 

XML 33 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Preferred Stock
12 Months Ended
Dec. 31, 2011
Preferred Stock [Abstract]  
Preferred Stock
Note 8 - Preferred Stock
 
Our Amended and Restated Certificate of Incorporation, as amended in October 2007, authorizes us to issue 10,000,000 shares of $0.0001 par value per share preferred stock having rights, preferences and privileges to be designated by our Board of Directors.  There were no shares of preferred stock outstanding at December 31, 2011.
 
XML 34 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
12 Months Ended
Dec. 31, 2011
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 6 - Stock-Based Compensation
 
We account for equity instruments issued to employees in accordance with the fair value method which requires that such issuances be recorded at their fair value on the grant date.  The recognition of the expense is subject to periodic adjustment as the underlying equity instrument vests.
 
Stock-based compensation expense is included in general and administrative expense for each period as follows:
 
Stock-Based Compensation by Type of Award
 
Year Ended
December 31, 2011
  
Year Ended
December 31, 2010
  
Year Ended
December 31, 2009
 
Employee stock options
 4,367  3,381   3,032 
Total stock-based compensation
 $4,367  $3,381  $3,032 

As of December 31, 2011, the unrecorded deferred stock-based compensation balance related to stock options was $9,697, which will be amortized as expense over an estimated weighted average vesting amortization period of approximately 0.7 years, as compared to $4,027 and 1.2 years for 2010 and $5,741 and 1.6 years for 2009.
 
The fair value of each option grant was estimated on the date of grant using the following weighted average assumptions:
 
   
Year Ended
December 31, 2011
 
Year Ended
December 31, 2010
 
Year Ended
December 31, 2009
Expected stock price volatility
  123
%
     110
%
    120
%
Risk-free interest rate
  3.05
%
  3.66
%
  2.93
%
Expected life term (in years)
  6.6
 years
  
7.0
 years
  6.6
 years
Expected dividends
  0
%
  0
%
  0
%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $21.13, $4.83 and $1.06 during the years ended December 31, 2011, 2010 and 2009 respectively.
 
The expected life was determined using the simplified method outlined in FASB Codification Topic 718, taking the average of the vesting term and the contractual term of the option.  Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle.  We have not provided an estimate for forfeitures because we have no history of forfeited options and believe that all outstanding options at December 31, 2011, will vest.  In the future, the Company may change this estimate based on actual and expected future forfeiture rates.
 
The following table summarizes activity under the Plan for the indicated periods:
 
   
Number of
Shares
   
Weighted Average Exercise
Price
   
Weighted Average Remaining Contractual
Life (Years)
   
Aggregate Intrinsic
Value
 
Outstanding at December 31, 2008
   
4,468,595
    $
2.98
     
-
     
-
 
Options granted
   
1,317,195
     
1.18
     
-
     
-
 
Options exercised
   
-
    
-
     
-
     
-
 
Options cancelled
   
-
    
-
     
-
     
-
 
Outstanding at December 31, 2009
   
5,785,790
     
2.57
     
-
     
-
 
Options granted
   
345,250
     
5.53
     
-
     
-
 
Options exercised
   
(1,269,149
)
   
1.11
     
-
     
-
 
Options cancelled
   
(31,500
)
   
5.48
     
-
     
-
 
Outstanding at December 31, 2010
   
4,830,391
     
3.14
                 
Options granted
   
475,000
     
23.30
     
-
     
-
 
Options exercised
   
(398,393
)
   
2.68
     
-
     
-
 
Options cancelled
   
-
    
-
     
-
     
-
 
Outstanding at December 31, 2011
   
4,906,998
   
$
5.12
     
6.43
   
$
97,385
 
 
Intrinsic value is calculated at the difference between the per share market price of our common stock on the last trading day of 2011 was $24.97 and the exercise price of the options.  For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise.

The following table summarizes information about stock options outstanding at December 31, 2011:
 
   
Options Outstanding
   
Options Vested and Exercisable
 
Date of Option Issue  
Range of
Exercise Prices
  
Number
Outstanding
   
Weighted Average
Remaining
Contractual Life (Years)
   
Weighted Average
Exercise Price
   
Number Exercisable
   
Weighted Average
Remaining
Contractual Life (Years)
   
Weighted Average
Exercise Price
 
2006  $0.24    
690,612
     
4.22
   
$
0.24
     
690,612
     
4.22
   
$
0.24
 
2007   4.20    
1,312,899
     
5.56
     
4.20
     
1,312,899
     
5.56
     
4.20
 
2007   5.88-6.47    
697,026
     
6.00
     
6.06
     
697,026
     
6.00
     
6.06
 
2008   1.74-6.20    
250,016
     
6.46
     
4.39
     
221,294
     
6.45
     
4.52
 
2009   1.15- 1.58    
1,167,695
     
7.26
     
1.16
     
799,297
     
7.27
     
1.17
 
2010   5.48-6.03    
313,750
     
8.18
     
5.47
     
160,055
     
8.21
     
5.41
 
2011   19.85-23.62    
475,000
     
9.42
     
23.30
     
83,957
     
9.38
     
23.58
 
         
4,906,998
     
6.43
   
$
5.12
     
3,965,140
     
5.99
   
$
3.70
 
 
XML 35 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Share
12 Months Ended
Dec. 31, 2011
Earnings Per Share [Abstract]  
Earnings Per Share
Note 7 - Earnings Per Share
 
Basic earnings per share are based on the weighted average number of shares outstanding for a period.  Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding.  Potential common shares outstanding principally include stock options, warrants, under our stock plan.  During 2011 and 2009, the Company has incurred losses; therefore the effect of any common stock equivalent would be anti-dilutive during that period.
 
The table below sets forth the basic loss per share calculations:
 
 
Period Ended December 31,
 
 
2011
  
2010
  
2009
 
Net income (loss)
$(17,263) $41,417  $(12,524)
Weighted average number of shares outstanding
 50,547   45,453   37,911 
Diluted weighted average number of shares outstanding
 50,547   49,067   37,911 
Basic earnings (loss) per share
$(0.35) $0.91  $(0.33)
Diluted earnings (loss) per share
$(0.35) $0.84  $(0.33)
 
For the years ended December 31, 2011, 2010 and 2009, there were the following stock equivalents:
 
  
2011
  
2010
  
2009
 
Options
  4,906,998   4,830,391   5,785,790 
Warrants
  204,908   1,090,444   12,271,946 
 
XML 36 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common Stock
12 Months Ended
Dec. 31, 2011
Common Stock Disclosure [Abstract]  
Common Stock
Note 9 - Common Stock
 
Each share of common stock has the right to one vote.  The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends.  On June 15, 2010, the Company's Board of Directors declared a special cash dividend of $0.50 per share of the Company's common stock to holders of record on July 1, 2010.  Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.

XML 37 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Patent Portfolio
12 Months Ended
Dec. 31, 2011
Patent Portfolio [Abstract]  
Patent Portfolio
Note 14 - Patent Portfolio
 
As of September 30, 2011, we own 20 issued U.S. and 26 issued foreign patents, in addition to several pending U.S. and foreign patent applications.  Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation, or SAIC, in 2006 and we are required to make payments to SAIC based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, SAIC is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX or from the settlement of certain patent infringement claims of ours.
 
As of December 31, 2011, the expected future amortization of the intangible assets is as follows:
 
2012
 
 $
48
 
2013
   
12
 
Total
 
$
60
 

XML 38 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (USD $)
Common Stock [Member]
Common Stock [Member]
Issued at $1.50 per share [Member]
Common Stock [Member]
Issued at $2.52 per share [Member]
Common Stock [Member]
Issued at $2.00 per share [Member]
Common Stock [Member]
Issued at $3.00 per share [Member]
Common Stock [Member]
Issued at $4.00 per share [Member]
Common Stock [Member]
Issued at $1.80 per share [Member]
Common Stock [Member]
Issued at $4.80 per share [Member]
Common Stock [Member]
Issued at $3.93-3.59 per share [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Issued at $1.50 per share [Member]
Additional Paid-in Capital [Member]
Issued at $2.52 per share [Member]
Additional Paid-in Capital [Member]
Issued at $2.00 per share [Member]
Additional Paid-in Capital [Member]
Issued at $3.00 per share [Member]
Additional Paid-in Capital [Member]
Issued at $4.00 per share [Member]
Additional Paid-in Capital [Member]
Issued at $1.80 per share [Member]
Additional Paid-in Capital [Member]
Issued at $4.80 per share [Member]
Additional Paid-in Capital [Member]
Issued at $3.93-3.59 per share [Member]
Accumulated Deficit [Member]
Other Comprehensive Income (Expense) [Member]
Total
Balance at Dec. 31, 2008 $ 3,500                 $ 22,150,000                 $ (23,048,000) $ 0 $ (895,000)
Balance (in shares) at Dec. 31, 2008 34,899,985                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock issued for cash, net   300 200               3,273,000 5,400,000                 3,274,000
Stock issued for cash, net (in shares)   2,470,000 2,380,942                                    
Deferred offering costs                   (125,000)                     (125,000)
Stock-based compensation                   3,032,000                     3,032,000
Derivative liability                   (6,869,000)                     (6,869,000)
Net Income (loss)                                     (12,524,000)   (12,524,000)
Balance at Dec. 31, 2009 4,000                 26,861,000                 (35,572,000) 0 (8,707,000)
Balance (in shares) at Dec. 31, 2009 39,750,927                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock-based compensation                   3,381,000                     3,381,000
Deferred tax benefit related to stock based compensation                   528,000                     528,000
Fees and commissions                   (980,000)                     (980,000)
Derivative liability                   22,462,000                     22,462,000
Unrealized loss on available for sale investments, net                                       (984,000) (984,000)
Dividend                                     (23,600,000)   (23,600,000)
Net Income (loss)                                     41,417,000   41,417,000
Stock issued for cash exercise of warrants, net     240 120 120 120 20 20 170     5,395,000 2,354,000 3,750,000 4,945,000 396,000 1,098,000 6,593,000     5,395,000
Stock issued for cash exercise of warrants, net (in shares)     2,380,943 1,233,741 1,235,000 1,235,000 220,000 228,648 1,787,620                        
Stock issued for cash exercise of options, net 120                 1,404,000                     1,404,000
Stock issued for cash exercise of options, net (in shares) 1,269,149                                        
Balance at Dec. 31, 2010 493,000                 78,187,000                 (17,755,000) (984,000) 59,453,000
Balance (in shares) at Dec. 31, 2010 49,341,028                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Stock-based compensation                   4,368,000                     4,368,000
Deferred tax benefit related to stock based compensation                   2,331,000                     2,331,000
Derivative liability                   15,260,000                     15,260,000
Cashless exercise underwriter warrants                                         0
Cashless exercise underwriter warrants (in shares) 24,178                                        
Exercise of options 40                 1,068,000                     1,068,000
Exercise of options (in shares) 398,394                                        
Unrealized loss on available for sale investments, net                                       (3,000) (3,000)
Reclassification adjustment for net loss included in net income                                     (983,000) 983,000 0
Net Income (loss)                                     (17,263,000)   (17,263,000)
Stock issued for cash exercise of warrants, net                 90                 3,063,000     3,063,000
Stock issued for cash exercise of warrants, net (in shares)                 855,536                        
Balance at Dec. 31, 2011 $ 5,060                 $ 104,277,000                 $ (36,001,000) $ (4,000) $ 68,277,000
Balance (in shares) at Dec. 31, 2011 50,619,136                                        
ZIP 39 0001140361-12-011924-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-12-011924-xbrl.zip M4$L#!!0````(`(Z*74"$5#`4W(<``/GP"@`0`!P`=FAC+3(P,3$Q,C,Q+GAM M;%54"0`#JZ1.3ZND3D]U>`L``00E#@``!#D!``#L77N/XS:2__^`^PY<9[+H M`6RW'K;;[LG,HC.3#0:7S`0SG>P=#H<%+=%M)K+D4%1W.Y_^BI+?5MM2MRU1 M_>=_?/>W5NM'YC-!)7/)<$9NQ\$D#'SRA442&B`WCL,\J-)2A1^'PB/0 MMA]>JY_\;6,LY?3Z\O+AX:&MGK0#<7=I&89]R?U04M]AC7EYC_M_["FN7@]I MN"S^N%/^P8Y+FX/!X#)^NRP:\K2"T*QY^=\___35&;,);6W3H[IW5Q77J>E= M)B\717D8="SS:A^S28EE!?^>A7*S[9`Y[;O@_C)Y!]5,LV68+=M<5`(9WU$Z M7=8:T7`8]S!_D5+%93R]$WB14MR/)ND\N%)H$?FNK MGA-$OA2S=-KF+U/HI-2@3TZX_0*ZDU*A?OQBJ![+GPF']M.,(E+FM:R7!9M`RTEY#NE'M=A#/PO M;$1B=;E6H_6V$?+)U%-:$#\;"S9ZVX#^6XN^VH^AVR"723NQDL-P^I(]2L+= MMPUG25-<8EF&^9++V?S9\BEWU?,19X+$U+`-%A92>?_QOQKO#%!7HV_95N>[ MR^W*BZXN4_J:]S0%_`7N3O^Q6.2[6.2F!2)?-CY_L]GR6BN+1W/F]\G#J*(\ MC-/)PU0BD4&ED`+<"_D!)L%W"_4TEK)9O=NJQ'QW565#G(LW1X'74IS5`=J& M.(W\XC1.)DYCL!"G,:BD.(U!;G%"E9.)LZ^$^.^O$MJ;`$,__!D!3^^#R33P MX<_PYI&'_X8_)X'_50;.'S^SR9")$H2^DB6[4X0N'\]?N$#&X]3C#I<)C<3E M4"[QH.-AOO%L5V^/WN,K6+%6F7:;2]Q+X;_9/9]TQ#?N.Z7(+LJ/<+ MY>Y'_SV=!0;2F3Z_P;]QG&@2>2JZ M\%F.F5"O!1LKJ=ZSCSZL*<>/RGGHA16XS5`/E3O M=8\0X<=Q(Q'MFJ`]CPVWNM99(;PL&[XC9T1U03;\W!"N@PU'M)\4[8A@1%)F M)&$LK/!8F,[8P;T3+?=.!B<,`.%TH_]THP\4<+XH<^^D;#N`>R?:[YV<&B)5 MVSLYG3RVST%AW`WC;M4_CI83U1AWP[C;^:`]EPTWSFMWL#0;OBUG1'51-OS, M$*Z%#4>T%VC#[3-#>%DV?$?.B.J";/BY(5P'&XYH+]*&=\X,X679\!TY(ZH+ MLN'GAG`=;#BBO4@;;O;/"^&E?4NP+6=$=4$V_-P0KH,-1[07ZH>?&<)+\\,1 MU67YX6>&6DA\111([:+BHJ?'\YU,.:(^5/8\YH# MM[3O,VJ#&/R\0Z.O":N-)/Q`0,\/!&J#,/S^J-3O577##OI#^OA#Q>1R1H>F M`@Z-/E#`^:+$[U7+'GQT1S5U1TM)^X]Q<(R#O\#SU>L.AGS8QC@XQL$1\[@( M0"0=Q3.H.7KTV%&I,F)PX:'IPJ,V",.X1KEQ<,VP@[.8/K-8,7<\H@M<`1=8 M'RC@?%%F'+QL.X#NJ)[N:"$06:;VK.T]-CK?&U-L]M;:IMO3.;U=0=E&<8AU M&.(B]K1KFW!-YP1G>@QQY?,QZ9S_2(\AKGRZ%IW3H^@QQ)7/YJ!S]@0]AKCR M'WOK_'&U'D-@@(`ZT1@-=0#`4C79]A]CHV4;%+J%1N\6]EFV< M0AZ685E6U>1AM0RK95G'D$?D\T08OP+-6W*8,!I&@KWC8="QS*OK7[]^6+2T M>+7>NFKJJ::W1>SR>Q#)-HNJQJ=HP@25P.$T2^#(E@#N/W=.BQ)O&9 M;+62(FO;/'&Y+\MBGYA\'PD!6"5S"'UAH[4IHT%41_&S&$;$90Z?4"]\VV@! M"Z"X6=H^+:%&!D)M4-S\M"[VQ$B@-L6@X[5=,>(%89A"]Z%]M)^@&O3V>71+ M'Y\E\U9GFY<\79;*7I:1:@WZ1V)P>M]!,1SQH=T^A8 M5U>;#*0W?T)"L\CYJF_V\]'YJR\8]?A?`)@?*1!YH<3^F@0^^0`3TCV5,!X[ MD%E54G54C<_^6O%=&6\>]CL$EFYWT-U@XD!_Q3*S]07_(69LHVOVM.5F^_[L M`]S`R#R+E>]IR!W"Y@=3R(47V#JR,5^?*4-AIV5C?>H4S#:AJN"-[ZI_?EB5NI'OJ1`S:/\WZD7L6?-"9]#I6QL* MD:FOHEC(Y$-U>G976Q8R&:58Y;7EH)\%1]VK%S#P$3J$A84D:H;?)GKQ4KU[ MX;R\1N!ZJT>@(^>4JD;[9,3DG!%;O<.T+!=(4SI3ZY(8;=1Q1`13N\?ID'O@ MH^W.Y>`'P_0:L@\L^?>COVCIEZ0AP,A-TLQ/JU9>.,I71G^+H^<0H0OO>9VU M06\;6Q7F/B>4K;XQ.";SB^KD8M'`:P*>1;*Z(["J`XKG#67B7_635([KSJN^ M=+'1&U@9`)_>=]FLYD/WE=U].:?)=R8D5%'Y9N(9AH1&*6B?,?DZ8[# MN/:)2NS.A3>K:AF\+WN='T,MRN?_6YLWG^ZA:`92!N24#/!X.R07\WOH3AHOBN8,PNX,[(YI6/T7TAQ$4@7O77#":W>:22^UD/Q M+!QG``ZS,*6"W,=N]BNCK;9M5NM3LE*5:P*JU322_Y8J+@G8N62+T3:;1`D^ MGHX5^4T"1:;,45$+;T;F,%-OUZ1U3;I&$\:A"0.Q;!6*=`9-8*T)O,V?-O-T MMD?NSU^8=I^R*EM+'Q3N,Y;,&86[YA(UR7P?8IN>M3(OV;&!)?SF,F2WW6.3 ME450EF5US*QT?6+0R9CZ=TQY3BX;,7CO$AG[3A=#YK,1ESM6ZL.\W-)C^>%Q MROR0?9^4?Z%SV.WU-O>8#G17,#,Y%S=6OVOJRTW.QKT%GBS(_)9@`-!Q8Q\B$]K^.Y..&51^O-H4799 M]'@QT3V=%$!VOKG`LKN#S5A/J=0_W_9G(3L&4&M(0\"H.F<`4A=GT/_0M+SLC(@/P$ MWNA=0L]7)J47?UB_S[S98U5I5.IXIR=1=B8SE-#:[<2[-&7R^/]QG;XAZV1K1"??@X2V?P,KC$WL@7X() M]>=O0_X74]$)U4?\X($EI`T#STWO9DB=/^Y$$/ENRPF\0%R3;T;Q_]:HG%,0 MU_\42$9,B[0V0ONJU4O5[**+S3_6)'Y9F/2IQ^_\MXW?HU#RT:QQBI[H9/KF M&[-G'.1R3HMJ\B2$'!<[<9NW8Q8?G4SRJBB'1X[5ZC<>=%CX$I:L,:&V4*]6 MPI@QY3V#`P)&:B=,%?^_,0]6&0.B0FLTA$8\+W@(K_=BYUDZ-13D,LNP+)[+ M9)^)>=Z4NBHNIV*W\=_AE#J+OQ^X*\=O&WWCV^5X;LA8QC+V0<9BCXSC_L3R MEZN"CS%%PT#*8++LIM-9=3.GJI44N2;6]/$Y(,A(X')0R>[(2/C*NO5F#$#QX$G;YM)/\VGN1I;="'@7"96/(T],"<*LY(&'C<335(#E,G M),HW`]D$^3^@S"MA_J"4^J".5I+1'4NU?QK;`%%6X'R[*8RXU#51_+XA>JH' MJC6J=:49W59K`]4:U1K5NNJ,KIC<4G!C@`I^N;:F6%]=;*Q"]RPU(`<;`[CY+A71P@?]OX MQG$8&XT::[R6-;.:_8*GUG\R<*"IEV-FG;,9$[K8-T6F/9 MGX[8BW[3L'L5M@:O#]".$*X[A*VK9M^R*@SAS!!!+)=`=#F@;M4>ST\X:`]C M+ME9NF?QO2CHG.F`3=VLP<55[ZK"!@%]-`V)+@?)@V8O+I4WN*!4RN MQ6Z;'\MY1,W1A2D]-2?MT&BU->?HOFK55:B2*K*K`L6BJ`#O5D>UR!J>S!"1 M/!T#AS[LP$6H;KI[RHWCQUAQ]%Z(M. MW0R#W;3M`K:%RI8&GXG@?9`%WN` MOAKBN4YXKO_\AGA&/-<)S\>.K^%W$N=Y5!5/>U?>$NEXJA4U"#4(-0@U"#4( M-4@S%SDEI%G=&S701*").-8&=`$'X74T$ZA%J$45V_+&#^-1>^JG/>BFGC22 MVSE%)+?H#UUN`TD],A7!/0_5C:;J7L'5=8-I=TR>+,+;*1\ZSS=;0#QQ@VCH ML2+MULO3_>9BYM2S?;?9*66V/RGR3CW;H]JYC37+V3W@*=N>5R+^>^(8(Y@>]PCU.IG.7Y]=R_ M^K"R<$E\O#4DH^2[).B8RD@&8K;F3Q,!18@,2!`)PD8CYDA^SW8*\+#"MW,/ MBKF=NZO_7D)5(S=XW^=^0:;<]YD"A3I<^(G7HU[77Z_Q?F[4:]3KVNDU M7LN=Y]!2EOV@;@URFQU:KHI\7VGB=S\U_N['[K:-*J<<^/;9"-$5!PA>!"^" M%\%;:?`>\XA.;I=,/[<]=L62\S9-*"S5QL+"+QLRGXVX1(=,-Z)+NC.[;5;Y M%D:A&\.A!=DNFUVL95E<%;:,PKTX".4!DG5V*^N\BS M-%/?<9_2_]4@&1>F@M,B%9S5*63576PZN..[P*@PJ#!)FYU..RV+#"H,*@PJ M3!I;Q>RG:Z0OF&8T:YK1,/GLA+ED.",W7]^3JX[1)!^3)*&WR5?"#XQ$(910 M?C%U9$2]M7RBRT2B*IO_PG-6GC14V$GI1X;,H=!6G),T?D!]/THN!1AQ":^A ME:1-#A`()&$AP"%."1K[Z/!4P:.]IJC+7[=!XL0_2A!VDO7T<0I4`B%)\W3( M/2YGQ!E3_PZ$XT8"X+HDNIE4W^7L(8@\D`\C@MWS6!`!_!QY4"ZNDK37WKM< M.#K8[:5NXZ$!,UPG39^NUG7N4C0IGO!EE<]D]\X+I1)UL=01S MN=P*PP4J8E$XTVA.<'RLI7:WP;%E5SK2%B-9"NEHANEOIO*<8 MJ7N6V#ZI2QBG3%"IOD;R@C`D#A5B!J7%`Q7[S_&AJ2B=Z)(FOV;?JG)V>IS^ MM)"N5IBVKQ#1B.@Z(=HTFF?LTYUS'"^Y4FA(U??B3C"9,C^,KWE$;TX'P.IF M)^RFV<5@!F*Z9IA.^SH+,:T;//26KE:8KO\6RK'#_*RF M(I/4=%-)S&M<7/0O+5_).7SKC#J$.E2=N1PU"#4(-:AN&J1_M-.Z*M@/O@TD M]8B[FX@#PYV5,2P%&HY>T[(QW(F8KA.FKYI&'S&-F*X3IDVS:9SO]O5.S#.# M!W\"MT8+CHE[6_4 MB^+C?LGU.NJ2R?R1L+TBQ/"\1DSI&9Z_Z#7-7O_TIJG8&/VARZ)1>5!YCJ$\ M=K/7+^-:5E0>5)[**T]1@4.-M$?W[YH+WQ-.NR"0CB03BNO3>\>Z:JS&BSS= MUM>]`N;?\D6.>#X7/-M->U#`>JQ\J2.DSP729_M!3$KD$[>'40MQ(P+WU&HB M3X0R0KDF\D0H:W*"KJS@5ZE7DGJ<#KG'Y2Q'D`L-`QJ&.A@&A#)"&:&,4$8H MZR1Z_;]@+3R3RPVK'$LZAX%K5BRSH=LQ5AOB]4I>K,JJA! MJ$&H0773(/WCC3IDS'O./C&N:<]F38M11@1R/8",448$*])RO3J-P7J*F1-;K$X9F=3T0!WJ#NK.2[/&],M(I:8'\%!]4'UT M#]+JJ#IK/O*EI"#T-"]/>;1I3JR1XL.F];VGJ;E\?H]"R4>S^8CO:W_31S:. MYB/?QD+]!$+]LD>H'_W8*PY#&$8BQXP(!APD'_V08)3F/S>!/I_>L0FP1)S` M#SE@/B0/8Z8NA29<$AZ222`8\?@?S)M!L]0'N$GU`X@/)HQ,U:=%J@>A4B%N M=#3/F/C`X;FJ-%S0Q-SVVC`L?]T"T9$'$*)RAWK%4`H'BD"735D\*B2:0F%5 M\H[Y3"SKCB(9`0]02Z$(9.PHPMU(+"0U98('+C3F`^_<&4^[% M`Q(,?V<@RGM&V#T@$*3<)`\,!.UQ!@\/P5`UYJ$(;$H4+,@,L'*MP8 M&'0Z%<%C;'```J\&IIW(HV,WN[WN)G>$/4YY;#)@2"S#NHJ+`C76MA3R40QU M8>3`Z*CF7`"\%TP3@PRR5O`Y0/5?3`0KVH8,E-E?4FF;*=9I_8^UB-#QPLW-1R"4 M/Z#H;9/W,'30G<]IK,TAL.*!`1:1Q\(V^1P)H&@*W"V=&)>%CN!#L)_@6S'H M8T*5(;A7KDX(;@^\@(=AI"S!G)(V^7%!;'/%TIR1I$@SA3@E*C6W)2[*(4.H M>F6/,%KAPL]*'Z(V^7ES)H2_O-E?RL]3/T*8H^=#&$F^[KHMIL!]-"RFRZTQ M!]+FSMO"14N,)$AB$D_!:B9,=PV&5%$$OD,\U0-PXG9E0"*8_I2GJL@2X,O= M^8U+^!8,BE"K\&?'8QPA6@Q.#:L1]<'>4 MNQ5/[S$*&7CECDSFQ-@KF08ACV$'2QA_C^/85/!8N:*2.?_?WI?_.&X<"_\> M(/]#9^(@:X`:D[I&VM@&9J_WYCU[9]_NVOL%01!05&M$FR(5'C,[^>N_JN[F M(8F22)TD50X<2R.RNZJ[JKJZSJEK6S#V#,@,U9I$L4Q'5&04P+I*]4_<-OA7 M0--5#'*+$D]RL]!@%7<#%^)<(!(>?*3\/%UPI`YRH7X8[4&NR]]PZGO1PY3! M?@D=1ER&X`8IA"=@NHJCIN:7`PB,8;BE]V-U-T?1E4(5A_,YB`28"@DFB,3E M0=++HPU4!N,^FB`LHD#.'<%E#C;51K'\65R+-[TM;WX3WYO!VNI")T8!16Q_ M'+;'+9U[CFT](ZLN,+V-2@:',P$I$6[XIH-[R$S+\B,E^4&3CMR,#%^@=CRA MX%2$*[S+I4*A#A5\"H0Y=P.@*9`[8WLL&$*0.I"JAS54D-C53`D@P%JY_0)->SBDQD`,S:'3=>US=1&E'>0:Z78%SA1'#O15-++$](<;([X*!12 M<'E:4U#6E9_8@X6>8W''42;='Z[T*_$]F)M6_#TV>.NI37@7 M.ZX(7]AN5^]1$.VQW#*6A_L*@+>O"OL!],(A07EW98NCM#L_FQ=;R+^#F$T7 M\ZV0MT7/\GIANG**E(B.:6B4%?$U\77M,5VY[Q%?$U\37]<>TR6^UH?$UX>- MBNXUH`K_*].1[F1IC4POJ,I4CU:$$G139-DHL??0L60G#!4SVG5.3"\;4DET MW%0Z;GY>.E$Q47']J?B079.:H*_=@DXM_:"I@SGCET9GD".<2Z$G]#5Q&")A%"!R&1,Y$SD7-%%Y?(N0H*W@6;Y!(5+UU`D8*QH.9Y$S;W;?@S M*G8[U"D@V4&RH_:R@\CY@LB9+,]$T(TBZ.;+9S+>+:[:)QZ&CL@L(8VM"O1) M$H$..")G(F+U^8M^C( MR4OKZF3E??[^NRAH/9CF_.6=*`GWV?SZQ@XLQPLBGW^&*5_AV#_^\0^,??^G M5NO.?>1!*.(",E7+1;5LT^&MEGPP'3)]&FNUPG`?^>2'*PMK\ACMCG'%(M>6 M?_M%U^'KF%OVS'2"'ZY:G:L?C6ZW,]!U/0MD,N(18-(+P-3M='LW6V'ZR39' MMF/+,GUP5WC[[\@.GY=AR3QUZXX_A;#24\_!Q@/R^9T6[:;;[W06`-PVS;&A M+K*L`Z,_[.X&-79$>VT&4_8AKLTY>F8O?@E$O<)OV3M9+=5]8+=8%U0,N(P2 M#($CQ`.\>L:W[]SDU?3-U2U!_$*OX.9TC8ZQ@&7QF2N"KY[@6V1;#6-X4VM\ M]6&,KSXL0L8]O7=D?*6XV0G?Y-6#T7-[,.P/BB"<,W5%$"Y'T*UNM]OKUAKC MDB3=ZA\9V_NDU'AI;)-7#T;0+6/0[K6+8)PS=T4P+D?1-[W!H-"95%F$2Q/T ML%M(2&]#6!51?H$5\K_-04=JU#_)E@3[$>5-N]]9!CD=_E!0E2.U7._A7/&L\J9RR\E@NT\HQL-R=P`Z%Y!*;'F M9=I+%YEU\QP)VI(7:V%'.!^X)X[H2_%?V-]'_HYEICYQ*Y)M;MBM;XLFL&]DMQ$I?C2&&H,W89_-KZU;RXIF MD:Q$M77VM6J$>'/A1?E>"JR"%4'%H>[=%$H%I(11@@@`WD\`O#W5K@QRZR`L MIJ0,!XO2_5CXGI$0*K*CM!-U8\EREX2#L62GZ610D?VLV#Y\,)]GJHF7[SV; M3OC,O)%C/\C.30[VKK1G\RC,=.M:7LD/OF=Q/@[>^=Y,#1>\\WP!^N%=7IG% M*3EQE7`N*:6-_J)V7E_,R^I[W>YA$$?F$8WMXC/@@Q>$/@]M7S:\?!7W&TO# M%=@_,&"!B8B%E>-`#0A74C''?9!\=T5\-SUD9:GVP;5'!3Y?J$'X_85*#6L3J0'Y!,#T*37S@+0&T+/.PS M/09:1&NRZ#=MCR+9%K:K&[]C=V_X:'F/7*@Q030*0M,-;=%5&WLK8P=8KL@Z MN,[L:O().[&BQF"ZSW\-8(U":RJZ>&G$>@Z,5`HQ^04W+D:9+?K*92>BW[<33C` MB"B-!5/3QW`MV=L7=>\7V#M=_'7%OI.\+<*I/HF';M,W"X2;=;('OHYV*/E/ M]L3?-,=Y$,G1V8Z.B!T$47DD[N1;.^S$%LCEP*>%NL"R'P9J+PI1[(HK9TG0 M[S.O'G[5,Z.?"XG]-Z$0$G/3%ZW*N8!][#F.Z0=L#HJ[P&,+&A],_]X7AI/Q MKS@(7'[%W$6VI)W%YN[].\#G&AC96(?4NKG.CEO.3AT#M[EIBY;-JR$XZL?/ M^-MN`=MZMS=<%J+)D`<`HLCE>_OL\DHJ6]MCC+B&6A?:8)YE;_0DGGO37?H3 MO`CG^,_JS?O);1Q[#O=;_#%C[-K/@M+OX//K;M4EX*C2$I0SJ#0*]Y(FE:/B M+NIS6]YL!I<,(>TVX8RG,69!WT]>BS>$R#F.>3!WJM/B<1`*/3\>I2/8N\L2 M?#=L^%?N6[8L._5D^KZYA:'2L;^HI_>DK(Z^%%>U>;;3H5&.L-J=OM&K(AZ' M$6,[(>#-1;&RC?(92?->/O=6O9ISKRH7TJ8O)3MLG?"4N)0-(.INT"G.C,N! M3LAM6(`&#V<^6IWXOR-[CF=^;E14_"A:HT,X<]_&3Z.W7O0=GEKP1,^9W<;="OU^&=//;PQ>;3<0=#5!XLI'9LF.PD" M)2/MX1^C4@CLP:"[0AX3G2:<0D#X<8:JH+RMR*REV3V)J[=E8];.6PUDRQX: M=4:V)-'V]\4U&\>$+B3+7D%F.64@\\H;^<9.YTNKT]>73`;;9SHRW,7B)FYN M>KU=X?[('[D;<=9B'T6L1$Z2F?SA.7YRSXCQ17_!XM@'A*H"JB0S MM?N%H%(Q+ER&@Z^!Z##Q_JO0+`>A[P=-N5WK#=OZ3=X2'12HW8_M-=#\%W>Y M;SH:"[CCH/,W1&3QB_EO\3J+Q9F3N69/;"(8^*\$1>H=7X= MY=>$Y[]I7_?:Z4]KHXY?.V80)+:,>_\C!@[$E\\/OITU=*A?UW@Y_B40BLTC M(G98@G,;MGOMV+&3%RN\X#1J@^P%T#.)63M`>+I%UO7*++*NEUODA>RW"B]R MIT*+W"FWR)W:+'*W0HO<+;?(W=HLLG$]J,PB&X-2BXR@UV.1NQ5:Y&ZY1>X> M;I%5JHN,2OA@VN/5NG*6+)_'`_QYWZR287\I&FUI_,,!5C*SH3WL+5FOCP59 MV!I!"A7V&0Z-?`)`O M(J`?N?T1%.T'GA>/-K:=")7N38%I\3BW0-OLK'!:+M-G'(2CV71Q5(XAVZ= MRX/RYLZ5-Y:OX)95_>1#^#^AO=#O`C)2,-Y;E`) M>^(@":*[\'U'L0OMW6HA2G+2F!LO2]J' M$"5YVI64*.=7;G9>2[PH;%8U+I2QB1,NCQ-TX@3B!.($M)D1)VQ3]M)>OG^V M+,XGDUVZ^98JIE+!AKWWDXEM<3:)?-<.(Y^7(!N%KH!R$]'4X'*]WJAP:*#W M[W:8A373S+!W_ MXYRXQ$)50:J:+'33(Q8B%B(6V@.K_@E4XRJR4/4-CL;@Q%KQ9R\T'3(SUD:* MG%!*&-U!XV_01-&71-'#&R)H(N@&$?2@VWB")AMGB27]"7MKF0N5L.8^MVS1 M>8O,G731//%%\\6P<3?-;\E&0ZQS"M:Y(=8AUFD\Z[SH&TVG[.)6QQW4UFXU MLESV9=T3H7$_N'XQ3"IDC'W>]_AE.NVI0'?$.\UBG:(9=:_-/4.WF3 ML=?&U=(9EL?$1MK/'`M>&(9M5 M&[U]FE07W8@\8BS>X``5LB:"BS'''#S"S@6<708"%-1>3(98O%%9L[GCFT)52:X MSNQ7\@F+NRV#L30YZD#8;[N7-^PNK.V/0QG3N>"J>/<4SSNJ#Y&0_%)JGWX=HDVQ`I0./%P\]_8U/O M"0E;DZMFPV1.X(&V'=JA`\L"7,C3M;-LWP*`0BSV+I8:M':.Q89-!OLF.`4@ M$M09]QV5S>,]%@5"H8]'$@05V)((X!U%,+A1:B=@*7@(,`B0L=&R>E/1J.U. MD!7DSY9CVK-`$7A04K,_I]2F6^71#X:<*R,2%]XR+<'X$9:<0*8&`OZ/F25B M.]4B3:E%(G_L4FKS%#M0F,BR@"0FGS+5-0>9TC:[F&JVNP2+A+7U!_6O?`+T MF!/OL"U`;>.RG"3$M:!CM"B@E1-09=H@M%5:E<6HKE+M&.=UE6GZL,FC MFX1>]QA"KRZ9I;N22+4"X?82>QE7>-T5PV.H@_NL7:TD;+],`=T&L$_1F(0J M^9!&/OMNFZ]EU;U=P+F6>/#>V(_V6)A3Q]QR3+3U8F-+RYO-/-7L:5U#S.5N ME^(5T:@R&33N3/DF'KN4^[N]U/@IV[BRP&15P7&CGWRY/Z=^W:LGFIM]Z@?; M2C[AOG!(F%_9B+M\8J^$`L3/?#:_2OI_S\/WGFOMT*U M-_K=WD[@IJY[;\*PH!UW`VFH_G0]Y/L MP&I<,:P8]!6.&0]9U5"`2FE*%6FUUFX[.YXSUS@$JX3"U0_='U M"HIM.!4>JHEI*U\V>GVGWI@]36UK&KMX`WC(#*6;VE9-N@.0^.BWQ6N$Z!H. MX\`@F9&4]_H!NVNS,/`_B0BQH"&NIF6:=!K=-W M,'KKLXI)NGTR_7$)0\LN2WH"5`LG&V4[]FQ+;MG=E5'[KCU_YZ;/WHI$G"4`2H*0$.&@/ MPYI+@`.'@C2]*N5;9;R#,=%5X,U%LL.A(P/.'SY4\M"HP8:'6U M3O\$-:"KV/N`V(C8Z%!H=;3.P-@6"4=\1'Q$?+2%C_1.XZJ\[J5"[Y9`4K0^ M9ET5:!%*+;7G''_<"17I"A2NHG)IYRR7=BX%NAJ$1^Q#[+._XDSL0^S3?/9) M==M+H.ZFIJ[4/G2P%$54H!I+Y"81J>,X.6&=XL]&IB.B8'T5_(_%N;(F=ED$ M=*CUAS>:BH=]LAT'XUY5E1`Q7<9A/V9B1.DAP:>PYM<#%W&H M&*&Z4"5&1?,!5N9\[GM?Q2`E:!72 MC<'<^+A\)`KB6G(R&A6_K5"^&0313/)578-52Q\1U8QP7:,S=/6SFUR/W2:E MFN[P;$!)9SU:.]I@943%>EUG\;'S)/<<,;<<.GTM( MK*+:=0U,R+5L`7I"1XJQM6]3$?;)KRU:#0-*L77XRT$.]*K2%C'$(:!NQ%1& MGNY:<#NJ['(@-BDT/UKT9!/N$!_MX/?6Q.>B4P7W>1`R M;#!3_NYP_K+K)$*/'8-UK6_KETS2AMCC_$"?BSWZ?=*TB2DJ"O1YF*)]/21[ MTR$T5+)SCYEC3S@#+74F:CV+P+9ORTL=LG(W7^STK_N'Z#=1?[&3;I]@%^*6 M)G!+9L\.C<#-8H"POI/%M!'Z[.Z<0[Q2$5Z!4X#D?BGJ)?/H&M5S'+?OH%MN MS87",:`F)TQ9"Q"QPP6S0Y/51C*#$D?0`7$X&^CZI/"]<_2R:=S%43U-?J;L MO*!R+E]AS'SKDS7U')A:Y6ABN"^F6\Z\,7=D"O1*YF6:O;F4ZYE;5U3F=&+N M,B8_MXUKHZ.Q;[K7@X[,*S:N]3X;1WZ<\BDSB[F(9L])RDX2DC'*F_D\0%7: M?N3.<\DDY*,G_IXEO;F*1]SI!*0 M0/&/V(;/-ZTP,AWY@WI8\D9N^ZKDF&EL MAJ8`P8.W?"Q'P!\QKWH"D'B8_2_Z;JDV5XO3R*(`(IUX'HT6X#!6)4Z M,%T;MM(,F8F+:#NF#T"I11!K;CU;3GY;KB^<36')F.N%(&4\O/B.L\4-&!83 M@'\GW`XC7W0#L\PH0/D3OZAP%("J)U&M:(B%19BM5X$`-7>VB!KLW'#L?Z-D^&-3W M(DES?!^)LPI.O:*,6WN416_C@YG%JTWU-0:=&#:7>K_$5^9;=4=X^Y7[E@W* M[,4P\`?,&R;^K3CHQ+_%^/\VK_X^XZAD75DC!J# M3CR=2\.W#P\^?T"[S!UPL.T&MG4Q_/LKFN@O@'$/&^7>:]<_U.@^8_](P:X2H)N#H?,=M.J=RDLD,697Z_8'6F^8D^=)U'8I@&XK?7\I MS-"^'I+4)4#I>$C&;!$[$*#$#LUEAT/F?S3B4K88&=>X_:XAH(V7*H;6,6XT M@^Y@!"BQ188MK@VZC1&@Q!$-5C\)4&('8@=RDFV]CW$5I44WL@H`NB190F]. M8F7->L3;MAA57^O=KPV@=`#6>/,(4&('8@<"E-B!V&'+]6AG9U6A>,FZWYPL M['OO.,>X.54YWK0\%D4CK\^.T.;KUQZ!Y)?\['#%,%1AF?8$H MXID+)^EF8$&,28S9,))N!A;$F,28E29I%->3[L9 MP+_#G*JR1&T$Z*6R1?NZ=T,<08`21S37YT.`$CL0.U"^WA8O)^7K50;0QDN5 M3K>GM7MT%R-`B2E2$\5U+Z?O-W$$`7JI'-$\Y9,`)78@=B!G&67KU0G0QDN6 M%X;6[@\UHWM$9VSE>AT56YJ#E02O(%W7!M#&,Z!Q;1A$:`0H<41SE5T"E-B! MV(%2$?>Y%E(J(L6)-S1._$7'T'KZ$7R"AQ,,U5NT(]Q.20Z0'#BO&[1[A**E MS:+J9F!!O%DWWKRP7*Y+Q8(8DQBSTB1]>+]QLZT'&S,PC7/=NII^#.=O9;:0`"6F*%N%`ZPR/6)"$(FXK1]6U`;3Q[->^[A\A M"+8R^T>`$D=`BIL[$4C MAU<(H_T$8AY*=96(76VH][7A\(056.I)W,W`8A=ZKI.S_IOR9$RR(!ZS=VVT M20Q<`A9T4M>/._O7W2,$9S6+KIN!!1W2)`;6+M[P1NL,>IZ.CC)CI: M&G,$7/_@>Y$[;@F;UTOVYXGX)P.WFDZ\?^>&ONT&MH4,$G%F8Z"%8T6.&?(Q MVH+"*8/[,Q,UEYLB+ M0DEJR7Y[6XR;+XOOS05*W2P@R=DJM@"CL=29^<.5?B6^!W/3BK_')ZRNIV?L M+B>EL.%GCO5U)WGOK/XI^8KRI7TNM&6.5B!6(+*!W0,KIK M-D2M2.U_\H# MH3B#=OA6ZG[BUG91A+_@?,^@YGI/OCG_X4K^=SUVU3S(WRB57NXTNPN"*&=? M%_:R*,*5Q+?P87@96"9"L'U5&&/]LF7B1]-]$.:`;=?=IB#\-K8%?$!;0%!" MZI?GH:RQ"A?@;^Q41\'>K-2`(XX$PBX4\CY"P\O%B`.Z^=0=BRR/$T_G$OD7 M\1>X\MP^D'U`RRGEB0TD0"=K?;%#%\+;$@AM_QEG2YYN/&8$&W!SKO.'V.AEU;U_M;),`./JH3;`8!?5R@3T_@124D^?7&NH&:..+J_:'NM8_1O)S9;:0`"6F*%L: MY+I-'%$C0"D;N#&LEZ^Q$>L1H)?*$:2A$:#$%*2AU1I0TM`:PWJ-U-"*=F2I MFHW^9C=K;+6MF03TF8$^C[$>SO2<%O!DK*_+&7]V0!M_]!I:QVAK@^&P<>*/I;5)+"5!BBI0IKO7FJ:4$ M*''$/AQ!9P0!2AQ!BA,!2DQ!BA,!2AQQL8I370.X!Q=D=26@FVW?-JYONJT^ M17%72"S6$-#&G[_MGJ[I1O..8`*4F&(/I;1+'$&`$D=D`I$Z%*Q*@!)'I(I3 MV]#:P^8EGQ.@Q!3[*$X]X@@"E#@B59QZS:L-5-\([APEMK%V5P*ZZ19NH]=B MQG5OF]N&3-QT!%_P$6QH1O]&ZP]),R5`B2V2,6^N*3J/`"6.6%"HB",(4.*( M](P8#K7V,"=%E)B"`+U8IKAN$T<0H,016<6I>1Q1TR!N8UO`:RVM?P3T19JX M>]==+%*B=[8`319N.G\O^/SM&!WMID>9A00H,44RYN#:R'&,$D<0H)?*$;W< M:F_$$03HI7($K(6F]R@P@``EIL@H3FV#.((`)8[(*$[-XXCC!G&SN3D>V^Y# M2[[TDK7G7X]J]L[9H'V-L:?%X9AF9<*D@E;STZ)B#*\'O5:[<]W/R41,<&\[:+<#/O+\,?<3N$>.:?V.T+/`<^QQ%7`HJBR4Q:BN2D7WIJ?I MIV&UYWRD2>-)AV:PLX,5W=F`XTS+Q"&`WCNEHF)5QD MP#P!74TG2[<2GHAC^%BJ@5E!Y_AJ0[VO#8='"!)O%G$W`PMBT?JQ:/^ZFY/Y1]S9/"QV(64Y=CTH^9OR M9$QB(`V_-(Y00[=9#-0,+.B0KA]W=K1AOZ<9W2.D'S>+N)N!!;%H_5BT=ST\ M0O>>9M%U,[`@/9K$P/J3^OKFP@[IC+OLN]"$33'/^\HT=6(X71#Z_G[SV9G/N!F9H>^Y'[I@A'[_V M@C#X-#5]_LH,^/B#^3P#8(//`/@KA/#'/_Z!L>__U&J],VV?_6HZ$6?ID`'[ M!S[)Q*/_;+7DT_'4^(IX(_-",C"S8#/ART<^^>'*PM0N'?X7>OC):'>,JQ_5 MVIYF`XN.O`.M?Q:T_AYH_6,^KC$!4/?A>Y(Y;PB/\DOUY M(O[)0*D@$.^_]T+.C$Y*.:WT8V8[?^8F;@WN^RJ7K1,BYR;Z$\U_V(T^R*Z* MG7L4.V<'+)QR-O=MB\,G,V1/7N2,&?!9Y(1L`K*5F2X3)Y[SS$+?!.:WD/O9 MB(=/G+N(^.\\9'/3#VW+GIO`^PS&P6%G*5VP,%!&,_RC$-& MKCG&;8<)_AUY^!^Q!@%,S1#!1ZX0"V`/?&8C+=B6Z3`S"/"/\#?'-D>V`U## M6R]^XH_<8486Y6]AY<8"`,=[6IW?&P7'7''Y@GQ+0H/*8&`]Y%ND2M!6Q1L ME(>Y!I\M)T*- M#S2$#*"W42H*B65Y,R[F4CB)A3*MJ<1Y9L*:X>+@PSBH-\EA5/&Z[:X\F2[TZRP\Y/OX&,P8`K[6&H'RF@/C3>!@"P6= MC?G<"^PP6"&4?8362_9NA3B%E)J8%E=_GCL14+]E^1$?"Q$%"DA8@GBK13S$ M(DUB$<^?>SXRR,ASQP=FC;Q39PVWX'&`=V"4]E)?]X%;?3SQ\62"7Q<4.OSC MT]06YP^>&;"K]A@4`1;@F2&U5M0'0*4';8!8K=)87@BK?>(^DN4=^V+Z/NJ" M)SB'1L^@9`GMD;VR76^&ZF6J\,V\,7=R=%=KNR.$KS1>G`GN3?&/_* M?[U\`9_A]6S\/[`?*46 MZ->#SE\TH9V:[-%SS%"""S\9[$_BTB;N*X$RHH13 M9#8'31=P7;3#J2V/K3R+D";(/^_"%QM@S'S^>UEA6CR:`ZWP*98%)/'@B$VR MN.,HS\P/5_J5^![,32O^'OMQ=#WUY.SBC\$)T]2DU5R-\^94[>-DK7`V&(`. MW`O;">"VUT*^)?./J=]#;PY20!?_8%?I>;@A-=#B>)<[O_3;NISK/"C*KGLH M=^@&(BF^OA6-,J@Y;L0A^W#(P0)O:TY%3<:-.&0?#CE8ADK-J:C)N!&'[,8A MG[W0=$[`'^*UM(L$U?7:N273UU\S6\.MQ#`\<:QAQ@$59#Q0AZ*%RE11 M+P\H1=XVIB]`6^L-ND32!"BURHC';!$[$*#$#L0.-024-+/&\%TS-;,]J_]E M[Y75]+559J5K"&AAGCX[I+594@*4B+3R2TJ`$I%6?DD)4"+2BBXI^6Y6?#=) M9L0KS(S(";VL^3VJAH`2NQ.@E0>4B)0`K3R@1*0$:.4!)2(]L0;%O%DDW`PMB3&+,AI%T,[`@QJP;8UZ@.DMNV<5E M$X52V%+@9>/,034$M/&&1\/0!KWFI4H2H,035=*4*[-Y!"BQ`[$#`4KL0!K3 MN7VU)T"9+$1D(:H01I=%:,W`HC;$1>Q2;T)K!A:U(2YBEWH36C.PJ`UQ$;M4 MB=`.[4!;AVLWBVN]O6MW[B,/0M56/91-(W_%]G2'O\H76LW:T'\N0P,J;.Q% M(X>7I(_J&72.44!UG[6KES6LJW4[`V*A2\"B,#&?'2/BSS-$_=63J)N!!;$F ML6;CB+H96)#Z3#*`U.=\V\5WHDMY'M87TKG]Z"C^%@6A/7D^/S]\%B3T'DCH MXR826AIS!`S_X'N1.VX)$]=+]N>)^"<#MYI.FGJF'`9V'.\)J)X)ZF(!#P/X MHQ].-39Z9HYHV_IDAU/;92$^CY:@1[0$L:G-?=.WIL\:\R*?36S7="W;=&". M(/0C-!XQQS9'MF.'-J!CBN:&;[C%9R/NLXZAL;9N&.R%&-J+`M,=!]_F5-!= MR^R5HH]._S1LD,@WL5\6=QPEMWZXTJ_$]V!N6O'W6,KI>BKG=I%6PG::$:W+ MTK3"YM_:04L==#C02;X;3WP" M-$1'='=S%_0FX7P/UZO+D?/WHX#[C\*@<2DHW[GSB`0]"7H2])D%+-+N)9ML70K,U!IT(>!,!=XB`JPXZ$7`N`8M4I0L@WL-WW2Z$;5TSV#YQ M'\.-'/;%]'W3W<7JL#GFLN+ICL?+JZ6@VXNKMWNQA;!)!)`((!%`(J#^:)`( M(!&PY]IUM?YP2&*@UFB0&"`Q0&+@0+87JAV4MZ8[&N1V%K!52-"D'.>S2]@F MY3A?;)T#$@(D!$@(D!`@(4!"@(3`Z2];U>(@$@0D"$@07*P@J$[5HV.6!%I; M\:4,9CML516J"S&3!=$,5N89BP)94]-]$+4LEHL,P8]87$B%*FXN,O2,0XL! MGKGI,PZK-J9Z0WN7WSMAB%=8LQU M*=Y,II6L+,TN(^:EIERZYWG'J']4CDH9$2KH7GYE.J#\\Q657C\\89Q?R2H) M*!F&FM,SN:MU^A?3,WFG2)IC2#-C<.)]?L]#YG@!6CTL)T);A>TR;OHNG$0' MJY12F>VO(:"-ES0]K3?L-8[2#J\X%5(3:RN'/O$P=`KEJ[?X0;PN%D0O46K7!%B$/K=(V.CEYW?35.1YQ5\.U2=`1%1U!TQ($4W'-% M1Y2.3ACY[+O6;ODO"`.W?B^3,SM#V7_0-?8>*=?[9:\K5XAN3=Y-7, MF\E4S(*=@"\?^>2'*PMEM@[_"SW\9+0[QM6/:F%RN.GL3:56[>KOO9`SH\]: M;-O2O8A<,QK#:3Y>U0E.(6TWA<@D3$V-D*@(UN5&%MA^L-G[VA@*J#'H1+SY M`00<#M;-';L:0P(U!IVH-Y=Z/T]MGXBWZJ`3\>;K#5[DA],+H-Z"9>[/3ZB; M%OC\T"5L9'370M'JIE<4=XH`G(-S?#K]OJ` M1OCS,^H"=!L.O^-#6FMY5R/H:)-IDVF3FP`=;7(%(KZP3%N-E1PQYD?^R-TM MR69UC.VCP/CU*]+X<%6C3_1<'T")\9K#>,1W]0&4^*XQ?-&[ M(]3?K.8->>M+6; M7OMXI%;3X^A@S6@K2-.U`;3YS-T1H`24^2L2$\;W)0I%5*#W:L-F=4&T,;S`]PTV\81JSXV74,C5^IR M6;/`MI*ZM?&5$S/EX-(Y\UR9,$.F)S,`O4'E)BO,I5Z;7B]HB41S2;1T$Y9Z M[7J]H"4:S:71LJU6ZK7I]8*62#3_I"_;4*5&NUZ;'BIIEY(^=2DIWJ5DESX@ M#7%7KUO9MFZ42<>OL@&OAK`-*PQ;E=>-8"-Z(]BJ#QO1&\%&]%:5=:/X3>H? MTS`G);FS5]>D37TL:@0H,5YS&(\:6=0(4&*\QC`>=4RK$Z#$>(UAO$'C^([* M'E$'F5H!VG@9\Z*K=7LWQR.UFAY'E)I5`4`;SWR&T=,,G0Q*!"@Q17HBM;5N MAQ+@Z42J(*#-9[Z.UFM375\JXG.PI:,.,A4$M/ER;*`-=>J$14I$!0%M///= M#+3>#3F-"%#BBM'EMC%;1TR>R^2&031=(T")^9K$?'J9?`.ZK!._$;^=CM\N M@U(JX'8^N#`XPIBJ$4PJ9\I;`VH@/"L.YVD$)=E/3VA/J,6UX]O:<$A-X,SA M.F*T(]_I:\%I=2'@VL!)1V:M.3GOPE(#:T'%F:(N\\O[-=T[5LT[ES)YX_$PG5 MGV'R5SC+CW_\`V/?_ZG5NAW_%@7A#*`)6.BQV_'8Q@=-AWTP[3'L$GMMSNW0 M=#3VQ?1]$W;R+@@B/FXM/=I*'V7_^)G/1MS_9ZLEYXEARTSVV4O?Q]?O7/6R MFD5.PBS86H#Y(Y_\<&5A<5C=T(W0PT]&NV/\ZU-HAAP'?/OOR`Z?7WNSN>?B M^+=?[>!?:Z:0T%VQR+7ER+_HNG'%QMRR9Z83_'#5ZES]V.H/^D-=U].5+0W] M`1;YV`M8BT4X!Z49>KQ0\)_C4EJ[W>VWS[[(QU[`6BS"62C-2!;*.#*E&;UV M7S_[(A][`4^X"/>R4HG[P-Y^G7,WX,$R=LD3\0/[0G_3&?87H%^9X:#0E>/B MEJ%W^\;-Z>`K>9X9'6XP61S]D_4(=B0HE:D0695](W M$IUKZ\[_J%3%BNJCQ=7XST*-?P]J_,<2UYJ1:?W^X'N1.VX)Y]U+]N>)^"<# MTL)TJ^T#WGLA3R\'7=9BF2TI<=LY=0]'E#_VY/FT31Q/-'^U*$>\_X4SAYL! M9U[D,V\RL2V8%-[F/C/=N/P4B"7YT),=3IG)0NPQQ>9PNWJ&SV;(?`[GLP]O MSFS7GD4S^.U9BHL9P#9UGF'(T':8'3*.G4O@2/R?R.4,^+USG=F6Y!.`Y7/+ M>W`!7?@$^'$IE)CG`@!!Z)NXN"U$A(W,P`Z8]P@PAU/.X,HW`U3$9P'V=4ZD MR3IZ/SUN]R*/VG=Q^ED)R8]2:H[93T*X?HAE)DC'#]RWO8.U M\:L'\1PV;`EE4(UEBQ@3CL=V?6S1%-E)D9W;UJ37;QP]'S(%,ZLX;131-99H M1ZC#4N53K3P6156BLR.T55KMH>352JIUCR#5JDS3A]?4UF';/8;0,P8GIH_/ M7F@ZIR.1;@5(Y$!B#U!A8R\:.;PD&51/2!Q#'=QG[6HE80W]"!>A*O-/H8B= M*GE%"EDT5V-T-ON)$@]4W!KAI[0UPFM8.-N-T#A]GW1)8",^\7S.I+^8_`>VS7]9W87\AG\\;WGHH/*]QP'A[]# M>Q,,L.SCDB,A2.\`H!2>%)Q7`AKYG)CP9]OU?(`L'O+6'2^.(@&7<&?`WM-5 MVFJW;[J=!6_?"8&G75RWB^5][LV0-K%BFU@VCLQH]]K=L^_BIQ#=\+:, M(H'!F64&4PU.KY"]L%W0&QS']`.1*RF2)+_-<_![KACF@^G?^R)49_RKZ43\ M`_<_X3NK0FMU?=K9];E[_^[J1_T:%L=8/"&V3'1>K')8]]Q8J>@@,V3?&-<] M/?UI;>S6#H@G<:?P#DYHNA87<5ER]MO0Z.GQNWDQ60N+U+[Z$2$]PP*UKWOM M,RT02((R"X20[K9`]^$4$,3P.9]/N1O8CYPMR'&-?>268P:!/;$M(7-8&@HF MEO23Z7#TJG_B5@22QP95%T9PHC$7$6Y8V%N.J(G/\"0(JM9''IJ@*8_9VS@) M>]WZ"A`7()3#+<.5@O7.\Q&H^TD*4@S1G0LPR/?AP_T$0-DSUC!&),:C6.#T M<+"H=!T;R?-O^*UE1;/(05)D6X&H*S%DD%P':2'ZN#SRJ-@^;]F?L$PJ%^LDU78D]$$!B9(YS+=+#N/JQT[O"`CO$/)_(/3W MRQD!/?,8^U]<=SG0*NRF8[0[>G=P#/P/A2Y=O0$WYN!,3@*!1Q2KA5:A=WDFG%S MTSO*N7XJN5:,0@XDUUK#P5%T@D.)BR*VHK)*4$_OUT58'#U'6^\>R1)Q4&EQ M//-QIX\.XCI+BU-:4UN%985"+S2_)FF%+T;9RX0>=KKY4E^(,,)?TMI<`]H//)]S'=*P`*4?#_%8,'HLX M^T9Z;S->PMLHG'J^_1\^QM@N#7[%?^6/`;H5WW!+T"SK&!JFN1K,=,?X0=<8 M/#+G5@C4[3RSV!,)OWI1&(3P`03$2[;+8,MKFJ`D>$&X!G>R"&=6,6?(2U_! M(KQ3<`6E1J(0>A/Y&/(B4P$U)I[41$*X>"!8H\:4]_TG#FH^EG/**<6$,)V< M;<_Z4RMJT.YQ`ZO&\!6QOPV9'1>\B!I5S>7?J(8=:BOPC&C?Y-QVC[0=QUC' M[?CE:!E'PF\K?Q<,7:D:?V\)>UGA[W9%^;M"R[\K?Y?:"G2V(O4?=3OD(_=S M&4/Z]BOW+3O@XQ)W]C70B-_4N,FP>]:Z*WNY-]H%ERX7V$,LXZZ6@!,NZEXF M@ZY>7#X?;9&/O8#56`0A-8)3:J1RQ@JJI)WL%NAP8G5O"HG))82.MNS[G53G M6_8MQ]/*LG<&^K#;WGW9\>^MD8DLB%!S-U"Q;UCQ\$'@Q$;/+/N]SC`)\QD.L>5%-MK]H=$=%ESDS>*E1.7,+$MH+*86V*8@ M+*:X[5!K,X-9/*&8[YRUF(WVHO]H'SP.O@\G7..JKU.:V\1B4Z;(E5HG8XY% MPVCPG$RX%6)6D)C\%T<1I#(J.7)N-I9#CQV--MJI5D"M54V-K]=MUQ17W+8B[6#?Y MAK78ZG87+R=+Y9,K2T`'H180$K;%D@ZSZ14;_Y4"$^09%H.5E(KW\4?NFP^< MN9%P2'J3V$V9<5Z*#"L3AX.+5&Z!9-7E=O/4T;SPY.@.G0/INZ%M.LXS8`OC M8RB(E>F4NP!C+E@?XB'6O\?F<$>T[+F8QI894=)AS+SX\OPD6PS`)UF*&HM3 MRT=@"]S\!9%6DHQO5Q]J`GF4X:;[S*8FWL6M2'BHL14P#_Z&#_BR3@$^RL41 M@,N"+\0HB(FQ5NNCZ>!5_\F+G#$;P4H#JJUDI<82`E$0.]ZYPH*"6/A<+/P9 M2X:+^*@1=[PG%G!0E(`BPJD@B9'@<"27#(M9IF-AQ!)2Z\OZ;/+!BXN#GG78 MZN++Q9HJ7`0O6^O:T%?K3%UP@6MI`&1O74P&CD-OTF7M&%J)8EZN]^2;\Q^N MY'_7KK-8)?'32X8+\3=V*J)9JXF6; MC%6N!>R9&68_*;"E<<(%<,T&"M>;1-1[TPG1>4/I7!\2G1^GPG2W6_]>(%A$ MQU9I.7@;_;8$L6PO@;M")Z&A`N3"-%RTVGYA='6>NUNC8EYHSP^ M9"NA)N@\7\KXS&JJ#^TK-,[#B#U=ZW7I4*%#I4E$W>UIW5Z=E7TBZDJL;J6( MNG.C#?-\!`TC:C(8+:];'"%4*O"(E"A2HNB\J=GJ5HJHNT--[Q-1$U$WB:@O M6XFZ6/O34G2W]+NE8:`U59;J9?'5KSN]&C,>^=\NG8+UZV'S3PZBY`N@9)3% M=3:/[N)[(P,2Z3_GYCG2?^C4J"\%Z]>#.@=LD/Y#E'QA^L]W(@B3C>=LYHIA$6/\#IA ML2G=*LGB3U%JBY(''5WK4+`&T76CZ+JGW0S@WV'.3:IA='W(\-4F*&Y?5!5=TMRJ0)U5 MDPMM'74WTMNJ"EK]UO,\=&QH^E#7NET*,B&Z;A1=M[7VC:$-N_W&$W8%8D_4 MFIV]+'O\.>U>L[9]3-*/1K7M"W8X4HC^UO+\K&MF7CTL_F5!Z^Q M$0+L]DH3F@(M=KJ=Q?:6:T<_$HQ%.F'=='J#DD"^X7,?QI!-B#!JQ9QY?FC_ M)[?94?9A^.QP_'#KCF\S[^S9R:B_B$"1&4^(2\G&9,,*XU*RN6"_LP;QC\Q]$76?M`O#_U[,XQ\CI5+[N?DR_< M3S*/4\^UW2-'U[F1EZ?9I><:,UB+O?/\62KE7T4!/!($N.&91DZKFN1:V]9% MJ(^7V[KI5]MW>?C_V'\#)6(4\6O/GWN2T37V-+6M*7OBS.<3$&^A!Y(-OFHL M@B/'B_S%YF">S]1H&K,QH/G!?."B.Z9H`I6A1.P*AGVL8_CSW,0.:,$U^\)9P/GO.+%C6RC51!NSD%M3%Y![>-94]S,_L3 M@..ZW!(<\#EY4&[]H#MH_TW#X1Y-W_8B``;VR,9&GA@W/1==R&&MHXEIH=3S M$4V?W;_].=!D4[)H&02;!S&&8_[('4\.@KR7#H3@20:T?>8]N6SN>^/(`K'_ M9(=3]?K=AU;('3Z?>B[@-?.D@J^QB?V5CUOB.[:2?#Q!;M MRVA'GC\JG[#/M)W:<`?M"> MY"F><[42`ZCW43F5;V=>WN=":+3;-\N7K:(35@/+0G<88[@_DB5:K:]INZNQ MC\CQ`9`X^\3]1Z!(IEIN?>26!Z1^S';*`JK1N M(_99[NB==OF&\'O@>H8=K]ANTH[4@0=+&@CVXL'.H'QG[IKM>,5VDW:D%CRX M9(4X(@]V.TM6Y0;N>,5VL[([@O7MQ.WF@\\#F"XUO7S*7)B4EHOWP`]PR[7P MGK3)Z"9&O9]DQP3-.#-B.F`\7N+3(O-<5II[C/+>\)_0E!]$HL,>VZ8-@OF:W M\/,,)O%Q.AN3(BUE`T\FP5%"WP2EPI(FV:GYR*5EE:-IU46@K]EK[J.S."6F M.6@;OB@)HJRLV3=];CEF$$B3+^A_L``3SY^)C\HF)]Z<9[@SV-&X2OQ)!\GQ M#I)?`N&#?@O;CXQ$R@Z=(>C]_<84S3=@DQ`ET.X/3PS)!I,-U$SO(`)KF@Y@0 MQ?G,_)TS'G.'/)."()K)/&+IBS0G$VZ%8GA`PO-%@YI9&DN M;MQPREIA!./#XD2.B)")'`1]@J[HB>_!L3?U@LPJT4%W;BSIH%N1,1^57SUC M0"(RW8QE/0-QOF``"(HF/]WIC-S#@P`/#7]L8NR&.$1N/[UFG[VY;;&^WF-X MG(`TC:RI2`S`4!N\ABAY:_FVN&_`1<#QGC)W@AD/B])\@B]>3:U58TKYGK)VC=+K'(T92990+99)BPD MKBP":PPV:7<+&UTIQ:W"/8^$-FDT0F8$-O,M%C+0E M]*G`1.519!I+#3`HC$;AM!^2`"0!]I``394E%9!/A2(=SRRXQMP!H>4_B_!0 MSQ+&QC&&Q@;22;IHI`3:@)])AI$,(QE&,JPJ,DPF(3QS_Z\!VNQ`];(#&5R/ M@FS,,4[==I&W_X8VJHI*KV[GAN07R2^27Q$P@NGYN!A]+J63@& M0-_*,7_O*;&*2J@$Y9'/OCNC\G:$1?_"A:]"N%E,&!D+,,!IH0QSF#@UB41" MKP^0%X MN>E;V#7$S)M.VA3E@2:SL9Z3^31,XHL1\6(3Y7]X8IU$8Z/RU8RX*#,QCG:: M'Q/KQ/FR#,):"-1S"232UR1,H&+-\9O*&./!7Y6Q1-Q!_L:FWA.\YFL(M(FY M>4^+^V4F;P+1/"L7DQK"%AX]Z?E3V^'""W#5,9]A"4<8ZI1=MVR67-;&JRRS M\`FG,)W``VC0+)LSWO72`5UAFVU-&19#>1W^-26GC%5-T8!PN.)^QW[6;&KC M;]'X0;%,UN$JG):I.W;D14#O4[CM8F!0""^B)S2Y)2NGJF\"V7`G*PP$W6)B M+1<%`S!D*#N[YSYX(EET!(NO*5DPG+&;1V[E9$FD%_5"WB>"K_ZM@.UN?ZX\S!_C7RZHFP*LI+X M\#;MN+6;8ME<2FIL`$(5HI>^R`!84"VE/CH%F$%Z.3;0(\8=/?(X4V@>^=94 M)`()%2VI>3##;'D9X2-$NH]J$D`T%6+509F^%/D3CX3R&82FA?2?Z3A7R0B< MFM]B:B07[U*:*TX(YY91]55U#[A=4E%,8\OQ.OAHV@[>Y%J@QK7PRB2C$'UY M^_'QN@K286+:OBHW@J8\N#2R7UR?8V47>.#!M&5`/;8]YX%Z.PX.#.*R6:!: M^GR*%\I'#)1!]?":?9C^G]6O^ M&BP(32%;`U'D9,Q'L,B@:"MA*:2H$I[/0C8*BS*L@HT"&.4FW#Y=!MIQ+%!+ M2,;+9(@:B;D/<'7B/NP\DN3;N&X0;7#U)=["SJ45GU!*B"AF(=&FP/4>QF;C MY3$(-:4(P>5V%CGBH?&F6IJY8F9C]4UU2Y_-(QP\"N*`:(PA=[".$<+EHI?! M-W&1F2/D"MSVO;&R(8KKN+H&XQ!\$CD,C1%)X3<9V1V7]!(V$1E$/4&9"^I< M@`83V8LX%X6/6%S05X6M,.?)%8&,N$3J^)@"(C1(>9+,(%JB>`*P@ M?6ZP#NXX;/F2TM7:E1H="Z\]%YVI:2[):R![.V0?[>!WP3:B'*?X*K697^!Y MD?T7ELKVIN/C7.QY'_GRRHN[MWSW%3(PU0*%C)1UB/$._>1E3(^@SH9V&$D# M9EZ"T+HSQ`MLS`?ECKK)PXL!7SF@V_&.KAP/++1LYCA'1]C]A-3@+*[9)YL>JWGLQ?OWMR]_C8? MR20?*/V;2&F5_K$WW!(%6EC'T!@6M!`.FJDYUL0J(Q5H;`(;JE*DGCA:^ET% MZ%JLDB=B_'"TE;G8$YQGW[2'FC'H98;"P'^/N5Z(H?DV?^3QU%*OB$:_*9\7 M&OLC-PHPJ2ECAT;Q,.+/GC+-NV@T5W^&0]M#K2&VW*1U,P%0]W=<*9\[TD\P MM>>R8J:(Q$-P\!3V;0PR'HNYU>T)]R#RDZT6SHIU1%WRU"YG:MDH80X?Z%"C MH^0=:EJR+@[LSKN$5H"C0C^2!I8=C_"]K&%5$\BB"(#I^\_"$9WF&BYZ>NQT MU;+U8I=I74N3]T%7Y_#GD<,S?YS+"I6:U-]524TG6U)3>-6^"B5-<]#!5SR1LU;N'5XQPZR249FB2$28L(,.? M//>A]1-0U)A$5)U$%.8!(LI"KXCE5;JSJ=;NX`8[8H.5G(D"Z0#QTMX<(B@) MI8`JQV!-4:3(&A:V#U(.HY4L\8PKBFO/B5I2LTU]3U*2+*@^PNXF\`L?G@Y^ZUZ51 M$Q"7V\+'LN]!9I/DSTE0XW@9K\P%'+YE@JI6ESP5U>KV'DBOEN_])J*26`;Q MS()DU@`7$,=4-3+4<"3XFR/X/_(`M`)+WMG?I&TG:(NK+_$7]B[;,D1Z4N** M=4F%'-%K"N2+%X4HC)9><3&(T4R$?::.;2(#DY$P`!UOQAR459=S86B#TV`R M62.H-\*)\E&-/*ZVGZ=B-%@C,:,:3HH^C[2MQQN\"P338]ER[(0^9DUCE5)%?PD%2JOB"!S0_X3[0F38C".+YVZ[4I*5SBF0L8/8>S%F,T_D M,_W.$3T1Q^2%2V`=+C2^HJ;)0[%S=KL$5TEM7M`\=_D$2%:HZ;#*4>P.%K\* MYXPP,+FP#?8$S@IQJ`EP841 MD*2O.$UV#/!BN;H[Q1<);J/L4^<,]E`L:TQU2JNW=87#\#XS\;?Y"K`;F"O1=CPUO\* M5C?3;@R9W)?MK')YAV6>#K1&AWD#=/<("_G(%[Q?55[3"H>V'UK$843$)W0R M!^R.?1&Y=JJ7K0S\%>:;UMAV(K&#J7*SD.]EB^-%&9)4EW#/%X%^I,(Y/4ZZ"4E=1QF`J M#J_4C_O"ON;7F@I'1XB$!OIM?":FN"0OKP?P4WH2+K1BWI+$7U')LELD1Q$A M5:/;LNASCOV`EAHNTMQ$FB/HL8E]3G,U$5*;(@J[(+S!0W8=B+L;@5 MPBW=\9YY4@<<9@\]/S8[(N[Q$_*X;7DJSSK1Q%,G=HIN?KS@+\E=>N:-95Z1 MST/?"_"F*Z+.L3^&Q%RM%UH`QCBE>!%6&KU58\!`6W^34,TN8'0X,$#1QV;5 MF/">OY1B:P5F$B.U/FC!G,2.%JFC!(F:'P.!@8:RQAW>_1&?Q,42)TC".O+Y M&K6?V+YJ;'_G)I ME'.',C$78NXEA#*,+7LA%,1X'<5)FATSJ;G*"2Z%ZS53"@8CO M1RF/C;>ELA&;;J<9[Z:Z\_T-'P`UPY,&R]C>+P)FGO%%!%S_J>ZZ&EGZHDG+=F307/&M!&?S:?55J32*BZ M_?0JT?Y$3:W,'36YE$1SO'S$4<0F$)8*&5NXCJ:7SH?(EO=6%'=*'@>RLB%W MIZ9(%QJG#:*43JQLHFL2J&8>EBC+%#*35C2\N*9#"0^VJ'8XQWM?&N.7K126 MJ.!X4?L)PTY8)PM^YB8:N=X(ZX\KYRN<98'T1R5+`_-)T8QR%@><`#!PR$B' M[(@#98@*9N8$G4=QPE>*FM'3TB^X+]>+:,N[:NQP0P.V.)S,M/P8Q@A:89QS MM;UAY6)WKCI%:Y__5*@(#_]/Y/)U3.Q*_HQC1@4SV($,AL`R#ZX:G(7A'F80E%1F'TJU%]:E78T,RPMK_`B4^@G; M,QZ..N/C5Z7]P+D#OZM^B\IR)&A46FO@A``R<.Q0NK[0R14$\4QQ)7J>5/2< M1+[X;S;@G$M08-@'SQL+TK.QYCI6XC3]_-C[3W-N"4:`VY$F,$(@Y0T'\4_A ME*0JX5H`%?A"V(MSX90A*@D,680S$54H94!YYW.!Q+I8_!0Z%9_S]]]%0>O!-.X#0&@! MDW\&*/?_P#8]__J=6"MU7*9?[9:\K%XPN19\6@RECBH MX%_H8>?C';'N/I12?+3>(3K56'S:-=Y+\Q4IABP%EO:Z=VH M\"1;5XEKP0FUC@M7?FSC"!'R.>^_6@[_$%>?$88:H.VACBY&8^+5QX>?S#M MF]BEOHM6!Q_\?/8J]6CEGYXOV"2V7A@-4'>*S^*PG->BM0\5T)1%&/\HNN=*R!.RYZ93H"]DG[L=`?#X7#02_%;`>,4F`V/ M@-GPIJ'IP9,^/PF/7TOC$T.OTBF/W$'T#?_MD, M0[2WB&KWPG#T`'(9[[6;-%KQKGH5=.>%%ZNJWYXSEOJ8VBK6$&FQG^Q0-10A M!95LU4DDMKB#R\+_:!X0C6+07C"/"^7:[@2]T]+(ZIA/081&D#E7JI&(A0[9 M+')">^YP5/:$T2NOJ"&H9D'HVW#%?PT:6YH=]]8,0$ZXZ<^@CX&0,$&J?@:\ M?/A!!N1IV'X@0%,+JH'2WH95]AQ4#1.+3I"%0@*/-H4XMTI5!\."$FC'QH)Y M`>>_L[$Y,Q^4OFF[OT6NM*'X:'S"L+Z4@##2B,@^4>,_7W0$8O\!9+ M'DK#11=7YP[-,S(]"S;@LX\!FRC>0<5&L\F+N\^OOY6X)M$"MW-<<]#?A06/ MNP_F@]3:(U>8M4(QR!S;WX@>O2J@P\9,S5"I^Z*PNT@US?Y5E!L6)=^%N2?S MFXC,4&LYYK+WK\!(!%F(F)A9Y"IC.[/,>1JU+VURZ9Z(3FHBHH1F#/!V[0@ZPRQ4D]RZ[C1X`9V;(4IFZ*,MI8U2S M+,,2BPXDP0G0`\J.#$O$=_3#="AP&F7R957;/D@[$/Q4CHDXUG5<#> MHCB=^W8@I6@BDJ2$_QDDKP.8A4^>_WL@2.::(1G#&T[&J-U>NN4+P&+SB'#R MI1"@DV@\9K>/YK.9T&0@.@!.X`73I1(\=2#'+WRQCJ^428D`$J)'0T&CQ;2F M*7)"PA*[7T#QD-YU;X0_Q840XD9]@K+C=G<)82^J-JIK'=9:L"WA#Y.G-"@+ M(R<_Q4V=J$YR$Y"9+%.NRAQ@Q>'GI$.@%X4R:"!($]/SL.E%5;3XLHS%^6;^Y;WP(O'5:TIL20;K^,_S?# MA;_)DMK8#UL:;".XYX-F9G%SW9;>JD@#+'PM1)-ENCCE'(MA6&&2,^,DVRE# M&@*>)8.9O*B?H'E7F6(/-7$TQ4?8>R`&$4Y@K#G"XN,KT76$\E[@HK3#-2@> M6Q*>B$'(A%A+>E,":2WC;+\5Y;[YWF-3;HJ(9J1QX=F5'9+2N.W\:G140&03 M675CLOJ"+.T(DJ([Y0'NE")B%.O_BJS)6'9G\Q2PC!K&<7R8POA80OR#.1;_ MP?8[0ILT+=@$+YC&*15^QA*`T1OPNM`75_ M!HJMQTYBBA%!(6+MY.1H>L$8"FRL:_IJ_T1>HGQ*[BQ6')(_)2AZ:6!1``=P MG+61F6;I!55O!:,V'#B&Q\\JDV(F^[D11Q?AZ)1`DU25(J8W1.3$0M@C^*J@B*@"W516->6J',X$V\J M_51F,+F>Z`4MFXS$73>$6@<:$"Y/TMAD&:KM`:RCF`M2`''U'2!\H?VE`XIJ M(K["5I['^"1V_!(R!.5/7)E-I8+))AY8`0-_E&J"DW!:$LOO9\N02>$8EV&L MMBULU:U;R"64NM6$[^Q.AF*J%*T/(C=*DWTQ--E-J:"O#7^5@\FQY%!BH'O% M)1M=4?MYX8RL%ZYE7/W8U3,.N&VPE5^3VU35^V#:8]AL]MJ<8Y[4V58H!0DA MNG,5/-M7JW/UHZ'W![I^W"4[]'*_&&RT_?HLS\X'-10E<4<5M&/WXG?N/.58^+I_?>Y6YON+#-FZ<[ M)29Z@HE>`),JHJ`/8Q1D=,L6%%K#[BY;D2D_]U-<7E7#6H%2OMX*0]$R(NE+ MR3OQ&_*%_%B/+1AT^\-%:MHZS:FQ*$)*1K?3[^Z(QFV2D/'.,1]B>,?JU2%=[)(/B_8P>ZMUAK'41==E[UG'P,GX*'\)GM M(+1:1KO5,200ZX9)-]"S1#$0)>IS88F?D8\4!@0_96')'28!Y*W,R?B"%MO? M7>\)$VG,P,,2HT)*^UF(Y,/X[/_BH_&3\L'MD/V=!Q*DC>,L@_:KYP#-H#?I MG>V`LKD*4/*$?&`[(.^]+!Q+KR_/'Y/.QR21!`_(*`<.]63RH'RN]+KD#[,, ME@`6],"0/WC^\RHPXO?XY^TP_(26>TQL3SH4BP&R<"V,N`S.AVCDV!;PL6>& MJ\#(7\6/.:#T._H&(0-*A&'<=/1NIV=TLO!D!EV&YB-_0),KFE3?FS.^"E#Z M`/Z^?7E^M7V7A_^/_;?GC&7M/W^>A65QO!42XMA&%MO]C?E7]K\\9[O4(^() M>&`[1!B+K0_:G79W@786AUD!)*-"QNKE0JCC*ERINK<]PK&MM]OMK1&+-X:( M6"PVQZK$S(KP=_#'($]FII)7/%),:B[*RZ4AU@*B)/@64.13!8%Y]_<\4#)# MK`+S^7F>>WC@W[=/B"6/%Z?$]S+*7]HL+^E[+'M2Q7,^3JV7Z6/PE'A(/K.3 M=M37A5*Q:=RCP5=([]$'Q0'\F/2?##(0QB?+*J29Y^,1U?>.O;,8YWG'6%B(2HR1%&.(0OO:PEH,#)](V7;0G%^++$"/KIXK%3+Z!PN,>(RLX_\;J6 M7"Y1X531GLJ'G*>QD_(O\\BWIFC@DTF;<8W^Q?K"F?YD^04I%@:/"ZLNPAZ' MNF%E75>6\UMX"V!V/5?4@1`EAA=^7>/FRQ_IQ=7=I_NK;\6$HNO*B&>+O2ZB M]R*MF.QA#%Z<))645/YV37C,.E!A^O=B^O5KK%9B+4PK2TX'2>4/DH0+!6M+ MP0'#J[H;*E0FE`=%+"[+Y3S?*_I:HIXE+A/Q-J+(C9!4&/9AB_91JLC+AEDU MT7R:C?%P`1@]6S9EQ3BC,.1?RN!(O!I6AV7!)-MBC//_&PNUWP33&#E? M@#3RPM";)4,K4%KRSR]9>_YU%VHL"-3BUBP023C.`*M@%:M[=6[0U]H;BF(# MG`8[[.*FKD5FY/G`8`DN(P<8%3%BHN*6J@*B2H.@JLS]D^(:*RP9L_X6I%WO MR3?G/US)_Z[%.XL7NQ\I:MV7]@M MT\@66E))O%VP:?P7ZH@E M)STS)*]4BB\J1K=-Q(F.G2,PU9>XP\VMZG#S-C:/?$#SR`EYK+9:*1L]B#O^ M#U=_MBS.)Y.KS$(LW(.75T'=0?O=OY2S?[2&6^EO>'[ZBQO19HI(LHY($=8' M)4AIL^X<7^/_<@(MOZ3,34%;2^Z5!7J8#[38A.-!W=;Z/4/K#-M[WGD+K_P& M;9;([F+(#GWA`ZTW[)V*[*IK\B.ZS@7ZFSJ1<_MZF'.^-HR2UVA@3U,[Y!>F M?XDQL<(YUDU)0BN4-Y,4K2I0:]5$1(L4+"*W!I(;*59$ST3/QU.O+M/`M>"9 M)[VJ0F1:-<'PPM`ZQHUFU-J4\"T==-4#^CSTW`1R)@6N$JM;+;J^-LA$=JD: M7)P`0#I<)TL MJ^UPEXE;K0(+%!(Z99`ZLE`:=#2]8QQ?,NV6.$%43E1>DZ/W9/'9Q]$OB8.J M@A1Q4(5HCRR%^R0S#,F.6!M9XT=KMDSD:R)Y8+:#/0W8][68`_P[U MQMMAB*XOB:[;U[V;QI,TA=U17D.=Z+5J0J+YS@>B9Z)GHN=*D4:U5Y?HN0H: MW"6:TA:\OZ2V58A(JR867G2Z/:W=T[>54:RR>*"LB0H"?1YR5M1<8V(FW:T2 MJULIJNY=]SJ-)VDRP%'61"T(M6K2H3#4]9<11-B71-@O#*W='VI&=UCOVPF1 M-I'V:A;L"6*BJZG1[6R0HUP-RM6@&-QC6D\,K:>?P'A2Q4!<8B-BHX/9U`4? MG4!I/2TC'K>`B1#72O?!`C1WDBE*D;),ZD.M51,1 MS8]B)GHF>B9ZKA1I5'MUB9ZKH+]=IHENP7--BEN%R+1J@N%%]Z:GZ:=P+E?> M_555PB!J+FYXJSTQD_)6B=6M%%6W.]>#YM,T&>`.EV5"XJ#!XH#R2HBP&TG8 M+SK#@=89UCFEDNXB%03Z7-7Y^LV/:Z'&'Y1,GY)VEV(`/!M[TG25]9D6;5H$'B).*D0Z7,#/6^-AP2+Q$OU2@+ITHLU+LVVI?) M/1F]^KO0A'7/U0$SGPOIQ/I6E5C?I!(O0KX&D/CS]]\]3JV7GS#1Y@/HN)\! MCER\03[(T=6(X71#YG_\!'F7CVGZV6?!R'DL^+ MQ].GDV&9!0L)7S[RR0]7%JK/.OPO]/"3T>X85S^J5)^"<#I8)`O/_> M"WE*+4/68MG-7J7[M9><&N_7H?FJP?@?EJ@/0L%O36O*@JD)\LB;@&P1U"NS M!J=FP,(IEV$/IN,\,_/1M!T\&9CICL6#;,PM!QX9 ML]$S\R*?O?),?XRSOK%AZ-#S`XT%T>@W^(S3(1)SW_9\B8J`+P,JS,)@O"#@ MXJL$V8O"((0)X;B$A7C$_X@A[/`Y'@67QTMQR%V5>Y?]3^1F9(31T](O6%Y# M$^"!V)B;[O-?@QQ<4G1-%LRY99L`KQE,DZGQZ6_TZY[.YK""R68NCKNP(0!W M9@%@'@_G1%B=YPRL2Z#F8PCK[W-8*TPW-?W0MARYCK8+H\X]WT2_*3.C<`JK M]Q_.(K%L=A!$\'F.GPU=Q]!?_%="+][_YAJ^&Z"S^*CKP,-9#*X/(UN/)T8* MG7`CGWVW#>1%-6.S;I"H'%],'S-'@K4Z1OS`X=2*,R]E[90%0P=M(=Z&*E*S M4K+507@^/?M$L!SA;+YS)YX_4_)O!"<*>XKY,GN\C",?_X/B.GSB#IR+P.+A M-(`C*LYEC(=15\L?KO0K\3V8FU;\ M/;Y[Z^G==)?[I'"]9&[$P'0P"X#4OBI\.]8+^]1V$D<["6.$`WTJ>3<$].6WO4*G9$ABVUK55)\?IVB/R<+;&VJ"2%4,D M=D[,>F]5ALWE")L/OFUQ<=&+34UX8R*90S*'9,Y)98Y0?2]&[)CAY>!:L@0N M25>2KB1=#[5+K[AESCC+"%GB/N(^XK[3WJ?(B$%,1TQWHEWZS/V9[0H'ZG<7 MHV2_CO-H+PCGMU_GMD^RE60KR58RUAS76%,RR8J$S@:A<3S4,9'7`QO MO@$];Q=>7$A`+7^Z'`'#I/I5%81@E1:W5OUDNY?0SH** M?5^6>+X4Z4QDW&`R;GZ;2!++ET3/+VHOE[>4E"\29;"AT7N5`L.-SW6E1:6M]8ZCIG?[Q M6?*TB+TP"G9=VV91/'50\-$/H]/NPS%LD*?%H'/=&S:-.PY^+:X[EU!OE^.J M?(:F]W6MV^T>G).:LW/%D6H`"C7:EVIRU.$O437QK<)J?_9"TRFZT,UMHK53O8RZ MP%WS'2AG(Z\&*LUEDWTMY=7`HE:=&H^MX9VI9:.AZ<,3VLKKN7(E\YA0*_XGAW"@DZL M1:Q5$2-ZI6_Y&XSH)X*[:&6)[T1[R#RK;/GFE&M;A68^RFZ42XX#2=%)7\H" M?2H-_1"-*I/M"[UYUHBOQA5SP5N#I=J>Y7?OLP#J/=_2)WS3[JVUEV\!=OT> MGK7O:FY4^3H13[CORS[H9B#:EW_BO@UOWB7M@'.Z6V_U'1V& MV2K9]'JE6772YUHTPE9M-]D;V4?W`ZRF-];8K]@T7$O6E"6M+5IQXSSQ\C]^ M%CDR_VRI4"U^#VZ]V\*],TV\)R;^2V;&(OGA&@G(;MGMM M@$3T!)3/7K'(M>7,O\"T5]A-WIZ93O##54BET)HSPVX!1F,57]- MAWTP[3'0#7MMSNT0OM=@.U+H$?@[5X%^V*WI7/W8ZPQ[NGZ&[3G6NE85WP+R M0-!_%&Q M[=B5/TIM#?!'YP:/CRKR1[=:&U*&/[H-Y(^*;<>N_%%J:X`_NL-N1?4KXWI0 MI0TIPQ_&H!Q_U(`]*K8;N[)'J9W!XV/8KR9W=*NU'Z5.C^9Q1\5V8^?#HR1W M&/IP4$WVZ%P/.RTL_U"A72EU`QEV.KUA.27KIOI\4L5MV?DF4G*+@%_ZO6'G MDOG%2#;&.#^_#(E==MF5$[)+1^^?AUV.M;3GQ5KTYV&W2T MJ`[T8;>S<1?6('6";=C52%&!;=ALF5C>!IB]<],U*KD-N]M2S[\-6PRH.=NP MU3YTKFW8W61W_FW88J>KTS;L;AHZ_S9LL0>MG`WMKZ@DKNPI\9^_JW8KJ:OB*:;P4U_BXVNX=MQSGOM\G8,>KU>I[_7;MR.?XN" M$.$/,"!QZ=+*[M)+ZSO.`V:Z8X8XV4$`3P6%+KF9M<_,]ME;<[O$>6[=<6:6 M8QI]MES36L+HJ0A^-^@/M=1'7\83+L5K,Y@Z/`@85P0)4X^Y_^3;(?#N4\S] MCW@!SB(>OQ?3\2_I6S&)BTOSGI=SA631VZ+ MF>\G:M![7XP83RKF3'X,U*^!FFZ5<]2J[B[*V]E%;5_]B%BH-=T=SH:MLM'P M5;;=DZZRG.XDM-P;[K'*$LZ&K?(Q:/F@J[QR='F3W-.KY#UT^82XG^2<$:57 M:\LE>%(P M>#_9R3)2R/_&!=E8?C0^?C=^?_SF*8V/E(KRL8.0@ORI0:]L.O[PX<,D?[HC M!4;$PGIG-GAO--KZC[,$W^'92/[^=G>Y:[TFG&+Q]"9BRXE\-CEG4;;$5)S2 M^`L51&PNZ8SQ9>XS4"!G)C8K?'*4DN4JP<5G"XYG)T?K103N.#X^?K=UQ@]V M=A,?#7_-$`>4))L+0L%,@I(2SV\493$!6'GHZLK82^LK(LCB]8-'O M'L(KK?WZ"##&G./85X4Z`S\\($YAQ$RGF-\O$,<^8&BP\-(DM^(,AJ@8?+O" M-/7-7B9&_EIY]I)26V^$$B&3C4_WJ+3V1"A;82XV7M@LFOIY/5LN$=_"505\9^HTTQ>,/LXRQ+"<5I>CN3($34QXDM M_#PQ15.P,I93X7L!/W.``%>4+BX2]NB'M%:>O>J:]ZL%2V*8NW_Y7P:SO',8 MA2(B9WW2.QPOH->3-=X.EU0EZA88`$13WHT\7!5AO;,L,[HV?[;E2SR MH,?T:5:9Z<':GJ%$UDKW"XQ%KZBT,>Y7ZSX5K>H&RD99DOOZ"OZOR,%/4!#$ M^T)+ZNBC?"ZN$)BPJ"(DD=4ZXU5KE(R\Z)VA]"&O?+-T/$=H-9%F3G`BTN*3 MW/#QVV-5GO^@/O[MBJ`'DD!AA5/H#LVN4LA,T`-.3HY]5.I>I[SJ,,2C M0A;\6>E;S04?13%)Y61**U\T'X<:VQ9#'(+:Y*"B^?>6:+ZD$YQG>LQAJE1Q2AMGZ2(= MQ_#&PI(EGS/.2ZOXS>ERC:`Y0=X1#&;..>9D#4%:XT*MS0W;9I_3I5R+JEGG M3*^,=:`/`N_U4+'NIIH`KUA+B#NP#`_Q,/?@&8Y+&SYZX+?2[4L'$UVH4'`U MS0$"%E8!3NBVZ]'I%&W00X(A=2OU6[.@1\L]/-Q;!@P83_/=(.3.W''2&.HT MP]M?QFF&Q4DA];PT+:UO%IVJ\F'17]2'`TXAMGN_D,RVNMQ@<<-HI,T+;L2[ MR8.=>#@(UR+!.AI6`>V6?#L]L//H#FEV`F7YP#R8VF0$U=R9PE@5HNP"ZERC)TTI$AW,,H0 M;3N'\-9GMIH;9FBZ9Y4Q9?CJ5&[;RQU;^"5=O4:)W`<]%9\1YQM"Y]I%IRYM MBI4HMS9#@UDST?2Q5@/NTNS2D6-X=>HE7>.T>D9I-UXUGNR&J-*3`,-KUMP> MQ$J[\$:BHH*YPQ$&A,'H"0G47DC:2&N5HYXTP.AVL,T>;CNC\,:E*</=S*/Y:#?3*#\*,)X6W>WQJS9TW!D8N,33=U<'2DMQ%W)G=;?,'FLK'Q7Z M'\,)O8+FER=Y?-E>%KJ05KNR@33`Z'>PS:FK&QBI^/\4T&I=LXZR50Z&PJG6 MI"7#?9K4K;R"_U_V=)[EW.+S2#><\QRJWT-6:I[,51U=^TP!H/9LP&I`;;"H MGJ;>#VI4!E:J795@H!JN5^I#P%PMJG33"J]M]6#@H2OZQD-7?87F%^`8Z%"" MT`S*U'T7.L,SQG%IP^V:4,;S%S(%YE`F01*N\,HVQI$YUM=%1SKV:B-KLA,9KKA^O$0(&+N/JODB1?4568ABX[A+3Y] MHQRCA/R!XU\0H=*Z6[H_[5%/'8[4*@BMU-\=?+OY;T@0MVH:WN+<;;73:>9_ M%@KE_5,(D\,Q4M"22IXGH?T$ZMN MC8HWI!P;!0H<+YO;D>/*-KS1X`ZG&+PJMP3/\1HG+-_OU@/&B7;WQH^5-E!X M=+&P'14MW,+;M[EC&Y2(C2'ZVH=%N&L/0XVOS0:'@-::!_B.AVWNQMJG0GH? M5)>/-#P"'!)5K.Z@X]'&(1+]PRJ6=P^##:;5"I=(UADX#D_?007:7@(-675J MM0OP)'C+*O80:ZLN*^,OI%=+;QMHEZS7:U:"5''0K;_]345A';J<8DXD/B.. M48K/\?9W;=CT:6H]@FEJ.MRF!!92Q2EG:P*Q/MM\2^7+7.K>3#H_C:">RU\N M:>Z9=FRXWU!U;CCDT?((XSC/9Y=IFLE]]/Q^L/J]AOOSY6[T^T/F;?2#CF)= M0\NZNZ`^,#F*5,?6VT2%MZ.B5[I^2:<53XT;/6U@JM_A^=J19#"^=QCMY82W M>%76.`?Z[2J?I'UYPCPBZ7ZLUL#(2J]!DH'^-8/)Q04]XT M>`QV\(.%U`2R0%XV[0E6[DOHAP"I=4%\:.B4:QB4WP)Q MC40F%_QO9Z=K1!+Y-B9,"N3#>QS))_8)G@<7737:AT30&W#(=W2_[MF`:0Q6WB8W327 MY*1AK[J(9ML_H#+H'*\XCDAN'/R=X#Q&-#Y=,B[('_GG-11T:;)[O]RER6O# MC(7Z M+#?B_3T"5N+7!J1.QA\`HS8Y"D3_"!I$+K>(MX*K"Q,CZ-R8O'XP>CBK5Y"Z MR5?@_6O]^A`_9?+]RS`N`C7 MM[3B.Q>A<^6K6L\7>;7F47F!X3GB7WM'HF\1]9/SO0=DN4K8!A=K0<^)M-)8 M]%PB+A#A^1WJUY"K,UZY1Z5WB"&@%E/&Q0S2&'LN,?MK4)Y+PJ\9X@+S9*-. M^J'DDLZ*P>(;15D,`W;\7-+/693),,F#3#`HR'0L``!63```4`!P`=FAC+3(P,3$Q,C,Q7V1E M9BYX;6Q55`D``ZND3D^KI$Y/=7@+``$$)0X```0Y`0``[5U?<^.V$7_O3+^# MHCSK9-EQ&WO.S=AG._6,'3F6K^U;!B9!"0T)*`!H2_WT`2A2IDB`!$'2I*YZ M\9V$Q6+__!8$%DOH\T^KP!^\0LH0P1?#R:>CX0!BA[@(SR^&(1L!YB`T_.D? M?_W+Y^]&HY\AAA1PZ`Y>UH/G!0D8P8,G&'+!8'#I.-`774:2V$?X]W/YYP4P M.!"#8':^8NABN.!\>3X>O[V]?7H[^43H?'Q\=#09_^?A?N8L8`!&"#,.L`.' M`T%_SJ(O[XD#>"1AJOOJA?H)@Y/Q=BPMA?PT2LA&\JO1Y'AT,OFT8NXP%E$V M&PR2D*]R]+%.D[.SLW'4NB45C%`!ZY3:$3V?;(G3A*?1)Y:(K^^P1V@0F5:,&S'C MZR6\&#(4+'V8?+>@T+L8OBX<8;7)9'*\L=GWQ>S&-A+^&@(JP.2O;Q$6UD#` M3_'\BD'H(H$^"UE-&5M)?8\XFMM:,=W9:O1'$9"8/Q+*/>(C8B%"CH.5'+<` MT7\!/X0/$+"00@D-"V'4;*PDNA,S60"?P0HR"T%V>EN-?R-&(6L(K\2TZ2'^ MZ`,;@"BY6,GS;T`IP-S&&.]=K4;^0H*`X!DGSN\6@^_TMHL1P1A2"EU;$;(, M[/``*!8/5O8(Z6P!*+0!0XZ%E221%E?B2>8*VRXA9K:SEXZ1O52649+J:XU0 MQ.5D8Q,>.[TM$4J6D/*U%3:3KG96#X,`T/74FZ$Y1AYR1)R+M1P)Q3,=SQ_% M$\%!5A.H*6.[ITWR\!:KCZN0(0P9FWH2A`#;&+&$GR6F,!-:NG+%/./B;P00 MP16PQ:U/WNR05LJS45FCN%H0WQ5+_)L_0K'*NQ9/(0?)59^T#H4+$?7H%6X> ME_>$L4_Y" MBFLU)WSL>`437"N#FSP/6A_8YOD:R9=(Z!-G1RQ?YC`)5<(N@IP'V$N$NY"- MY@`LQW)6'T.?L^2;:)X?'4WBI.7W\=>_;>46MH!WXK_;QX8/7J!_,=03<,2E M=50$X^[4R9H^IXZ.8*M.GF!7G7?\7-)=Q<0TDG"+9Q3+R=&C)"@T/3'0Y%W. M\T&>U8"3@8H%H>+3Q?!8IO.[:"GW2X5K>IY_>M]#7 M,*C+N<8H^:&/*-F`NB),-)V*<9+KM$]`*=;8&BDYMC%43CN%RJ7[WY!MTJ3/ MY-)U(\V`_PB0>X>_@"7BP$\I)/_*9>@7PG@60$VPBHU^]#Z9GL+KQ/.CP6^'(2&?M:62%F*G`M4)H&''=VPBH M;K-F@&XT;HSG'RWQG,N-BR^,X'D+(=LD>@+$6/J,HP(:]4PJ@$_%9&^Q5FJ1 M9J"E&B9&TEGO9\:XTF:S5K)`G;)_!=H]1(5>TYKYV0PNNLWC1\(HCK:_8@J! MC_X'W7\27YY._2R,*\^[IW@&':$31V*Y31$336D5?X%\ZHE=7@9-;0\3>Z:] M87J)W`^R:CG>VQ,DB9)NCS!T^CU!QP=BLRG+G",T;#<0MX3.@`^GWKN>HHL? MNE!L)81ZF_X5HZ7IX4JBIKGA]BIZ6K*R?10U)U`23=V>NURC5^1"[++4*SYR MC9V)@C*RV*YZLEZBSE"K[O9`8`N_=`U\[%IE6ZQYIJV73BR2O]QS MF=Z)NQK-=Q=M3))-:[*?S28?=(K:ILNHI-MFUBGL;S#S:/KO$[B, M[5!O!M*,D$#,-L/]`4FL&A@S8&`R?7T#*#.W1,UIK`1G7>?/8WV>P8N?/653 M-V9?J8@;V_1]ZJ4\,X\7R&WBS=WNR;I$.HI/SAV".5SQ&S^BN1@R.$_?X=&! M$S>O1N'@2\<)@]"7[YGJLKOJB;MJOV02 M-^_75V38JFXVN9LS[P5^MJNNC$;LO$)EO9;][=AF-=N:PW>OZ6C"XSD%Z_M`E+LQ+.3D],S,S\6D&9=J23=!V^6ZUC9H4J6;;SXFHSX@V%@ M:NDRWE30[8$KR[2KZD<%OYH)@V(G&JYSM'19)^[E.J=,N\I.U*YS;"LHR[>Y MROR=IEVUL>T^3Z<3EACOU+5^2M(S>CX]3$/D,E&FB8@/SK99^*TDR5;!<[K< MFF)7V*/<6G%9U2^%Q][?O'I[@6QG1^0W'\3MZ"F#JJ%?:7*WZ1;X$-/7B`N`I?4+S M!4]JYZ(Y=MO(XM;1S* M//KGQ$.9QZ',HT*91Z/''X7QHF4^N2MK=_5 MO24TV%Q1B=VKD"$,Y>&!+"`!>-W2F+,P"`!=3[T9FN/HCDS,+QV'A)C+.V>$ M&1P$VU+XD1(!.-Z6;M&/F6Q^D*(MZT6%#SYHZ_>L(_[:7TYJ>+#D"H!L&4OC M3H<>I%2&EE"N1=?'=2DMC9`]Q&K:&<'2)VL(KR`6+'F+&-O4I#V#56MA?@L0 MC4J"'B!@(87I@Y&FP25F:\P?">6>F+I(2Z/<"R;S-D/QUQ!0#JF_OD58/!(1 M\.^PESP=OF(0NHB_7X[6\.#7Q`FEB\13Z$8\!?@Z-?9FR/A)+/_(G]T3W_P) M4$L#!!0````(`(Z*74`V:Q^<.4```-AK`P`4`!P`=FAC+3(P,3$Q,C,Q7VQA M8BYX;6Q55`D``ZND3D^KI$Y/=7@+``$$)0X```0Y`0``[7UK<]RZE>WW6W7_ M`ZYGJF)7M1\MYTS%IR8])>LQ445V*Y9.`+W)?8`#C> M;&"*55X3X33)_O$S^;_;J(``.\F*G[\5R1]?/)3E[N>W;[]^_?KFZ_LW*+]_ M>_3NW?+M__UT>;UY@-OH=9(5991MX`N`Y7\NZ,5+M(E*^H0=]6^W>=H8>/^V M]264(/]ZW8B])I=>+X]>OU^^^5;$+^I')+X)=&Y0&:5NGI/: M&S[KP(W]0W]V]6IEC_S9Y5O&C(03O.6.&_N'OH)Y@N*S+/;_X*PK5P]_74;Y M!%`9.K/_`?Z?FO.H*;ETB?_J^87?2IC%,&X\$]N2V$E=TV!++;>VT:9G-26] M",JY/X<:O(N*6VH5]V+W4;3#UI?+MS`MB^;*:W+E];MEW6W\2WWY[[CO0_NL M++[`#4P>H]L48C*?[/,<9F7CC_[4/[[0$2V3DOQ@N>C;_H\EUGL_-X<%VN<; MR/C7>>2_I[>IT;OO0:=Z>`,_VQ0_'$DX8/;ZE^L7((D-U%>-!,A;D07`/=:_ MOSW\[.&K.L[[X(CR3?,#\)^*'UU+O-T@W&/ORM>]WW^7HZUF,R/SYJC?+O7X M,Y!I@1(!?>MO`U)GO]VG)#ZLRP>8GZ#M+H8! MO4T,,8PW?X9P02".$_*!%Z5741)?9"?1+L'Y.TMVN51#:I&4+7GY=IV25.I" M2D:)YNIP$^SP7?R)#3;5_90Q1\?" MBMP"+TGG]`H@S)X';`T"?.TQ2O<0H#L`M[Z24M];,&*>17F69/?%%XIXM1FD:Y<7A\JNP?)(W,3)HD3YCN.)=BDCL M!>/$250\'&D#_@03HLJ\Q`@2S:K,\Z+?4N"PW\385&O6_G&HX[ MT1SY2&2JOJ(-#(FQN0"W\#[)2/@C']A/N,MX[G`5?%S[PZO]A[:V*Z//[1U_ M1`*\=4?!*B"#W)_0`WY<7Z1E1"SH"2S%0P+>+?J5]*_9)]3@)V^0`I$<`=RD%2RX=E!;>MD/H=]R'> ME>HB>:CMN,F-.GQ9_LDS;-+:N,]N+@%R[?MJ54$7J]NLPPYSRCBTR6%4P%-8 M_?&;`$'G()`Y;[8^SUH\3X)YI7."&/6*U2NHF^ MP>;Q=6*(7%,6.$2:/J(%WY>'!1+FWHW#@\3:JKH.RNC;7*:CQX!&17IU:VHP MG6]$26^9[VF1ZS`S-/;K$+0TKZPDP-<[LA$2?V'6BP8%D^/FBL(.2JSHG.4B5WXS6(57,X9+C=7KI@K"Z:@H($Y9 M2:K:25%_GANME;"1LEJG056<%MF04UKN.=S4(=IN479=HLT_Z'1F<;PO'U!. MUN6P$X9JR6::4"9I.[HMMNUT2E#I1CI\K=!>50*@(!*+:CX=,Z\5HC/NU=7` MT^PZC8Z,6X<9HQ8K]4:F5;;GPZ&+HMBK^=.7$G&GD7+-F\JN5\[T7!CQI:/) MYTI"!6;,$Z9Q91P9MH2"'Y6"E!M=F_/AQ7I?DMH.I*:&BAP<41%#>J*N:=(Q M[I4K0S]&A&'5^:Q!!ZD94X?7]#+^")I(0:*.EI1)`^MSH!-W09?@]I`VCI9I M,08]T4-[\15/A:'!+LKK_2'_^N[-NW?OEH?EC."03?P,EN_>+=Y5_VN3LQ+@ M7)[L; MRG:A+;+D!0W.AJ;%YLVAL'RQZMQ8@/K6]PL#P?CP&!R$'.T=/I%@=%(=!C5+80\AD[6S7CT MX%!*DZ0'E,8P+WY'%\263^!E#.^235*^>D9(THZRYE`*&75/X1W$#W28_3O[ MMH-9`3_"#+M7I)2V9)#"OLMO1#U7,B;I6%A]AF6GRD55M)1IX"$47`VA40_79I5#L4DS+1W":X>TA MP5%[TV&62'MUVN$1J$DT#P[)&IG#'T5K\+G#4>+Q1FC;+Y*S6!,N8J>2'&.8GVW MSN,DB_*GT^0QB6$6LYM*-"3K=R*5M&2-Q+:'/7-J;S(2J;17M0`M+5;?"4L1 MG39&QHW1IXI$J4L7I6V_0'*6L6CXL<#0L@5105#4R(!6Z#GA29"NN`%4R'2E MJ?H"8U))&'_/T@-9&.#*A9KJ7P(AVWI?7+,>OA&ECJ2EO<2*U>CE:W*V3$PK M8C=W`Y?ODKH.`NI>EGJ7AP;^ID*CLVANY-$)$)=-S?&JM&XM M3][W00-<_S`8%?0._D`:>+SSS?78'T.UE=G7XYO+K#`;`KHJEH9&37)8(\?3X'9T">V M&9@@-]&WTZ38I*C8Y_`&?BL_8I?_X+)$+MJCBDC4"5_XQOU4?5"Y4Q-(HM[4 M=:";M.?`$$4+#VBB;@D>5_A:0\+(K'L&DLLB#$I'-AA:=D$$#D+@5R(&J-PL M@J\[:(GK)SC!5MB4V!V'-RB'?EUYU+H#H M,4I26@.#E"(LHO"E0X;M@I0OE$7NX??U@,KHSF$I]W$6=Y>(GM$%H@R:=,6' MR[H%XNY6YG(=^-SH(G.HN5!7;*+>!--9ZDTW>A6<-;RS6;@K1P1_^:ZRU81K M>+F:@I6\$B\3`-#'`G&I,UOT]??=4."=/6.HJ=>+.\':3';L<)]/O7]'2TTS M[/O8VR-UY#+C,?1IP\7^N,SEQ?''B\N+FXNS:W#\F0S-K$_^_*?UY>G9E^O? M@;.__')Q\U_@Y>G9^<7)Q4W@95K&P#&@K-&F(:D%$P;/9&2'+,^,BH>K')%E M#_''IU\*LI"^/I4INS\F^[]YY83-%>MW:J)H26=]5\[S.F/7,EX;&JOVDM#" M[+4&N'T"=XTTB%KQL*0>`2%DV[A]8NO;Z%+;U/.D*':6')J[=0?A985A>KC` M50?#+XD62+)7H%4$QS\@F@49YA1P#IEUZC^I(/\<;\"X\W*6DYJ[=)F=CO;N M)A@P,XDD'MREZ&L!".>X75K@?<<6"!L5#=3)J[FM<<%AW@EM-4(Z(J&5*,IC M`E?13RS@N)HJH16['A$`1,;X">W+?9,,)(W>W%-;&9C4]%?:>V$K?NP*Q.;5O%N:>V7M!LEMHZA?,,4UO.DYJEMAH&C+LQWZFMQ.4$ MJ:W:NYM@($]M>5W:/%-;'82-B@:C4UN)K7'!8=ZI;5OQWS2UE2C*8P)7T4\L MX+B:*K45NQX1`$3&5*DM:O3FGMK*P*2FOZ*9M6C/L:%!=Z'G2?'L.[65N'4' M9G5JVRK./;7U@F:SU-8IG&>8VG*>U"RUU3!@W(WY3FTE+B=(;=7>W00#>6K+ MZ]+FF=KJ(&Q4-!B=VDILC0L.\TEMJ\769*_8D/[#>P=F=^_9D_9@S4>:.;"N MX!LC3[O7>@U_55XI.&TX+8,T7N@`[`LONLF-LJ\2IC+MP%QS1LU\O(9 MM+(XT=%LYF&Z8MW.1P[[UJ%EHR8^JIHX^9Z;^,BVB8]"GG"#^\;C+";_(8OQ M'J.4[)RX@GF"8O9$109?8U2;DW&,5&U/S3%PYKRG&^%<>N2.J;F&7M61PDE6 M#;"09>?T#W@P$OA8FS%@0O:-S!R'8V"E=U2.L?>),>UL4&6,8Y>`7M8?403! M](^.U@)4>NT!LITCM'\L=`NRCJG@'72(!67M5W75S=8ET-E/*95<\UDEEK/- MRT26G0Y_*)Q(LS6I[NHBP]\`L&BRMP7(8.!:,.HV18:OGTGI1"J]]$YN-Q@Q MUOV'XHPN2"3J]\"5L*0!QZ;S+$SL0X9_D593.Z`NZ]P=R4-9X#Q*UH9(^Z7W M8<\1[@)>:,L/,)RE,A+[(U"!$Y/#E$X#D,OPW[-V@!`D$N,0$3(M6)Z3]2NSGWQ53;]@@/,W\NAYW&N98>]#'"8O<`F1P] M16GY!-!MVI0P3B'.CI+MCIY$E-2C68$/!!D),.2DU9ES0\P,]L#5&G%,'K43G&\+Q]03CX_ M!IFYCG";B,N%K?-NF7FW:;:&)WE6K32P:F6J$JF+ZK#2`D2M'#W.M+H:>+9# M$P9H3&.QV;%,KY\,JSW,BF071;'7(EA?4$*N1M`#L2K3ODG5\V)*J(ZRD$P) ME9DWD9CF5I!HV#!J`E4Z*O)T+<^*..M]690X$<(?MQKLX4A+*-23]L"CCGW? M9!JZ,F44:T%(*W00G#>W>&!0$$S08FJ6=1155!OXF`G?KJ)\G=.C@>*_1ND> M-H>&2VFG4N*R3ZSDE(0B-_ZXJ/"H3TFIH2$S=U$.'HD<)62,TC3*"[##'XZ4 MG+/BIA(Q0HKJM*>,J2)],6'E'D/R=AH)!.73^N[XV:= MS#G*R?$"X&\P\C`]>`K!LB4/EJLQT/GR60T'`7&5KB3G* M516Q4>)G9KS[6Y3GT?!,0#UA*>,.PE[HUICWSS7&DSG1>@88EL%O,-\D!21$ M^UK+S9%D@Z97,HS70#KT:O34W.I[F`6Q*-'7.[K'Z:QNVN$D@:8\+P'FR[M, M=7D>O"6U$F?:Z:O0AH1J:#>#;6CZ0!`EHJJVDJ2D>^.3Y#MAZYH)C3MFF,J/@EQR]54C0=>SP.;V#';( M:+4T,F^1`8^$6@R%%-;GQQY!245M>16/G!5,5'J8A%$&Y1#U;!RX]6MS/?3B M+^VFUR&6NI*A4E6+8C.I4]BLZ[Y!QQO\:#D4'\.N(]JP2RIJ2RR)<6U.?:@X ME<%[,M4B7<6L=B=EE4I]=85_ZT-4I7WS&9G4:6QDWB@,E21:/18IK7O&E+LU MP!J.;."T;+?+T!=8"X&+YXHKT8I;1\`*NG*6?39A7Z(*U$I%4=B6*+HFG-#5 M%"%=Y=R(D7)CO7"_XWZGS(RA:O3(^*K5K@KR"FU(J:SP/"F`_?4?2K?NL"OH M6QJ=!=U&A;^R"9C/?CPPZW9%'M`W"Y=>ZMC<9=S6-K#K705S=",M)@_9'8UNH3T&U M;I=ZNI[",:[:!/\%/L)LSR*:?[-A$G/3EC4]*T=A55\#L+HX M"Y1*BJZ*WR87I9SRJCP+P5!Z#=.4U,"!&7KZ74:: M>`S'5+(Q@GSTK.](&?-S<@:78$)01[1AI534EHL2XTX9J/8CY9U*?76R_GR] MOKPX/;XY.P77-_@_G\X^WUR#]3DX.;[^$SB_7/_M>C:3@EK-C\R;B:&91*M' M+J7U.5"*KJ)Y0&D,\X(,+Y1/:FZI=88DD^FX8YO8BX=21R9^-6FHL"/CX_7- M^N3/?UI?GIY]N?X=./O++QGIZ=7YQR:H[DO=!W?N_HQ.8Y5/@DV]-V32F M>]"CC>>.8*+H;Q?R%7&^CY]*!!R799[<[DM:Z1Z_T:LH)Y-C\XG<[@`FC-'V M"`L9C4_2J"C:[2_K_$MR_U`VZ_*O\J2[-Z:^RRXVM#'1'$\YRH3MD7XCG+H< M!K#P+SW@;ZS9BN)-82QR;D5U8B5G5QF(RD,!$;I6?Y:U1:R0B=PAA3D4<(2U MWN&`HY\F7,ZWW^U2FIE&:3.J'Z<#AT8N MI=V]@:555QC$AZ*R9#\WB1!W6!DD!^W0::4A;)!5FS+I@)Z!7FY@XC,8@ZO# M*&@]F:LH8;>A"N[6[V9PUY)YC#T/JT[Y'F2$XFE4!^?2@D-Q=6Y+^0#!$XQR MVKO.H`B1J-V0ULON0Y\1[$*<:\,]")Q]2@EL&[;_LCVWLBK/1*Y_C\TM^/(Q M:^^0WSC'10'+XF2?Y\,%^-Q[]0]E[ED"MF?--"M0'KC*LR[#ZU!^=4-\@$UU M"414("Q>^8V#--YI'ZH]L2Y0.?JN6]E94.):-FIB')"J:PM07_W>FE<0BO3; M=S9A2/#)(Y7AA25GGS-VM%`;X9 MC1@@\Q]NQO%0Q?(3),_)3B>*[C=SA&CL?6+0NJOI,,*Q2[PN#X"M:SCT2SC, M],S/B=$M*N\P$;S#EG@H(&Z1!_R8I_`1IH@^J&!7KXYL6]A!*FM=TT%BW6TY M![4C>24'E?ZJ$:'$C`]"H2LYZ+0U&M$D;/T&B5J_=(/2?N"1>N[0/'TQ]NXTX'RF_\1#Z*HQ\^$@N<,I/@]S>_J3>KW9O/DWDG3:CM]*(?O0 MBZS$KS^Y36'U/.J//0.-=DV4AH;U$AFE#P]?=/I>Y>MI]*RLKJ*2Y+U7*"_O M4)J@T"ML](&`1K<4NQ!'J=Q?G*/I:QKT.5RTI>W/`?#HXJY&LHEDL_SX\@M) MX>(P'Y@,NE'F,"QYFCPF,@I'U MM#ZG]R;Z5@64S[#\C-\[=PFHGG#]SE3"EM24FW=)2BU/,CIJ&%@U,F2M.[B% M&;P+7=%2L['1F";ITTJNUR64CH=P5&J[8GH`(1F>H?M2OD!:9O,$%65!J?\Q M*F#X%WY3$O;"6?NMS0#:G_P3";?Y.M,%??M%K`Q?=DMWIK8%.\=(L1 M7;7_Q@0C5X+70.&V`Y*_/4$AJINFT`M?-_"$G71/C70SC>-=-/ZVSQCOF^EO MF#F^OCZ[N9[#A)%Z@XSNSACQEIB9[(5I67*99/`"_\G.+(L%V'#9$1@?,CD/ M]/>*SS6*K`.HVH,@G*H4N\&52``J,I<(.VP^9/+"!3&WU:GCKM):,*!+J_E) M*_@YKMIG5ZE/%H6-R_+Q2O%=YR;ETM0ETG3K[HDKH6G4UYL.L.=1 MDO\U2O?PD(@+1ZZT9.NWH)"U1+?4NHZCJ2,UHW,,]Q`1C%NXP%G*\X2_[ M*"]AGCZ=)UF4;9(H[=3)$L5M,Z7ZM>DJ6?)-SXV'D&[D6$9#`T.K5A:TPJ`C M#5[NLV@?)R6,`T_#&T(&V31HGZ=Z^EW"FGB<#*W.N@DSEVZ`NE0C=3X]R!10 M%?0I/K$:=O7O)LT?$OA!2]C%_[TORN:T\Q@GZ[CGCE)2 MY/,B.XEV21FE=>GQ"UI&GIV*&ZO?S-:9Z]M.Z)EZ]-!'CGT&Z>S@*)NK4Y@G MC_2429`FT6V2)J$K)XR'%'+4RLRDI*FIWKSEN.<(@7%W>Q_'>G<.;[*C\J!' MVN6@2:LWDZZQ5EZ`6AU4^C\J"41;.R=G0OBY:B:*4JU^B M1,Z2ZD+++B=)54YDQ)7KKMK;S?GKH:N^JIL4&;[]/I&$*EW"*.S.AQV7?> M^H),P;SY0_;T9U&>X<=I]SN*%CLIQ)IE3T(QVP50`L-.ET+)?4@71OJSQX1Y6S;$//E1V@ECU$ MS;/,B0^D"5(6EU`+/-.-MO`2%<4Y?H4G*,.9UAYW+G76A;+B([Q#.>PE$\760DQ!T@US+Z5:LKB$RP?$+[S".MQG.$L^=2>>V<13N39R1%WDSRK M\\_@Z9]=?3K?=$_3'/SW$C.^>`5NJ?'Y'/@X+?$&IPM.CFC>P863/,3P4,0) M?_OW%7T<']XYZ7//*/0<#AU]>4EC#^$].+@%![]-6*J7=U3F0,?>`G3/+UV` MLV_X4Q/E<9)%^5.U]6X!2*$:;!TW2TK,-\_\6Y@+0)T?,<[-I";@592O<[HS M,Z;[)YKQ&<[0AZ;&L"*@6,-=04"1#T\C(7I>-:L"2JTTY^D41'(!=E$.'NG6 MH)D7`E3"A%\'4*<=A64`1\L$%E@EW<<0=XF?85GIXS_6=[A396?:)W+73-Q[=V<[ M`^SY`3UTEQ,]LG22>HI'6+'60-2:H_&11$8RK@*2VA)9EDMC0(84LHR%N0,]/,[A1C9,LP"#L'/?# M#G%*ZBP>W(*+3@#"#FN+"_HWEL3N?PM&7AGPO*-1V-J.[#8D)N*)!=JB94,! MR^@Z-.E\WDKH0A;$!$KU`LZBMYD.TONA*Y8)VP[IOFVV6ADKVR6+R)(7.!AU MC_BK.D$Q_C[,2W-4J/HVD=;J8X1U-H$S51L0"`+P&!0,@YP;&!R9P^`LB\U! M<#0*!$?/``1'[D!PY`D$[UVERF+SYFW_OA[S8_=7'Y=EGMSNRZ;&[E64!R^" M9H./]^[P\3[X*BF6NU#/@/,U MF\EJY\K4X!V,%LY+^^>_/NW;OE8;H''._+!Y0G M_X3QSV#Y;H'ODO]5-PL0E>`4;N#V%LN_7RX`:3=Z\C3^X]T"8)$=W)#]^NE3 MO5.9WD7[LBCQ'TEV_S,88RST@?)BD"%M5+"GPP^$^X?`"VR%KRM>]9-D,`)E M9%G$\;=$6&)<)LM6&^?+NCFK0?8<8]FJYT+C)`>NYJ'V^*+)V`X2X%3J'#.A=!"T)3E:[BU!#[1B,?@54NV+4LCE;5BC-9SV#%& MY4+,&+GFBBF?\?I0/@/\6LD$9HQ>(R.CMF`+84A4#HPQ0]!TC/D"RRC)8-QL M.^1212Y4OP^1D!4YY)[M6"&T+::#0&757&]W>,X$_HJ&0WJON0]XONP!Z1/B MP&@DN(0Y?_V%RH,I'$B5HPZ($`P+CX-$T#IWAP82 M3?3QDP93O2:!T->S2R;4?LALN-/DPM"E)-DPLM0CF7+Z?R;T,\E['?V+$C#"O6K=0#@S\:=D45YSR#-VC5F?YG]"G:XOZ2X8A4 MIG?,UD#&BI52OW9=A\BTF%Y\C14[7`-^K>Z$KB8C;3*D]89YYVXQH@?`Z[7_ MQ(N,JE'ITWV.4[\K.@]/!U<_PZ_TSG`DTT"GNQ1)K>-B"EKEQH:KD@:5 M^*(Z`HRLROU:"02NP>`?I++E65Y0&GREJN`AZ;WUCNXZ/OL&\TU2#&K2C];7 MZ%P$^AXIS?4X<:X:Q?!?;Y'=&`-9"9"$^JO1FWD')P:89!Y3MKQ\2N*9T MPX/D.4*@?Y+.3>K=.?#U.KU*I-8'K8$?E04C>D8_-)AACTGW11>&WUT")7G? M.%#R$Q(8-]/U@GS'(R(`SY"J8$"UEBOPXDE#M*AI+6E++2HS^AK\Y7J<#*B^ M.RR!2S<8571-E<;L/\B<@M6LXW&"UMEV,19?91H&=+J>2;_+)"ZG[I(W$6D;,@<#LZ(N M-$".LKJG"V;![1/HREU%3_3R,3G]<=%\QRW:#SE2!*7N5W]^BAU/SJM-F7A.[P M'R1GWY";H1=I.P"CX3F'.J`P/_%09-7T\$/YTP7FS*0'@ZH>Q"==S(X+[7X0 M+T!C#)S\QB\A@.9)L+EW\63+,([>FY(43J;IRD>22G8SSA&]O8%5@XY?R^H$ M\4SC.8PK#8G6E/IY+MM`I^OID"*0+?OU3GV0PVJ=-:990>-<]?6RZ6C//\:9 M0-PPW!GBRSSP:3@PC8':SSP??DZ:>A@\TT3D-$M(#F<[@*;\!#TK0C1,\1N! M#0#X/3%X3N>IBHZ,5,H)3E1U=U"DT+*'<0*5+Y.S59F3(8>'J\[K1%7IB7U: M;2`_4Y5[3)_"KD_D..NRE%Y&@V;)/Y)W-B<_NH.0('S;8RCP7M:CMLY MV>>DLAS[%:B2.^Q5%'K M'VRZXZOT4A6YW6#$.(6['&X2F@?AOU-(ZS5G\?$6Y67R3]Y(B8E*_:;T5"R9 MH^/$)8D,_,GXI&UFU96D%0%(LZO.WJCDL_"\L\SR0(TCX;:$3,MV_RN$N2N*Z M.`2.\+2TP7%1P,$J#QW10\U6B:A]\5:A<<=57%5^%.5JK6J*I9%Q4I59I M"8]-G1='5#QX]51UNR/S]AG44Q5J,855%=;G,=WZ!9)7FJ2P/:N%%`>Y083T M5SDBT2#^^/1+0;YTZK-NL_MC4BZ7GO5R?%N4>;09?'5[=,&;B'7FPN6LCZ.' M#7+IE9X;RQG;GY#SP,J6UL/!MA M;)L.'LFU!LWAP6^#NPND%PT'E)\YG^L<&$X/MO#"@"3_&@/0[H5]$3 M.3R(#.M58^Z7]31$(IGT,=4\3`/I:]I/#.GZ\K%JW]B[8@[)R-JJ40"[2J,: M_JYTVGFF)/0>VC%`0M8M/)B-TC7"S$^9^9X6S>X6M9G[=0CD90?)5QTDUTJ@ MH[4`M=Z/!&EQ6=,),#WW->UT1<4MNWCM"SE+M4A*>`WSQV0#JQUZY)OF/J-6 M>.=33>7.9/N;E;LIMOM8/&"H;73VCVR]=\CV$:KM\Z^_Q[7T3AADNJ?($4I' M;#NR\&R\-^WVRA_(H.A'35PT`.-8M@HZ02?R#U. M^L'-QFHW<-D_76`:.D6.HKU%RU-ZOU\,'7\DK;$AF]^,$*7IX" MLWA7;-,?4)SERPH?(S&R'(!D1KFK&\0(,DX[R`2M6$T+>Z[W95'B;AMGL@PJ MA?>;>M/#^[;5C<^5X!<.0*`$S>R23&IIG;PYPS^O"%C-3`C(S6G2;%) M4;'/H6"T8Y1N_;(,=2T)8N3-Y2C%&,H)(5'V8<5C008Z=3O5%/'DLI:7CR,&9CXE3%8W\[J,BF3 M^QFLZS(#`[)HJSX[M=2[K#3P-Q4*G0U(&'ET`D"N>^(P&+_QC M5)#O^P/I#(_IHJMUZ#9\=A!$5U[C;.1:WN-IL-2#ASY"U^?8(U\/-E9GPZ.R M9GG.#PU#AI)_V16JJI[$FO'SQ20F^3`X9XW:[3I'2A,Q9\K!D<<#SP. MA#,,^O68A7[4YRCHG+WH->YW7$P7^(=.1Y\?)P_],QI/U8>$[O%NXSJ"CJ[V MZ6W>NP+&S30'&MIV!@,K6F?XSK<[<(+%,4<+C@1CR"ZAK*&T'X\M_(A1_3=(4 M?]A?9"4&0$(V6=.2=4H&C=*MWY^AKB7+C+RYY-T8QS(FFMM;744EV5)_A?+R M#J4)F@T_Q\$'.6C5/H>-S'19/<)_,)Z?1TE./]P.3R9:$ZXC6K]!N:@E:67& M77)4PX^,DDKU%9&H!AW`)Q@1`7H2]EQXJ-7>R+Q=^BR3:75)I;8>5XR8&A6\6"`R-KJ[/M+D5/$(+F[+@K M;'LVY!R#'&3=I(-%![I&F"4'9KZ#$?LO^R@O89X^M?LA+K*[9N^+DMPCM>MW M;*QM27)#?RZ)/LZUC.QC+*Y:)=!J@8X:>+G/HGV:'W7KQ%!SPBFYV@?JDA<14^RG99NC+5'PM@9LSX/Q,:] MRY#BY$GD)XM8.ZB+7WT<%*F9371QA$WD`R'L>28V=ONGGM@_8!"\;L5>D M\ED#M9OG"37!+*5+K,V@O'FGNHCH,!VE8+]X.5?0375GCFF7&9S2BT;E9I&R M09&KV>1B&BT_+,VL:"-N(6:.#J?NLM!RP,-N\^01IVJ/L*D`_?095?7]CK?D MD=D/+UWY]IA;I;SU&;<*#QX6?.GZE!]RJV-C=1";R^'1^A!`(UN)/=)6H=H_ MSU;+SQ286IZXW:[@M>WAK!1>@$065[',%H.C<3^<(M$^;"KAYW\8P MJ:(]_H,-\OC2WX_QEW9,OK;/TXBM7<&]UZ1"_7LC"3-X`A?)CL@H#_Y\V55[ M"9!K@7,4;BL@QE2W`;D/L``@$H%G5E5-B?1?.S-?*M!H4"ZW M.!'@3]%F3YAVU914X:!=*M.DRWP9"YQS+;H"N(EMB:",YG^%.U?!)5!Q#!E;KF#+-RL"+$]Z55V< MT0YH4:,@Y9OL(Y,1;##)U9\4C7^#:?KG#'W-KF%4H`S&=.<$NR=-2[:'5*&L M-6X%EMVB6.Y$CFF9;H-P(O/Z'T0(-%+5UI_`NWOT&AH9M@>/"P*U/C.DMB?E MR5]1BC\RH_SI/$EASDY?2F5ZO!C(6/.!L>B6!WSC&S@:_5)(;,\*3YYIN5P'VHT**=W0'-K#MCF-Q72>K<\)/>$^P#FV)D4MU?[ MVS39G*F,.2.4U#])XHSR4 M=D3[&!W8F!2A7^!]0J;GL_)SM&6A(Q/IX905L89JWZ!;M')MRP'+46DP>[@% MR+TYP%;08$CO!?/`VY?NXY=G:=K$&:)IRX/$ZCG^`H[Q**0*OO3EP,I!Q.8C$W74YA\\ZI)3)[681JS.TU/ M[\]C(E/4ADC[A9?Z.R]?R1_;WP,$BD6=@?-$4A[?-A0,"V/:BCA"W_OU&7* M8EJ@L*K/Q#2[2JQL-D>*Q$;"3?:(+J"G89\'0Z7:ZG`7X-M5[4Q0"83>E*9H M2:3_UOO`%6D0$*LM>@*(T8K]N*89W>=LB!318GVU'MF$U1P9O(GR_(E\6$1T M73D]2CA*4Y`ZB)*?!=(._8>YA\88`&)N^O\_I;F+V&55> M\:T,P[&>@ZR>'E\I00%W48Y%TB<05WO-\0,E&<_0GD;"+1;.DX@LOP<8X442 MPYP^.7[&SP,7^`,,OZ,=W)#?B;5O(<@A5OXG_B?*J0'O?JA:W`+W*N*M$1]./"/M:ZJN.5"?S:9:@S"$#TFYZ9-X\?6JH M-!N*Z'GPC#"GF9*N0QNLX0(M7$^Z[[Q=ZU0=B=LD%B4J M<:]>92XTK_B:E`_X7J__)_]@.OY7@("'YF(X:RD34A`?!W:T26@>1:R`?1:3 MTEWT$?(H*Z)-=91#^1"5-!W9I%@EN4M(UE%T/!#!QX08K9.MTNAW5=U,YX&' MN185^4J.F(CA79(=$JTR^H8RM'T*G,SXX*0@N7%)2KMD1\>#7M*C+O=CXL^& ME$?]'N"0!?5!^?S0)LB.7*+-8;9$)ZE('5?1AB"Q0-DY^(<1L.#"T)RKK$=H M601S@4)]1DI5_'8V>X0D[81TWFP?K4/9!I\B*\Z;W&D:(G9AUOAUJH$]);@; MC]O*>,VX1PR+39[0DYN:2SML8U&/911)`>YP7A'#$N;;)*.=-,K*/+G=TQ1A M@;OC9C2'J,"FY/)]CO:[`@OC[UE(1F%P/*7)0502]^2?\.X.;NC`3M&IX+-M M3OBD=RN'6S+>4I4O(.))IZ0K>3J:V]"DH@`[W&[XU\+X#3C'MU*(_4?W.&TX MNUY?56&=%`0DJCFY1_^B]ZK?W'E%V^BI_G60>1TY3"'^!WZVZJ`K:O8!?<7: MCTD,,_P<9%0JI6&-Y$SX]CX[_+O1PD[V!7[4[Y.)LG.'#*AHEXKP;;H<<1%[ M,*/B43<0?Y\M+D@53%O<1SH@J+8FO,\F`]:UU;A/XSP5T*B@)I;O)0(S*8HF M;B`6B>KR9P/1`0RM"YUQ0=A9/J5S7H1:MFQ/B)#)6@!5:MD5:'6*E:@WX-VSZA9)07*_IB+6>C,;5D0/4\D21(V]Q` M:5PM,?VH*OKJUQ.6Q54WHP%RTUXCJ^XH@8:R.+;.9OA`L\%EI-`85I#K25GA M;KA!;=[IT(.>N_'H$@Y)W-'%#11X!=$/_%GL&F$F<7<$Q.P^H]7V77Y2ZWD; M#[&C?@1[7C@2?(2[PI'#C_._13G9=%B(.FWA_?J7<>Y;0'Q@S55O+#(LPB]? M?M5B]S5!MUT=S3;KLEH4.C%!]=`AEWV-# M"[I7LX;VT(D*QA-%MYDNU,FH(6O,=0>J.3;(%>]TGS,9M1&V#%*_33[VV-$8 MO@57P+O$T?^^.N*5#SVQ0/WX/`$+^`W-N0*@T+((@@*%U>'Z;&`H:26D\U[[ M4!S*-F`467$ZTT<+6<:G=%5AM8>1'BC>$.'L&\PW20%CWBR@J6YWAE!?UW;V M4->3TYE%0Z?2644>\@[5()NZ<+U,R=>X,\>WBIAKK="P_*AZX>*8;.G\D M3,O637G'M.O55D/?5A0F5W;-8X,IS'B;W:DA?F3%I)E8I?C>I MF`I2I\4U5/D8PKW[O"-,[+/^^TMV6UVURR_)G\9Y6=U M_]7V:3--S+S!WRPU9H@K'":#]H]AGM^X/RPA?VFTUALI80J8:P60G!J)20% MB&&\IY6;JK(+!YKM",UPG[JIGB-P[AB:4H)<,A2G['++\7Y=YIAV3^&>4T=\ M3OW8N!E#!O\EPZ2,GPQU2MV<.AK6:S M*EK3B;-]'6;^A`ND31A$^8!LXARZO,`5J17M+/,+6G.T\, M_;J`[9%NC'W^.!7M7?&(TVDSG&IOIYSB-GE\J5EXFS')Z#BTXV+&C MF^=4*K.G(@,8?2X.V]*8B_7A2OID[/J<"JE39SM]STXPVYNT?%8)CP/TCD]Y M+.#K/>DYN)HXZ^D[=@)?[;QG/E.-TT!W?!9D`5V7>1"I!KR^JWVL\R]D]V#S M$%=D^U][LZCO%I^B;\EVOV4S(WM+3:YD8\F&T^/].LNGK!]!2'=+RRMJ`*SO MFI5C8)T#*M:N(`/43$>D:&4*4-L*'!,<8!0Y!0L3-L8;;0.)[7.%(Y#;-,_^ M63Q1J=XJOJW;K>U.J\W6.#V$T>:A*M,NV#W>V2$>.C^<#:%$.61P1EGFF7;. MG6:>]H_BB5%&*^)(B8,=SEAIDEHMCWO=DI%DKS%*TR@O#D*A$]G9<$R4[`;G M6.B$.,E<)<1]2S8)<6-IZN!3^0V:$/<>P6G,Z5BV3H@K6]]A;&$P:A-;AF!Q M$%HJHU:AI?MZ4S1B&YS9&P:HYZ>T& MK`Y3F6KO[G&Y_.G=%QL_13T=:T5(HQT1+CIP#^`^LNHZ6 M(@H\MQ0X4*8(7+U^;OF'&>>6 MPE9E,P)9`P@2`E9ED!#P;?J"BY_<4N1I%'!T<\L_S#"WM$*2*K<4[ MO6@IE&-SRZ&H\MQ0X4*8(7+U^;OENOM%2W*IL1B!K`$%"P*H,$@*^ M35]P\9-;BCR-`HYN;OEN?M'2#DFJW'(4E#Q$R_>:T5(HQT1+CIP#^`^LNHZ6 M(@HJ70TRC@Z$7+]W.,EG9( M4D3+<5#R$2T_O'__TP>]@"D196,F5]0%#SB&G4=.L0\E!T2J_?CYX?WK]V]^ M^C#?("IK:1;]BA81X)^C-:"`T+)'(/F)J1)G8R&E&UD'6)M+>'6`,560M0"9 MAU#[>\W$5"C'!%F.G`-B#*RZ#J\B!RHB\/6Z@?7W1@%'+WS^?HZ)J1V2%#%S')1\1$O-*2*A'!LMO4P1#:PZCY8C MIXCX>OUH.>,I(G&KLA@WGR(:J`P@[FV*B&O93[0<.T4D4-2+EC.<(K)#DBI: MCH*2PVC9GK82X1=Q_"UA]Y@([[/'S!WNNSARJ+'F*AJ*#"O/"^K)=XY\(]?! MK^1.X(`G;B#V.!_>.Q44X M.)51DM'8A6@PHT!H#D:;R_%F1EA0'5*F!09?(8ENPCM%6_S299&)(\8+4#TQ M5^CM&/42KH;VM1#,JK'!JZJ:\&LE,:<@QFM+'GX%[UV"XHX&%\P#BYX@XB_. M<1R-`8LTZM5)6YWVMQO.NB=#SBD.CH233E0TQ%,;([MOYQ+_A2\VE_#_W48% MQ%?^/U!+`P04````"`".BEU`;J'OA>,<``"0U@$`%``<`'9H8RTR,#$Q,3(S M,5]P&UL550)``.KI$Y/JZ1.3W5X"P`!!"4.```$.0$``.U=6W?;.))^ MWW/V/WC3SX[C9'JVTZ=[Y_@2]_J,8VGL9'KWJ0]-03)V*,)#4HXUOWX!BJ!X MP:4`4@*@^*6=%@N%JL)7A7OAE[^\+).C9Y3EF*2_OCE]^^[-$4IC,L/IXM?OOPEF2+D_?O MWIV>_,_GF_OX$2VC8YSF193&Z,T1I?\Y+W^\(7%4E!(VBK\\9`EG\.&DKDM* MP?[OF),=LY^.3]\??SA]^Y+/WE0BLL^`2CCY2X^^TNGTX\>/)^77FI0RP@K6 MM=K4>D='&_ME)$%W:'[$_GZ]NY:6_GC"*$Y25-Q$#RBA59;%B_43^O5-CI=/ M">*_/69H+N:39%G-AEGG([/.Z9^9=7[8<+*:)D'#E+?GU9>]4, M%_IV+-.J1+X=T\K4(]$>K-RH9KC04Y1A,ON4SG8O>+>JL82_+Z)L#U#I5S9< M@=U+;2#J,\YHT'EY&Y/EAO,EB5=+E!9G*6VU`A?KZW1.LF79+>B%?GZ,J4RG MIZ?O-_'^!S4[*PG_MJ*M@;)D?853&LEQE#1X?DVCU0Q3&UC("F5L)?4-+O#" MUHK-PE:U3RDLTF)*LF).$DPL1.AQL)+C*L+9WZ-DA3ZC*%]EB$'#0A@Q&RN) MKNDH;(F^1"\HMQ"D5=JJ_D^T%K)&Z)P.^>:XF":1#4"$7*SD^3W*LB@M;(RQ M+6I5\P59+DEZ7Y#X'Q:5MTK;^0AEC+(,S6Q%Z#*PPT.4I712D-.>Y_XQRI`- M&'HLK"0IM3BGH_`9M>T32G/;Z"5C9"^5I95$[JZ^6RRA;3^;W>)'B.8ZIG]-Y*%G1/CU=3&F/$&.K``IE;-?;\,Z; MCC[.5SE.49Y/Y@R$46IC1`T_2TRE.=5RQL9M=)Q9E'T9XQKECU<)^6:'-"W/ M464M_>J1)#,Z2_GTSQ4=Y5W27BC&;-3'K).A1^KU^!EMNLL;DN=3&I?2XA$5 MM,4!@V&PBL-%<6T9M\886?_)$UO'HAXSIEI-IH.E/8\2MAQT_XA0,2HJ58S' ME7I,0=NR483D5.[2V#?TAU9%Z(7."&;;F183TD;ZLCY>8T+B5B4)6Y$DF7!J M7$Z+YU'^4,Z-5_GQ(HJ>3IB>)R@IFR1L1OWK&Y,B=+++[`$KK'>F@5J^H<%[^'OK+B@TZPU'1R5$^".GD9E*KV! M9=IV:$:&LZQMDRB+>17TGZVPT%^/KRA.GLH(>1P_XJ2.*/.,+'5M1^R4;LK_ M\Y&PBJ."'`%9DXQVL=6VSA.?!=YLFD2J>:EVTERJTI304EP9?* M=JTO_L)"K@"P\5L,JB9^'UX35].I_`[%B"+X(4&WJ*C4[89)`"F/EDI2?U%A MH"(0)FJ.%6X^A(>;:8:>(CQK+8U6.!%]JHS6_N0O#A0J`-N]S:%JYS^%U\Z7 ME;!4D8VNTO``H*Q,J*3T%Q1P!8$843*L(/.C.62>4?9`.AO"[B+$IQ>VJ(OH M.&E"I[C91E%QQ%"2MB.(A-1?\!BH:!9A)!PK^/PYO(C34E@U4U/-T'R&@DH) MZ*BBS:)J[/\T;^RB=T#'F<6TII+,S$4FD]IJRR/<61G?K6%[5>71"3KW?&(3 M$=I]]`*KGK0.K"I2#[%AH)L.(FI6+B9WO359^@.=CA=1NL!T#J'L375D]41= M1N9A8P-UTC6TG(W]3,R3X99H,'E+TA@\5N\3*X;K36(/X6*DGPXT.F;A3NZ$ MX4/H6!Z'!JM`T'%[BUF6%R,GHRTGHMFS:=L,PGIKR4,85]W@Z`$G5$&4T]ZA MOSTNV3TR+599&U[,!X.H-]#TA'VE_=E*XTNTTV@=;48&])=L15';DU:R(FY0 MLK-`#BKI++P`VI4,L4([XLAK:RZD@VJQ#T*>C.8JW1HGB*4(5--M\2:C\Q]= M(`T-L23C&>Y.WB7*\#-5_QEQY=>WA%DC2LZ6S'5Z`=_!13VQ]J`WZ`O=NHG9BBK[*8/GHQ!3$>_@IM"IJ20*L26WJ,*8HGC@B> MFX!G(U[./]I79D0GVA04V_W"/H7#^3K$/?1:=:?J*D\0<@MWEMZXRB4\XRCY MS(\S]CY[C@6-/B9`Z+,*=[![-IOAS>AJ&F$ZD+^(GG"Q/97/9T=J*CXWDE%Y M#@V8=B8(D7(,]YS:'2HBG*(9O_9(IWZKY2IA%PVJZRX=S,`+5`:&%/`<2<8Z MFX`*PCS@+92M-N5^HN3FU"TJ)O,OT4M_^<:F]'91QZRTYS`<9@VC0&=:D_T^ MD6N`]@VAG2-HYP;>(TFKDPE81,SLC]<%.VD'SR7M)^VJ*NS'JIY,VG6&,-Q6 M--Q.#`QLAMJ/LDXDJ$;#'[]8JSQU'Y]=#'81[Z:*^*4H><9"529^726#>_DG"Y65=(N`(M+^1#_ZR^ MP&*NN\G>&+2"<)>NVQJ6ZN1GJ^*19/A?VSY%B#49L1!C?>*@L*71U1Y3?<;A M+H"+-+O.\Q4(1VU"!88X88#X$>HX%#N<:;CKX2*M)JN"I;UFZ<8!X!%0*Q#4 MH@X01G)MAV*IQ3G`44^/H*0 MRB`3TLC(0,]!X!&-B7X:"4'A['B$=2;6M;$/:X-C:`,XV^"0Y.!UE[J0'>*H MA9*L86NHZDP)$BIWI]K(.DJ*]1UZ1FGO"*SX(S^MUOGHS&UUIB<:1=K^*.%6 MGC_K<`EW_;ARJW11Y7R29>;5TE4F5-"Y1G8ED1C9G8]M9-4E]-2)F!1P($"&U]/E=)ZSE,#!0U08V:;;C; M(O+G&H"%_,:7E>H&0(/R#W=#Y;<( MI^RL\!U*-B]>;I]CNT<%M5?S%;,*<$9E*J,#R_@--QO%#=`&9&^QV2)\I-&? M@:!N`*@;^/F.&YU"!A@1L`H\"11@)@6=$8`G50J&X0X>:J7Z[RUU'4OP(E/' MM?JO)GD.#:E*YJ!HLMK%\>D]8N)KFJ$H87M?O'.9I-M<'UU\`*DKPVJI?<:- MF:I@#&G9VI^4\&03^Y:DI.THXEF)EJXRK8+.9_Q`U0,C1\$PW-M[VTAZ10U[ M0=C#ERNJX':%_1S-288:J:P^XY1DY5O:!:*V8_F,VUPV.P^?4?%(9JH7?O9> MP)VX1X]N46%=.XA_,;'`.UO/H-`I0:\KV\SL3\IXD5@Z#[)?A[E..ZTOI*F M,I^$QFA2YRLBMZ110V5!!PU54CP$*MF#9":'=\U M?1<>1GY'>/%(E3BCT]MH@6Y7RP>43>:]\W2BH&)5MC*Z85F?43;$#&#L&5;" M$1G@1KY$T\K9=$=J+4NK42DO'2`N@:88BDQY-1R;`2[Q-TX<7^)G/$/I;-L; MH#BA?Q0W`K1%^F>]%45\AIZ%TF"\P7ASD`T]$N#%@=C^P=\J]1U[/ER<>\R' MM"`&>88-RO03@WB9"*.6[PM[;T*F<.MC5[/JHWL5-D9E2",I0^39"^XN+X!H MNPJ*:7V([I\1Z\7DH;S]O1^W^7?WUQJ4[4'T2DDN+HC8=J(S9Q?NF5))0ELA M.$"TZI3!X8#&1%E#`&E8AWL\I)O(5H@B-9$D97`XN`&I9P@8&<\!)T?H.,+Y M/C\@QZPX#IF6@V<##@=GMD8PC57P:@8\T^(#&CL6N"1+ZG/=A605#5]&%M/X MCRB([F\3`IQ5IS^^(ZO]`C[/BT=/_X@ MIW.;F5QE;`+7K^M"8L[E(0@Y1V\N_@_F^E*[;^GVZ,%I?HY]%Z_^@*.+T^[J4=]/P%&?C*X[ZNO3 M!='Z.OTL1GU]CBX2]*E]']CZ4KJN[P?:^CK]+'Q?VOI[/?JL[O<_?OCPXT=8 MUZ\@[?;^0M(@8`#0TF(,(&0:;@(]^=(*`:]J**S(%_#DG`X@'9Y@#4^]7J5? MM^N5#WAZB1]`]!-$@<'FW*$-1SLY/E7^OT_Z9FCN2)%B=- M=X!9=R[7LT/(U@@R/7YL#"#IP6.+[L8G_/!N%,TN5QG5:UK*5N;JOT7?RB_2 MK29(F>ZNCKI,D-BS,,9<\X1IN@<8=BLDA++F4?9^,V M(U1GXEJ#JCM8]QNO$?;CHH/DM=_^",B-6$%+*'],4)Y_>D%9C'/T-:7R?%1;HC=;O-T$!GN M1J3L1O;VB8#_IC9BKTO5+P7Q\E:#+?VH@6 M258S1.>Y=4YG0S\=NSJ-OXY7W2'Y[8X:86?^.YZ\W(_#W3BNDS`V4G^Q>5C' M_W1D59/)R4+$.U#IP3B5U\/Q%>Z.Y@$\:F`+'Z/'#DPQ(WX$X73_&W;.#N?_ M\?Z[.9[?4W6G!_0MMLPV)ZP_IT-\!AN3)P2UVID:`D#I; MDF#]CJ\J\P7G[A:J55G`^JN@;)`8&V">G:[+"BKGMT>\V;12+N-9`E-3&+(4 M>]C0A!EHMTNT"G`>YFY6^6WRQ*QI%6F5Y0'15E+^@&`--M-.HZY$``[N`]T= M&X!N``-(R#Y\?,,-M=O0K4'XR+MM+O)&W/3R'9"A&0(DF27JFJK7/,UJL+], M[IO%Y=EV^VUAF&*WP6#DE(`N#`5Z789(+:NTG8IWRZ05SY$RQ(3Z/-&T;*U' M5.`X2E[?*OJ>WRIZ39[]FCS[-7GV:_+LU^39KVD4#SB-HC^YM%\SJ>\_D[H_ MN;1?,ZGO/Y.Z/[FT7S.I[S^3NC^YM%\SJ>\_D[H_N;1?,ZGO/Y/Z:_+LU^39 MNTV>'>"SRJ_)LYM1]SM)GMTXF3Z-LDE6-N%FVY_'SHYE#$KT'V"7EPAQ5]O< M%,.OTD.J##<&7;#[.Y-Y=91JDMWAQ6/!=^3+[JC^F%=?>\D?!K#@@+5B$22" MAQMK.*2M9/!F,==&_,_1"UZNEB,@M\-I`(!K3M\+CL6F<;'`S=. MQP)WF],0<'-.WPVXA:9S`VXNBL/\Y*#T4I.Y(#%1%\8F921II21E@H2FA3E& M3R9/W1VP">P;; MA`C&#%ZS/EB&KP&M993XP;P>1>Z'\);Q6JF/V7,.:8P3U%+O"QGF=[NL0I0H M>[0JW&4$0A1$,2X12O^=H-+?TMG9DF0%_I?H@0F3(CQ3$*B(LP"P4]@0*XNU M(\;9DG"O&E]6,F_LPYYJ M>6'JH7.4HCGN=FY`ZCKD:J@/%KEF=MI7H-7(Y.+D^3@@WN9'W29&O409?J;F M>.YEX0=25XVCI3Y8$)O9:3\@ULIDL9;_<0/B%"W8FH?K@-Q?W*Q-4KW-(IEX MF!>4'@J2%QQKBX-"`M%&>TC*=Y0V>5-7&4/Z69ZCWNX&E+S22$_NT9Z&MI6( ML?ZZG0Q9E-`7'<(L-4E56B6E3P$"(.L,CIN9;7NYN3,`W6[$='&:>=\;Z-8;Y]8;YL'Z@K5M1MJ%!E=N/XHJ M"(UZKKLET/D5H_8`11Y5M68MT(L@`>[<2;2]3I]1/N0(#H"!.J(H&3@S%QT4 M\C>EXW^N<(:HV!08Q7J:1"G+[EQE/9X*%M'6MAD#Q":5VR\='L(,#3X'&&6&IJSNX-9XKG`:I?&` M&1J`@3JB*!EX,=+@@RK:HY1[_`*)%2,,@]*"D06HM&_Q%X(),M1*H""LD*0[ MD@!)$.X*#5=O,I]D,ZI:MJY?MI5,V124G1F;D#)44(*U'P6`JMH.:[H&>(H) M3"^:@GGVT-)XH='\::7AP5#]F%*`$ZBF)O486.!#\!/1*!+;H#PJ$M.EWD'M_W+-!Z]F<]ZPL6 MI=:V&0.N)I7;9TT_A'4D^$K%*.M(RNK"'4@Q5=GC<_0/V])\CA(V?]D\Q-D] M(M>)(39%&^FWX$6]1^@`2YAATZRB7:PS.X?F&?7.+%M31RPS[((P*2FC!&.O M3*`H5.L^!OQZ-=B/IYXV#P`7458<+/K^>/\]XZ^G_2X1:#$RVB#P4^I\L>U^ M]?24E*:($FZ*ZW1.LN6FS279O\Q*\?0:T%(N+]AL;V!@PW']IL@S_$=IT6B%JC$,*C_ZG&1O-36,"0*C4`%4V>N]FO M\+#CL@N:9AT7N(Z1'L/::^+,JUJ-=':^RG&*6$9JEBXH2M?.DF9.LD645FFT MMJD]-U).&\I/YM7NH/"L@C<33W2(D.ZR')O/J+@35H+O8*"7@ MBXH"`F=18]PF)@#UVY%DE/K+A2Q!O?8''D2W5O<:9.Y7RV64K2?S>[Q(\1S' M["#^YEXY'?A/J9EBMBKJ++]F3Q19EDPM(<]UJ2!TYNSG48YI;&\"D>)2V21? M:#N?)_U]L3%85:8:QLK=%6P]%,BH=NI-5/4G=XA`[U?D)P9VF\ZTBR M67+D`MVAA"U"7Y"\R,LP%;[* MR+$J?K*Q`FCGH\,ENJ8EY:MQ2JIZX4U"Y<[GI,]FPC3J^%GOH4PIEX!]JWF; M9JR'H+CW:R.]R8F`7 M<`@8WY^63PE9(_XHE^5:ZF@;"/6T]2R=W:$"9ZB]FR7OBTQ+;@,[O*2[P1\5 M<2-@F55E2B?S62UIU72`39>A;/CPT9J-RV[2&"!D-(/UNE.H+.70U5J&@,-2 MXZ2\LW!4RZ`-/P#*[JT(K\*+0"I9"(&0RG7U(11`&HL8*=IV;P7_UAV00W/9 MJPAGY46PSRAB6I5IFETANA9F:V79D!M"6C6TFM29^XK$DODOB%:AK@\>#&HQ M8J9KVX=5-3`GUG`.V(NG$:4NIB0KYB3!Q)D#_T;([!M.$CKLN:::I0O,7C`K M'X34=L=692L<&)9U>?%.(IR\YP:7V%[3TY=P%@7L6IG8&*(='(PJKB[XZ2L, M.&;CMAPE+BXGJ)I,1.#,66_0(DH^1T6!LMZ9/9F[&I7A2L/* M.'-91:L1.XW;GMGGS]P/R#=@!_S;*LJH=LFZOIO6N.3Z-8U6,UQ07J[@KQ1/ MVYM;EJX`8ES:69!02BJ+$F:%(#;Q(4[8-CFQ-$@[BAC6SD(,M-:`8\PEB5?E M]9-T]HD&T&+=T'!@9,E1_'9!GD]F"&_F[).Y.:TA,34#*=,YJM'F51Z&$/%QGC3=K M\0NJ8<;"P`R]_!6MA4TNH6FU>8_&WT97JP-L]1X3UX^%0)O]8I4QRUW1_B%* M_A=%V:=T=AD5O61E&C*^+2DE\[']@4II(2#GXSK5IYGS_XZ2Y*\I^9;>HR@G M*9JQ%,@H$P8!#6TK&$AI?02%B7K`X"!EYCJMN1D\_DZ2%54VHZ/%A,Y)A;"0 MT+3@T*/Q%P9J=8#-WV/B.H6XX9!@$]WNT!/)V`H$RQ^S$K>^FK0]0)"0^HL% MD'+0X8*$EWTJ2A?(*/%\03NZ! MKAX2'%\E).I=1)!];S5TZ[N_S2Q7`]C(+095$_\41A,WSD.7=WGRR:K(BRB= MT0@ECO>``NVHKRS@+RH,%(7V`$J.%6X^^HX;OKJVG?IR0'APNV[*\J;T?EGPC,H\*_&81-V^7_BMLD?GFX^MJ1)? MVYR=PKP]O5_@XS"<\A<+!&N\2IJ.LW9H?&QGB#I@]^TPX>T^=.5.OA5:?6'_ M8;DSZ"__#U!+`P04````"`".BEU`I7G74Z\(``!>2P``$``<`'9H8RTR,#$Q M,3(S,2YXZ M2WO\A"W-C&9^,Y)&8OSQ^T48@!?$.*:D4:I=5$L`$8_ZF$P;I8B7(?88CX''JH49H),;^M5%XP(T@L+CP:5BZKM5KMLEZ3@PO]0O*IE)(M5;Y]:$WU.,:VI>9YQ@R MII.*B^4F?H$]5K M-S(=H3+B`Q$,VO2]2!IOXNA)W&E),7A#?(.7(NYC2ETKBJ1`#'LI`R5[\%!2WN#S$LD@`T"%&22$"BAD_.JF MI'$^QV1"DQ;9IK"]-?YX0A.@T;Y56C1*'(?S0$&IVV8,31HE&3=E$R._SQFZ MD.H9"D8#M,,WJKLB6;@,9*U8;S6N$0&9EY&2"08IA,X1$U@&WRJ6*F]EE0># M0ZV2+%X4G+-1/IH<:I1DP02?L4T!'!]JDV1!P=]KCI(SD@8`]?#\U,U=9K4R M+4HX#;"O=HX[&*AU:SA#2/`2P'ZCM+T['=&,N7+5)[G:5ZM54`9#.G;\*=D.SB MW)@B^S.NAV$^7])JH'][CPP@DV;/D,#2#H=[UFE=OJH=X"OP;DWV=X7OMO@N MQ9/W)_VYRLVD"CG3:@O=;I]=.N;7<"1_'CJ/TE_]>]`?=)Z:HZXD*+RUA[>& M@GI_SFC@R]2Y\U>$Q5+FN]C#HDG\%@TE*C-$.'Y!79F.AZA'N<.MQPC<[?_Z M0?X?COJM'S_W>^W.T_!;T/GIN3OZ#;QK=^Z[K>[H.]!\;$ONA\%3YW/G<=C] MN0.ZC_*]`][U^L-A,,IF+_."*Z6I#/[@/ZZEAG M5F2[_7UUT.K1:@X_@_M>_Y=B][!]I>Y!M(IR#MY%'!/$E0OD;(1D&?MI-\EN M'[V/YV0;4*BJ<$RR43 M$M'T/!H1@1)T]2L;?VI'6Y[3+CMD2P\I,E&JQD`R.\\)WENT%\TDWF M4OKFPK^>P=^P%NBN;35AB(7>.,RFLFIP87R5P=CB+F"V%R"5N0WDR3Q98])7 M%\37V65$\0+%7""\B?`=E,+5!BC38*VO!7>VSX7]^WSLRUH2L$45GK`\T8&, MR-V,#Q`;SF22'_L@T^I"_W\9](T((&4`+:3`?6VC1!/$F#H+R"@UV^5:FPOS M#SF;9B(@COT"\(V]DQ(+;;O!!?5-[MXI<_H"YTVJ&80- M:X&NO5R'\X`N$;I#1(XJ5DE*7H<+\^QAU4@!B9@B<]ET0'Q9-X(+3TNY+,'3"4&:#G`$E3XP,Y1 MH)#6#2@3$QI@FB0I&XTNY+/'SE@"2$44F%N8]^0X4^LT9+V[D,Z>/E?,!<86 MQC]%D`G$@N4])I!X&`9=,C'7M,\$1CX6JCI.X;\GK6WJ16JE;A*_0P062PNTV&4[*78[JGH39_J)!/M12@.Q.-M-_V+7 M?*QL%/[%#>OE@:HX$(=SN90#DBE)M4L^IQ#.U^H@XW+6'O6TL/4:Q5S&"@H$ M-RWEE:B+!?=--=5.=7:5/^Y49Y-'/9RL0$YIZ#XZ6&S)\\F:Z'\TV/)@56P^ M\W*Z,A%CB'A':&,SIF\GZX,6WNQ@75(F_72R#@1BCQ^LQ(HK?CQ9#8Z]@Y4P M/.KA&`4VRS%OXDV`H"G46_06'=;8`L;6N,I*3KEV6:Z]/UT/<;`.XICQUT$5 MU6N?BC7 MJH/`.R7RDD\B00E@#!00#'JN!PB]J+&XL:.E-56R:ZJ;\ MTB;[$4O.`QLV>PSYNXQ._^H=H86X"]+_"I29>7VQ8?&W.;?"M'\9TYPV-!-I M.2:LNFS7R#9,IF^@??Q^C/+6GS*KTW+6$`?9/\&HG`AST9UCM)E_:7+,R>DZ M9PNR49;M.;/`6MWO997/ZSLS]76D=SF/D-^.E#8#S:XOY0WVG05B'N;F.BY= MQ?9G^V=M/EF[=.T$/QR/K7QK4:")ONX$;/I_1#PN0QO1IN_KVRH8#"#VNZ0% MYUC`X![IY$)7K''U<;65?QS+?S:!XL;IT&Y5.=JTY7;0SDD9VN->RW( M(3DW:]*SE^N/5QJ#X$IMK2+V"&SG+:&MLMUJQ1?$V7 MZ)*#^%)?OOT?4$L!`AX#%`````@`CHI=0(14,!3`L``00E#@`` M!#D!``!02P$"'@,4````"`".BEU`O_&2>8X+```5C```%``8```````!```` MI($FB```=FAC+3(P,3$Q,C,Q7V-A;"YX;6Q55`4``ZND3D]U>`L``00E#@`` M!#D!``!02P$"'@,4````"`".BEU`BNN%B'D+```5DP``%``8```````!```` MI($"E```=FAC+3(P,3$Q,C,Q7V1E9BYX;6Q55`4``ZND3D]U>`L``00E#@`` M!#D!``!02P$"'@,4````"`".BEU`-FL?G#E```#8:P,`%``8```````!```` MI(')GP``=FAC+3(P,3$Q,C,Q7VQA8BYX;6Q55`4``ZND3D]U>`L``00E#@`` M!#D!``!02P$"'@,4````"`".BEU`;J'OA>,<``"0U@$`%``8```````!```` MI(%0X```=FAC+3(P,3$Q,C,Q7W!R92YX;6Q55`4``ZND3D]U>`L``00E#@`` M!#D!``!02P$"'@,4````"`".BEU`I7G74Z\(``!>2P``$``8```````!```` MI(&!_0``=FAC+3(P,3$Q,C,Q+GAS9%54!0`#JZ1.3W5X"P`!!"4.```$.0$` 7`%!+!08`````!@`&`!0"``!Z!@$````` ` end XML 40 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Property
12 Months Ended
Dec. 31, 2011
Property [Abstract]  
Property
Note 3 - Property 
 
Our major classes of property and equipment were as follows:
 
    December 31 
   
2011
  
2010
  
2009
 
Office furniture
 $57  $22  $22 
Computer equipment
  91   75   62 
Total
  148   97   84 
Less accumulated depreciation
  (92)  (72)  (61)
   $56  $25  $23 
 
Depreciation expense for the years ended December 31, 2011, 2010 and 2009 was $20, $11 and $15 respectively.
 
XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 66 121 1 false 12 0 false 3 false false R1.htm 000990 - Document - Document And Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://virnetx.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://virnetx.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 003000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityDeficitAndComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) false false R6.htm 003010 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityDeficitAndComprehensiveIncomeLossParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) false false R7.htm 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://virnetx.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 006010 - Disclosure - Formation and Business of the Company Sheet http://virnetx.com/role/FormationAndBusinessOfCompany Formation and Business of the Company false false R9.htm 006020 - Disclosure - Summary of Significant Accounting Policies Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R10.htm 006030 - Disclosure - Property Sheet http://virnetx.com/role/Property Property false false R11.htm 006040 - Disclosure - Commitments Sheet http://virnetx.com/role/Commitments Commitments false false R12.htm 006050 - Disclosure - Stock Plan Sheet http://virnetx.com/role/StockPlan Stock Plan false false R13.htm 006060 - Disclosure - Stock-Based Compensation Sheet http://virnetx.com/role/StockBasedCompensation Stock-Based Compensation false false R14.htm 006070 - Disclosure - Earnings Per Share Sheet http://virnetx.com/role/EarningsPerShare Earnings Per Share false false R15.htm 006080 - Disclosure - Preferred Stock Sheet http://virnetx.com/role/PreferredStock Preferred Stock false false R16.htm 006090 - Disclosure - Common Stock Sheet http://virnetx.com/role/CommonStock Common Stock false false R17.htm 006100 - Disclosure - Warrants Sheet http://virnetx.com/role/Warrants Warrants false false R18.htm 006110 - Disclosure - Employee Benefit Plan Sheet http://virnetx.com/role/EmployeeBenefitPlan Employee Benefit Plan false false R19.htm 006120 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes false false R20.htm 006130 - Disclosure - Fair Value Measurement Sheet http://virnetx.com/role/FairValueMeasurement Fair Value Measurement false false R21.htm 006140 - Disclosure - Patent Portfolio Sheet http://virnetx.com/role/PatentPortfolio Patent Portfolio false false R22.htm 006150 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation false false R23.htm 006160 - Disclosure - Quarterly Financial Information (unaudited) Sheet http://virnetx.com/role/QuarterlyFinancialInformationUnaudited Quarterly Financial Information (unaudited) false false All Reports Book All Reports Element us-gaap_CommonStockDividendsPerShareDeclared had a mix of decimals attribute values: 0 2. Element us-gaap_CommonStockParOrStatedValuePerShare had a mix of decimals attribute values: 0 2. Element us-gaap_StockholdersEquity had a mix of decimals attribute values: -3 -1. Element us-gaap_StockIssuedDuringPeriodValueNewIssues had a mix of decimals attribute values: -3 -1. Element us-gaap_StockIssuedDuringPeriodValueOther had a mix of decimals attribute values: -3 -1. Element us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised had a mix of decimals attribute values: -3 -1. Element vhc_StockIssuedDuringPeriodValueWarrantsExercised had a mix of decimals attribute values: -3 -1. Process Flow-Through: 001000 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: 001010 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 003010 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS vhc-20111231.xml vhc-20111231.xsd vhc-20111231_cal.xml vhc-20111231_def.xml vhc-20111231_lab.xml vhc-20111231_pre.xml true true XML 42 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurement
12 Months Ended
Dec. 31, 2011
Fair Value Measurement [Abstract]  
Fair Value Measurement
Note 13 - Fair Value Measurement
 
Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize observable inputs in markets other than active markets.
 
Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.
 
Certificate of deposits: Fair value measured at face value plus accrued interest.
 
Corporate bonds:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.
 
Series I Warrants: Fair value measured by using a Binomial valuation model.  As of December 31, 2011, the assumptions used to measure fair value of the liability embedded in our outstanding Series I Warrants included a warrant exercise price of $3.59 per share, a common share price of $24.97, a discount rate of 0.83%, and a volatility of 123%.
 
The following table sets forth by level, within the fair value hierarchy, our financial instrument assets as of December 31, 2011:
 
  
Level 1
   
Level 2
   
Level 3
   
Total
 
Certificates of deposit
 
$
2,584
     
-
     
-
   
$
2,584
 
                                
Corporate Bonds:
                               
AA
   
2,011
     
-
     
-
     
2,011
 
A
   
9,843
     
-
     
-
     
9,843
 
Total Corporate Bonds
   
11,854
     
-
     
-
     
11,854
 
                                
Total Investments at Fair Value
 
$
14,438
     
-
     
-
   
$
14,438
 
 
The following table sets forth, by level within the fair value hierarchy, our financial instrument liabilities as of December 31, 2011 (in thousands):
 
   
Quoted
Prices in
Active
Markets for
Identical
Assets
   
Significant
Other
Observable
Inputs
   
Significant
Unobservable
Inputs
      
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
Series l Warrants
 
$
-
   
$
-
   
$
4,699
   
$
4,699
 
Total
 
$
-
   
$
-
   
$
4,699
   
$
4,699
 
 
The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2011 (in thousands):
 
   
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level3)
 
Balance December 31, 2010
 
$
14,364
 
Net loss included in earnings
   
5,595
 
Settlements
   
(15,260
)
Balance December 31, 2011
 
$
4,699